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Foreword
In 2000, the global community took an historic step in the United Nations Millennium 
Declaration by acknowledging the importance of an effective response to HIV/
AIDS and by placing it in the context of the broader development agenda. Among 
the many health targets that were then established in the Millennium Development 
Goals (MDGs), MDG 6 calls for unprecedented action to halt and begin to reverse 
the AIDS epidemic. As the United Nations Member States implicitly recognized when 
they endorsed the Millennium Declaration, the persistent burden associated with 
communicable diseases undermines efforts to reduce poverty, prevent hunger and 
preserve human potential in the world’s most resource-limited settings. 
We are now less than two years from the deadline for the MDGs. Over the years, 
the gloom and disappointments chronicled in the early editions of the UNAIDS 
Global report on the AIDS epidemic have given way to more promising tidings, 
including historic declines in AIDS-related deaths and new HIV infections and 
the mobilisation of unprecedented financing for HIV-related activities in low- and 
middle-income countries. Yet AIDS remains an unfinished MDG, underscoring the 
need for continued and strengthened international solidarity and determination to 
address this most serious of contemporary health challenges.
When the Millennium Development Goals were established at the dawn of this 
century, a lack of critical HIV treatment and prevention tools often hindered efforts 
to respond effectively to the epidemic. As this latest Global report makes clear, today 
we have the tools we need to lay the groundwork to end the AIDS epidemic.
This report highlights continued progress towards the global vision of zero new HIV 
infections, zero discrimination and zero AIDS-related deaths. The annual number 
of new HIV infections continues to decline, with especially sharp reductions in the 
number of children newly infected with HIV. More people than ever are now receiving 
life-saving antiretroviral therapy, contributing to steady declines in the number of 
AIDS-related deaths and further buttressing efforts to prevent new infections. 
These achievements reflect the synergistic efforts of diverse stakeholders – the 
leadership and commitment of national governments, the solidarity of the 
international community, innovation by programme implementers, the historic 
advances achieved by the scientific research community and the passionate 
engagement of civil society, most notably people living with HIV themselves. As a 
result of working together, many countries are now within reach of achieving several 
of the key targets outlined in the 2011 UN Political Declaration on HIV and AIDS, 
and they are thus making clear progress towards MDG 6. 
However, this report also includes notes of caution, as well as signs of stagnating 
progress towards other targets and elimination commitments in the 2011 UN Political 
Declaration. In several countries that have experienced significant declines in new HIV 
infections, disturbing signs have emerged of increases in sexual risk behaviours among 
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young people. Stigma and discrimination remain rife in many parts of the world, and 
punitive laws continue to deter those most at risk from seeking essential HIV services. 
Although total financial resources for HIV programmes in low- and middle-income 
countries rose modestly in 2012, our ability to lay the foundation for an end to the 
AIDS epidemic continues to be undermined by a major resource gap.
These challenges are real, and they must be taken seriously if countries are to achieve 
their AIDS targets. However, the enormous progress that this report describes 
highlights the undeniable fact that the AIDS response has encountered – and 
overcome – such challenges in the past. 
As this report emerged, just over two years remain before we reach the deadline for 
targets and commitments made in the 2011 UN Political Declaration. It is my hope 
that countries will use the results summarised in this report – both the evidence of 
all that has been achieved, as well as proof of where countries are falling short – to 
redouble their determination to keep the commitments they have made. In addition 
to doing more, we also need to do better, improving the strategic focus of our work 
and enhancing the efficiency and effectiveness of our efforts. 
In endorsing the 2011 UN Political Declaration, United Nations Member States 
aimed to outline a series of targets and elimination commitments that were 
ambitious and visionary. However, these targets remain achievable – if we recognize 
our shared responsibility for the AIDS response and put into practice the many 
lessons we have learned. 
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IntroductIon
When countries gathered in New York at the beginning of this century to articulate a new 
development agenda, one of the most momentous steps they took was to elevate health on 
the global development agenda. Acknowledging the historic impact of the AIDS epidemic, 
Millennium Development Goal 6 called for global efforts to halt and begin to reverse the 
epidemic, an objective that has helped inspire unprecedented action.
Through a series of high-level meetings, the United Nations General Assembly established 
strategies, goals and targets to give life to MDG 6 and to accelerate progress towards 
achieving those objectives by 2015. At the 2011 High-Level Meeting on HIV and 
AIDS, UN Member States reviewed a decade of historic progress in the HIV response. 
Determined to build on prior gains in reducing new HIV infections and AIDS-related 
deaths, and looking forwards to the eventual end of the AIDS epidemic, they endorsed the 
2011 UN Political Declaration on HIV/AIDS, which set forth a series of ambitious targets 
and elimination commitments for 2015.
HISTORIC GAINS, CONTINUING CHALLENGES
As the 2015 deadline draws ever closer, this report summarizes progress towards the 
targets and elimination commitments established in the 2011 UN Political Declaration, 
which support achievement of MDG 6. Specifically, the report describes both gains 
and persistent challenges for 10 targets and commitments. The pledges made by 
countries in the 2011 UN Political Declaration include specific improvements in 
health outcomes (e.g. 50% reductions in both sexual and drug-related HIV and the 
transmission, elimination of new HIV infections among children); coverage and 
resource targets (e.g. reaching 15 million people with HIV treatment, mobilizing US$ 
22–24 billion for HIV programmes); elimination targets (e.g. elimination of stigma 
and discrimination, gender inequalities and restrictions on entry, stay and residence); 
and steps to ensure the sustainability of the response (e.g. integrating HIV with other 
health and development efforts).
Globally, an estimated 35.3 (32.2–38.8) million people were living with HIV in 
2012. An increase from previous years as more people are receiving the life-saving 
antiretroviral therapy. There were 2.3 (1.9–2.7) million new HIV infections globally, 
showing a 33% decline in the number of new infections from 3.4 (3.1–3.7) million in 
2001. At the same time the number of AIDS deaths is also declining with 1.6 (1.4–1.9) 
million AIDS deaths in 2012, down from 2.3 (2.1–2.6) million in 2005 (see Figure A).
As this report reveals, striking gains have been made towards many of the 2015 targets 
and elimination commitments, although significant challenges remain. 
1. Reduce sexual transmission of HIV by 50% by 2015
The annual number of new HIV infections among adults and adolescents decreased 
by 50% or more in 26 countries between 2001 and 2012. However, other countries are 
not on track to halve sexual HIV transmission, which underscores the importance 
of intensifying prevention efforts. Although trends in sexual behaviours in high-
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prevalence countries have generally been favourable over the last decade, recent 
surveys in several countries in sub-Saharan Africa have detected decreases in 
condom use and/or an increase in the number of sexual partners. Efforts to 
reduce transmission related to sex work and men who have sex with men remain 
insufficient, as evidence by recent trends in prevalence among these groups. 
However, prospects for strengthening prevention efforts have never been more 
promising, as a series of highly effective biomedical prevention tools have emerged 
in recent years to buttress the prevention benefits of behavioural and structural 
approaches. Momentum accelerated in 2012 towards the scale-up of one such 
biomedical intervention – voluntary medical male circumcision.
2. Halve the transmission of HIV among people who inject drugs by 2015
The world is not on track to reduce HIV transmission among people who inject 
drugs by 50%, as recent evidence suggests little change in the HIV burden in this 
population. HIV prevalence among people who inject drugs remains high – up to 
28% in Asia. HIV prevention coverage for people who inject drugs remains low, with 
only two of 32 reporting countries providing the recommended minimum of at least 
200 sterile syringes per year for each person who injects drugs. Among 35 countries 
providing data in 2013, all but four reached less than 10% of opiate users with 
FIGURE A  
Numbers of people living with HIV, new HIV infections, and AIDS deaths, 2001-2012, globally
Source: UNAIDS 2012 estimates.
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substitution therapy. In addition to exceptionally low coverage, an effective AIDS 
response among people who inject drugs is undermined by punitive policy frameworks 
and law enforcement practices, which discourage individuals from seeking the health 
and social services they need.
3. Eliminate HIV infections among children and reduce maternal deaths
As a result of sustained progress, the world has the potential to reach at least 90% 
of pregnant women living with HIV with antiretroviral interventions by 2015. 
Antiretroviral coverage among pregnant women living with HIV reached 62% in 2012, 
and the number of children newly infected with HIV in 2012 was 35% lower than in 
2009. However, achieving the global goal of reducing the number of children newly 
infected by 2015 will require similar scale-up of other prevention strategies, including 
primary HIV prevention for women and access to contraception and other family 
planning services. However, substantially greater efforts are needed to link pregnant 
women and children to HIV treatment and care; pregnant women living with HIV 
are less likely than treatment-eligible adults overall to receive antiretroviral therapy, 
and treatment coverage among children living with HIV in 2012 was less than half the 
coverage for adults. 
4. Reach 15 million people living with HIV with lifesaving antiretroviral 
treatment by 2015
The world is within reach of providing antiretroviral therapy to 15 million people 
by 2015. In 2012, 9.7 million people in low- and middle-income countries received 
antiretroviral therapy, representing 61% of all who were eligible under the 2010 World 
Health Organization (WHO) HIV treatment guidelines. However, under the 2013 
WHO guidelines, the HIV treatment coverage in low- and middle-income countries 
represented only 34% (32-37%) of the 28.3 million people eligible in 2013. Antiretroviral 
therapy not only prevents AIDS-related illness and death: it also has the potential to 
significantly reduce the risk of HIV transmission and the spread of tuberculosis. From 
1996 to 2012, antiretroviral therapy averted 6.3 million AIDS-related deaths worldwide, 
including 5.2 million deaths in low- and middle-income countries. But despite historic 
gains in expanding treatment services, efforts to reach universal treatment access face 
considerable challenges. In addition to persistent low treatment coverage for children, 
men are notably less likely than women worldwide to receive antiretroviral therapy, and 
key populations often experience major barriers to obtaining treatment and care services. 
Only relatively modest gains in treatment access have occurred in Eastern Europe and 
Central Asia and in North Africa and the Middle East, underscoring the need to extend 
recent coverage gains to all parts of the world.
5. Halve tuberculosis deaths among people living with HIV by 2015
As a result of sustained progress in meeting the needs of tuberculosis patients living 
with HIV, the world is within reach of achieving the 2015 target of reducing by 50% 
tuberculosis-related deaths among people living with HIV. Since 2004, tuberculosis-
related deaths among people living with HIV have declined by 36% worldwide and 
slightly less in Africa, home to 75% of all people living with tuberculosis and HIV. 
WHO estimates that the scale-up of collaborative HIV/TB activities (including HIV 
testing, antiretroviral therapy and recommended preventive measures) prevented 1.3 
million people from dying from 2005 to 2012. However, challenges persist, as progress 
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in reducing tuberculosis-related deaths among people living with HIV has slowed in 
recent years. While antiretroviral therapy reduces the risk that a person living with HIV 
will develop tuberculosis, inadequate use is currently being made of this life-saving tool; 
among the 10 reporting countries with the largest number of HIV/TB patients, only two 
(Kenya and Malawi) were delivering antiretroviral therapy in 2012 to more than 50% 
of HIV-positive TB patients, while the pace of treatment scale-up for HIV/TB patients 
has slowed. Less than half (46%) of notified tuberculosis patients were tested for HIV in 
2012, and the number of people with HIV/TB co-infection receiving isoniazid preventive 
therapy (500 000) represented a mere fraction of those who could benefit from the 
intervention.
6. Close the global AIDS resource gap
Continued gains were made in mobilizing financial resources for the AIDS response in 
2012, although AIDS expenditures remain short of the global target of US$ 22-24 billion 
in annual financial resources. In 2012, an estimated US$ 18.9 billion were available 
for HIV programmes in low- and middle-income countries – a 10% increase over 
2011. Although international HIV assistance remained flat in real terms in 2012, many 
low- and middle-income countries have increased financial outlays for HIV; domestic 
spending accounted for 53% of all HIV-related spending in 2012. Although increases in 
domestic investments have occurred among countries at all income levels, spending has 
risen most sharply among upper middle-income countries, with many lower middle-
income and low-income countries remaining heavily dependent on international 
assistance. In 2012, 51 countries looked to international sources for more than 75% of 
HIV-related spending. Whereas domestic resources account for the majority of spending 
for treatment and care, international spending financed the majority of prevention 
efforts. In an effort to promote long-term sustainability of national responses, a growing 
number of countries are exploring innovative financing methods, including dedicated tax 
levies and AIDS trust funds. 
7. Eliminate gender inequalities and gender-based abuse and violence and 
increase the capacity of women and girls to protect themselves from HIV
Gender inequalities and harmful gender norms continue to contribute to HIV-related 
vulnerability. As one manifestation of the role of gender issues in national epidemics, a 
recent review found that women who have experienced intimate partner violence are 
50% more likely to be living with HIV. Nearly all countries (92%) that conducted mid-
term reviews of their national AIDS response acknowledged the central importance of 
addressing gender inequalities. However, mid-term reviews indicate that less than half 
of countries allocate funds for women’s organizations, broadly integrate HIV and sexual 
and reproductive health services, or have scaled-up initiative to engage men and boys in 
national responses. 
8. Eliminate HIV-related stigma, discrimination, punitive laws and practices
HIV-related stigma and discrimination persist as major obstacles to an effective HIV 
response in all parts of the world, with national surveys finding that discriminatory 
treatment of people living with HIV remains common in multiple facets of life, 
including access to health care. In 2012, 61% of countries reported the existence of 
anti-discrimination laws that protect people living with HIV. The proportion of 
countries reporting the existence of HIV-related legal services increased from 45% 
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in 2008 to 55% in 2012, but the frequent lack of accessible legal services means that 
many instances of HIV-related discrimination are never addressed. As of 2013, 
63 countries have in at least one jurisdiction specific provisions that allow for the 
prosecution of HIV non-disclosure, exposure and/or transmission. Criminalisation 
of key populations also remains widespread, and 60% of countries report having laws, 
regulations or policies which present obstacles to effective HIV prevention, treatment, 
care and support for key populations and vulnerable groups.
9. Eliminate HIV-related restrictions on entry, stay and residence
Since 2010, eight countries, territories or areas have eliminated restrictions on entry, stay 
and residence for people living with HIV. However, eliminating the remaining HIV-
related restrictions on freedom of movement will require intensified action to remove 
such counterproductive and discriminatory laws that remain in force in 44 countries. 
Removing HIV-related restrictions to entry, stay and residence is a priority for both 
symbolic and practical reasons. In addition to reflecting and reinforcing the stigma and 
discrimination that impedes an effective AIDS response, such restrictions also impose 
severe hardship on many people living with HIV. Increasingly, business leaders are 
encouraging countries to repeal HIV-related travel restrictions on economic grounds, 
arguing that in a globalized world companies require flexibility to recruit and deploy 
workers where they are most needed. 
10. Strengthen HIV integration
Although a clear trend towards integration of HIV with diverse systems and sectors is 
apparent, greater efforts are needed to eliminate parallel structures and systems and to 
ensure integration of HIV in broad health and development efforts. Nearly all countries 
(90%) recognize integration as a core HIV priority, 82% address integration in their 
national strategic plans and 45% report that HIV has been aligned with other disease-
specific planning. More than half (53%) of countries have either fully integrated HIV 
and tuberculosis services or strengthened joint service provision, 70% of countries 
have integrated services to prevent mother-to-child HIV transmission in antenatal 
care, and two-thirds have integrated HIV and sexual and reproductive health services. 
Nearly one in four (23%) countries have linked HIV and management of chronic non-
communicable diseases, and more than half have integrated HIV testing and counselling 
and/or antiretroviral therapy in general outpatient care. 
GLOBAL AIDS RESPONSE PROGRESS REPORTING AND HIV 
ESTImATES
This report draws on an unprecedented body of data and analysis. It is primarily based 
on three sources: epidemiological estimates, Global AIDS Response Progress Reporting 
(GARPR) 2013 and the national mid-term reviews conducted in 2013 of progress 
towards the targets and elimination commitments for 2015 that were established in 
the 2011 UN Political Declaration. GARPR and the model-derived HIV estimates 
provide the sources for information on quantifiable progress towards the 10 targets and 
elimination commitments. Beginning this year and continuing until 2015, countries are 
now reporting annually, rather than biennially, on progress in their national response. 
The move to annual reporting reflects the urgency of intensified accountability and 
accelerated action as the 2015 deadline approaches.
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In 2013, 172 countries submitted GARPR reports on progress towards core HIV 
indicators (see Figure B). Of these 172 countries, 12 (11 from Western and Central 
Europe and one from Oceania) requested that UNAIDS use data submitted in 2012. 
As countries become accustomed to annual rather than biennial reporting, UNAIDS 
anticipates that the number of countries submitting up-to-date, annual progress reports 
will again reach the 186 that reported in 2012. 
The HIV estimates are developed by country teams using Spectrum, a standard software 
developed by the Futures Institute and supported by UNAIDS and partners. In 2013, 
Spectrum files were available for 155 countries globally.
Source: GARPR 2013.
Note: Countries reporting / total number of UN Member States in the region.
FIGURE b  
Proportion of countries that participated in the 2013 Global AIDS Response Progress Reporting 
(GARPR), by region
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mID-TERm REVIEwS Of TARGETS AND ELImINATION 
COmmITmENTS
To provide qualitative assessments of progress towards the targets and commitments in 
the 2011 UN Political Declaration and to identify priority actions in moving forward, 
UNAIDS encouraged countries to conduct mid-term progress reviews. For each of 
the 10 targets and commitments, countries were asked to specify national priorities 
and objectives, summarize achievements to date and identify gaps. With the aim of 
expediting progress in the time remaining before expiration of the 2015 targets, countries 
were requested to identify opportunities for innovation and more efficient service 
delivery. They were also asked about their plans for increasing domestic investment, 
accelerating action to respond to lags in progress and options for sustaining progress 
on the 10 targets beyond 2015. Mid-term reviews were intended to consist of a formal 
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stocktaking exercise, as well as a national consultation of stakeholders including people 
living with HIV, to review progress and chart future directions. UNAIDS asked that 
countries submit a report summarizing key findings from the mid-term review, as well as 
a matrix of responses to specific questions posed for each target.
Mid-term reviews aimed to serve four key purposes:
 • Reaffirming and strengthening leadership and commitment to achieve the targets 
and commitments in the 2011 UN Political Declaration on HIV and AIDS.
 • Strengthening accountability, ownership and transparency regarding strategic 
data on progress towards targets and commitments.
 • Improving the effectiveness and efficiency of national programmes by using the 
mid-term review as a springboard for development of national HIV investment 
cases.
 • Promoting and applying principles of shared responsibility and global solidarity 
regarding HIV responses and identifying strategies to ensure long-term 
sustainability.
One hundred and twenty low- and middle-income countries committed to conduct 
mid-term reviews of progress in relation to the 10 targets and commitments. As of 
5 August 2013, 109 countries had conducted mid-term reviews of national progress, 
representing 91% of those that had made the commitment (see Figure C). Of these 
109 countries, 100 had conducted a formal stocktaking exercise and 101 had also 
held a national stakeholders’ consultation. 
FIGURE c  
Number of countries that conducted mid-term reviews in 2013
Source: Mid-Term Reviews 2013.
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1 One country was not able to hold a mid-term review as a result of the security situation.
In four regions – sub-Saharan Africa, Central and South America, Middle East and 
North Africa, and Oceania – 100% of countries1 that committed to hold a mid-term 
review had completed the process as of August 2013. Mid-term reviews were also 
conducted by 94% of countries in South and South East Asia, and 70% in Eastern Europe 
and Central Asia. The lowest rate was reported in the Caribbean, where 54% of countries 
that had committed to hold a mid-term review had done so as of August 2013.
mOVING fORwARD: 2015 AND BEyOND
This report summarizes findings for each of the 10 targets and commitments. Each 
section takes account of GARPR results, findings from the mid-term reviews and 
other important developments that have occurred over the past year.
Each section looks both to the past and to the future. While progress as of December 
2012 is noted, with findings derived primarily from GARPR reporting and the HIV 
estimates, each section also examines what needs to happen to accelerate progress 
in each area. The forward-looking component of each section draws primarily 
from mid-term reviews, highlighting commitments that countries have made to 
expand the reach of key services, improve service efficiency and enhance domestic 
investment. 
The following analysis demonstrates that HIV continues to be a pathfinder in the 
provision of people-centred and rights-based services. As section 10 discusses, 
elements of the HIV response are being integrated with other health and 
development programmes in an effort to eliminate parallel systems and achieve 
greater effectiveness and efficiencies. Yet, for the sake of continued progress against 
the AIDS epidemic, the high priority accorded to HIV needs to be maintained 
and the effective aspects developed further and embedded into future health and 
development goals.
12  |  Reduce sexual transmission of HIV by 50% by 2015
1. reduce sexual transmIssIon 
oF HIV by 50% by 2015
Prevention efforts continue to bear fruit, with the number of new HIV infections 
among adults in low- and middle-income countries in 2012 being 1.9 million 
(1.6–2.3), which was 30% lower than in 2001 (see Figure 1.1). Declining rates of 
new HIV infections in 26 low- and middle-income countries are a testament to 
these efforts. Reductions in new infections among adults since 2001 primarily 
represent a reduction in sexual transmission, although the declining trend in the 
global number of new HIV infections among adults needs to be accelerated if the 
2015 target is to be reached. 
While challenges persist in preventing new infections, opportunities to 
dramatically lower HIV incidence have never been more promising. In recent 
years, evidence has emerged that antiretroviral therapies can reduce the risk of 
HIV transmission by as much as 96%,1 voluntary medical male circumcision by 
approximately 60%,2,3,4 pre-exposure antiretroviral prophylaxis by more than 40% 
among men who have sex with men5 and 49% among people who inject drugs.6 
Structural approaches, including cash transfers, vouchers and food and nutrition 
support, show potentially promising results as a possible strategy to reduce 
vulnerability to HIV infection faced by girls and young women. While these new 
approaches have proven effective in trials, they have not yet led to a measurable 
and sustained decline in new infections at the population level, in large measure 
due to the failure to bring these strategies to scale.
As the 2011 UN Political Declaration on HIV and AIDS confirms, HIV prevention 
must remain the cornerstone of the HIV response. To be optimally effective, 
prevention efforts should include strategic combinations of behavioural, bio-
medical and structural programming and approaches that focus on rapid scale-up in 
geographic settings and populations at greatest risk of acquiring and transmitting HIV. 
TRENDS IN SExUAL HIV TRANSmISSION
Trends in new adult infections differ among regions. The epidemic continues 
to disproportionately affect sub-Saharan Africa, home to 70% of all new HIV 
infections in 2012. 
However, since 2001, the annual number of new HIV infections among adults in sub-
Saharan Africa has declined by 34%. The most pronounced decline in new infections 
since 2001 (49%) has occurred in the Caribbean. New HIV infections have been on the 
rise in Eastern Europe and Central Asia in recent years despite declines in Ukraine. By 
contrast, new HIV infections continue to rise in the Middle East and North Africa.
Countries where new HIV infections 
declined more than 50% between 
2001 and 2012:
1. Belize
2. Botswana
3. Cambodia
4. Côte d’Ivoire
5. Djibouti
6. Dominican Republic
7. Eritrea
8. Ethiopia
9. Gabon
10. Ghana
11. India
12. Jamaica
13. Liberia
14. Malawi
15. Myanmar
16. Namibia
17. Nepal
18. Niger
19. Nigeria
20. Papua New Guinea
21. São Tomé and Príncipe
22. Senegal
23. Thailand
24. Togo
25. Ukraine
26. Zambia
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1
FIGURE 1.1  
New HIV infections among adults in low- and middle-income countries, by region, 2001–2012
Source: UNAIDS, 2012 estimates.
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Although the natural dynamics of the epidemic have undoubtedly also played an important 
role, changes in sexual behaviour, such as delayed sexual debut, high levels of condom use 
and reductions in multiple partners, are also responsible for significant declines in high-
prevalence countries. For example, in Zimbabwe, declines in HIV incidence (new infections) 
were driven by behavioural shifts, notably a reduction in multiple sexual partners.7,8
Recent trends (since 2000) in sexual behaviour, demonstrated in most countries, 
continue to indicate that more people are adopting safer sexual behaviours. Knowledge 
regarding the prevention of HIV transmission has increased amongst young people; the 
proportion of 15–24 year olds who have had sex before 15 years is decreasing; condom 
use has risen amongst people with multiple sexual partners; and the proportion of young 
people who have received an HIV test and learned their results has also increased. 
However, there are signs of an increase in risky sexual behaviours in several countries. 
Recent evidence indicates a significant increase in the number of sexual partners in some 
countries (Burkina Faso, Congo, Côte d’Ivoire, Ethiopia, Gabon, Guyana, Rwanda, South 
Africa, Uganda, the United Republic of Tanzania and Zimbabwe), as well as a decline in 
condom use (in Côte d’Ivoire, Niger, Senegal and Uganda); see Table 1.1. 
REINVIGORATING SOCIAL AND BEHAVIOUR CHANGE
Although a global meta-analysis of studies determined that ‘behavioural interventions 
reduce sexual risk behaviour and avert sexually transmitted infections and HIV’,9 many 
countries lack a comprehensive strategy for rolling out these programmatic approaches. 
Social-behavioural programmes are often implemented in isolation, uncoordinated, 
insufficiently tailored to address the needs of the intended population and lacking in 
rigorous evaluation at a scale necessary for widespread roll-out. It is clear that only when 
a comprehensive set of HIV prevention initiatives is rolled out at a national scale, with 
sufficient access to, and frequent use of, quality services, will countries realize the optimal 
prevention returns. 
There are worrisome signs that social and behavioural programming might now have 
a lower priority. Mid-term reviews identified declining support for social-behavioural 
HIV prevention programmes in several countries, including in Namibia, where the 
highly successful ‘Take control’ campaign was discontinued in 2011. However, as new 
biomedical tools are rolled out, effective social-behavioural and structural programmes 
will not only remain essential in their own right but will also be needed to maximize 
the efficacy of biomedical approaches, including averting the possible emergence of 
risk compensation. Prevention programmes must be able to address the biomedical 
aspects of HIV prevention without focusing solely on the medical aspects of sexual 
relations. It is necessary to harmonize messages and the dissemination of information 
about HIV transmission and various prevention approaches. Behavioural and 
structural programmes also help to overcome barriers to service uptake, such as social 
exclusion, criminalization, stigma and inequity. These activities amplify the impact of 
antiretroviral therapy, other antiretroviral-based HIV prevention strategies (such as 
pre-exposure prophylaxis) and voluntary medical male circumcision. 
The global revolution in information and communications technology – which has 
dramatically altered the ways in which people network, interact, communicate and share 
information – offers new opportunities to expand and reinvigorate social-behavioural 
and structural programming. These include strategic use of ‘old’ media opportunities 
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tAblE 1.1  
Knowledge, sexual behaviour and testing in countries with HIV prevalence among adults 
greater than 1%, 2000–2012*
INDICATOR 1.1 
PERCENTAGE yOUNG 
PEOPLE (15 TO 24) 
KNOwLEDGE ABOUT 
HIV PREVENTION
INDICATOR 1.2 
PERCENTAGE yOUNG 
wOmEN AND mEN 
AGED 15 TO 24 wHO 
HAVE HAD SExUAL 
INTERCOURSE BEfORE 
THE AGE Of 15
INDICATOR 1.3 
PERCENTAGE wOmEN 
AND mEN AGED 15 TO 
49 wHO HAVE HAD 
SExUAL INTERCOURSE 
wITH mORE THAN 
ONE PARTNER IN THE 
PAST 12 mONTHS
INDICATOR 1.4 
PERCENTAGE Of 
wOmEN AND mEN 
AGED 15 TO 49 wHO 
HAD mORE THAN ONE 
PARTNER IN THE PAST 
12 mONTHS wHO 
USED A CONDOm 
DURING THEIR LAST 
SExUAL INTERCOURSE
Men Women Men Women Men Women Men Women Year
Benin 2006 2011
Burkina Faso 2003 2011
Cameroon 2004 2011
Cape Verde 2005 2012
Congo 2005 2009
Côte d'Ivoire 2005 2011
Ethiopia 2005 2011
Gabon 2002 2012
Ghana 2003 2008
Guyana 2005 2009
Haiti 2000 2005
Kenya 2003 2008
Lesotho 2004 2009
Malawi 2000 2010
Mali 2001 2006
Mozambique 2003 2009
Namibia 2000 2006
Niger 2006 2012
Nigeria 2003 2008
Rwanda 2000 2010
Senegal 2005 2008
South Africa 2005 2008
Uganda 2000 2011
United Republic of Tanzania 2004 2010
Zambia 2001 2007
Zimbabwe 2005 2010
Sources: GARPR 2013; nationally representative household surveys.
*Comparison of indicators is carried out between the two most recent surveys and test of significance at 0.05.
Increasing risk behaviours, not statistically significant
Decreasing risk behaviours, not statistically significantDecreasing risk behaviours, statistically significant
Data not available or based on fewer than 50 respondents
Increasing risk behaviours, statistically significant
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(such as fictional television series that promote HIV prevention in Zambia),10 as well as 
increased leveraging of new information tools, such as strategies that integrate mobile 
telecommunications within health programmes for improved delivery of services. 
INVESTING IN CONDOm PROGRAmmING
Condom programming is an integral component of effective HIV prevention. When used 
correctly and consistently, condoms remain one of the most efficient technologies available 
to prevent sexual transmission of HIV. In South Africa, modelling indicates that increases 
in condom use, which occurred at the same time that distribution of male condoms 
significantly increased, played a primary role in the declines in national HIV incidence that 
occurred during 2000–2008.11 Condom and lubricant programming is an especially critical 
element of an evidence-based package to prevent HIV transmission especially for people 
involved in short-term sexual partnerships, serodiscordant couples, sex workers, men who 
have sex with men and other key populations including people who inject drugs and their 
sexual partners. Programmes that combine couples’ counselling with condom distribution 
have proven effective in many countries, such as Kenya12 and Zambia.13 Condom 
programming should be an integral component of behavioural approaches, especially those 
that empower women and young people to negotiate condom use. 
In light of their especially high risk of acquiring HIV, uninfected partners in 
serodiscordant couples (where one of the partners is HIV-negative) have an urgent need 
for effective HIV prevention programming. Key prevention strategies include testing (to 
enable individuals to be aware of their own and their partner’s status), condom use and 
provision of antiretroviral therapy to the partner living with HIV, regardless of their CD4 
count. Antiretroviral therapy for the HIV-negative partner is also an efficacious strategy.
Funding challenges undermine efforts to ensure ready access to both male and female 
condoms. With condom programming largely funded by international donors in many 
countries, funding uncertainties have complicated national forecasting, procurement, 
supply and distribution. In 2012, the donor community decreased their supplies of both 
male and female condoms compared to 2011. Approximately 2.4 billion male condoms 
and 31.8 million female condoms were donated in 2012 as compared to 3.4 billion male 
condoms and 43.4 million female condoms in 2011.14 Country reports confirm that 
condom access dropped in 2012; Namibia reports that funding challenges contributed 
to a decline in the number of condoms distributed in 2011–2012, while Uganda reports 
frequent periodic shortages and stock-outs of free condoms. 
A review of sex workers’ experiences of public health facilities in four countries in 
Eastern and Southern Africa identified insufficient access to condoms and lubricants 
among their unmet health needs.15 A 2012 survey in 165 countries among 5 000 men 
who have sex with men also found that they had difficulties in accessing lubricants.16 
New technological advances in condom design aim to generate products that meet the 
needs and desires of the people who are most likely to use them. PATH, an international 
health organization, is testing a new female condom in an effort to generate a more user-
friendly product, while the Origami condom is a collapsible, accordion-shaped product 
designed for use by both men and women during both vaginal and anal intercourse.17 In 
2012, the World Health Organization (WHO) prequalified a female condom produced 
by Cupid Ltd., and this product has been added to the procurement list of the United 
Nations Population Fund (UNFPA).
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PREVENTING NEw HIV INfECTIONS AmONG ADOLESCENTS 
AND yOUNG PEOPLE
Across sub-Saharan Africa, diverse countries have achieved notable reductions in 
HIV prevalence among young people (15–24 years). In sub-Saharan Africa, HIV 
prevalence among young women and men fell by 42% from 2001 to 2012. Even with 
these favourable trends, HIV prevalence among young women remains more than 
twice as high as among young men throughout sub-Saharan Africa. 
Trends are mixed among other regions, with the Caribbean experiencing substantial 
declines but with no clear downward trend apparent in the Middle East or North 
Africa (see Figure 1.2). Evidence is limited regarding HIV prevalence among young 
people who are members of key populations at higher risk (or members’ partners), 
although limited surveys and anecdotal reports suggest that their HIV risk is 
extremely high. 
FIGURE 1.2  
Prevalence of HIV among young women and men (15–24 years), by region, 2001 and 2012
Source: UNAIDS 2012 estimates.
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An estimated 2.1 million adolescents (10–19 years) were living with HIV in 2012 
in low- and middle-income countries. Data on young adolescents (10–14 years) are 
limited, resulting in little information on progress toward preventing new infections 
or averting deaths for the adolescent age group.
In sub-Saharan Africa, the percentage of young people (15–24 years) demonstrating 
comprehensive and accurate understanding of HIV rose by five percentage points for 
men and by three for women from 2002 to 2011, although knowledge levels remain 
low (36% for young men and 28% for young women). The percentage of young 
people reporting condom-use the last time they had sex also rose during this period 
for both women and men. 
Persistent challenges to effective HIV prevention for adolescents and young people 
include inadequate access to high-quality, youth-friendly HIV and sexual and 
reproductive health services, and sexual violence against young women and girls.18 
In addition, some young people are hindered in their ability to obtain essential 
services by limited protection for young people’s confidentiality and right to 
medical privacy.19 Inadequate access to comprehensive sex education, shown to be 
effective in delaying sexual debut and increasing condom use among young people 
who are sexually active,20 also undermines efforts to protect young people from 
acquiring HIV. 
New strategies have emerged to reduce young people’s vulnerability to HIV, 
including social cash transfers that create incentives for safer behaviours. Recently, 
a randomized controlled study in Lesotho found that a programme of financial 
incentives reduced the probability of acquiring HIV by 25% over two years.21 In 
a separate randomized controlled study in Malawi, cash transfers for schoolgirls 
were found to reduce new HIV infections by 60%.22 There is clear potential for cash 
transfers to support HIV prevention for young people, and continued research on the 
HIV prevention role of such programmes is recommended.23
SCALING UP VOLUNTARy mEDICAL mALE CIRCUmCISION
It is projected that circumcising 80% of all uncircumcised adult men in the countries 
with high HIV prevalence and low prevalence of male circumcision by 2015 would 
avert one in five new HIV infections by 2025, with long-term prevention benefits for 
women as well as men.24 At the same time that priority countries scale-up voluntary 
medical male circumcision for adults, they are advised to roll out the routine offer of 
medical circumcision for newborn males.
Immediately following issuance of the recommendation for scale-up in 2007, 
progress in implementing voluntary medical adult male circumcision was initially 
slow, although there are encouraging signs that the pace of uptake may be increasing. 
However, scale-up of voluntary medical adult male circumcision varies considerably 
among priority countries (see Figures 1.3, 1.4).  
As of December 2012, 3.2 million African men had been circumcised through 
specific services for voluntary medical male circumcision. The cumulative number 
of men circumcised almost doubled in 2012, rising from 1.5 million as of December 
2011. Still, it is clear that reaching the estimated target number of 20 million in 201525 
will require a dramatic acceleration. 
UNAIDS priority countries for 
voluntary medical male circumcision:
1. Botswana
2. Ethiopia
3. Central African Republic
4. Kenya
5. Lesotho
6. Malawi
7. Mozambique
8. Namibia
9. Rwanda
10. South Africa
11. South Sudan
12. Swaziland
13. Uganda
14. United Republic of Tanzania
15. Zambia
16. Zimbabwe
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Sources: GARPR 2013; WHO (2012). Progress in Scaling up Voluntary Medical Male Circumcision for HIV Prevention in East and Southern Africa, 
January–December 2012.
Notes: 
1. Implementation of voluntary male medical circumcisions (VMMCs) is done at different rates in the priority countries. 
2. At the end of December 2012 just over 3 million VMMCs were reported in these countries, which amounts to the achievement of 15% of the 
estimated number needed to reach the 80% prevalence rate overall.
FIGURE 1.3  
Annual number of voluntary medical male circumcisions, selected countries, 2009–2012
FIGURE 1.4  
Voluntary medical male circumcision: countries’ progress towards 2015 targets,  
by December 2012
Percentage of target achieved
Zimbabwe 5%
Zambia 17%
Uganda 11%
United Rep. Tanzania 24%
Swaziland 26%
South Africa 20%
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Kenya 63%
Ethiopia 57%
Botswana 18%
0% 100%
0
200 000
1 200 000
1 000 000
800 000
600 000
400 000
1 400 000
1 600 000
1 800 000
2009
N
um
b
er
 o
f m
al
e 
ci
rc
um
ci
si
on
s
2012
Zimbabwe
Malawi
Zambia
Lesotho
Uganda
Kenya
Tanzania
Ethiopia
Swaziland
Botswana
South Africa Rwanda
Namibia Mozambique
20  |  Reduce sexual transmission of HIV by 50% by 2015
Progress has been most pronounced in the provinces prioritized for scale-up in 
Ethiopia (reaching 57% of the coverage target) and Kenya (63%). In five countries 
where voluntary medical male circumcision is stated to be a priority (Lesotho, 
Malawi, Namibia, Rwanda and Zimbabwe), coverage of voluntary medical male 
circumcision for adults is less than 10%.
Twelve countries submitted national mid-term reports that identified voluntary medical 
male circumcision as a priority. Five countries (Botswana, Malawi, Namibia, the United 
Republic of Tanzania and Zimbabwe) cited low male circumcision uptake as a challenge in 
their national response. Mid-term reports identified a variety of impediments to expedited 
scale-up, including financial constraints (Namibia), stock-outs of essential circumcision 
commodities (Uganda) and human resource limitations (Zimbabwe). Swaziland’s mid-term 
report makes no mention of voluntary medical male circumcision, even though the country 
has been identified as a key priority for scale-up. Moving forward, Lesotho has committed 
to increase resources for adult and neonatal medical male circumcision; Zimbabwe aims 
to provide improved circumcision training for nurses; and Uganda has pledged to intensify 
circumcision scale-up in the formal health sector and among district health systems. 
There is evidence that programmes have had much greater success in reaching males 
younger than 25 years.26 As men in sub-Saharan Africa are at highest risk for acquiring 
HIV when they are in their twenties and thirties, men in these age groups are the 
top priority for scale-up. While voluntary medical circumcision confers a clear HIV 
prevention benefit on young men and should be continued, it has less immediate impact 
on new HIV infections than circumcision for men at greater risk. In an effort to reach 
men aged 25–29 years whose circumcisions would be more likely to result in immediate 
HIV prevention benefits, studies are currently underway to evaluate various innovative 
strategies to build demand for circumcision.
In 2013, WHO prequalified the first adult circumcision device for use in low-resource 
settings. The device, PrePex, requires no sutures or injected local anaesthetic and may be 
placed and removed by trained mid-level health providers including nurses. It is hoped that 
the device will accelerate scale-up by providing men with an alternative and by relieving 
demands on the limited number of surgeons available in priority countries.
HIV PREVENTION fOR SEx wORKERS
The epidemic continues to have a profound effect on female, male and transgender 
sex workers. Globally, female sex workers are 13.5 times more likely to be living with 
HIV than other women.27 In countries in West Africa, substantial proportions of 
new infections (10–32%) were estimated to occur as a result of sex work; in Uganda, 
Swaziland and Zambia, 7–11% of new infections are thought to be attributable to sex 
workers, their clients and clients’ regular partners.28 Median HIV prevalence among 
sex workers varies across the world, from 22% in Eastern and Southern Africa (eight 
countries) and 17% in Western and Central Africa (17 countries) to less than 5% in all 
other regions (see Figure 1.5). These surveys are typically conducted in capital cities 
and are not nationally representative, so the findings may not be applicable to the entire 
population. A separate analysis of available data found a pooled HIV prevalence among 
female sex workers of 36.9% in sub-Saharan Africa, 10.9% in Eastern Europe and 6.1% 
in Latin America.29 Median prevalence among male sex workers gleaned from published 
literature from 24 countries since 2006 is 14%. 
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Source: GARPR 2013.
*See footnote to Figure 1.5.
Source: GARPR 2013.
*Data on HIV prevention, care and treatment services for key populations can be difficult to obtain. Most countries rely on community or facility-based surveys 
to estimate programme coverage for these populations. Frequency of these surveys varies from semi-annual to every three to four years. This approach 
yields valuable data for local programmes but cannot be readily extrapolated to provide a fully accurate picture of a national situation. UNAIDS excludes 
data that derive from small (< 100) samples (unless the country is very small), other clearly biased samples (e.g. HIV testing uptake from a VCT site) or and 
data collected more than three years ago. Data where background information is not submitted is included. Further key populations are unevenly distributed 
throughout most countries and may be reluctant to participate in government-led activities depending on the local legal environment. This makes surveys of 
key populations challenging.
FIGURE 1.5  
HIV median prevalence among sex workers, by region, 2007–2012*
FIGURE 1.6  
HIV prevalence among sex workers in Africa, selected countries, 2007–2012*
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Among countries reporting data in 2013, median HIV prevalence among sex workers 
appears to have declined in recent years in parts of West and Central Africa. However, it 
is difficult to draw firm conclusions based on the limited survey data available, and HIV 
prevalence among sex workers remains extremely high in many countries. Among 62 
countries reporting data, prevalence ranged from < 1% in 14 countries to 70% (from a 
survey of 323 female sex workers) in Swaziland. In other regions, where HIV prevalence 
among sex workers is considerably lower, prevalence trends appear to be stable, although 
there are indications of a reduction in HIV prevalence since 2007 among sex workers 
in the Caribbean. Among eight countries in Eastern and Southern Africa, median HIV 
prevalence among sex workers under 25 years is 11% (range: < 1%, 64%), and 29% (range: 
< 1%, 74%) among sex workers older than 25.
Countries report that condom use at last commercial sex is high and improving; 44 
countries reported higher median condom use in 2012 than in 2009: 85% compared to 
78% (see Figure 1.7).  
Inadequate financing for HIV prevention programming focused on sex workers is a 
critical reason why HIV prevention coverage remains so low. Notwithstanding sex 
workers’ disproportionate risk of acquiring HIV, prevention programmes for sex workers 
account for a meagre share of HIV prevention funding globally.30 In most regions, 
national governments have allocated relatively few national resources to preventing HIV 
among sex workers, with international donors funding the overwhelming majority of 
HIV prevention efforts for this group (see Figure 1.8). Notable exceptions to these global 
patterns are Latin America and Southern Africa, where domestic spending on HIV 
prevention services for sex workers outweighs international contributions. 
For sex workers, as for men who have sex with men and other marginalized populations 
who have elevated risk of acquiring HIV, programmatic deficits are compounded by social 
and legal disadvantages that increase vulnerability and deter individuals from obtaining 
the services they need. These factors are addressed in greater detail in Section 8.
PREVENTING NEw HIV INfECTIONS AmONG mEN wHO HAVE 
SEx wITH mEN
Recent modes of transmission analyses found new infections among men who have sex with 
men, along with other key populations, to be important components of national epidemics 
in Kenya and South Africa. According to modes of transmission analyses in Latin America, 
men who have sex with men represent the largest source of new infections in the region, 
ranging from 33% in Dominican Republic to 56% in Peru. Median HIV prevalence among 
men who have sex with men exceeds 1% in all regions of the world and is consistently 
higher than prevalence among men overall. In 2012, according to national GARPR reports, 
the highest median HIV prevalence among men who have sex with men was reported in 
Western and Central Africa (19%) and Eastern and Southern Africa (15%), with somewhat 
lower but still high levels of HIV infection reported among men who have sex with men in 
Latin America (12%), Asia and the Pacific (11%), Western and Central Europe and North 
America (8%) and the Caribbean (7%). This information is roughly consistent with a 2012 
global analysis of available epidemiologic studies, which found that HIV prevalence among 
men who have sex with men in the Americas, South and South-East Asia and sub-Saharan 
Africa ranging from 14–18%.31 As in the case of sex workers, epidemiological surveys 
of men who have sex with men are limited and may not be nationally representative. 
Epidemiological trends among men who have sex with men vary by region. 
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Source: GARPR 2013.
*See footnote to Figure 1.5.
FIGURE 1.7  
Reported condom use at last commercial sex, by region, 2009–2012*
FIGURE 1.8  
International and domestic public spending on programmes for sex workers in low- and  
middle-income countries, by region, latest available data as of 2013
Source: GARPR 2013.
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Globally, prevalence among men who have sex with men appears to have increased 
slightly, and has been at very high levels in recent years. Reported HIV prevalence 
among men who have sex with men in 2012 ranged from < 1% in seven countries to 
57% in Guinea (survey of 242 men) (see Figure 1.9). Men who have sex with men are 
often infected while quite young, with median HIV prevalence of 5.4% for men who 
have sex with men under 25 years old, according to studies primarily in countries with 
concentrated epidemics. Median prevalence rises to over 15% among men who have sex 
with men 25 years and older in the 20 countries reporting age-disaggregated data for this 
key population.
According to surveys, men who have sex with men often have extremely limited access to 
condoms, water-based lubricants, HIV education and support for sexual risk reduction.32 
Antiretroviral-based HIV prevention methods, including HIV treatment as prevention 
and pre-exposure antiretroviral prophylaxis, offer promise in terms of improving 
HIV prevention efforts for men who have sex with men,33 although minor side-effects 
and possible long-term effects still need to be assessed. The fear of disapproval and 
discrimination by health care providers might also deter many men who have sex with 
men from accessing mainstream health services.34 Increasing the access of men who have 
sex with men to culturally sensitive HIV counselling and testing and antiretroviral therapy 
is an urgent global health priority.
The percentage of men who have sex with men reached by HIV prevention programmes, 
reported by 20 countries in both 2009 and 2012, was relatively stable at a mean of 52% and 
54%, respectively. Median coverage rose appreciably in Asia and the Pacific and in Eastern 
Europe and Central Asia (34% vs 56% and 43% vs 64%, respectively). In Latin America, 
the median was unchanged, at 51%. Median condom use at last anal sex reported from 
FIGURE 1.9 
Median prevalence of reported condom use at last anal intercourse among men who have sex 
with men, by region, 2009–2012*
Source: GARPR 2013.
*See footnote to Figure 1.5. 43 countries reporting.
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FIGURE 1.10  
HIV median prevalence among men who have sex with men, by region, 2007–2012*
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Source: GARPR 2013
*See footnote to Figure 1.5.
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FIGURE 1.11  
Percentage of men who have sex with men living with HIV in selected countries of latin America, 
2003–2012*
Source: GARPR 2013
*See footnote to Figure 1.5.
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43 countries, at 57%, did not change over the same time period (see Figure 1.10). With 
only 20 countries reporting HIV prevention coverage data for men who have sex with 
men, reported figures may not be indicative of global coverage. The limited information 
provided by countries through GARPR generates estimates of HIV prevention coverage 
for men who have sex with men that are considerably higher than other estimates, with 
one international review concluding that fewer than one in ten men who have sex with 
men receive a basic package of HIV prevention interventions.35 GARPR reporting may 
overestimate programmatic reach, as countries that have made no commitments on HIV 
prevention among men who have sex with men do not provide reports. 
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Inadequate resources impede efforts to reach men who have sex with men with 
essential HIV prevention services. International funding vastly outweighs domestic 
spending on focused prevention services for men who have sex with men globally, 
including in all regions except the Caribbean. Funding for HIV prevention services 
for men who have sex with men is especially limited in East Asia, the Middle East 
and North Africa, and across sub-Saharan Africa (see Figure 1.12). 
The effects of limited funding are compounded by a host of additional challenges, 
including the deterrent effects of homophobia on the ability or willingness of men who 
have sex with men to seek essential HIV services. Punitive laws regarding same-sex 
sexual relations, an issue addressed at greater length in Section 8, also create a climate 
of fear and intolerance that is inconsistent with a rights- and evidence-based response.
TOwARDS 2015
Political commitment and strategic action are needed to reduce the number of adults 
who acquire HIV sexually. The world is not on track to halve sexual transmission by 
2015 and that is particularly true of several high-prevalence countries. Momentum 
needs to be revived. In particular, key HIV prevention programme elements – 
including social-behavioural approaches (with financial incentives, where appropriate), 
condom and lubricant promotion, male circumcision and HIV prevention 
programmes focused on key populations, such as men who have sex with men and sex 
workers – need to be scaled up and strategically combined to maximize the impact of 
finite funding. To maximize the number of new infections averted, scale-up of these 
key elements of HIV prevention programmes need to be coupled with continued roll-
out of HIV treatment. 
FIGURE 1.12  
International and domestic public spending for programmes for men who have sex with 
men in low- and middle-income countries, by region, latest data available (2007–2012) 
Source: GARPR 2013
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There appears to be strong commitment on which to build. Among the 109 countries 
reporting results from mid-term reviews, all identified reducing sexual transmission 
as a national priority, with the target integrated into all national HIV strategic plans. 
Social-behavioural programmes need to be better coordinated and more strategically 
focused. Intensified efforts are needed to ensure that social-behavioural programmes 
are evidence-informed, rigorously evaluated, gender- and youth-sensitive and 
address key drivers of the epidemic, including concurrency among sexual partners. 
High transmission zones are heterogeneously distributed across countries, whether 
sexual transmission is primarily among heterosexual, non-commercial partners, sex 
workers and their clients or men who have sex with men. National responses should 
consider the distribution of HIV infection to focus resources on geographic and 
population zones where transmission risks are greatest. In concentrated epidemics, 
it is also important to recognize data gaps and to structure the national response to 
allow for uncovering other, as yet unrecognized, high transmission zones. Structural 
and financial empowerment approaches urgently need to be scaled up and linked 
synergistically with other HIV prevention efforts. 
All key stakeholders, including international donors and health ministries, should 
work to expand access to male and female condoms, as well as lubricants, and to 
increase their use. Steps to ensure the consistency and reliability of condom and 
lubricant supplies are critical. Specific efforts should focus on ensuring condom 
security for young people and key populations, and learning from marketing in 
other fields should be leveraged to increase the reach and effectiveness of condom 
programming. 
Priority countries where scale-up of voluntary medical male circumcision has 
been slow should take immediate action to promote and deliver this essential HIV 
prevention method, using lessons learnt from settings where rapid scale-up has 
occurred. Among priority countries generally, enhanced efforts are needed to reach 
men in their twenties and thirties, who are currently less likely to seek circumcision 
services than younger men. 
Countries need to translate recognition of HIV prevention needs among sex 
workers and their clients and partners into scaled-up evidence- and rights-based 
programmes. According to Malawi’s mid-term review, sex workers have high 
HIV prevalence, but the national prevention approach lists eight categories of key 
populations for HIV prevention including truck drivers, teachers and male vendors, 
though not people who inject drugs. Prevention programmes for people who inject 
drugs should take into account the fact that, in some countries, many people who 
inject drugs are also engaged in sex work. 
National commitments to respond to the HIV epidemic among men who have sex 
with men lag behind those for other key populations. Where data are collected, men 
who have sex with men typically share a disproportionate burden of HIV infection. 
In many countries, data on HIV prevalence among men who have sex with men do 
not exist. Countries need to undertake more concerted efforts to measure the extent 
of the epidemic among men who have sex with men while building comprehensive 
services that remove barriers to access. Stigma, discrimination and oppressive 
legal environments in many settings discourage men who have sex with men from 
seeking HIV testing and appropriate, high-quality prevention, care and treatment 
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services. National programmes should endeavour to remove legal obstacles to 
practising homosexuality, increase sensitivity to the health needs of men who have 
sex with men, improve access to health services and build programmes to intensify 
HIV preventive behaviours in this population through improved access to condoms 
and lubricants and by creating a cultural norm of safer sex. Programmes should 
also consider using STI services targeted to men as a gateway to improve HIV 
prevention, treatment and care for men who have sex with men. 
At the same time, countries should seize the HIV prevention potential of 
antiretroviral therapy by accelerating scale-up of HIV treatment and taking steps to 
implement the 2013 WHO antiretroviral guidelines (discussed in section 4). 
Major resources should be directed towards critical enablers and development 
synergies that reduce vulnerability and enhance the effectiveness, efficiency and 
reach of HIV prevention efforts. Such approaches should include legal reform, stigma 
reduction, legal services, rights literacy, sensitization of police and training of health 
care workers. Among the many populations who could benefit from critical enablers 
and development synergies, such funding is notably important for sex workers, men 
who have sex with men and other marginalized groups at high risk of HIV. 
Rapidly scaling-up voluntary medical male circumcision in the United 
Republic of Tanzania
Benefiting from strong political commitment, strategic focusing of services, 
innovative marketing strategies and implementation of recommended human 
resource strategies, the United Republic of Tanzania has recorded rapid progress in 
its quest to deliver voluntary medical male circumcision services to at least 80% of 
previously uncircumcised adult men. By circumcising 1.4 million men, it is projected 
that the United Republic of Tanzania could avert 200 000 new HIV infections by 
2025.
The circumcision campaign in the United Republic of Tanzania prioritizes scale-
up in the Iringa and Njombe regions, where HIV prevalence (estimated at 16%) is 
three times the national average. Only one in three men in these regions has been 
circumcised. Geographic information systems and other methods have been used 
to track service uptake and to identify areas where scale-up is lagging, enabling 
programme implementers to reallocate human and financial resources as needed.
The United Republic of Tanzania has had enormous success in mounting time-
limited campaigns that reach large numbers of men with circumcision services. A 
six-week campaign in Iringa in 2010 performed more than 10 000 circumcisions, 
exceeding the campaign target by 72%.36
Scale-up of voluntary medical male circumcision has been aided by implementation 
of task-shifting in service settings, reducing demands on the limited number of 
surgeons. According to the US Agency for International Development, nurses 
account for 70% of the 200 health providers working on circumcision scale-up.
Results achieved in recent years have been impressive, demonstrating the feasibility 
of rapid scale-up. As programmatic scale-up accelerated, the annual number of men 
circumcised in the United Republic of Tanzania rose from 1 033 in 2009 to 183 480 
in 2012. 
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2. HalVe tHe transmIssIon  
oF HIV among people wHo 
Inject drugs by 2015
Recent data suggest little change has occurred in the HIV burden among people who 
inject drugs. HIV incidence among this population remains high, with people who inject 
drugs accounting for more than 40% of new infections in some countries.
The prominence of injecting drug use as a driver of national HIV epidemics varies from 
country to country. In part, this is a result of substantial differences in the prevalence 
of injecting drug use around the world. As estimated by the United Nations Office on 
Drugs and Crime (UNODC), regional prevalence of injecting drug use ranges from less 
than 0.2% in sub-Saharan Africa to approximately 1.3% of adults in Eastern Europe and 
Central Asia. Globally, at least 158 countries reported injecting drug use and 120 countries 
have documented HIV among people who inject drugs.1 According to recent modes 
of transmission analysis, people who inject drugs and their sexual partners accounted 
for 68% of new HIV infections in Iran (uncertainty range = 57–78%), 40% in Eastern 
European countries where such studies were conducted, and 36% in the Philippines.2
In several parts of the world where people who inject drugs represent sizable components 
of national epidemics, countries have yet to demonstrate a robust response to this public 
health challenge. In addition to lacking strong political and programmatic commitment 
to reduce HIV transmission among people who inject drugs, these countries also lack 
relevant data. Of the top four countries representing roughly 45% of the global injecting 
drug using population,3 only China and Brazil reported this year; without data from 
Russia and the United States, it is difficult to make accurate global statements about 
people who inject drugs. Considerably greater efforts to implement evidence-based 
strategies and sound policy frameworks will be needed if the world is to achieve its goal of 
halving the number of new HIV infections among people who inject drugs.
THE EPIDEmIC’S ENDURING ImPACT ON PEOPLE wHO INjECT 
DRUGS
Although people who inject drugs account for an estimated 0.2–0.5% of the world’s 
population, they make up approximately 5–10% of all people living with HIV.4,5 All regions 
report high HIV prevalence in this population, although the severity varies. HIV prevalence 
among people who inject drugs ranged from 5% in Eastern Europe to 28% in Asia. 
Monitoring HIV prevalence among people who inject drugs is challenging. Country 
reports of prevalence data in this population often differ by year and may rely on surveys 
that use different methodologies. In addition, extrapolation from setting-specific studies 
to estimate national prevalence among people who inject drugs can be difficult. 
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Fifty-one countries reported HIV prevalence data for people who inject drugs in 2012, 
although data are often derived from local surveys that are not nationally representative. 
Taking methodological challenges into account, there appears to be little change at the 
regional level in HIV prevalence among people who inject drugs although the recent trend 
in Asia Pacific is of concern (see Figure 2.1). 
Among those countries with consistent reporting since 2009, HIV prevalence has declined 
in each. For example, in Eastern Europe and Central Asia – where HIV transmission 
related to injecting behaviour is driving many national epidemics – HIV prevalence 
among people who inject drugs appears to have fallen by more than half in Ukraine from 
2007 to 2012, though this is likely attributable to changes in survey methods. HIV case 
reports among people who inject drugs in Ukraine remained relatively stable, with 6 500 
to 7 000 per year in the same time period.6 HIV prevalence in this population appears to 
have remained stable for other countries in Eastern Europe and Central Asia (see Figure 
2.2). Median HIV prevalence among young (< 25) people who inject drugs was 3%, and 
6% among older people who inject drugs; in Asia younger people who inject drugs had 9% 
HIV prevalence and older people 19%.
In Asia, available evidence also suggests that HIV prevalence among people who inject 
drugs has fallen since 2005–2007 in several countries, including Myanmar, Nepal and 
Vietnam. In Malaysia, the Philippines and Thailand have reported increasing HIV 
prevalence among people who inject drugs, while other Asian countries appear to have 
remained stable.
Source: GARPR 2013.
*See footnote to Figure 1.5.
FIGURE 2.1  
HIV median prevalence among people who inject drugs, by region, 2007–2012*
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Source: GARPR 2013.
*See footnote to Figure 1.5.
FIGURE 2.2  
HIV prevalence among people who inject drugs in Eastern Europe, central Asia, East Asia and 
South-East Asia, selected countries, 2005–2012*
0
10
30
40
50
60
70
20
2005
Belarus Georgia Kazakhstan  Kyrgyzstan Russia Tajikistan Ukraine UzbekistanAzerbaijanArmenia
2012
%
 H
IV
-p
os
iti
ve
0
30
20
10
50
60
40
2005
China Malaysia Myanmar  Nepal Philippines Thailand VietnamBangladeshAfghanistan
2012
%
 H
IV
-p
os
iti
ve
32  |  Halve the transmission of HIV among people who inject drugs by 2015  UNAIDS 2013 Global report  |  33
2
THE STATE Of HIV PREVENTION SERVICES fOR PEOPLE wHO 
INjECT DRUGS
A package of HIV prevention, care and treatment services is recommended for the 
prevention of new HIV infections among people who inject drugs.7 Recommended 
services include access to HIV testing and counselling, sterile injecting equipment 
(through needle and syringe programmes), opioid substitution therapy, antiretroviral 
therapy and other health and social services. People who inject drugs and their sexual 
partners also need counselling, education, behavioural interventions and access to 
condoms to prevent sexual transmission. 
Coverage of HIV prevention services for people who inject drugs is quite low. Only in 
high-income countries does the annual number of syringes distributed per person who 
injects drugs approach the global recommendation of 200. Among 32 low- and middle-
income countries reporting needle distribution in 2011 and 2012, only two countries 
with a significant epidemic among people who inject drugs, Bangladesh and Malaysia, 
reported more than 200 syringes per year (see Figure 2.3). Countries in Asia, overall, 
had higher needle distribution compared to other regions, while countries in the Middle 
East and North Africa showed expansion of needle distribution per person who injects 
drugs, with gains reported in Afghanistan, Iran and Morocco. Based on available data, 
overall coverage for needle and syringe programmes did not appear to have meaningfully 
increased between 2011 and 2012. 
Data on opiate substitution therapy were reported by 35 countries (11 in Asia and 15 
in Eastern Europe and Central Asia), with over 400 000 receiving methadone. Among 
the 20 countries providing coverage estimates for opioid substitution therapy, coverage 
ranged from less than 1% of opiate users in several countries to 26% in Malaysia, with all 
but four countries reporting coverage of less than 10%. 
Despite persistent low programmatic coverage, surveys indicate that more people who 
inject drugs report having used sterile equipment the last time they injected. It is possible 
that people who inject drugs access clean needles and syringes through channels other 
than needle and syringe programmes. With the exception of Latin America, Asia and 
the Pacific, survey data indicate that at least 70% of people who inject drugs used sterile 
equipment during their most recent episode of injecting drug use. In 2012, out of 40 
reporting countries, 23 reported having reached the global target of 80% for use of sterile 
injecting equipment.
In all regions, the median proportion of people who inject drugs who report using a 
condom the last time they had sex was less than 50%. Substantially greater success in 
reaching people who inject drugs with effective sexual risk reduction strategies will 
be needed to reduce sexual transmission from people who inject drugs to their sexual 
partners.
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Source: GARPR 2013.
*See footnote to Figure 1.5.
FIGURE 2.3  
Number of syringes distributed by needle and syringe programmes, per person who injects 
drugs per year, by region, 2011–2012*
RESOURCE CHALLENGES fACING AN EffECTIVE RESPONSE 
TO HIV fOR PEOPLE wHO INjECT DRUGS
Given the severity of the challenge, HIV prevention programming for people who 
inject drugs is badly under-resourced. Only two regions – Eastern Europe and 
South and South-East Asia – have large-scale funding in place for harm reduction 
services. In these regions, as well as globally, international donors account for the 
overwhelming majority of funding for harm reduction services (see Figure 2.4). 
The degree of domestic financing for harm reduction services is closely correlated 
with national income level. Whereas domestic funding accounts for 10% of harm 
reduction funding in low-income countries, domestic sources fund 18% and 36% 
of harm reduction services in lower-middle and upper-middle income countries, 
respectively. 
Several countries have allocated a substantial share of national HIV spending to 
harm reduction services. Programmes for people who inject drugs represent 31% 
of HIV spending in Macedonia, 23% in Pakistan, 18% in Georgia and 16% in 
Bangladesh. 
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FIGURE 2.4  
International and domestic public spending for harm reduction programmes for people who 
inject drugs in low- and middle-income countries, by region, latest data available (2007–2012)
Source: GARPR 2013.
However, funding lags in a number of countries where HIV prevalence among 
people who inject drugs is high. Ten countries in which HIV prevalence among 
people who inject drugs exceeds 10% allocate less than 5% of HIV spending to 
harm reduction programmes. 
LOOKING fORwARD
Among the 109 countries that reported results from mid-term reviews, 45 
identified prevention of HIV among people who use drugs as a national priority, 
with all but one country having recognized this target in their national strategic 
plans. A majority (27, or 60%) of these 45 countries report that they are on 
track to reduce new infections among people who inject drugs by 50% by 2015 
– a conclusion that does not appear to be supported by available data on HIV 
prevalence and prevention-related indicators.
Countries that undertook mid-term reviews reported numerous impediments to 
effective HIV prevention for people who inject drugs. Even in countries where 
the national HIV epidemic is heavily concentrated among people who inject 
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drugs, there are often no reliable estimates of the size of this population. Uptake 
of voluntary HIV testing and counselling is extremely low among people who inject 
drugs, and criminalization, stigma and discrimination deter individuals from seeking 
services.
Funding for services to address the HIV-related needs of people who inject drugs is 
likely to pose a particular challenge. Several countries, such as Armenia, currently 
receive grant funding for harm reduction services from the Global Fund to Fight 
AIDS, Tuberculosis and Malaria, but such support is scheduled to expire in 2015. 
As many of the countries with epidemics driven by injecting drug use are middle-
income, other international financing sources for HIV programmes are likely to be 
quite limited. It is vital that countries recognize the public health importance of these 
programmes and step forward with new financing. 
National ownership of the HIV response for people who inject drugs is critical. 
Currently, many countries have yet to face up to the gap between current responses 
and the agreed target of halving new infections among people who inject drugs by 
2015. In Central Asia, for example, seven out of eight countries report that they are 
‘on target’ to achieve the 50% target, even though draconian policy and legislative 
obstacles, and low service coverage, prevent meaningful HIV prevention for many 
people who inject drugs in many countries in the region. 
While countries that have introduced needle and syringe programmes, opioid 
substitution therapy and other harm reduction components should be applauded, 
urgent attention is now needed to bring these services to scale. In Azerbaijan, only 
68 people are receiving opioid substitution therapy. In Georgia and Kazakhstan, the 
figures are 650 and 207 people, respectively – a tiny fraction in each country of the 
number of people who need the service. 
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FIGURE 2.5  
HIV diagnoses among people who inject with drugs and  
other populations, Mauritius, 2000–2012
1 000
900
800
700
600
500
400
300
200
100
0
2000 2012
OthersPeople who inject drugsTotal cases
Source: Mauritius National AIDS Secretariat (2013). National Strategic Framework for HIV and AIDS 
2013–2016, p. 30.
Scaling up harm reduction in mauritius
HIV transmission through injecting drug use plays a critical role in the national 
epidemic in Mauritius (see Figure 2.5). In 2011, it was estimated that 51.6% of the 
country’s 10 000 people who inject drugs were living with HIV, with a particularly 
heavy concentration in Port Louis. In 2012, a separate study determined that 
22.3% of the 9 125 sex workers in the country were living with HIV, with 40% of sex 
workers also injecting drugs. People who inject drugs account for 40% of prison 
inmates, a population with an estimated HIV prevalence in 2012 of 24.8%.
Mauritius demonstrates the potential for political will to expedite service scale-up 
and dramatically improve health outcomes for people who inject drugs. Following 
the introduction of large-scale harm reduction measures in 2006, the proportion 
of estimated HIV transmissions stemming from injecting drug use fell from 92% in 
2005 to 47% in 2012. Harm reduction coverage is much higher in Mauritius than in 
many other countries – 25% for needle and syringe programmes, 60% for opioid 
substitution therapy and 75% for antiretroviral therapy. 
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Priority countries of the Global Plan 
towards the elimination of new 
infections among children by 2015 
and keeping their mothers alive:
1. Angola 
2. Botswana 
3. Burundi 
4. Cameroon 
5. Chad 
6. Côte d’Ivoire 
7. Democratic Republic of the Congo 
8. Ethiopia 
9. Ghana 
10. India
11. Kenya 
12. Lesotho 
13. Malawi 
14. Mozambique 
15. Namibia 
16. Nigeria 
17. South Africa 
18. Swaziland 
19. Uganda 
20. United Republic of Tanzania 
21. Zambia 
22. Zimbabwe
3. elImInate HIV InFectIons  
among cHIldren and reduce  
maternal deatHs
As a result of sustained progress in scaling up services to prevent mother-to-child 
transmission, the world is within reach of key components of the push to eliminate 
new infections among children. If scale-up is continued, it is possible to provide 
services to 90% of pregnant women living with HIV by 2015 to prevent mother-
to-child transmission of HIV. If other services to end vertical transmission and 
safeguard maternal health are accelerated (see box below), it will be possible to 
reduce the number of new HIV infections among children by 90%. To keep mothers 
alive and healthy, continued progress is needed in scaling up antiretroviral therapy. 
GAINS IN SCALING UP ANTIRETROVIRAL mEDICINES fOR 
PREGNANT wOmEN
As of December 2012, over 900 000 pregnant women living with HIV globally received 
antiretroviral prophylaxis or treatment. Coverage of antiretroviral programmes for 
prevention of mother-to-child transmission (excluding the less-effective single dose 
nevirapine regimen) increased from 57% (51–64%) in 2011 to 63% (57–70%) in 2012. 
Globally, eight low- and middle-income countries – including four priority countries 
(Botswana, Ghana, Namibia and Zambia) – have already met the goal of providing 
antiretroviral medicines to 90% of pregnant women living with HIV.
ImPACT Of SCALED-UP ANTIRETROVIRAL PREVENTION 
SERVICES 
As a result of scaled-up HIV prevention services, the annual number of newly infected 
children in 2012 was 260 000 (230 000 – 320 000) in low- and middle-income countries, 
35% lower than in 2009 (see Figure 3.1). From 2001 to 2012, there was a 52% decline in 
new HIV infections among children. Expanded access to services to prevent mother-
to-child transmission prevented more than 670 000 children from acquiring HIV from 
2009 to 2012. To reach the global target of reducing by at least 90% the number of new 
infections among children by 2015 (using a 2009 baseline), programme expansion will 
need to accelerate.
Low- and middle-income countries that are now approaching the low HIV transmission 
rates among children seen in high-income countries have achieved this by providing high 
coverage of services for pregnant women living with HIV, to prevent mother-to-child 
transmission of HIV. In Ghana, for example, the risk that a woman living with HIV will 
transmit the virus to her child has declined from 31% in 2009 to 9% (7–11%) in 2012. The 
coverage of services for women living with HIV, to prevent mother-to-child transmission in 
Ghana, increased dramatically from 32% (27–38%) in 2009 to more than 90% in 2012. 
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Key elements of eliminating new HIV infections among children and 
keeping their mothers alive
The Global Plan towards the elimination of new infections among children by 2015 
and keeping their mothers alive recommends a set of priority actions under four 
key programmatic components:
1. Preventing new HIV infections among women of reproductive age.
2. Helping women living with HIV avoid unintended pregnancies.
3. Ensuring that pregnant women have access to HIV testing and counselling; and 
that those who test positive have access to antiretroviral medicines to prevent 
transmission during pregnancy, delivery or breastfeeding.
4. Providing HIV care, treatment and support for women, children living with HIV 
and their families.
The Global Plan prioritizes scale-up in 22 priority countries that collectively account 
for almost 90% of pregnant women living with HIV 
LAGS IN COVERAGE Of ANTIRETROVIRAL PREVENTION 
SERVICES fOR PREGNANT wOmEN
Among regions, there is considerable variation in the coverage of prevention services 
for pregnant women living with HIV. Coverage is highest in Eastern and Central 
Europe and the Caribbean (more than 90%), while coverage is much lower in Asia 
and the Pacific and the Middle East and North Africa (less than 20%). Among 
FIGURE 3.1  
Number of new HIV infections among children in low- and middle-income countries, 
2001–2012 and 2015 target
Source: UNAIDS 2012 estimates
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While many countries have made historic strides in expanding access to anti-
retroviral medicine for pregnant women living with HIV, progress has been much 
slower in other countries. As of December 2012, 13 countries with generalized 
epidemics – including five priority countries (Angola, Chad, Democratic Republic of 
the Congo, Ethiopia and Nigeria) – reached less than 50% of pregnant women living 
with HIV with antiretroviral medicines to prevent vertical transmission. Although 
vertical transmission prevention coverage among pregnant women living with HIV 
typically trends upwards, even in settings where sub-optimal coverage prevails, 
notable declines in coverage occurred in Lesotho (from 75% in 2011 to 57% in 2012) 
and Kenya (66% to 53%), while it stalled in Angola (17% in both years).
Breastfeeding women living with HIV are advised to use antiretroviral medicines 
when breastfeeding their newborns. In 2012, antiretroviral coverage was 
substantially lower during the breastfeeding period (49%) than during pregnancy 
and delivery (62%). It is now estimated that half of all new episodes of HIV 
transmission to children occur during the breastfeeding period when the majority 
of lactating women are not receiving the prophylaxis necessary to prevent HIV 
transmission (see Figure 3.2). 
Less than 50%
Angola
Benin
Chad
Congo
Democratic Republic of the Congo
Djibouti
Eritrea
Ethiopia
Guinea
Guinea-Bissau
Nigeria
Papua New Guinea
South Sudan
Source: UNAIDS 2012 estimates
tAblE 3.1  
coverage of antiretroviral prevention services for pregnant women living with HIV in 
generalized epidemic countries, 2012
80% and above
Botswana
Ghana
Haiti
Liberia
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Rwanda
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South Africa
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Togo
Zambia
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50–79%
Burkina Faso
Burundi
Cameroon
Côte d’Ivoire
Gabon
Kenya
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United Republic of Tanzania
the 21 sub-Saharan African countries prioritized by the Global Plan, antiretroviral 
medicines were provided during pregnancy for the prevention of new HIV infections 
among children to 65% (57–70%) of pregnant women living with HIV compared to 
62% (57–70%) in all low- and middle-income countries overall (see Table 3.1). 
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PERSISTENT GAPS IN KEy ELEmENTS Of PREVENTION Of 
mOTHER-TO-CHILD HIV TRANSmISSION
While access to antiretroviral medicines to prevent mother-to-child HIV transmission 
has increased, progress has been more modest on other programmatic aspects of the 
Global Plan, including primary HIV prevention for women. The number of women 
newly infected with HIV declined by 44% from 2009 to 2012 in Ghana, by 23% in 
Uganda and by 21% in South Africa. In other priority countries, however, the decline 
in the number of new HIV infections among women has decreased more slowly or 
even stalled, and remains at high levels. Globally, the pace of decline in new HIV 
infections among women has slowed since 2008, underscoring the need for intensified 
efforts to prevent new HIV infections among women and their sexual partners.
The unmet need for family planning services among women living with HIV 
continues to undermine efforts to eliminate new HIV infections among children. 
For women globally, unmet need for family planning declined from 15.4% in 1990 to 
12.3% in 2010, according to a recent review of nationally representative surveys.1 In 
East Africa and West Africa, however, more than 20% of women had an unmet need 
for family planning services, with no reduction in unmet need reported for 1990–
FIGURE 3.2  
Number and percentage of HIV-positive pregnant women in low- and middle-income countries 
who received antiretroviral medicine to prevent new HIV infections among children, during 
pregnancy and breastfeeding, 2012
Source: UNAIDS 2012 estimates
* The 2006 WHO guidelines proposed starting ARV prophylaxis in the third trimester of pregnancy, with a regimen of twice daily zidovudine (AZT), single-
dose nevirapine (NVP) at onset of labour, a combination of AZT+3TC during delivery and one week postpartum, as well as infant prophylaxis for one week 
after birth. The 2010 guidelines introduced options A and B, which should start earlier in pregnancy. Option A is twice-daily AZT for the mother and infant 
prophylaxis with daily NVP infant prophylaxis for one week after the end of the breastfeeding period, or either AZT or NVP for six weeks after birth if the 
infant is not breastfeeding. Option B is a three-drug prophylactic regimen for the mother taken during pregnancy and throughout the breastfeeding period, 
as well as infant prophylaxis for six weeks after birth, whether or not the infant is breastfeeding. http://www.who.int/hiv/pub/mtct/PMTCTfactsheet/en/
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2010. This means that more than one in five women in the region express the desire 
to delay or stop childbearing, but are not using contraception. In addition to reducing 
the risks of HIV acquisition among children, rights-based prevention of unintended 
pregnancies also helps improve maternal morbidity and reduces maternal deaths.
TREATmENT COVERAGE DEfICITS fOR PREGNANT wOmEN
Among pregnant women who needed antiretroviral therapy for their own health in 
2012, 58% received HIV treatment – lower than the 65% (61–70%) treatment coverage 
for adults overall. In ten priority countries in 2012, fewer than half of pregnant women 
living with HIV and with CD4 counts equal to or lower than 350 cells per microlitre (the 
threshold for HIV treatment initiation under the earlier 2010 World Health Organization 
(WHO) antiretroviral treatment guidelines) received antiretroviral therapy for their 
own health. However, the gap between pregnant women and all adults is declining as 
new guidelines are being rolled out on the importance of starting pregnant women on 
antiretroviral therapy. 
To spur accelerated HIV treatment scale-up, Malawi has begun systematically offering 
lifelong antiretroviral therapy to pregnant women living with HIV (Option B+), leading 
to a 7.5-fold increase in the number of such women receiving therapy over a 15-month 
period in 2011–2012.2 In 2013, WHO issued new consolidated guidelines for use of 
antiretroviral medicines for HIV treatment and prevention, recommending initiation of 
lifelong antiretroviral therapy for all pregnant and breastfeeding women living with HIV, 
regardless of their CD4 count.
National empirical data on maternal mortality are rare as the result of various monitoring 
challenges, including the frequent lack of complete civil registration systems and the 
lack of reliable attribution of death in the civil registration systems that do exist. Most 
countries continue to rely on modelling to estimate maternal mortality and UNAIDS 
is working with partners to improve estimates of excess pregnancy-related mortality 
associated with HIV. However, current data suggest that, in high-prevalence countries, 
HIV contributes significantly to pregnancy-related mortality, and points at the urgent 
need to ensure that eligible women living with HIV receive complete treatment, and 
that HIV treatment services be integrated into sexual and reproductive health services. 
Recent research demonstrates that provision of antiretroviral therapy would avert much 
of the maternal mortality in countries with a heavy HIV burden.3
TREATmENT COVERAGE DEfICITS fOR CHILDREN
Children living with HIV continue to experience persistent treatment gaps. In 2012, 647 
000 children under 15 years of age were receiving antiretroviral treatment. HIV treatment 
coverage for children (34% (31-39%)) remained half of coverage for adults (65% (61–70%)) 
in 2012. Although the number of children receiving antiretroviral therapy in 2012 increased 
by 14% in comparison to 2011, the pace of scale-up was substantially slower than for adults 
(a 21% increase). In priority countries, only three in 10 children receive HIV treatment.
The failure to expand access in many settings to early infant diagnosis is an important 
reason explaining why HIV treatment coverage remains much lower for children than 
for adults. In five priority countries, coverage of less than 5% was reported for early infant 
diagnostic services in 2012. 
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ImPROVING PROGRAmmATIC PERfORmANCE AND RESULTS
Since services to prevent mother-to-child transmission were launched, programme 
managers have struggled to find effective strategies to minimize the number of 
pregnant women who drop out of services at some point during the process. Until 
recently, receipt of antiretroviral medicines to prevent HIV transmission has 
tended to be the final service outcome that has been routinely monitored. Although 
programmatic aspirations today extend further, with the aim of ensuring HIV-
free child survival, monitoring systems have not always kept pace. Key aspects of 
the service cascade for prevention of mother-to-child transmission, each of which 
requires rigorous data collection and analysis, include attendance at antenatal clinics, 
receipt of HIV test results, receipt of antiretroviral medicines during pregnancy and 
delivery, receipt of antiretroviral medicines during breastfeeding, infant feeding 
counselling and support, early diagnosis of HIV-exposed newborns, linking HIV-
positive newborns to care, and survival for children living with HIV. 
Improving both short- and long-term health outcomes for pregnant women living 
with HIV and their children requires the implementation of systems and protocols 
for the routine collection, analysis and strategic use of data across the breadth of the 
service cascade for prevention of mother-to-child transmission. Using such a data-
driven approach, countries such as Malawi have gained an increased understanding 
of the impact of the service cascade and used these findings to inform programme 
development and implementation. 
LOOKING TOwARDS 2015
Among 109 countries reporting results in the mid-term reviews, all but two 
identified elimination of new HIV infections among children and substantially 
reducing AIDS-related maternal deaths as a national priority. In all countries 
recognizing this target as a national priority, it has been integrated into national 
strategic plans. Although most mid-term reviews in all 22 Global Plan priority 
countries concluded that these countries are on track to reach the 2015 elimination 
target, the 2013 Global Plan progress report suggests that only about half of 
priority countries are on track to achieve the 2015 target. The report concluded that 
improving the situation would require a number of steps, including: reducing the 
number of women acquiring HIV infection, reducing the unmet need for family 
planning, increasing access to safe and noncoercive HIV testing, improving the 
availability of antiretroviral medicines for pregnant women living with HIV and 
improving the diagnosis and treatment of HIV among children.4
An updated analysis of what it will take to reach a 90% reduction in new child 
infections between 2009 and 2015 shows that, given the achievements by 2012 in 
the 21 sub-Saharan African Global Plan priority countries, significant effort and 
innovation will be needed to reach the target. If 90% of HIV positive pregnant 
women received combined ARV (50% started during the pregnancy and 40% 
started ART before the pregnancy) and 100% of those women received prophylaxis 
during breastfeeding HIV incidence was reduced by 50% among reproductive age 
women, and women living with HIV were able to meet their family planning needs 
the reduction in new child infections would still only reach an 83% reduction from 
2009 levels in 2015. Additional efforts to reduce unmet need for family planning 
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among women living with HIV and to reaching higher levels of ARV coverage will allow 
countries to reach the goal of eliminating new child infections (see Figure 3.3). 
National mid-term reviews noted several challenges to reaching the target of eliminating 
new HIV infections among children and substantially improving health outcomes for 
pregnant women living with HIV. These include operational issues (e.g. women’s lack 
Reduce incidence by 50%2012 coverage maintained ARV coverage scaled up to 90% Eliminate unmet need for family 
planning 
FIGURE 3.3  
Projected impact on new child HIV infections by programmes to prevent mother to child 
transmission, 21 Global Plan priority countries in sub-Saharan Africa, 2009–2015
Source: UNAIDS analysis 2013, data from 2013–2015 are projections
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of awareness of services, loss of mother-baby pairs across the service cascade, insufficient 
male involvement, failure to identify many children exposed to HIV, stock-outs of key 
commodities, difficulties in implementing recommended policy changes for infant 
feeding, shortages of essential human and financial resources, and insufficient integration 
and decentralization of services), issues of programmatic reach (e.g. late diagnosis of many 
pregnant women, inadequate access to safe delivery and post-delivery follow-up, a high 
proportion of home deliveries in many countries) and policy issues (e.g. deterrent effects of 
stigma and discrimination). The Global Plan provides a framework to enable countries to 
critically examine existing barriers and improve service delivery and health outcomes for 
mothers living with HIV and their children. 
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Cambodia’s Boosted Linked Response
In 2008, Cambodia introduced the Linked Response initiative to reach all pregnant 
women by developing and utilizing linkages between existing HIV/STI and sexual 
and reproductive health services and mobilizing existing community‐based entities. 
Building on the success of this initiative, in 2013 Cambodia launched the Boosted 
Linked Response strategy to accelerate uptake of services to prevent mother-to-child 
transmission, reduce loss across the HIV prevention cascade, improve service quality and 
health outcomes for women living with HIV and their children and reduce deaths among 
mothers living with HIV and HIV-exposed children. The overarching goal of the Boosted 
Linked Response is to achieve the virtual elimination of new HIV infections among 
children, lowering the mother-to-child transmission rate to less than 5% in 2015 and to 
less than 2% by 2020. The Boosted Linked Response also seeks to reduce the incidence 
of congenital syphilis to 0.5 cases per 1 000 live births. 
The Boosted Linked Response calls for focused programmatic action5 to:
 • Increase access to antenatal care for pregnant women.
 • Increase coverage of HIV and syphilis testing for pregnant women.
 • Improve early service uptake and retention of pregnant women infected with HIV 
and/or syphilis throughout the prevention cascade.
 • Improve the health, dignity and access to prevention of women living with HIV or at 
high risk of acquiring HIV.
 • Reduce loss to follow-up among HIV-exposed infants to optimize antiretroviral 
prophylaxis and ensure early infant diagnosis through HIV DNA-PCR testing.
 • Ensure rapid enrolment of infants living with HIV in paediatric HIV care.
During mid-term reviews, countries recognized the need to take action to speed scale-up 
and address programmatic shortcomings. Key actions include focused training and capacity 
building support for health care workers, further integration and decentralization of services, 
expanded access to early infant diagnosis, implementation of task shifting and other measures 
to address human resource challenges, and investment in programming to generate greater 
demand for services. Countries also cited the need to strengthen procurement and supply 
management systems, enhance community engagement, broaden efforts to promote the 
realization of women’s human rights, and increase the investment of national governments in 
services to prevent mother-to-child transmission and in broader services for maternal and child 
health. A number of countries in sub-Saharan Africa reported planning to offer Option B+, for 
lifelong antiretroviral therapy to all pregnant women living with HIV.
While attention to date has primarily focused on scaling up HIV testing and counselling and 
antiretroviral prophylaxis in antenatal settings, countries cited an urgent need to improve 
results relating to other key aspects of the Global Plan. In particular, countries emphasized the 
importance of primary HIV prevention, reducing unmet need for family planning among 
women living with HIV and reaching HIV-positive breastfeeding women with prevention 
services. Modelling commissioned by UNAIDS indicates that integrating the continued scale-
up of antiretroviral prophylaxis with strengthened primary prevention, achievement of high 
prevention coverage for breastfeeding women and elimination of the unmet need for family 
planning services would increase the likelihood of achieving the 2015 target compared to an 
approach that does not include these gains. 
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4. reacH 15 mIllIon people 
lIVIng wItH HIV wItH 
lIFesaVIng antIretroVIral 
treatment by 2015
Sustained progress in scaling up access to HIV treatment has put within reach the goal of 
providing antiretroviral therapy to 15 million people by 2015. However, access to treatment 
varies considerably within and between countries and regions, with especially poor coverage 
for children. 
Antiretroviral therapy can help to prevent people living with HIV from dying from AIDS and 
from developing tuberculosis, becoming ill and transmitting tuberculosis and HIV. Emerging 
science indicates that people should start HIV treatment earlier to realize these benefits. The 
new HIV treatment guidelines provided by the World Health Organization (WHO), issued 
in June 2013, recommend starting treatment when an individual’s CD4 count falls below 
500 cells/μL  and immediately for pregnant women, HIV-positive partners in serodiscordant 
couples, children younger than five and people with HIV-associated tuberculosis and 
Hepatitis B. The 2013 WHO guidelines on HIV treatment will require substantially faster 
scale-up, coupled with innovation and programmatic adaptation, to ensure that those who 
are eligible for HIV treatment receive it. 
In July 2013, UNAIDS joined with WHO, the US President’s Emergency Plan For AIDS 
Relief (PEPFAR), the Global Fund to Fight AIDS, tuberculosis and Malaria and other 
partners to launch the Treatment 2015 initiative, which aims to ensure that the world reaches 
its 2015 HIV treatment target as a critical stepping-stone towards universal treatment access. 
Treatment 2015 emphasizes speed in scaling up, enhanced strategic focus to intensify scale-up 
in key geographic areas and populations, and innovation in programme planning and service 
delivery.
CONTINUED PROGRESS IN 2012
As of December 2012, an estimated 9.7 million people in low- and middle-income countries 
were receiving antiretroviral therapy, an increase of 1.6 million over 2011. That brings the 
world nearly two-thirds of the way towards the 2015 target of 15 million people accessing 
antiretroviral treatment. Under the 2010 WHO guidelines,  61% (57–66%) of all persons 
eligible for HIV treatment in low- and middle-income countries had obtained antiretroviral 
therapy in 2012 (see Figure 4.1). Taking into account the 875 000 people receiving 
antiretroviral therapy in high-income countries, a total of 10.6 million people were receiving 
antiretroviral therapy as of December 2012. However, under the 2013 WHO guidelines, 
Countries where 90% of the 
people with an unmet need for 
antiretroviral treatment live:
1. Angola
2. Brazil
3. China
4. Cameroon
5. Central African Republic
6. Chad
7. Colombia
8. Côte d’Ivoire
9. Democratic Republic of the Congo
10. Ethiopia
11. Ghana
12. India
13. Indonesia
14. Kenya
15. Lesotho
16. Malawi
17. Mozambique
18. Myanmar
19. Nigeria
20. Russian Federation
21. South Africa
22. South Sudan
23. Thailand
24. Togo
25. Uganda
26. Ukraine
27. United Republic of Tanzania
28. Viet Nam
29. Zambia 
30. Zimbabwe
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the 9.7 million people receiving antiretroviral therapy in low- and middle-income countries 
represents only 34% (32-37%) of the 28.3 million people eligible in 2013. 
It is increasingly clear that everyone infected with HIV will eventually need treatment. With 
an estimated 35.3 (32.2–38.8) million people now living with HIV, this represents a significant 
need to scale up HIV testing and treatment, while continuing to invest in prevention and 
other programmes to combat new HIV infections. 
Globally, the number of people receiving antiretroviral treatment has tripled over the last five 
years. Since 2005, sharp increases in the number of people receiving antiretroviral treatment 
have occurred in all regions of the world, with the exception of Eastern Europe, Central Asia, 
the Middle East and North Africa.
National mid-term reviews highlighted several approaches that have proven effective in 
spurring accelerated HIV treatment scale-up. Bringing services closer to people living with 
HIV through decentralization has improved treatment uptake. Establishment and updating 
of clinical protocols have enhanced the quality of care and strengthened HIV treatment 
capacity. In the face of limited human resources for health, many countries have successfully 
implemented task shifting in clinical settings, with nurses administering antiretroviral 
therapy. Efforts to maximize existing human resources for health need to be combined 
with intensified efforts to train and deploy new physicians, nurses, community health 
workers and other health personnel.
PERSISTENT DEfICITS IN COVERAGE
Although progress in scaling up HIV treatment is genuine, health gains from antiretroviral 
therapy are unevenly shared as a result of substantial variations in treatment access.
Source: UNAIDS 2012 estimates.
FIGURE 4.1  
Percentage of people eligible who are receiving antiretroviral therapy (based on 2010 wHo 
guidelines) in low- and middle-income countries, by region, 2009–2012
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As Section 3 explained, HIV treatment coverage for children is a little more than half that of 
adults. In nine of the 22 countries prioritized by the Global Plan in relation to the elimination 
of new infections among children by 2015 and efforts to keep their mothers alive, 25% or less 
of treatment-eligible children received antiretroviral therapy in 2012.
In most regions, including sub-Saharan Africa, HIV treatment coverage for men is lower 
than coverage among women. In low and middle income countries, 57% of treatment-
eligible men received antiretroviral therapy in 2012, compared to 73% of treatment-eligible 
women. 
Key populations also experience unique barriers to HIV treatment, often as the result of fears 
that they will experience discrimination if they seek services in mainstream health settings. 
Although reliable HIV treatment coverage estimates are not available for men who have sex 
with men, people who inject drugs, sex workers or transgender individuals, previous reports 
indicate that these populations face substantial barriers to essential health services and 
experience extremely low HIV treatment coverage. A lack of clear commitments to scale-
up coverage for many key populations has contributed to the neglect of their needs in the 
establishment and expansion of HIV treatment services.
People affected by humanitarian crises confront unique barriers to health care access, 
including concerns regarding confidentiality, denial of access to asylum procedures, fears 
regarding refoulement and restrictions on freedom of movement. Globally, there were an 
estimated 45.2 million refugees in 2012, including 26.4 million internally displaced persons.1 
Adolescents (10–19 years) are the only age group in which AIDS deaths have risen between 
2001 and 2012. This trend in AIDS deaths is a result of poor prioritization of adolescents in 
strategic plans for scale-up of HIV treatment and lack of testing and counselling.
ImPACT Of SCALED-UP ANTIRETROVIRAL THERAPy
By reducing the virus circulating within a setting or population, scaled-up antiretroviral 
therapy helps reduce the number of new HIV infections. From 1995 to 2012, antiretroviral 
therapy averted 6.6 million AIDS-related deaths worldwide, including 5.4 million deaths in 
low- and middle-income countries (see Figure 4.2). 
Where antiretroviral therapy has been scaled up, clear health gains have resulted. In 2011, 
life expectancy in the KwaZulu-Natal province of South Africa was 11.3 years higher than in 
2003, when HIV treatment scale-up began.2 
Investment in antiretroviral therapy is cost-effective and may also result in cost savings. 
Recent economic analysis found that investment in HIV treatment services generates 
economic returns up to three times greater as a result of increased employment and 
productivity and averted or deferred future expenses for medical services and care of 
orphans.3 
Declines in the annual number of AIDS-related deaths illustrate the powerful health benefits 
of scaled-up antiretroviral treatment. From a high of 2.3 (2.1–2.6) million in 2005, the annual 
number of AIDS-related deaths fell to 1.6 (1.4–1.9) million in 2012. Despite the slow increase 
in antiretroviral treatment coverage among children aged 0–14 years, AIDS-related deaths 
among children have declined more quickly due to the impact of efforts to prevent mother-
to-child transmission. In 2012, 210 000 (190 000 – 250 000) children died of AIDS-related 
causes, compared to 320 000 (290 000 – 360 000) in 2005. 
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Scaled-up antiretroviral therapy has the potential to dramatically alter the trajectory of 
national epidemics, lowering viral loads within communities and thereby slowing the spread 
of HIV. Further scale-up will be required to maximize the impact of HIV treatment and help 
create a foundation for ending the AIDS epidemic. A recent analysis by Futures Institute 
estimates that achieving 80% of the HIV treatment coverage recommended by the 2013 
antiretroviral guidelines would lower the annual number of adults acquiring HIV from 2.4 
million in 2011 to 800 000 in 2025 (compared to the 1.25 million suggested by the 2010 
guidelines).4
FIGURE 4.2
Estimated number of AIDS-related deaths, with and without antiretroviral therapy, in 
low- and middle-income countries, and by region, 1995–2012
Source: UNAIDS 2012 estimates.
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CLOSING GAPS IN THE HIV TREATmENT CASCADE TO mAxImIZE 
ITS PUBLIC HEALTH ImPACT 
Over the years, the goal of antiretroviral treatment has expanded to include not only 
prevention of AIDS-related morbidity and mortality but also prevention of HIV 
transmission. The public health and clinical goal is to ensure that everyone living with HIV 
knows their status, accesses care and treatment, and achieves sustained viral suppression. 
However, despite the ongoing scale-up of antiretroviral therapy, HIV transmission and 
AIDS-related mortality remain high in many parts of the world. In the quest to optimize 
HIV treatment, the HIV treatment cascade has emerged as an important tool that 
graphically illustrates key transitions in the HIV treatment continuum and how each of these 
steps affects the ultimate aim of ensuring viral suppression. 
To achieve viral suppression, an individual must be diagnosed with HIV, linked to care, remain 
engaged in care and receive antiretroviral therapy where medically indicated. Although the 
number of people receiving antiretroviral therapy continues to rise in sub-Saharan Africa, 
helping lower rates of HIV-related illness and death, the region has yet to experience the full 
potential benefit of HIV treatment. In sub-Saharan Africa, it is estimated that approximately 
three-quarters of adults living with HIV have not achieved viral suppression as a result of gaps/
shortfalls at each stage of the treatment cascade (see Figure 4.3).
FIGURE 4.3  
Abbreviated HIV treatment cascade for sub-Saharan Africa, 2012
Sources:  
1. UNAIDS 2012 estimates.   
2. Demographic and Health Surveys, 2007–2011 (www.measuredhs.com) and one community based survey in South Africa (Kranzer, K., van Schaik, N., et al. 
(2011). High prevalence of self-reported undiagnosed HIV despite high coverage of HIV testing: a cross-sectional population based sero-survey in South Africa. 
PLoS ONE 6(9): e25244.) 51% is the mid-point between the low and high bounds. The low bound (39%) is the percentage of people living with HIV who are 
very likely to know their status – they tested positive in the survey and report receiving the results of an HIV test in the previous twelve months. The high bound 
(64%) is calculated as the percentage who tested positive in the survey and who self-report ever being tested for HIV (the test conducted in the survey is not 
disclosed to the recipients). Those persons who report never having been tested for HIV do not know their HIV status and make up the remaining 36%.  
3. GARPR 2012.  
4. Barth R E, van der Loeff MR, et al. (2010). “Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic 
review.” Lancet Infect Disease 10(3): 155-166.
Notes: No systematic data are available for the proportion of people living with HIV who are linked to care, although this is a vital step to ensuring viral 
suppression in the community. 
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A major impediment to the goal of zero AIDS-related deaths and of achieving 
widespread viral suppression among people living with HIV occurs at the beginning 
of the HIV treatment cascade. Notwithstanding that HIV testing has been 
significantly scaled up in sub-Saharan Africa in the past decade, according to 15 
household surveys conducted between 2007 and 2011 in sub-Saharan Africa, an 
estimated 36% of people in the region have never been tested for HIV. While the 
estimated 39% of people in sub-Saharan Africa tested within the last year are likely to 
know their HIV status, the additional 25% of people who were tested in earlier years 
may not have knowledge of their current HIV status (see Figure 4.4). In geographic 
settings and populations with high HIV prevalence and incidence, annual HIV 
testing is recommended among HIV-negative persons.
FIGURE 4.4  
Knowledge of HIV status among men and women living with HIV, selected countries,  
2010–2011
Source: Demographic and Health Surveys 2010–11
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Due to lack of access to testing, one in four people who initiate antiretroviral therapy 
in low- and middle-income countries have CD4 counts under 100, reflecting late 
diagnosis and, therefore, a high risk of HIV-related illness and death.5 
In all regions, women are more likely to have been tested than men, most likely due 
to the implementation of the routine offer of HIV testing in antenatal settings. While 
the number of HIV tests performed in 76 countries submitting relevant data in their 
Global AIDS Progress Reports rose by nearly 12% in 2012, substantially greater gains 
in HIV testing uptake will be needed to increase the proportion of people living with 
HIV who have access to treatment.
Until recently, stand-alone voluntary counselling and testing clinics were the principal 
testing modality in many countries. In 2004, UNAIDS amplified its testing guidance to 
support provider-initiated offers of HIV testing and detailed WHO/UNAIDS guidance 
on provider-initiated testing was issued in 2007. Some country studies suggest that 
provider-initiated counselling and testing has increased HIV testing coverage.6 In recent 
years, door-to-door home-based testing has been demonstrated to increase the reach 
of HIV testing services in sub-Saharan Africa.7,8 Using rapid diagnostic tests delivers 
an initial HIV test result in less than 30 minutes, potentially accelerating an individual’s 
receipt of the information, services and support systems they need. Such tests have 
provided some promising results in hard-to-reach populations.
Limitations of these approaches have been noted, including the under-use of stand-
alone and facility-based voluntary counselling and testing, low rates of client-initiated 
testing among key populations,9 high costs and anonymity concerns associated with 
door-to-door campaigns, and lack of access by men, rural populations and the poor.10 
Recognizing the need to increase knowledge of HIV status and to encourage earlier 
diagnosis of infection, many countries are using partner/couples testing and other 
innovative testing approaches. 
In addition to their suitability for facility-based and community settings, rapid diagnostic 
tests may be used by an individual to test themselves in the privacy of their own home. 
In 2012, an HIV oral fluid rapid diagnostic test was approved by the United States Food 
and Drug Administration (US FDA) and made available for over-the-counter purchase 
in the United States. Oral fluid rapid diagnostic tests have been prequalified by WHO 
since 2004, but they remain relatively expensive. With the anonymity offered by self-
testing and the high acceptability found in pilot exercises in both concentrated and 
generalized epidemic settings, the approach offers potential for rethinking conventional 
approaches and assumptions about testing. The impact of self-testing on linkage to care 
is under investigation in a number of studies. Preliminary results from a major cluster-
randomized trial in Malawi found that, in the initial follow-up period (four months), 
HIV treatment uptake in communities with self-testing alone was no better than the 
control condition, but uptake more than doubled when self-testing was accompanied by 
assisted home initiation of antiretroviral therapy. 
Ensuring that people living with HIV are diagnosed earlier requires scale-up of both 
clinical and community-based HIV testing. Brazil, Kenya, Malawi, South Africa, 
Uganda, the United Republic of Tanzania and Zambia have integrated the promotion 
of HIV testing in community campaigns that provide screening or prevention services 
for multiple diseases (e.g. distribution of long-lasting insecticide treatment bed 
nets, safe water filters, diabetes, hepatitis and/or screening for sexually-transmitted 
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infections). Grass-roots community organizations played a pivotal role in increasing 
testing uptake in Zimbabwe in the mid-2000s.11 Project Accept (HPTN 043), a large 
randomized community trial, found that community engagement, mobile testing 
and post-test services resulted in higher uptake of testing than standard clinic-based 
voluntary counselling and testing. A systematic review and meta-analysis of evidence for 
community-based HIV testing and counselling showed that community-based testing 
achieved high rates of uptake, reached people living with HIV with high CD4 counts, 
and linked individuals into care.12
Little systematic data exist on the proportion of people living with HIV who are linked 
to care.13 Once linked to care there are mixed findings regarding retention in care. 
According to data from 18 countries, retention in HIV care declines over time, with 
12- and 60-month retention rates of 86% and 72%, respectively. There is considerable 
variation in reported retention rates among countries. Food support has been shown to 
support HIV treatment success, including adherence and retention in care.14 
Recent cascade analyses in Brazil, China, Malawi and Viet Nam confirm that many 
individuals are lost at various stages of the HIV treatment continuum, reducing 
the proportion of people living with HIV who achieve viral suppression and other 
treatment benefits.15 Such analyses can help national planners and programme 
implementers in devising focused interventions to improve programme outcomes. 
These exercises also provide useful guidance for planning and implementing studies 
to identify risk factors for non-retention and evaluate interventions to reduce patient 
loss during the HIV treatment process. Community groups and caregivers can play 
an important role in treatment adherence. Efforts to monitor results across the 
HIV treatment cascade should use the total population of people living with HIV, 
diagnosed and undiagnosed, as the denominator for analysis. 
Improving retention through community engagement
Catholic Relief Services, a member organization of Caritas Internationalis, has 
worked with a consortium of partners to implement AIDSRelief, an HIV care and 
treatment program that was funded by the US President’s Emergency Plan for 
AIDS Relief (PEPFAR) since 2004.  The AIDSRelief programme supported the rapid 
scale-up of HIV care and treatment services for poor and underserved people in 
10 countries across Africa, the Caribbean, and Latin America. The programme 
worked mainly with faith-based local partners including hospitals, clinics, 
dispensaries, and local community groups, including people living with HIV.
AIDSRelief developed an approach that enabled strong adherence to treatment, 
by using family and community engagement, optimal drug selection, use of 
longitudinal medical records and the provision of qualified medical, laboratory, 
community and pharmacy support. AIDSRelief understood how to treat each 
patient for the best individual outcomes and how to scale that model to treat 
tens of thousands without compromising quality or capping patient enrolment. 
Catholic Relief Services and its partners deliberately strengthened local capacities 
and later transitioned the AIDSRelief program to local ownership. By the end of 
the AIDSRelief programme in February 2013, it had enrolled more than 700 000 
patients in care including 395 000 patients on antiretroviral therapy, with 10.6% 
loss to follow-up, an 85% retention rate, 7.8% mortality rate and 88.2% viral 
suppression.
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Continuity of care is particularly challenging for people living with HIV who are 
affected by humanitarian crises. A 2013 mapping exercise conducted by UNHCR 
concluded that many people receiving antiretroviral therapy in the Central African 
Republic were forced to flee as a result of conflict, leading to the discontinuation of 
HIV treatment for thousands as a result of the lack of functional health services in 
the remote settings to which they migrated.
As an adjunct to the cascade, countries may find it useful to estimate the proportion of 
the total adult population that has unsuppressed HIV. In countries with very low HIV 
treatment coverage, this will be roughly the same as adult HIV prevalence. However, 
as countries scale up HIV treatment, the proportion with an unsuppressed virus load 
will decline, reflecting a safer population-level environment with fewer opportunities 
for transmission. As HIV prevalence is projected to increase as people live longer as a 
result of HIV treatment, the percentage of people with an unsuppressed virus load may 
become a more useful indicator of the potential for transmission of HIV.
ENHANCING THE DURABILITy AND EffICIENCy Of HIV 
TREATmENT
HIV treatment is life-long and, in most cases, should lead to a near-normal life span. 
Towards this end, optimal durability of treatment regimens is needed to delay the 
emergence of drug resistance, which reflects treatment failure and signals the need to 
switch regimens. Earlier assessments had suggested that 6% of all individuals receiving 
first-line therapy in sub-Saharan Africa needed to switch to second-line regimens in any 
given year. Despite the shortfalls seen in the HIV treatment cascade, strong results are 
achievable. Recently, Rwanda reported that 86% of people starting antiretroviral therapy 
were virally suppressed 18 months later, while Senegal reported that 80% of people 
receiving antiretroviral therapy had viral suppression after five years.16 
With the aim of increasing HIV treatment durability, simplifying procurement, saving 
costs, minimizing side effects and enhancing treatment adherence, the 2013 WHO 
antiretroviral guidelines recommend that eligible patients receive a simplified, daily, 
single-pill regimen where possible. WHO recommends that patients currently receiving 
more complicated regimens be switched to the simpler regimen and that particular 
efforts focus on transitioning patients off regimens that contain d4T (stavudine), which 
has been associated with sometimes-severe side effects. In 2012, Viet Nam’s use of daily, 
single-pill regimens was associated with increases in HIV treatment adherence.
Using optimized, more durable regimens is an important component of the Treatment 
2.0 approach, which aims to catalyse a new phase of HIV treatment and care. 
According to mid-term reports, countries in Latin America, Asia and the Pacific, 
Eastern Europe and Central Asia are using Treatment 2.0 as a tool to aid them in 
defining and implementing locally relevant HIV treatment policies and programmes. 
Some aspects of Treatment 2.0, such as laboratory simplification, remain works in 
progress; CD4 technologies that may be used at the point of care are being rolled out 
in some settings, such as Jamaica, but additional work is needed to build sufficient 
capacity for the monitoring of antiretroviral treatment, using tests of viral loads. 
Consistent with the Treatment 2.0 goal of leveraging community engagement to 
increase HIV treatment uptake, Argentina has strengthened linkages between 
treatment centres and community groups to support treatment adherence. 
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fUNDING Of ANTIRETROVIRAL THERAPy
In 2012, an estimated US$ 9.9 billion was available for HIV treatment and care 
in low- and middle-income countries. In most regions, domestic expenditure 
represents the single largest source of funding for HIV treatment programmes. 
However, many countries, notably those in East, Central and West Africa, remain 
heavily dependent on international financing for their antiretroviral treatment 
programmes (see Figure 4.5). Several countries are exploring innovative strategies 
to diversify funding sources and generate renewable sources of funding for HIV 
programmes, an issue addressed in greater detail in Section 6.
Although the cost of antiretroviral medicines has declined, further reductions 
will be needed to expedite uptake and ensure the sustainability of HIV treatment 
programmes. One strategy to reduce dependence on international funding for HIV 
treatment is to build robust capacity in low- and middle-income countries to import 
and also manufacture essential medicines. The African Union’s Roadmap on Shared 
Responsibility and Global Solidarity for the AIDS, Tuberculosis and Malaria Response 
in Africa calls for investment in the establishment of regional pharmaceutical 
manufacturing hubs, stepped-up efforts to ensure that knowledge and technology 
are transferred to the region, harmonization of regulatory systems and maximum 
use of flexibilities permitted under the TRIPS (Trade-Related Aspects of Intellectual 
Property Rights) Agreement. 
Treatment 2015: Speed, focus, Innovation
Treatment 2015 aims to catalyze faster progress towards universal access to HIV 
treatment. New ways of thinking and operating will be needed. Treatment 2015 builds 
on previous work to expand access to HIV treatment including the earlier 3x5 effort, the 
PEPFAR Blueprint: creating an AIDS-free generation, the Treatment 2.0 initiative and 
the Global Plan towards the elimination of new HIV infections among children by 2015 
and keeping their mothers alive. Treatment 2015 emphasizes three critical elements of 
success:
Speed. Rapid scale-up enables responses to modify the epidemic itself, with prevalence 
increasing as more people live longer and healthier lives, and with the potential to 
reduce new HIV infections in communities. In numerous countries and areas, rapid 
HIV treatment scale-up has led to sharp reductions in AIDS-related deaths while high 
coverage of treatment is associated with lower rates of new HIV infections.
Focus. As those currently receiving HIV treatment may be the easiest the reach, 
further progress towards universal access will demand intensified action to bring HIV 
testing and treatment services to those who currently lack it. Treatment 2015 calls for 
all countries to immediately use available data to identify key geographic settings 
and populations with high HIV prevalence and disproportionate unmet need for HIV 
treatment. Globally, Treatment 2015 urges particularly intensive focus on 30 countries 
where 90% of the people with an unmet need for HIV treatment are living.
Innovation. New approaches are needed to more swiftly translate scientific advances 
into concrete action in countries. Innovation should be unleashed to re-conceptualize 
HIV testing, link individuals to comprehensive treatment and care at an early stage of 
infection and strengthen community systems.
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Although several countries have effectively used available flexibilities to enhance the 
affordability of essential HIV medicines, TRIPS flexibilities remain under-utilized as a 
strategy to further lower antiretroviral drug prices. While mid-term country reviews 
acknowledged the impact of intellectual property rights on access to medicines, only 
a very few countries from the Asia Pacific and Latin America regions mentioned 
concrete actions to use existing TRIPS flexibilities. Some countries cited concerns 
regarding the potential impact of bilateral and multinational free trade agreements on 
the future availability of affordable medicines, although country reports also cited lack 
of knowledge and expertise as barriers to the development of favourable legislative 
environments to minimise intellectual property barriers to accessing essential 
medicines. 
LOOKING AHEAD
All 109 countries that reported results of their mid-term review as of August 2013 
identified HIV treatment as a priority in the national strategic plan. Of these 109 
countries, 15 report that they are not on track to achieve their HIV treatment targets 
by 2015. Globally, although the 2015 target of reaching 15 million people with 
antiretroviral treatment is within reach, the pace of scale-up will need to accelerate if 
the world is to attain this goal. If all low- and middle-income countries adopt the 2013 
WHO guidelines the estimated number of people in need of antiretroviral therapy will 
increase to 30.7 million in 2015.
FIGURE 4.5  
International and domestic public spending on antiretroviral therapy in low- and middle-income 
countries, by region, various years up to 2013
Source: GARPR 2013.
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National mid-term reviews noted several challenges to accelerated HIV treatment 
scale-up, including difficulties in motivating people to learn their HIV status, the 
deterrent effects of stigma and discrimination, frequent stock-outs of antiretroviral 
medicines, and the lack of laboratory capacity for CD4, viral load and drug resistance 
monitoring. As an overarching concern, countries expressed anxiety regarding the 
sustainability of HIV treatment programmes, citing the need for further reductions 
in antiretroviral drug prices (including but not limited to second- and third-line 
regimens) and sustainable financing. A number of countries from Latin America, 
Asia and the Pacific, and West and Central Africa have expressed concerns regarding 
the financial implication of implementing the 2013 WHO HIV treatment guidelines, 
which substantially increase the number of people eligible for HIV treatment.
With the aim of reaching the 2015 HIV treatment target, mid-term reviews 
identified several key strategies for moving forward. Reports emphasized the critical 
importance of strong and sustained political commitment to ensure the investments 
that will be needed to continue scaling up. Efforts must intensify to involve civil 
society in demand creation, service delivery, treatment literacy programming and 
development of early warning systems for antiretroviral stock-outs. Countries called 
for regional and global initiatives to address bottlenecks in the pharmaceutical 
market, including regulatory aspects such as drug quality control, management 
of intellectual property rights, optimal drug pricing and local production of 
antiretroviral drugs. Numerous country reports also emphasized the need for further 
integration of the HIV response in the health and other sectors.
The Treatment 2015 framework provides a clear way forward to expedite progress 
in scaling up HIV treatment. Using the 2015 target as a key milestone for scaling 
up, Treatment 2015 provides a framework for accelerated scale-up towards universal 
HIV treatment access. To generate robust demand for HIV treatment, countries 
should re-conceptualize HIV testing by adopting multiple, proactive strategies to 
encourage knowledge of HIV status; invest in community literacy initiatives; remove 
deterrents to HIV treatment access; and emphasize the preventative, as well as 
therapeutic, benefits of HIV treatment. To ensure that we invest in accelerating scale-
up, domestic and international contributions should increase, continued strides 
should be made in improving the efficiency of HIV treatment programmes, health 
and community systems should be strengthened, programmatic innovation to spur 
swifter scale-up should be encouraged, and the means to manufacture antiretroviral 
medicines in Africa should be created. Finally, steps are needed to effectively deliver 
services through implementation of efficient, innovative delivery models; take steps 
to ensure equitable access; promote accountability through rigorous measurement of 
outcomes; and forge strategic HIV treatment partnerships that leverage the unique 
experience and expertise of diverse stakeholders.
Treatment 2015 calls for enhanced focus to accelerate scale-up.17 Although the 
framework is applicable in all countries and regions, it calls for intensified efforts in 
30 countries where 9 out of 10 people who have an unmet need for HIV treatment 
live: Angola, Brazil, China, Cameroon, Central African Republic, Chad, Colombia, 
Côte d’Ivoire, Democratic Republic of the Congo, Ethiopia, Ghana, India, Indonesia, 
Kenya, Lesotho, Malawi, Mozambique, Myanmar, Nigeria, Russian Federation, South 
Africa, South Sudan, Thailand, Togo, Uganda, Ukraine, United Republic of Tanzania, 
Viet Nam, Zambia and Zimbabwe.
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Just as HIV treatment is contingent upon the scale-up of HIV diagnosis, by the same 
token the simplification, improvement, availability, new standard eligibility criteria 
and scaled up access to HIV treatment have profound impacts on HIV testing and 
the meaning and implications of learning one’s status. Empowering people to know 
their status requires simplification in testing technologies and in the way that people 
can access testing services.
LEADERSHIP AND INNOVATION fOR HIV TREATmENT SCALE-UP
Throughout the world, countries have taken bold steps to deliver HIV treatment 
services to those who need them. For example, Viet Nam is rapidly scaling up, with new 
patients accounting for 23% of the 72 711 individuals receiving antiretroviral therapy 
in 2012. Viet Nam has expanded antiretroviral therapy in closed settings (such as 
education centres and prisons), and achieved a retention rate exceeding 80%. It has also 
implemented projects in two districts for early initiation of antiretroviral therapy. 
Several countries have worked to extend human resources for health. For example, 
Malawi has been a pioneer in nurses’ administration of antiretroviral therapy 
and integration of community health workers in various HIV services, including 
administration of HIV treatment for specialized community health workers. 
Innovative efforts are helping improve the quality of HIV treatment services. 
Mozambique, for example, is at the forefront with regard to the use of new 
diagnostic tools, such as point-of-care devices that are already being used for CD4 
readings and are currently being studied for viral load monitoring. Use of mobile 
technology in Mozambique is helping improve patient retention, provide adherence 
support and enhance information management. 
Argentina has established early warning systems to monitor viral resistance and 
foster HIV treatment adherence. Interdisciplinary teams in hospitals and health 
centres collaborate with civil society organizations in an effort to improve treatment 
efficiency.
South Africa is enhancing the long-term sustainability of its HIV treatment 
programme. In 2012, a nearly US$ 700 million tender for fixed-dose antiretroviral 
regimens led to price reductions of 38% for one fixed-dose combination (tenofovir, 
emtricitabine and efaverinz), yielding savings estimated at US$ 260 million in 
2013–2014.
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countries
Although efforts to expand access to antiretroviral therapy have primarily focused 
on low-income countries, ensuring universal HIV treatment access in middle-income 
countries remains a major challenge. In June 2013, delegates from more than 20 
middle-income countries, from all regions, joined civil society representatives and 
international organizations in Brazil to explore strategies to expand HIV treatment 
access in middle-income countries. Success in middle-income countries will play 
a critical role in the push for universal access, as it is projected that a majority of 
people living with HIV will be living in such countries by 2020.
Middle-income countries, increasingly viewed as potentially lucrative 
pharmaceutical markets, often do not benefit from international drug access 
initiatives. Many middle-income countries pay high prices for antiretroviral 
medicines. Although this is especially true for drugs used in second- and third-line 
regimens, even certain WHO-recommended first-line, fixed-dose combinations are 
unaffordable for some middle-income countries. Currently, antiretroviral treatment 
in middle-income countries is financed through a combination of domestic budget 
allocations and out-of-pocket spending. As demand grows for HIV treatment, in 
part due to expanded eligibility under the 2013 WHO consolidated antiretroviral 
guidelines, future access to affordable HIV treatment options is potentially 
jeopardized.
The Brasilia meeting included considerable discussion and analysis regarding 
markets and pricing for HIV medicines, their regulatory status in different countries 
and strategies that are being implemented to ensure a public health-oriented 
management of intellectual property rights. The importance of information-sharing 
and technical support between middle-income countries was emphasized, with 
a particular focus on establishing or improving platforms for the exchange of 
information regarding prices and patents. Participants developed recommendations 
for how countries and multilateral agencies might collaborate to overcome 
bottlenecks pertaining to pricing mechanisms, regulatory issues, intellectual 
property management and community mobilization:18
 • Mapping on pricing mechanisms
 • Information exchange platforms on pricing and patents
 • Support civil society on intellectual property (IP) related advocacy
 • Improve transparency of licence agreements
 • Strengthen collaboration between WHO and national drug regulatory agencies 
on quality control under the WHO pre-qualification programme
 • Campaigning on the quality of generics.
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5. HalVe tuberculosIs deatHs 
among people lIVIng wItH HIV 
by 2015
Tuberculosis remains the leading cause of death among people living with HIV. 
In 2012, people living with HIV accounted for 1.1 million (13%) of the estimated 
8.7 million people globally who developed tuberculosis. Of the 2.8 million people 
with tuberculosis who received an HIV test result in 2012, 20% tested HIV-positive, 
including 42% of people with tuberculosis in sub-Saharan Africa. More than 75% 
of the estimated HIV-positive incident tuberculosis cases live in just 10 countries 
(Ethiopia, India, Kenya, Mozambique, Nigeria, South Africa, United Republic of 
Tanzania, Uganda, Zambia and Zimbabwe).
As a result of sustained progress in meeting the needs of tuberculosis patients living 
with HIV, the world is within reach of achieving the 2015 target of reducing by 50% 
tuberculosis-related deaths among people living with HIV. However, progress in 
reducing deaths is levelling off; hence countries need to continue stepping up their 
efforts.
There is an urgent need to implement proven prevention and treatment strategies for 
the linked epidemics of HIV and tuberculosis. If gains are to be accelerated, scaled-
up antiretroviral therapy is critical. While focused efforts to deliver antiretroviral 
therapy to all HIV-positive people with TB are vital, broader scale-up of HIV 
treatment would also contribute to the global goal by reducing the number of people 
who develop active tuberculosis. To further buttress prevention efforts, the Three Is of 
HIV/TB – Intensified case finding, Isoniazid preventive therapy and Infection control 
in clinical settings – must be effectively implemented. 
PROGRESS IN REDUCING TUBERCULOSIS-RELATED DEATHS
The global target calls to halve the number of tuberculosis-related deaths among 
people living with HIV to less than 250 000 in 2015. The world has made substantial 
gains towards this goal (see Figure 5.1). Since 2004, tuberculosis-related deaths 
among people living with HIV have declined by 36% worldwide, and slightly less 
in Africa, home to 75% of all people living with tuberculosis and HIV. The World 
Health Organization (WHO) estimates that the scale-up of collaborative HIV/
tuberculosis activities (including HIV testing, antiretroviral therapy and the Three Is) 
prevented some 1.3 million people from dying during 2005 to 2012. 
Among the 41 countries with high HIV/TB burden, 17 have been estimated to have 
reduced tuberculosis-related deaths among people living with HIV by over 50%, 
nine countries have reduced deaths by 25–50%. However, in some of the countries, 
mortality has decreased less, or even risen.
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tAblE 5.1  
Estimated change in tuberculosis-related deaths among people living with HIV in 41 
tuberculosis/HIV high-burden countries, 2004–2012 
>50% reduction
Botswana
Burkina Faso
Burundi
Cambodia
Central African Republic
Côte d’Ivoire
Ethiopia
Ghana
Haiti
Malawi
Myanmar
Namibia
Nigeria
Rwanda
Thailand
Uganda
Zimbabwe
<25% reduction
Angola
Brazil
Congo
Dem. Rep. Congo
Indonesia
Lesotho
Mozambique
Russian Federation
Sierra Leone
South Africa
Sudan
Swaziland
Togo
Ukraine
Viet Nam
25%–50% reduction
Cameroon
Chad
China
Djibouti
India
Kenya
Mali
United Republic of Tanzania
Zambia
Source: Global tuberculosis report 2013. Geneva, World Health Organization, 2013 (detailed country estimates are in the WHO report).
FIGURE 5.1  
Estimated number of tuberculosis-related deaths among people living with HIV, 
globally and for Africa, 2004–2012 
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SCALING UP ANTIRETROVIRAL THERAPy TO PREVENT  
TUBERCULOSIS-RELATED DEATHS AmONG PEOPLE LIVING 
wITH HIV
Antiretroviral therapy reduces by 65% the risk that a person living with HIV will develop 
tuberculosis,1 and HIV treatment lowers the risk of death among people living with 
HIV who have tuberculosis by about 50%. Among individuals co-infected with HIV 
and latent tuberculosis, antiretroviral therapy repairs immune systems damaged by HIV, 
preventing the development of active tuberculosis. Where latent infection has progressed 
to active tuberculosis, antiretroviral therapy boosts the body’s capacity to respond to 
N
um
b
er
 o
f d
ea
th
s
62  |  Halve tuberculosis deaths among people living with HIV by 2015
the disease. Acknowledging the central role of antiretroviral therapy in preventing 
tuberculosis-related deaths among people living with HIV, WHO’s policy on 
collaborative HIV/tuberculosis activities together with the 2013 antiretroviral guidelines 
recommends immediate initiation of HIV treatment for all people living with HIV who 
develop tuberculosis, regardless of CD4 count. 
Among the 10 countries with the largest number of tuberculosis cases living with HIV 
receiving antiretroviral therapy, South Africa has experienced the most noteworthy success 
in scaling up antiretroviral therapy, with more than 100 000 individuals with HIV and 
tuberculosis receiving HIV treatment in 2012. The percentage of those estimated to have 
HIV-associated tuberculosis who received antiretroviral therapy in 2012 was 59% in Kenya, 
57% in Malawi, 41% in Zambia and 34% in the United Republic of Tanzania. Among those 
countries, the greatest gains in increasing the number of people in antiretroviral therapy in 
2012 were made in Mozambique (a 101% increase), Malawi (a 48% increase), the United 
Republic of Tanzania (a 43% increase), and Nigeria (a 29% increase) (see Figure 5.2). 
Despite these gains, coverage continues to lag in the countries with the greatest HIV/
tuberculosis burdens. Among the 10 reporting countries with the largest number of 
HIV/tuberculosis cases on antiretroviral therapy, only Kenya and Malawi were delivering 
antiretroviral therapy in 2012 to more than 50% of estimated incident HIV positive 
tuberculosis cases. In general, the pace of antiretroviral treatment scale-up for people 
living with both HIV and tuberculosis is levelling in the top 10 HIV/tuberculosis high-
burden countries.
FIGURE 5.2  
Number of HIV positive tuberculosis patients on antiretroviral therapy, as reported by ten 
countries, 2004–2012
Source: GARPR reporting 2013, UNAIDS; Global tuberculosis report 2013. Geneva, World Health Organization, 2013
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Globally, antiretroviral treatment coverage for people living with both HIV and 
tuberculosis remains inadequate (see Table 5.2). Whereas antiretroviral treatment 
reached 65% of all treatment-eligible people living with HIV in 2012, only 57% of 
people diagnosed with HIV and tuberculosis co-infection received antiretroviral 
therapy. Among 41 priority countries for collaborative HIV/tuberculosis activities, 
only four (Brazil, Kenya, Malawi and Ukraine) reached at least 50% treatment coverage 
among estimated incident HIV and tuberculosis cases, with extremely low coverage 
reported in Congo, and Sudan, where less than 5% of estimated HIV-positive incident 
tuberculosis cases received HIV treatment in 2012. Especially in areas with a high 
prevalence of multi-drug resistant tuberculosis, the costs of essential drugs can be high, 
underscoring the importance of generic alternatives to ensure the affordability of HIV/
tuberculosis efforts.
HIV TESTING: A CRITICAL BOTTLENECK
Prompt diagnosis of HIV infection among tuberculosis patients is required for effective 
HIV treatment. The number of people living with HIV who are diagnosed with 
tuberculosis is increasing each year, but implementation of routine HIV testing and 
counselling in tuberculosis care settings remains inadequate, slowing further progress 
in reaching HIV-positive tuberculosis cases with essential HIV treatment.
The proportion of people with tuberculosis who received HIV testing in 2012 increased 
by 14% in comparison to 2011, to 2.8 million. Greatest progress has been reported in 
sub-Saharan Africa, where 75% of notified tuberculosis cases were tested for HIV in 
2012 (see Table 5.3). 
>50%
Ukraine   92
Kenya   59
Malawi   57
Brazil  57
Source: GARPR reporting 2013, UNAIDS; Global tuberculosis report 2013. Geneva, World Health Organization, 2013
Note: Indonesia tuberculosis and AIDS programme numbers had discrepancies, hence one coverage number could not be included.
tAblE 5.2  
Percentage of HIV-positive new tuberculosis patients receiving antiretroviral therapy
<25%
Viet Nam  24
Sierra Leone   24
Nigeria   24
Burundi   24
Myanmar   22
Cameroon   22
Angola   21
India   20
Mozambique  19
Djibouti   15
Chad   15
Dem. Rep. Congo 14
Congo   4
Sudan   1
50–25%
Botswana  49
Rwanda  48
China   47
Cambodia   47
Namibia   46
Lesotho   42
Zambia   41
Togo   40
Ghana   37
Mali   35
Ethiopia   35
United Rep. Tanzania 34
Burkina Faso  31
South Africa   31
Côte d’Ivoire  30
Thailand   30
Haiti   29
Swaziland   29
Uganda  28
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However, global coverage of HIV testing remains insufficient, with just 46% of notified 
tuberculosis cases being tested for HIV in 2012. In East Asia, South and South-East Asia, 
home to one in six tuberculosis cases living with HIV globally, HIV testing coverage for 
people living with HIV is especially low (31% and 36%, respectively, in 2012).
EffECTIVE TB PREVENTION fOR PEOPLE LIVING wITH HIV
The Three Is have yet to be fully implemented, contributing to the persistence of 
tuberculosis as the leading cause of death for people living with HIV. In 2012, 42 
countries reporting data provided isoniazid preventive therapy to nearly 520 000 
people living with HIV. Although the trend towards increased uptake of preventive 
therapy is encouraging, the number currently receiving isoniazid preventive 
therapy is believed to represent a fraction of the number of people living with 
HIV who could benefit from the intervention. Among 30 countries reporting both 
denominator and numerator for preventive therapy, 30% of those newly registered in 
care received isoniazid preventive therapy.
HIV service settings are increasingly integrating tuberculosis screening. From 2010 
to 2012, the number of people in HIV care who were screened for tuberculosis rose 
by more than 70%, from 2.4 million to 4.1 million.
tAblE 5.3  
HIV testing, treatment for HIV-positive tuberculosis patients and prevention of tuberculosis 
among people living with HIV, UNAIDS regions, 2012*
ESTImATED 
HIV-POSTIVE 
INCIDENT 
TUBERCULOSIS CASES
NUmBER Of 
TUBERCULOSIS 
PATIENTS wITH 
KNOwN HIV 
STATUS
PERCENTAGE 
Of NOTIfIED 
TUBERCULOSIS 
PATIENTS 
TESTED fOR HIV
PERCENTAGE 
Of TESTED 
TUBERCULOSIS 
PATIENTS 
HIV-POSITIVE
PERCENTAGE 
Of IDENTIfIED 
HIV-POSITIVE 
TUBERCULOSIS 
PATIENTS 
STARTED/ 
CONTINUED ON 
ANTIRETROVIRAL 
THERAPy
NUmBER Of 
HIV- POSITIVE 
PEOPLE 
SCREENED fOR 
TUBERCULOSIS
BEST LOW HIGH
Caribbean 5 4.2 5.8 17.4 77 20 47 3.97
East Asia 7.8 6.9 8.7 317 31 1.9 59 295
Eastern Europe and Central Asia 16 14 18 175 65 6.7 74 23.3
Latin America 25 22 28 103 52 16 83 0.52
Middle East and North Africa 7 6.2 7.8 36.2 26 4 56 12.8
North America 1.2 1.1 1.3 8.93 79 7.6 ... ...
Oceania 1.1 0.73 1.5 5.38 21 7.1 89 2.86
South and South-East Asia 190 170 200 1050 36 6.1 60 1360
Sub-Saharan Africa 830 760 900 1050 75 43 55 2390
Western and Central Europe 2.7 2.6 2.9 28.8 43 4.1 78 0.22
Global 1100 1000 1200 2790 46 20 57 4090
* Figures are in thousands, except where indicated as percentages.
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mEASURING KEy HIV/TB INDICATORS
Available data, summarized in country GARPR reports, provide a general 
understanding of the current situation regarding the interaction between HIV and 
tuberculosis, as well as some indication of trends for HIV-positive people with 
tuberculosis. However, available information also involves important uncertainties 
regarding data inputs and the reliability of extrapolations used to compensate for 
missing data elements in order to estimate tuberculosis incidence, prevalence, 
mortality, HIV-associated tuberculosis and multi-drug-resistant tuberculosis. The 
percentage of people living with HIV who die of tuberculosis remains unclear, with 
autopsy findings suggesting a proportion that is higher than that generated by case 
reports. Due to diagnostic challenges, information on tuberculosis among children 
living with HIV remains scarce. Implementation of the Three Is is inadequately 
monitored, and there is little information available on people living with HIV among 
the 500 000 estimated cases of extreme multi-drug-resistant tuberculosis. Data 
provided by countries regarding key indicators such as HIV or tuberculosis screening, 
antiretroviral therapy for people living with HIV and tuberculosis, and receipt of 
preventive services, is of unequal quality, reflecting underreporting, missing reports, 
misclassifications or duplication of entries that result in over-reporting.2 
Efforts are needed to improve the completeness and accuracy of strategic HIV/TB 
data. As an example of the practical challenges that monitoring and evaluation efforts 
confront, HIV and tuberculosis programmes in many countries interpret treatment 
indicators differently, resulting in substantial data discrepancies. Greater integration 
and coherence between tuberculosis and HIV data collection systems could help 
improve data quality while simultaneously facilitating enhanced linkages between 
tuberculosis and HIV services for people living with HIV and tuberculosis. 
LOOKING fORwARD
Nearly all countries that reported results from mid-term reviews (103 of 109) identified 
the reduction of tuberculosis deaths as a national priority. One hundred and one 
countries indicate that the target has been integrated in national strategic plans. 
Although the world appears to be on track to achieve the 2015 target for reducing 
tuberculosis deaths among people living with HIV, progress is not uniform, with 26 
countries reporting that they are not making adequate progress to reach the 2015 target. 
Moreover, the 2015 milestone represents but an interim step towards the ultimate goal 
of controlling and eventually eliminating tuberculosis. The continuing high level of 
morbidity and mortality associated with tuberculosis among people living with HIV can 
and must be stopped. tuberculosis is entirely preventable, including for people living with 
HIV, and no one should die from a disease that is both preventable and curable.
Of all available tools, antiretroviral therapy is the single most powerful for HIV-
associated tuberculosis – reducing the risk of death by between 54% and 95%.3 
Improving access to early HIV diagnosis and antiretroviral therapy for those who 
test HIV-positive is essential to reducing tuberculosis deaths among people living 
with HIV. In this regard, it is cause for concern than no national mid-term review 
report discussed early antiretroviral therapy as a strategy to reduce tuberculosis-
related mortality among people living with HIV. 
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All available tools need to be mobilized. These include effective prevention measures, 
including enhanced screening and diagnosis, isoniazid preventive therapy (life-long 
where indicated) and proper infection control. Contacts of adults with tuberculosis 
should receive isoniazid preventive therapy, and occupational health programmes for 
health care workers are urgently needed to ensure delivery of prevention interventions to 
workers who have been exposed to tuberculosis.
Full and rapid implementation of the 2013 WHO antiretroviral guidelines and of earlier 
guidance on collaborative HIV/TB activities is essential. This will demand immediate 
steps to strengthen collaborative HIV/TB activities and to implement policies and 
protocols that regularize the delivery of antiretroviral therapy for all HIV-positive people 
with tuberculosis, regardless of CD4 count.
Focused efforts are needed to address the impediments to an effective response to 
HIV-associated tuberculosis identified by national mid-term reviews. These include 
poor uptake of prevention and treatment interventions, lack of clear policy guidance 
on immediate initiation of antiretroviral therapy for people living with HIV who have 
tuberculosis, lack of HIV testing in many tuberculosis clinics and lack of proper infection 
control. 
Innovation is urgently needed to enhance the reach, timeliness and effectiveness 
of tuberculosis screening and treatment programmes for people living with HIV. 
Programme planners and implementers should be encouraged to adopt innovative 
testing and delivery strategies, and communities need to be engaged as partners in the 
effort to reduce tuberculosis deaths among people living with HIV. The ZAMSTAR study 
in Zambia and South Africa in 2010 showed that an integrated household approach 
to tuberculosis and HIV led to a reduction of the overall burden of tuberculosis in the 
community and a reduction in ongoing community transmission.4 New technologies 
should be developed and rapidly implemented. GeneXpert MTB/Rif, an automated 
molecular diagnostic test that more rapidly diagnoses tuberculosis and drug-resistant 
tuberculosis and is now being rolled out in many countries, represents the result of new 
thinking and offers an example of the potentially transformative impact of new health 
tools. 
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South Africa’s HIV and tuberculosis epidemics are inextricably linked, with 330 000 
of the country’s estimated 520 000 new tuberculosis cases in 2011 also living with 
HIV. Tuberculosis remains the leading cause of death for people living with HIV in 
South Africa, with 87 000 [76 000 – 100 000] tuberculosis deaths occurring in 2011. 
The country’s tuberculosis challenge is compounded by the high caseload of multi-
drug-resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis 
(XDR-TB); in 2011, an estimated 8 100 cases of MDRTB occurred in South Africa 
among notified pulmonary tuberculosis cases, with only 5 643 (70%) being enrolled 
on treatment. Among MDR-TB patients started on treatment in 2009, 42% had a 
successful outcome and 18% died, with poorer outcomes in XDR-TB.
In response to this health challenge, South Africa has taken a number of 
important public health actions to prevent tuberculosis among people living 
with HIV. In particular, the country has prioritized an integrated approach to HIV 
and tuberculosis; strategies for the two diseases are integrated and programme 
administration is closely linked. 
South Africa’s response to the linked epidemics of HIV and tuberculosis has been 
strengthened by a major expansion of HIV testing and treatment services. Following 
the launch of a major national testing campaign, the number of people receiving 
antiretroviral treatment in South Africa reached more than 2.15 million in 2012, 
representing 83% coverage under the 2010 WHO HIV treatment guidelines and a 
27% increase over 2011. Antiretroviral therapy is offered to people diagnosed with 
both HIV and tuberculosis, with 101 937 (or 31% of estimated HIV-positive incident 
tuberculosis cases) receiving HIV treatment in 2012.
South Africa has also implemented tuberculosis screening for people living with 
HIV. To address challenges in diagnosing tuberculosis in people living with HIV, 
the country developed and initiated a national plan for phased implementation of 
the Xpert MTB/RIF assay as a replacement for microscopy as the initial diagnostic 
method. Using existing microscopy centres, South Africa introduced more than 
290 GeneXpert machines in more than 140 centres, performing nearly 1.2 million 
tests in nine provinces as of March 2013, with plans in place for further expansion 
in additional centres. When compared with smear microscopy, GeneXpert doubled 
the number of laboratory-confirmed tuberculosis cases and detected 7% rifampin 
resistance, enabling clinicians to tailor regimens to the needs of individual patients.5
Enhanced screening has also enabled South Africa to scale up isoniazid preventive 
therapy. With some 370 000 people living with HIV receiving isoniazid preventive 
therapy in 2012, South Africa is now the largest provider of the prophylactic regimen 
in the world. 
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6. close tHe global aIds  
resource gap
Financial resources for the AIDS response reached their highest level ever in 2012, with 
increased contributions from both domestic sources and international donors. With 
funding increases in both 2011 and 2012, the world now has a meaningful chance to 
achieve the 2015 target of mobilizing annual funding of US$ 22–24 billion for HIV 
activities in low- and middle-income countries. However, to achieve the 2015 resource 
target, substantial additional funding will be needed.
Although genuine progress has been made in mobilizing resources for the response, 
an increase in new infections in many countries and regions and projected flattening 
in international HIV assistance in the coming years suggest that innovative funding 
mechanisms and new domestic resources will be required to ensure continued scale-up 
of life-saving services. International donors also need to renew their commitments to the 
HIV response in accordance with principles of shared responsibility and global solidarity.
HIV fUNDING GROwS, BUT mORE IS NEEDED
In 2012, an estimated US$ 18.9 (16.6–21.2) billion was available for HIV programmes in 
low- and middle-income countries (see Figure 6.1). This represents a 10% increase on the 
US$ 17.1 (15.7-18.5) billion estimated to have been spent in 2011, according to updated 
estimates, meaning that considerable further investment is needed to reach the 2015 
target. 
For the second consecutive year, domestic sources accounted for the majority of HIV 
funding, at an estimated US$ 9.9 (7.7–12.2) billion, corresponding to 53% of all global 
resources available in 2012.* International spending on HIV programmes also rose 
slightly in 2012, bringing it back to the level of the funding peak achieved in 2009 when 
the global financial and economic downturn began.
Including all sources, Eastern and Southern Africa accounted for 47% of all HIV 
spending in 2012, followed by Latin America (17%). Every other region made up less 
than 10% of global HIV spending. 
Although the 2015 target is within reach, the 2013 World Health Organization (WHO) 
antiretroviral guidelines modestly increase the total resource needs for the HIV response. 
It is estimated that full implementation of the new guidelines, which increase the number 
of people eligible for antiretroviral therapy and also encourage the use of standardized 
first-line regimens, will require a 5–10% increase in total HIV funding until 2025. 
* On HIV spending, reported data for any year ever reported are available for 136 of 141 low- and 
middle-income countries, with 43 countries having reported data for 2012. Trends in domestic public HIV 
funding are derived from modelling based on the data submitted through the Global AIDS Response 
Progress Reporting mechanism. Domestic private expenditure is estimated separately.
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Source: UNAIDS estimates.
* The UN General Assembly 2011 Political Declaration on HIV and AIDS set a target of US$ 22bn – 24bn by 2015.
FIGURE 6.1  
Resources available for HIV in low- and middle-income countries, 2002–2012 and 2015 target*
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COUNTRy LEADERSHIP IN RESOURCE mOBILIZATION
Low- and middle-income countries are developing and leading efforts to mobilize 
resources for the HIV response. Among countries that undertook mid-term reviews, 
90% cited resource mobilization as a national priority. More than 90% of national 
strategic plans address resource mobilization. In sub-Saharan Africa, numerous countries 
– including Kenya, South Africa, Togo and Zambia – have sharply increased domestic 
HIV spending in recent years.1
Based on total amount of funding, the upward trend in domestic HIV funding is 
especially visible among upper-middle-income countries, which generally finance 
a larger proportion of health services through domestic resources (see Figure 6.2). 
Proportionally, however, the estimated increase in 2012 was greatest for low-income 
countries (29%), followed by lower-middle-income countries (26%) and upper-middle-
income countries (6%). 
Among the 43 low- and middle-income countries reporting AIDS spending data in 
2012, more than two-thirds reported an increase in domestic HIV spending. In several 
countries – Chad, Guinea, Kyrgyzstan and Sierra Leone – domestic funding for HIV 
activities more than doubled. 
2012
Target for global resources in 2015
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Source: UNAIDS estimates.
FIGURE 6.2  
Domestic public funding for HIV in low- and middle-income countries, by income category, 
2005–2012
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INTERNATIONAL HIV ASSISTANCE RECOVERS
International investment in HIV programmes reached an estimated US$ 8.9 billion in 
2012, an 8% increase on amounts available from the international community in 2011 
(see Figure 6.3). Bilateral aid (that is, funds disbursed directly from a donor country to 
a recipient country) accounted for approximately 67% of international contributions, 
with the remainder provided through multilateral (28%) and philanthropic channels 
(5%). 
In 2012, HIV disbursements by donor governments, bilaterally and multilaterally, 
and by private philanthropic funders increased nominally but remained essentially 
flat in real terms. This nominal increase was primarily driven by an acceleration of 
bilateral disbursements by the US government, whereas most recent resource-tracking 
investigations suggest that most European donor governments decreased their HIV 
assistance in 2012. Without renewed commitment from international donors, it is 
projected that international funding for HIV activities will not grow in coming years. 
As shown in Figure 6.4, in 2012 the US President’s Emergency Plan for AIDS Relief 
(PEPFAR), a bilateral aid programme, made up approximately 73% of all bilateral aid for 
HIV, almost half (48.7%) of all international HIV contributions and 23% of total HIV 
funding available from all sources (including international, domestic, public and private). 
The UK accounted for an estimated 10.7% of all bilateral funding available in 2012, 
followed by the Netherlands (2.8%), Denmark (2.6%) and Germany (2.4%). A number of 
countries – including Denmark, Ireland, the Netherlands, Norway, Sweden, the UK and the 
US – contributed a share of international HIV funding that exceeds their respective share of 
global gross domestic product. 
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FIGURE 6.3  
Share of international HIV funding versus share of global GDP, selected countries, 2012
FIGURE 6.4  
International assistance funding for HIV, 2012
Share of world GDP Share of bilalateral contributions in total international funding for AIDS
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A sizeable proportion (28%) of all international assistance is provided through 
multilateral institutions, such as the Global Fund to Fight AIDS, Tuberculosis and 
Malaria, the global health organization UNITAID, and United Nations agencies. 
Multilateral funding accounted for 13% of total funding available for HIV activities 
from all sources (including international, domestic, public and private). Private 
philanthropic funders in the US and the European Union contributed more than 5% 
of international HIV assistance disbursed in 2012. 
HIV SPENDING PATTERNS: wHO PAyS fOR wHAT?
Care and treatment services consumed more than half (55%) of HIV expenditure 
in 2012, while prevention programmes represented 19% of HIV spending, a share 
that has remained relatively stable in recent years (see Figure 6.5). A notable share 
(12%) of spending supported programme management and administration. 
Whereas domestic resources account for the majority of spending for HIV 
treatment and care, international spending financed the majority of HIV 
prevention efforts. Nearly one-quarter of international HIV spending (23%) 
supports programme management and administration. It has to be noted, 
however, that the latter also covers investment in health systems, for example 
strengthening national drug supply systems.
FIGURE 6.5  
Distribution of HIV spending by programme categories and funding source, low- and middle-
income countries, latest data available as of 2013
Source: GARPR 2013.
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PERSISTENT DEPENDENCy ON INTERNATIONAL fINANCING
Based on the latest data officially reported to UNAIDS, low-income countries 
received 56% of international HIV spending, followed by lower-middle-income 
countries (26%) and upper-middle-income countries (18%). Consistent with 
these patterns, low-income countries remain the most dependent on international 
financing for their HIV responses, with domestic resources making up only 16% of 
HIV funding. Donor dependency also represents a challenge to the sustainability of 
HIV responses in lower-middle-income countries, where domestic sources account 
for only 27% of HIV funding overall. By contrast, upper-middle-income countries 
themselves contribute 88% of costs associated with HIV activities.
The differences in funding patterns based on national income are reflected in 
regional differences in the mix of HIV financing. In Latin America, East Asia, 
Eastern Europe and Central Asia, domestic sources account for more than 80% 
of HIV spending (see Figure 6.6). Domestic sources also account for 69% of HIV 
spending in Southern Africa, as the foundation for a sustainable response has been 
established in many countries, especially in upper-middle-income countries in 
Southern Africa with a high burden of disease. 
Fifty-one low- and middle-income countries looked to international assistance for 75% 
or more of HIV financing in 2012. Twenty-nine countries used domestic resources to 
finance at least 75% of the cost of HIV activities (see Table 6.1). 
Source: GARPR 2013.
FIGURE 6.6  
Domestic public spending as a percentage of total domestic public and international spending 
in low- and middle-income countries, latest data available in 2013
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Source: GAPR 2013.
tAblE 6.1  
Dependency of the national HIV response on international sources 
Funding from international sources as a percentage of the total international and domestic public 
funding in low- and middle-income countries, latest reports available as of 2013
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LOOKING fORwARD
Closing the AIDS resource gap has been identified as a national priority in 99 of the 
109 countries that reported results of mid-term reviews. In 91 countries, the target has 
been integrated in national strategic plans. Forty per cent of the countries that formally 
prioritize closing the AIDS resource gap (39 out of 99) report that they are not on track 
to reach their resource mobilization targets by 2015.
To meet the 2015 resource target, at least US$ 2.9–5.4 billion in additional annual 
funding needs to be generated. In their mid-term reviews, countries identified several 
strategies for closing the resource gap, with priority approaches varying little depending 
on regional, epidemic type or socio-economic context.
First and foremost, countries identified the need for high-level, sustained leadership 
and commitment to ensure sufficient national investments commensurate with 
national ability to pay, burden of disease and rate of economic growth. Mid-term 
reviews emphasized the importance of developing resource mobilization plans that 
clearly identify potential national and international sources of funding. As important 
strategies to close the resource gap, countries stressed the need to forge and strengthen 
public-private partnerships that leverage private sector resources as well as innovative 
mechanisms for sustainable funding, such as fund pooling, inclusion of HIV services 
in national social protection and health insurance schemes and use of different levies or 
taxes to generate new funding.
Mid-term reviews urgently called on the international community not to abandon the 
HIV response, especially at a moment when historic progress could be jeopardized 
by funding uncertainties. Even with increased domestic allocations, some countries, 
especially those with few resources and heavy HIV burdens, will be unable to close their 
resource gap without external assistance. For example, Malawi estimates that domestic 
resources are sufficient to cover only 30% of the HIV resource gap. Similarly, Viet Nam, 
which has committed to increase domestic HIV funding by 20% annually during 
2012–2020, nevertheless projects that it will need US$ 100 million per year in external 
aid to ensure an effective HIV response.
UNAIDS has urged countries to pursue an investment approach to HIV financing, 
focusing limited resources on interventions, settings and populations where impact is 
likely to be greatest. Recognizing the difficult international funding climate, as well as 
the urgent need to lay the groundwork for a sustainable response, a growing number 
of countries are developing ‘investment cases’ that promote mobilization of sufficient 
resources to do the ‘right things’ at the ‘right scale’ in order to maximize impact and 
minimise future costs. Jamaica, Nigeria and Thailand have already developed their 
investment cases, while several other countries have initiated processes to develop them.
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Sustainability of HIV financing – increased domestic funding through 
innovative mechanisms
In 2012, the African Union (AU) took the visionary step of articulating a Roadmap on 
Shared Responsibility and Global Solidarity for the AIDS, tuberculosis and Malaria 
Response in Africa.2 The first pillar of the roadmap stressed the need for sustainable 
HIV financing through diversified funding sources for AIDS, tuberculosis and malaria 
programmes in the region.
Consistent with the AU Roadmap’s emphasis on innovative approaches to resource 
mobilization, several African countries have explored a variety of strategies to 
generate substantial new domestic funding for the HIV response. Several countries, 
such as Ethiopia, Malawi and Namibia, are ‘mainstreaming’ HIV funding, requiring 
diverse government entities to allocate at least 2% of their budgets to HIV activities. 
Kenya, the United Republic of Tanzania and Zambia are considering options for 
establishing HIV trust funds. For the last 12 years, Zimbabwe has instituted a 
National HIV and AIDS levy as a component of the national tax system, and is now 
exploring ways to tap in to private and informal sector contributions to this levy. 
Seeking ways to diversify and increase domestic investment in AIDS, Malawi has 
projected that, by allocating to HIV programmes 1% of an existing 5% levy on the 
operating surpluses of telecommunication firms, up to US$ 2.4 million would be 
generated by 2013. Simultaneously, by introducing a levy of 3 cents per minute for 
calls terminated in Malawi, US$ 5.3 million could be generated for HIV funding by 
2013. Likewise, Namibia aims to generate US$ 4.1 million by 2020 through an airline 
levy of US$ 5 per passenger on outbound flights. 
While the need to reduce dependency on international HIV funding is especially 
pressing in sub-Saharan Africa, countries in other regions are also working to 
generate sustainable funding by integrating HIV with broader health sector 
funding instruments. For example, Moldova has provided treatment for HIV and 
opportunistic infections through its national health insurance system, which was 
launched in 2004. Since 2005, Thailand has similarly provided access to free 
antiretroviral therapy and voluntary HIV counselling and testing as part of its 
universal health insurance scheme. In addition, India and Georgia are also making 
plans to include essential HIV services in the standard benefit package of their 
universal health insurance systems.
Nigeria investment case
To implement the commitments in the 2011 UN Political Declaration on HIV and 
AIDS and accelerate progress towards universal access to HIV prevention, treatment, 
care and support, Nigeria has developed the President’s Comprehensive Response 
Plan (PCRP).3 Nigeria has the second-largest population of people living with HIV, 
with only one-third of treatment-eligible individuals receiving HIV treatment and 
only 18% of HIV-positive pregnant women receiving antiretroviral medicines to 
prevent mother-to-child transmission. 
PCRP aims to bridge the current gap in service provision and funding, offering an 
investment case for HIV financing. The investment case assesses needs and gaps, 
identifies focus areas, quantifies the degree of scale-up required to close gaps, 
projects financing needed and analyses expected impact in terms of lives saved, 
new infections averted and costs saved. 
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sexual transmission among young people and key populations at higher risk, HIV 
counselling and testing, provision of treatment and care for those in need and 
prevention of mother-to-child transmission. PCRP set target coverage levels for 
priority interventions, such as a 140% increase in HIV prevention efforts among 
key populations and a 400% increase in the provision of antiretroviral therapy to 
pregnant women. 
Nigeria projects that implementation of the President’s plan would save 46 000 lives 
and avert 105 000 new infections by 2015. It is projected that PCRP would save the 
lives of 13 000 children and avert 55 000 new infections among children. Total cost 
savings are projected at US$ 1.65 billion through delayed or averted HIV treatment 
costs.
To implement the plan, it will need to be funded. It is anticipated that total HIV 
investment in Nigeria would need to increase by 37%. PCRP calls for domestic 
investment to rise by 73%, which would increase the proportion of overall domestic 
spending on HIV from 25% to 45% during 2014–2015. However, it is projected that 
domestic spending alone will not be able to close the country’s resource gap. To 
further contribute to needed resource mobilization, PCRP calls for reductions in 
programme management costs, which are projected to save US$ 27.3 million that 
can be reinvested in prevention activities.
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7. elImInate gender InequalItIes 
and gender-based abuse and 
VIolence and Increase tHe 
capacIty oF women and gIrls to 
protect tHemselVes From HIV
HIV continues to be driven by gender inequalities and harmful gender norms that 
promote unsafe sex and reduce access to HIV and sexual and reproductive health 
services for men, women and transgender persons. The epidemic imposes a particular 
burden on women and girls. In addition to their greater physiological susceptibility to 
HIV acquisition, the pervasive social, legal and economic disadvantages faced by women 
reduce their ability to protect themselves from HIV infection, and diminish access to 
essential HIV and reproductive health services, in particular for women living with HIV. 
Women and girls also shoulder the primary care-giving burden, typically providing such 
vital services without compensation. Although country reports demonstrate recognition 
that gender equality is vital to an effective HIV response, focused investments and 
enhanced political leadership will be needed to reach the global goal of eliminating 
gender inequalities and gender-based abuse and violence and increasing the capacity of 
women and girls to protect themselves from HIV.
ENDURING ImPACT Of GENDER INEqUALITy ON HIV EPIDEmICS
Globally, women comprise 52% of all people living with HIV in low- and middle-income 
countries, and men 48%. However, in sub-Saharan Africa, the centre of the global 
epidemic, women still account for approximately 57% of all people living with HIV. 
In addition to the greater physiological vulnerability of women to HIV, gender 
inequalities include vulnerability to rape, sex with older men,1 and unequal access 
to education2 and economic opportunities.3 These make HIV-related risks especially 
acute for girls and young women. In comparison to men, women are more likely to 
acquire HIV at an early age, resulting in a global HIV prevalence among girls and 
young women that is double or greater than among males of the same age.4
In sub-Saharan Africa, national surveys find that young women (age 15–24 years) 
have lower levels of accurate and comprehensive HIV knowledge than young men 
of their own age. Young women in sub-Saharan Africa are also less likely to report 
having used a condom the last time they had sex (see Figure 7.1).
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In addition to the direct health impact of HIV infection, the epidemic also undermines 
the health and wellbeing of women in other ways. In settings with high HIV prevalence, 
young women aged 15–24 experience tuberculosis rates 1.5–2 times higher than 
men in the same age group.5 Women living with HIV also face a heightened risk of 
cervical cancer, underscoring the urgency of ensuring women’s access to HIV testing 
and treatment together with comprehensive sexual and reproductive health services.6 
They also face significant barriers to accessing services due to economic constraints 
and gender-related discrimination.7 Moreover, the disproportionate care-taking 
burden shouldered by women and girls diminishes their educational and economic 
opportunities.8
Women from key populations are particularly affected by HIV. Among female sex 
workers, global HIV prevalence is estimated at 12%, increasing to approximately 30% 
in settings with medium to high HIV prevalence.9 Though data are scarce, a global 
review of available data found that transgender women are 49 times more likely 
to be living with HIV than women overall, with a pooled HIV prevalence among 
transgender women of 19%.10 
Although particular attention has focused on the need for gender-sensitive responses 
in sub-Saharan Africa, women, particularly those from key populations, face 
significant risk of HIV acquisition and shoulder a disproportionate socio-economic 
burden in concentrated epidemics, as well. In the Asia and Pacific region, where 
men outnumber women among people living with HIV, women in HIV-affected 
households are more likely to be in debt and to assume the bulk of care tasks.11
The vulnerability of transgender women to acquiring HIV is also increased as a result 
of gender inequalities. Manifestations include the non-recognition of gender identity, 
which results in denial of basic citizenship rights, such as access to accurate personal 
identification documents. As a result, transgender women are often unable to access 
HIV services and encounter discriminatory treatment by health service providers.12
FIGURE 7.1  
HIV knowledge and condom use during higher risk sex, young men and women  
(15–24 years), around 2002 and 2011 in Sub-Saharan Africa
Source: DHS data, countries with available data in Sub-Saharan Africa
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Unequal gender norms also undermine effective HIV responses for men. Prevailing 
concepts of masculinity encourage men’s sexual risk-taking and discourage men from 
seeking health and HIV services.13 In addition, health services are often not designed 
to suit the needs of men, with opening hours that clash with work obligations and 
providers’ frequent lack of sensitivity to men’s needs.14 As a result, men are less likely to 
be tested for HIV, have lower CD4 counts when they enter treatment and are less likely 
to adhere to treatment.15,16 Consequently, men receiving antiretroviral therapy have 
consistently higher AIDS-related mortality rates than women.17,18
GENDER-BASED VIOLENCE AND wOmEN’S VULNERABILITy  
TO HIV
Gender-based violence is a worldwide phenomenon and a serious violation of human 
rights. Of the almost 50 countries that reported data on the prevalence of intimate partner 
violence, between 9% and 60% of women aged 15 to 49 years reported having experienced 
violence at the hands of an intimate partner in the last 12 months (see Figure 7.2). 
Gender-based violence increases the risk of HIV infection. Two recent studies of 
women in Uganda (15–49 years) and South Africa (15–26 years) found that women 
who had experienced intimate partner violence were 50% more likely to have acquired 
HIV than women who had not experienced violence.19,20 
FIGURE 7.2  
Intimate partner violence in the past 12 months reported by women aged 15–49 years
Source: GARPR 2013
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Women from key populations, such as female drug users, female sex workers and 
transgender women, are particularly likely to experience violence.21,22 Studies in 
different countries have detected the high prevalence of rape, physical violence and 
other forms of abuse among sex workers.23,24 Women in conflict-affected situations 
face increased vulnerability to sexual violence and mass rapes during conflicts.25 
Transgender women, many of whom may be engaged in sex work as a survival strategy, 
are also often targets of violence and abuse.26 The ‘corrective’ rape of lesbian women is a 
further source of trauma and HIV risk.
The links between violence against women and increased risk for HIV are multi-faceted: 
social, physiological and psychological. The experience of violence during childhood is 
associated with increased risk-taking later in life.27 Fear of violence undermines the capacity 
of women and girls to negotiate safer sex.28 Concerns regarding the possibility of stigma 
and discrimination, abuse and violence further deter women from seeking HIV testing or 
other essential health services. Sexual violence may result in traumatic injury to women’s 
genitalia, which in turn increases susceptibility to HIV acquisition; with physiological 
susceptibility being greater in cases of experience of sexual violence as a child or adolescent 
and repeated violence.29 Results of violence may be especially severe for women who are sex 
workers, use drugs or are transgender, as a result of the compounding effects of multiple 
forms of stigma and mistreatment.
One study in Uganda found that 29% of surveyed women living with HIV reported 
physical or sexual intimate-partner violence in the last 12 months, and that those on 
antiretroviral treatment were twice as likely to report intimate-partner violence.30 This 
violence may be partly attributable to the fact that women, who have higher testing 
rates, are more likely to be the first within a household to learn their HIV status and 
may be blamed accordingly.
Despite the disturbing prevalence and severe effects of gender-based violence, services 
for women who have experienced violence remain wholly inadequate. A recent survey 
in Kenya found that only one-quarter of females and 13% of males aged 18 to 24 who 
experienced sexual violence prior to age 18 knew of a place to seek services.31 
POLICIES fOR GENDER-TRANSfORmATIVE HIV RESPONSES
Increasingly, HIV responses are incorporating a focus on gender equality. This focus 
is especially common in sub-Saharan Africa but less prominent in countries where 
epidemics are concentrated among key populations.32 In the Middle East and North 
Africa and in Eastern Europe and Central Asia, gender issues, including gender-based 
violence, often go unaddressed in national responses, with little sex-disaggregated data 
collection or participation of women’s networks and groups of women living with HIV. 
Reports from countries that conducted mid-term reviews of implementation of the 
2011 UN Political Declaration on HIV/AIDS reveal widespread recognition that 
addressing gender inequalities is a critical component of an effective HIV response for 
women. One hundred of the 109 countries reporting in 2013 indicated that elimination 
of gender inequalities is a national priority. However, only 52% of countries reported 
in 2013 that they were on track to eliminate gender inequalities. While commitments 
by national governments are encouraging, there is an urgent need to see them more 
consistently translated into robust actions. 
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Figure 7.3 suggests that country policies and resource allocation are particularly 
lagging behind in key aspects of a comprehensive effort to overcome gender 
inequality: engaging men and empowering women, as well as providing services to 
help women fulfil their sexual and reproductive needs and rights and to access HIV 
prevention and other HIV services. Barely half of countries collect data on the links 
between HIV and gender-based violence, and less than one-quarter of national HIV 
strategic plans address gender-based violence.33
FIGURE 7.3  
Policies on key elements of gender-transformative HIV programming in 72 countries
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Source: UNAIDS Agenda for Accelerated Country Action for Women, Girls, Gender Equality and HIV Mid-Term review, report to UNAIDS PCB 2012.
mOVING fORwARD
To achieve zero new HIV infections, zero AIDS-related deaths and zero discrimination, 
there should be zero tolerance for gender-based violence. Towards this end, sustained 
progress is needed to eliminate gender inequality. Effective HIV responses must 
respond to, and seek to transform, harmful gender norms that perpetuate the HIV 
epidemic. While much has been done, investment by countries is required in a number 
of strategic areas with the support of civil society and development partners. 
Specifically, countries should work to reduce HIV infection among girls and young 
women by protecting them from sexual violence and providing universal access to 
comprehensive sex education and social protection services. To ensure access, girls and 
young women may require independent access points for needed services. Policy and 
programmatic steps are needed to transform harmful gender norms to prevent gender-
based violence and provided integrated services to survivors of gender-based violence.
HIV services need to be more sensitive to sexual and reproductive health and gender 
needs and rights of women, men and transgender persons in all their diversity, in 
particular those living with HIV, from key populations at higher risk or living in conflict-
affected settings. There is a need to invest in strengthening the evidence base in order to 
successfully respond to the gender dimensions of the HIV epidemic. Epidemic contexts 
and responses should be surveyed from the perspective of gender and inclusive and 
participatory assessments undertaken. 
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The needs of women and girls must be prioritized in the post-2015 development 
agenda. The goals of zero discrimination, zero tolerance for gender-based violence, and 
zero violation of sexual and reproductive health and rights should be at the centre of 
development policy at national and international levels in discussions regarding post-
2015 priorities. 
ENGAGING THE TRANSGENDER COmmUNITy IN NICARAGUA
Nicaragua’s female transgender community is estimated at 3 000 people, with an 
estimated HIV prevalence of 15–19%. To address the transgender community’s 
health care needs, nine organizations joined together to formulate the Strategic Plan 
of Comprehensive Care for the Transgender Population.
The process of developing the plan included a situation analysis, prioritization 
of interventions, planning and identification of resources. A review of available 
evidence on underlying determinants of the epidemic among transgender 
populations identified the most robust studies on socio-economic factors, life 
and work conditions, health services, biological and genetic factors, social and 
community networks and behaviours. 
The plan aims to close gaps relating to social determinants of HIV risk and 
vulnerability for transgender people in Nicaragua. Key action steps include advocacy 
for legal changes, human rights promotion, fund-raising, training workshops, 
health education and behaviour change communication. Although the plan is both 
ambitious and visionary, more than 80% of transgender participants in the planning 
process identified the proposed actions as feasible.
Political leadership on gender-transformative responses in Liberia and 
Rwanda
Liberia’s HIV response now includes a cadre of civil society organizations such as the Catholic 
and Lutheran churches, the Concerned Muslims of Liberia, traditional leaders and the 
Liberian Women Living with HIV Network that actively champions HIV and gender issues. 
Women living with HIV, together with the Ministry of Gender and Development, are also 
represented on the Global Fund Country Co-ordinating Mechanism - the highest in-country 
decision-making body of the Global Fund to fight AIDS, Tuberculosis and Malaria.
The National AIDS Commission, chaired by the President, was formed by an Act of 
Parliament. It includes representation from women living with HIV and the Ministry of Gender 
and Development and has an annual statutory budget allocation from the Government. An 
HIV Office in the Ministry of Gender and Development has been established and largely 
funded by the Government to co-ordinate work on AIDS and gender and an amendment 
to the Health act has been passed into law to protect the rights of people including women 
living with HIV.
A mid-term review in 2012 of Liberia’s national operational plan on Women and Girls, 
Gender Equality and HIV found that the plan had resulted in a stronger national AIDS 
response, with new linkages to broader efforts against gender-based violence and 
strengthened capacity within the Government. The plan was launched in 2010 by President 
Ellen Johnson Sirleaf, accompanied by UNAIDS Executive Director, Michel Sidibe and 
Princess Mathilda of Belgium in order to contribute to rebuilding the country’s health system, 
which had been destroyed by the civil war, and to stop the high rates of rape and sexual 
violence against girls and women. 
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8. elImInate HIV-related 
stIgma, dIscrImInatIon, 
punItIVe laws and practIces
HIV-related stigma and discrimination persist as major obstacles to an effective 
HIV response in all parts of the world. The People Living with HIV Stigma Index 
and other research have quantified and enhanced understanding of the prevalence 
and impact of stigma and discrimination, with a notable share of people living with 
HIV reporting having encountered employment discrimination and denial of family 
planning, dental and other health services (Table 8.1). 
EffECTS Of STIGmA AND DISCRImINATION
Numerous studies have linked HIV-related stigma with delayed HIV testing, non-
disclosure to partners and poor engagement with HIV services.1,2,3,4 Stigma and 
discrimination persist within many health care facilities, with people living with HIV 
experiencing judgemental attitudes from providers and refusal of services. There 
have been numerous reports of involuntary sterilization of women living with HIV, 
including instances that resulted in legal action in several countries, such as Chile,5 
Kenya6 and Namibia7. 
People who experience stigma and discrimination report a range of negative effects, 
including loss of income, isolation from communities and inability to participate 
as a productive member of society as a result of their HIV status. According to 
surveys conducted via the People Living with HIV Stigma Index, instances of 
stigma and discrimination exact profound psychological costs, resulting in feelings 
of guilt, shame and suicidal thoughts. As a result of the pernicious effects of stigma 
and discrimination, on both people living with HIV and the effectiveness of HIV 
programmes, the Global Commission on HIV and the Law urged that countries take 
immediate steps to repeal punitive laws and prohibit discrimination.8 
LEGAL PROTECTION AGAINST HIV DISCRImINATION
Protective laws, adequately resourced and enforced, help broaden access to essential 
health and social services, enhance the quality and effectiveness of services and 
protect people living with or vulnerable to HIV from stigma, discrimination and 
violence. In 2012, 61% of countries reported the existence of anti-discrimination 
laws that protect people living with HIV. 
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tAblE 8.1  
People living with HIV reporting being denied health services and jobs in the last 
12 months because of their HIV status, selected countries, 2008–2013
DENIED HEALTH AND/OR 
DENTAL SERVICES (%)
DENIED fAmILy 
PLANNING SERVICES (%) 
REfUSED 
EmPLOymENT (%)
Argentina 16 45 13
Bangladesh 4 4 9
Belarus 18 19 6
Bolivia 19 5 10
Cameroon 2 3 7
China 12 ... 15
Colombia 27 ... 9
Democratic Republic of the Congo 6 ... 13
Dominican Republic 8 2 10
Ecuador 20 5 10
El Salvador 8 4 3
Ethiopia 7 6 21
Fiji 13 11 14
Germany 19 ... ...
Guatemala 6 10 3
Jamaica 3 ... ...
Malawi 5 8 ...
Malaysia ... ... 12
Mexico 14 2 5
Moldova 13 2 5
Myanmar 10 35 15
Nepal 21 3 4
Nigeria 21 6 ...
Pakistan 33 3 35
Paraguay 17 4 9
Philippines 8 6 ...
Poland 20 3 11
Russia 10 5 3
Rwanda 13 88 37
South Africa 
(O.R. Tambo Region, Eastern Cape)
5 7 3
Sri Lanka ... ... 4
Swaziland 4 1 3
Thailand 20 14 26
Ukraine 20 3 8
Zambia 8 10 17
Source: Surveys conducted using People Living with HIV Stigma Index, www.stigmaindex.org
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However, many who experience rights abuses do not obtain redress through 
legal means.9 In 17 out of 23 countries where the People Living with HIV Stigma 
Index research was conducted, less than 30% of people living with HIV who have 
experienced rights violations reported having sought legal redress (regardless of 
whether redress was successful) (see Figure 8.1). 
To ensure access to legal redress, HIV-related legal services must be in place for 
people living with HIV. In 2012, 55% of countries reported the existence of HIV-
related legal services (compared to 45% in 2008), while 57% indicated that judges 
and magistrates had received training on HIV discrimination (up from 46% in 
2008). Countries reporting the existence of free or reduced-cost legal services to 
people living with HIV through private sector law firms or university-based centres 
increased from 39% in 2008 to 52% in 2012 (see Figure 8.2). 
FIGURE 8.1  
People living with HIV whose rights have been violated and who sought legal redress, 
selected countries, 2008–2013
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CRImINALIZATION Of HIV NON-DISCLOSURE, ExPOSURE AND 
TRANSmISSION
As of 2013, 63 countries have, in at least one jurisdiction, HIV-specific provisions that 
allow for the prosecution of HIV non-disclosure, exposure and/or transmission. In other 
countries, prosecutions for HIV non-disclosure, exposure or transmission have been based 
on general criminal law offences such as sexual assault, grievous bodily harm, criminal 
nuisance, manslaughter or attempted homicide. 
Reviews of these laws and prosecutions for HIV non-disclosure, exposure and transmission 
demonstrate that they often do not reflect the best available HIV-related scientific and 
medical evidence regarding modes of HIV transmission and the benefit of treatment.10 
Furthermore, these laws and prosecutions often ignore generally applicable criminal law and 
human rights principles. For instance, prosecutions for HIV exposure have been reported 
against people living with HIV for acts such as spitting or biting that represent no risk of 
HIV transmission.11 
Prosecutions have also been reported against people living with HIV who use condoms 
during sexual relations.12 Such prosecutions are contrary to the best scientific and medical 
evidence and are likely to result in miscarriages of justice. Prosecution of people living 
with HIV for these acts is also counterproductive, in that it creates a climate of fear that 
undermines public health efforts to encourage people to voluntarily seek HIV prevention, 
testing and treatment services. 
As recommended by the Global Commission on HIV and the Law, several countries have 
begun reviewing such laws, restricted their application or dropped them altogether (see Figure 
8.3). In 2011, Fiji removed HIV-specific criminal offences for transmission or exposure from 
a broader HIV statute; Guyana firmly rejected a proposed HIV-specific criminal law; and at 
least four African countries – Congo, Guinea, Senegal and Togo – have since 2010 restricted 
the use of criminal laws solely to cases of intentional transmission. In order to provide support 
to countries in this area, UNAIDS has recently published a new guidance note: on Ending 
overly-broad criminalisation of HIV non-disclosure, exposure and transmission.13
Source: 2008, 2010, 2012 NCPI country reporting, nongovernmental sources (www.unaids.org/ncpi)
FIGURE 8.2  
countries where private-sector law firms or university-based centres provide free or reduced-
cost legal services to people living with HIV
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FIGURE 8.3  
HIV-related punitive laws, 2010–2013
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criminalization of same-sex sexual activities 
2010: International Lesbian, Gay, Bisexual, and Trans and Intersex Association. State-sponsored Homophobia (accessed 8 April 2010). 
2013: International Lesbian, Gay, Bisexual, and Trans and Intersex Association. State-sponsored Homophobia (published May 2013, 8th edition).
criminalization of sex work 
2010: United States Department of State. 2009 Country Reports on Human Rights Practices.
criminalization of HIV-transmission 
2010: Global Network of People Living with HIV. Global Criminalisation Scan (accessed 8 April 2013). 
2013: Global Network of People Living with HIV. Global Criminalisation Scan (accessed 23 June 2013).
compulsory treatment for drug users 
2010: International Planned Parenthood Federation. Verdict on a Virus: Public Health, Human Rights and Criminal Law. 
2013: UNAIDS. Punitive laws hindering the HIV response in Asia and the Pacific in June 2013.
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8CRImINALIZATION Of KEy POPULATIONS
Punitive laws focused on key populations at higher risk of HIV remain common 
throughout the world. In 2012, non-governmental informants in 70% of countries 
and national governments in 60% reported the existence of laws, regulations or 
policies that present obstacles to effective HIV prevention, treatment, care and 
support for key populations and vulnerable groups. 
Seventy-six of 193 countries currently criminalize same-sex relations, with some 
jurisdictions permitting imposition of the death penalty for convictions under such 
laws.14 Seven of the 10 countries receiving the largest amounts of funding from 
the Global Fund, as well as more than half of the 88 countries receiving PEPFAR 
support, criminalize consensual sexual relations among people of the same sex.15 
Punitive policies pertaining to drug use – including harsh penalties for possession 
of small amounts of drugs for personal use, criminalization of drug dependence, 
compulsory drug detention and bans on drug substitution therapy or needle and 
syringe programmes – prevent or deter many people who inject drugs from receiving 
the services they urgently need.16 Compulsory drug detention regimes in some 
countries are so severe that a United Nations Special Rapporteur on torture or 
other cruel, inhuman or degrading treatment or punishment singled them out for 
denunciation in 2013.17 In 2012, 12 UN system agencies jointly called for the closure 
of compulsory drug detention and rehabilitation centres. 
Most countries have laws in place that criminalize some aspects of sex work,18 and 
sex workers are often vulnerable to police harassment and mistreatment. The UN 
Development Programme (UNDP), the World Health Organization (WHO), the 
UN Population Fund (UNFPA), UNAIDS and the Network of Sex Worker Projects 
have called for the decriminalization of sex work and the elimination of the unjust 
application of laws and regulations against sex workers. 
While the situation for key populations is worsening in some countries, there are 
some encouraging signs in others of leadership and innovation to ensure rights-
based responses for key populations. For example, Malaysia is transitioning 
away from compulsory drug and rehabilitation centres, creating a network of 
non-incarceration ‘cure and care’ clinics that are associated with a 37% decline in 
injecting drug use and a 76% reduction in arrests.19 The South African Commission 
on Gender Equity, a constitutionally mandated entity, has recommended the 
decriminalization of sex work on human rights grounds.20 In June 2013, the US 
Supreme Court invalidated a US policy that required recipients of federal funds to 
explicitly agree with the government’s policy to oppose ‘prostitution’. 
PROGRAmmING TO REDUCE HIV STIGmA 
Anti-stigma programmes are most effective when they simultaneously address 
individual, organizational and public policy factors that enable stigma and 
discrimination.21 Evidence indicates that anti-stigma programming reduces social 
isolation and improves HIV treatment adherence.22 Given the particularly serious 
effects of discrimination within health care settings on people living with HIV, 
intensified efforts are needed to reduce stigmatizing attitudes and behaviours among 
health care workers. 
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A recent systematic review found that, over the last decade, the evidence base for 
effective programming to reduce stigmatizing and discriminatory attitudes has 
expanded substantially.23 Notwithstanding the clear benefits of anti-stigma efforts 
to HIV responses, such programming remains badly under-resourced. Although 
the proportion of Global Fund grants that include activities addressing stigma 
and human rights increased from 13% in Round 8 to 62% in Round 10, a review 
determined that anti-stigma activities are frequently not integrated into grant work 
plans, budgets or performance frameworks.24
LOOKING AHEAD
Nearly all countries that reported results of mid-term reviews (103 of 109) 
identified eliminating stigma and discrimination as a national priority, with 99 
having integrated this target in their national HIV strategic plans. Although 
national mid-term reviews reflect clear recognition of the harmful effects of stigma 
and discrimination on national HIV responses, 62% of countries in Eastern and 
Southern Africa and 50% of countries in Asia and the Pacific report that they are not 
on track to eliminate stigma and discrimination. 
In addition to a shortage of strategic information on stigma and discrimination and 
insufficient enforcement of anti-discrimination provisions that are in place, national 
mid-term reviews also cited the inadequacy of resources for programmes to address 
stigma and discrimination as a major impediment to achieving zero discrimination. 
The majority (54%) of the 133 countries reporting HIV spending did not invest at all 
in human rights programmes and, out of those that did invest, only eight spent more 
than 1% of the total budget on these programmes.
Urgent efforts are needed to review national legal and policy frameworks to assess 
their adherence to human rights principles, revising or repealing laws as needed 
to ensure a rights-based response that provides equitable access to essential HIV 
programmes. Every national response needs to address stigma and discrimination 
and increase access to justice. Through education and awareness-raising, responses 
should address the causes of stigma and discrimination, including irrational fears of 
infection and moral judgement.
As recommended by the Global Commission on HIV and the Law, particular attention 
needs to focus on the removal of punitive laws regarding key populations. Legal 
frameworks need to be complemented by robust, sustained investment in anti-stigma 
programming that works to forge healthier social norms of inclusion, tolerance and 
non-discrimination. Much greater investment in enforcement mechanisms for anti-
discrimination laws is needed, including support for legal services for people living 
with HIV and members of key populations, as well as programmes that educate people 
living with or affected by HIV regarding their rights. 
Efforts to eliminate stigma and discrimination must reach beyond traditional health 
stakeholders and engage all arms of government, including legislative and judicial 
branches, as well as civil society and people living with HIV. Steps are also needed 
to inform and sensitize those who make the laws (parliamentarians) and those who 
enforce them (Ministers of Interior and Justice, police, prosecutors, judges, lawyers, 
prison officials and traditional and religious leaders) regarding human rights in the 
context of HIV.
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8Leadership to end discrimination
In many countries, leadership and innovation have had a positive effect on human 
rights-based HIV responses. 
Countries across the world have taken steps to remove punitive laws that impede 
rights-based HIV responses. In 2012, Viet Nam passed legislation that effectively ended 
the practice of holding sex workers in administrative detention centres. In June 2013, 
the Chinese Guangdong province announced its intention to abolish restrictions that 
prevent people living with HIV from working as teachers. In 2012, the East African 
Legislative Assembly passed the HIV and AIDS Prevention and Management Act, which 
aims to provide a rights-based legal framework for Burundi, Kenya, Rwanda, Uganda 
and the United Republic of Tanzania. 
Several countries have also taken steps to enhance the enforcement of rights provisions 
and improve access to justice for people who have experienced discrimination. In 
2010, Moldova implemented a multi-faceted programme to address human rights 
violations against people living with HIV and key populations, providing legal aid, 
strategic litigation and human rights training for judges, lawyers and those who work in 
law enforcement. Belize, Morocco and other countries report having engaged national 
human rights institutions and ombudsperson offices to respond to allegations of 
HIV-related stigma and discrimination. Kenya has established an HIV equity tribunal to 
enable individuals who have experienced discrimination to obtain redress.
The inclusion of religious leaders in capacity-building around HIV and Human Rights has 
been strengthened by the creation in August 2013 of a new framework for dialogue 
between religious leaders and people living with HIV. 25 The Framework for Dialogue 
is a tool for increasing systematic, inclusive and sustained dialogue and collaboration 
between people living with HIV and religious leaders at the national level to address 
stigma, discrimination and other issues of concern. It is intended to be used by 
national networks of people living with HIV, networks of religious leaders living with 
HIV, religious leaders, faith-based organizations, and inter-governmental bodies and 
development agencies working on related issues, including UNAIDS country offices.
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9. elImInate HIV-related 
restrIctIons on entry, 
stay and resIdence
Since 2010, 10 countries, territories or areas have eliminated restrictions on entry, 
stay and residence for people living with HIV. However, eliminating the remaining 
HIV-related restrictions on equal freedom of movement will require intensified 
action to remove such counterproductive and discriminatory laws that remain in 
force in 43 countries. This will involve the sensitization of key decision-makers in 
relation to how HIV is and is not transmitted, improving public attitudes about 
people living with HIV and about migrants, and galvanizing commitment to HIV 
programmes that reach people on the move. 
HIV-related restrictions on entry, stay and residence are not justified by public 
health considerations. There is no evidence that individuals who travel pose a risk of 
HIV transmission and, in any event, available evidence and extensive international 
experience indicate that evidence- and rights-based strategies, not mandatory 
testing and other punitive or coercive approaches, are most effective in preventing 
transmission. Furthermore, HIV-related restrictions on entry, stay and residence may 
limit the uptake of HIV voluntary testing and hinder adherence to HIV treatment. 
PROGRESS TOwARDS ELImINATION Of HIV-RELATED 
RESTRICTIONS ON ENTRy, STAy AND RESIDENCE
The overwhelming majority of countries worldwide have rejected restrictions on 
the entry, stay and residence of people living with HIV (see Table 9.1), and there is 
a clear international trend towards repeal of such discriminatory laws. From 2000 
to mid-2013, the number of countries, territories and areas with HIV-related travel 
restrictions fell by more than half – from 96 to 43 (see Figure 9.1). 
From 2010 to 2012, eight countries (Armenia, China, Fiji, Namibia, the 
Republic of Korea, the Republic of Moldova, Ukraine and the US) repealed their 
restrictions. In January 2013, Mongolia lifted HIV-related restrictions on entry, 
stay and residence when it implemented broader legislation that also removed 
employment restrictions that prevented people living with HIV from taking 
certain jobs, including in the food industry. In mid-2013, Andorra reported the 
removal of its restrictions.
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Source: for 2000, Weissner, P., Haerry, D. Entry and residency restrictions for people living with HIV. International Task Team on HIV-related Travel Restrictions.
First Meeting, 24–25 February 2008, Geneva, Switzerland; for 2008, 2010, 2012 and 2013, UNAIDS database on HIV-related restrictions on entry, stay and 
residence.
FIGURE 9.1  
Number of countries with restrictions on entry, stay and residence for people living with HIV, 
2000–2013 and 2015 target
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countries, territories and areas with restrictions on entry, stay or residence for people living 
with HIV as of July 2013
Source: UNAIDS database on HIV-related restrictions on entry, stay and residence, updated August 2013.
1. Aruba 
2. Australia
3. Bahrain
4. Belarus
5. Belize
6. Brunei Darussalam
7. Comoros
8. Cuba
9. Cyprus
10. Democratic People’s Republic of Korea
11. Dominican Republic
12. Egypt
13. Iraq
14. Israel
15. Jordan
16. Kuwait
17. Lebanon
18. Lithuania
19. Malaysia
20. Marshall Islands
21. Mauritius
22. New Zealand
23. Nicaragua
24. Oman
25. Papua New Guinea
26. Paraguay
27. Qatar
28. Russian Federation
29. Samoa
30. Saudi Arabia
31. Singapore
32. Slovakia
33. Solomon Islands
34. Sudan
35. Syrian Arab Republic
36. Chinese Taipei
37. Tajikistan
38. Tonga
39. Turkmenistan
40. Turks and Caicos Islands
41. United Arab Emirates
42. Uzbekistan
43. Yemen
CONTINUING CHALLENGES POSED By DISCRImINATORy 
RESTRICTIONS
Although the trend is towards removal of restrictions on entry, stay and residence 
of people living with HIV, these laws persist in many countries (see Figure 9.2). Five 
countries maintain a blanket ban on entry by people living with HIV, five require 
proof of HIV-negative status for those seeking to stay for 10–90 days, and at least 19 
countries authorize deportation of individuals found to be living with HIV. 
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These laws and the ways they are carried out violate the human rights of people 
living with HIV. People seeking to relocate or migrate are often tested without 
informed consent or counselling and are then denied visas. Others who become 
infected in the country of destination are found to be HIV-positive when seeking 
to renew their visas; they are often not told they are being tested for HIV, given 
their test results or counselled but instead are detained and deported summarily, 
sometimes without the opportunity to collect their personal effects and receive their 
final salary. Restrictions on entry, stay and residence based on HIV status exist in 
all Gulf Cooperation Council (GCC) countries, a major destination for migrant 
workers, in particular from Asia.
Women migrants face additional challenges as they are often more vulnerable to 
physical, sexual and verbal abuse. Many sexual abuse survivors, fearing societal 
blame and stigmatization as a result of the sexual abuse and violence they have 
experienced, never report incidents, thereby facing alone the negative physical and 
psychological consequences of rape, including the risk of being infected by HIV.1 
The trauma of abuse and violence is compounded by the stigma and financial 
consequences of being deported on account of their HIV-positive status.
Restrictions in the Middle East and North Africa not only affect people migrating 
from other regions but also people living with HIV within the region. In reporting 
FIGURE 9.2  
Restrictions on entry, stay and residence for people living with HIV as of July 2013
Source: UNAIDS database on HIV-related restrictions on entry, stay and residence, updated August 2013.
WELCOME
Restrictions on entry, stay and residence for people living with HIV, which may involve the following: mandatory and periodic HIV testing 
without confidentiality, counselling or referral to services or treatment; incarceration; deportation; total bar on entry or bars on short-term 
or long-term stays/work; and waiver requirements.
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FIGURE 9.3  
Mid-term reviews, priorities and plans in countries with restrictions on entry, stay and residence 
for people living with HIV, 2013
Source: Mid-term review reports 2013
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the findings of its mid-term review, Jordan highlights the practice of national 
restrictions on migrants from neighbouring countries (notably Egypt, Iraq and 
Syria), as well as the effect of mandatory HIV screening policies on the estimated 1 
million Jordanians working abroad, mostly in GCC countries. 
Of the 43 countries, territories and areas worldwide that retain discriminatory HIV-
related restrictions on entry, stay and residence, 15 submitted reports on their national 
mid-term reviews. Among these countries, only four (Egypt, Jordan, Mauritius and 
Paraguay) have indicated that lifting restrictions is a priority issue, and three of these 
countries (Egypt, Mauritius and Paraguay) indicate that they are on-track to achieve 
this target by 2015. Lebanon, Malaysia, Papua New Guinea, Sudan and Tajikistan have 
also reported that they are on-track for lifting restrictions by 2015 (see Figure 9.3). 
GROwING RECOGNITION Of THE HARm CAUSED By HIV-
RELATED RESTRICTIONS ON ENTRy, STAy AND RESIDENCE
There is increasing understanding that discriminatory restrictions on entry, stay 
and residence are inconsistent with the needs of an increasingly globalized business 
world. In November 2012, over 40 corporate chief executive officers (CEOs), 
representing nearly 2 million employees worldwide, cited both economic and 
human rights considerations in urging repeal of all HIV-related travel restrictions. 
Representing such prominent employers as Coca-Cola, Heineken, Johnson & 
Johnson, Kenya Airways, Merck, the National Basketball Association, Pfizer and 
Thomson Reuters, the CEOs emphasized that companies need the freedom to send 
their employees overseas, regardless of their HIV status, in order to succeed in a 
globalized, highly competitive world. 
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TOwARDS 2015
Reaching the goal of eliminating remaining HIV-related restrictions on entry, stay 
and residence will require accelerated progress, particularly in sensitizing senior 
officials and advancing law and regulatory reform. National coalitions or task forces 
– bringing together both government officials and civil society, including people 
living with HIV – have a potentially important role to play in building momentum 
for elimination of these restrictions. Efforts to educate and persuade key decision-
makers should engage ministries of health, interior, migration, justice and labour.
It appears that the largest numbers of migrants affected by mandatory HIV testing, 
restrictions and deportation are those seeking entry, stay and residence in countries 
of the Middle East and North Africa region. As such, much greater regional action is 
required, for example through study visits from national officials in GCC countries 
to other countries in the Middle East and North Africa that have no restrictions, 
such as Morocco and Tunisia. As countries that have lifted restrictions and reported 
no negative effects, such learning opportunities can play a potentially important 
role in helping decision-makers understand that no public health rationale exists for 
HIV-related restrictions on entry, stay and residence.
In lieu of discriminatory policies, countries should ensure that all people on the move, 
citizens and non-citizens alike, should have access to essential HIV services. Countries 
should implement evidence- and rights-based HIV prevention, treatment, care and 
support programmes for people on the move, for both the formal and informal sectors.
REfORmING ImmIGRATON LEGISLATION
Papua New Guinea is among the countries reporting action towards lifting its 
restrictions. A review of the Migration Act and Migration Regulation, which is being led 
by the Department of Foreign Affairs and Immigration, has presented an opportunity 
for national stakeholders in the HIV response to call for the removal of HIV and AIDS 
from the list of diseases that are defined as representing a ‘danger to the community’. 
As part of this review process, there have been calls for consular officials, immigration 
officers and medical officers to be provided with guidance that supports consistent 
application of immigration medical assessment criteria. All immigration health 
assessments should respect the HIV/AIDS Management and Prevention Act, which 
makes discrimination on the basis of HIV status unlawful. 
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10. strengtHen HIV 
IntegratIon
As sustainability has become a more prominent international priority in responding 
to AIDS, strides have been made towards the elimination of parallel systems and the 
integration of HIV in health systems and broader development efforts.* Countries 
are prioritizing the integration of HIV in diverse systems, with more than 90% of 
countries (103 out of 109) indicating that integration is a national priority. However, 
a smaller proportion (77 out of 109, or 70%), report that they are on track to achieve 
national integration commitments, with those not on track often citing donor 
policies and practices that use disease-specific funding channels and reporting 
requirements that undermine integration efforts.
Different countries have taken different approaches, reflecting in part the need for 
population-specific service delivery. The scope and scale of the integration of HIV 
services into other health services, and vice versa, vary depending on the nature of 
the epidemic and the needs of key populations. 
ALIGNING NATIONAL PLANNING PROCESSES 
At the level of national planning, many countries have taken major steps to align 
HIV with broader health or development plans. The overwhelming majority of 
countries that undertook mid-term reviews (82%) address integration in their 
national HIV strategic plans or equivalent documents. Many countries (45%) 
report that HIV has been aligned with other disease-specific planning (such as joint 
planning for HIV and other sexually transmitted infections (STIs)), or integrated 
into national health and development plans. 
In their efforts to harmonize planning, countries have taken a number of approaches. 
Several countries (e.g. Brazil, Cameroon, Côte d’Ivoire, Fiji, Madagascar, Malawi, 
Mauritania, Republic of Moldova and Togo) have aligned or fully integrated strategic 
planning and budget cycles for HIV and health generally. Through the Sector-Wide 
Approach and the Pool Fund mechanism, Nepal is financing HIV interventions 
within a broader framework that promotes integrated approaches. Other countries, 
such as Ethiopia, Gabon, Georgia, Malawi, Morocco, Thailand, Senegal, South Africa 
and Zambia, are in the process of integrating – or have integrated to different degrees 
– HIV services into their national health insurance, health funds or other domestic 
funding schemes. 
* As this cross-cutting section addresses integration of various HIV services (e.g. HIV counselling and 
testing, antiretroviral treatment, prevention of mother-to-child transmission and HIV/TB services) with 
health services and broader development, it touches on issues that are also addressed – yet from a 
different angle – in other sections of this report.
98  |  Strengthen HIV integration  UNAIDS 2013 Global report  |  99
10
SERVICE INTEGRATION
As HIV responses were first being developed and scaled up, many countries 
established specialized service systems to address the needs of people living 
with HIV. While this approach was warranted in earlier stages of the response, it 
has become increasingly clear that maximizing the effectiveness of services and 
sustaining responses demands strategic integration of HIV services within health 
systems and other sectors. 
No single approach to service integration will fit the needs of all countries. 
Diverse approaches to service integration have been adopted in different settings, 
responding in part to differences in underlying HIV service systems, health 
systems and needs and priorities of countries. Notwithstanding the plethora of 
approaches pursued, available evidence suggests that integrated approaches are 
beneficial, enhancing service uptake and improving coordination of care. Examples 
include tuberculosis and HIV services,1,2 services to prevent mother-to-child 
transmission integrated with maternal and child health care,3,4 linking HIV and 
chronic non-communicable diseases5,6 and, more broadly, HIV services integrated 
within primary health care and overall health and community systems.7 In addition 
to improving access to health services, integrated service delivery models may 
reduce unit costs, as reflected in lower costs of HIV testing and counselling when 
such services are integrated with other health services.8
Progress has been made in the integration of service delivery, as reflected by 2012 
GARPR data and reports of countries that conducted mid-term reviews9 (see 
Figure 10.1): 
 • HIV and tuberculosis. Among 105 countries reporting, 56 (53%) have taken 
active steps towards either fully integrating HIV/TB services or strengthening 
joint service provision. The degree of HIV/TB integration varied considerably, 
ranging from fully integrated service delivery to the addition of specific 
services (e.g. tuberculosis diagnostic services in HIV clinics). Several 
countries, including Armenia, Botswana, Comoros, Democratic Republic 
of the Congo, Ethiopia, Eritrea, Namibia, North Sudan and South Africa, 
identified the need to further integrate HIV and tuberculosis services in order 
to scale-up timely diagnosis and treatment of HIV/TB co-infections. 
 • Services to prevent mother-to-child transmission and support maternal and 
child health. Of the 118 countries reporting pertinent data, 70% said they had 
integrated HIV testing, counselling and services within antenatal care and 
maternal and child health services to prevent mother-to-child transmission. 
Forty-three countries report having linkages or integrated service delivery 
between services to prevent mother-to-child HIV transmission and broader 
maternal and child health services. Country examples include Gambia, 
Guinea-Bissau, Ethiopia and Viet Nam (see box below). 
 • HIV and services for STIs and sexual and reproductive health. Two-thirds 
of countries report having integrated HIV in sexual and reproductive health 
services, with more than 45 countries having conducted the rapid assessment 
for sexual and reproductive health and HIV linkages. For example, Nepal 
has established a coordination mechanism to integrate reproductive health 
services within HIV programmes, with coordinated provider training 
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programmes for HIV and sexual and reproductive health. In Morocco, the 
integration of HIV into public health services expanded the number of people 
receiving HIV counselling and testing, from 46 000 in 2010 to 222 620 people 
tested in 2012, while coverage of services for HIV-positive pregnant women 
to prevent mother-to-child HIV transmission rose from 29% in 2010 to 48% 
in 2012. Several countries reported that national leadership is key to effective 
integration. Some donors have separate funding streams for HIV and STI 
services, which may hinder effective integration.  
 • HIV and non-communicable diseases. HIV service scale-up has provided 
impetus for the development of broader chronic care systems in many countries 
where services for chronic diseases have historically been scarce. Among 115 
countries submitting pertinent information, 27 (23%) report having integrated 
HIV counselling, testing and antiretroviral treatment with services for chronic 
non-communicable diseases. Among countries that have taken steps towards 
such service integration, the extent and depth of integration varies. Some have 
started realizing positive synergies and spill-over effects for management of HIV 
and other chronic diseases.  
 • HIV and primary care and overall health and community systems. Fifty-five 
per cent of countries report having integrated HIV counselling and testing 
in general outpatient care, with 32% of countries integrating antiretroviral 
treatment in such settings. Primary health care and antenatal settings are 
providing integrated services for reproductive health, STIs, tuberculosis and 
HIV in Armenia; the Bahamas have integrated HIV and STI services in primary 
care; stand-alone antiretroviral clinics in Namibia are in the process of being 
integrated within primary health care. Brazil is providing integrated HIV and 
primary care services through the country’s public, decentralized health service. 
Additional efforts are needed to strengthen community systems and promote 
further decentralization of HIV service provision. 
Although integrated service delivery models have the potential to generate benefits 
in all regions, what works in one country or community may not be effective in 
another. As many key populations avoid mainstream service systems, especially in 
settings where stigma and discrimination are rife or where their status or behaviours 
are criminalized, special service delivery approaches are needed.10 
100  |  Strengthen HIV integration  UNAIDS 2013 Global report  |  101
10
FIGURE 10.1  
Integration of HIV in health service delivery
More than 90% of countries have reported a high number 
of services offering integrated HIV counselling and testing
and tuberculosis services (70 countries, 92%), while three 
countries (4%) had started the process, according to their 
2013 Global AIDS Progress Reports.
56 countries (53%) have gone further in integrating
services and they reported a high number of services
jointly addressing HIV counselling and testing, 
antiretroviral therapy and tuberculosis services.
HIV and tuberculosis services
79 countries (67%) reported that they had 
are many facilities offering HIV counselling 
and testing, integrated with sexual and 
reproductive health services.
34 countries (29%) reported that few facilities 
had integrated HIV counselling and testing 
with sexual and reproductive health services.
Sexual and reproductive
health services
71 countries (55%) reported a high 
number of HIV counselling and 
testing services integrated with 
general outpatient care in health 
facilities; 45 (35%) reported that 
only few services were providing 
joint services. 
37 countries (32%) had gone further 
in integrating services and reported 
a high number of facilities offering 
integrated HIV counselling and 
testing, antiretroviral therapy and 
general outpatient care; yet 51 
countries (44%) reported that only 
a few facilities offered integrated 
services.
HIV integrated
in primary health care
83 countries (70%) reported 
a high number of facilities 
integrating HIV counselling and 
testing with antenatal care, 
maternal and child healthcare and 
services to prevent mother-to-
child transmission.
However, 31 countries (26%) 
reported that only a few services 
provided HIV counselling and 
testing and mother-to-child 
transmission prevention services 
integrated with antenatal care or 
maternal and child health.
Ending mother-to-child 
HIV transmission, and 
supporting maternal and 
child health
33 countries (28%) reported 
that a high number of facilities 
were integrating services for HIV 
counselling and testing with those for 
chronic non-communicable diseases, 
while 45 countries (38%) reported that 
few of these services were integrated.
27 countries (23%) reported that 
there are many facilities integrating 
HIV counselling and testing with 
antiretroviral therapy and chronic 
non-communicable disease services, 
yet 47 countries (41%) reported 
few facilities were integrating these 
services.
HIV and non-
communicable diseases
Source: GARPR 2013
102  |  Strengthen HIV integration
INTEGRATION Of HIV wITHIN NON-HEALTH SECTORS
Critical enablers and development synergies ensure the efficacy, equity and roll-out 
of basic HIV programme activities. By integrating HIV responses not only within 
health sectors but also within non-health sectors, the sustainability of a robust 
response to HIV is enhanced. 
Use of social protection initiatives to promote HIV prevention is one example of 
how HIV responses may be effectively integrated within non-health development 
initiatives. Likewise, as food insecurity has been found to inhibit effective HIV 
prevention and treatment,11 HIV should be integrated within nutrition, feeding 
and other programmes to increase food security. Several studies have generated 
promising findings regarding the potential impact of education in general12 and cash 
transfers in particular on young people’s sexual behaviour and HIV risks.13,14,15
TOwARDS 2015
There is strong official support among countries for the integration of HIV with 
broader health and development efforts. Of the countries that reported results of 
mid-term reviews and identified HIV integration as a national priority, 94 have 
included integration commitments in their national HIV strategic plans.
Although considerable gains have been made in taking AIDS out of isolation, 
countries are at different stages of integrating the HIV response within the broader 
health sector and other development sectors. 
National mid-term reviews identified numerous challenges, including the need for 
enhanced leadership and commitment to eliminating parallel structures, moving 
towards service integration and improving cross-sectoral collaboration. Several 
countries reported that external funding should move from funding single diseases 
to funding integrated health services. Countries reported that to effectively improve 
their health systems requires investment in delivery of integrated services, such as 
physical infrastructure, new training requirements, new management approaches 
or integrated reporting structures for monitoring and evaluation. Systems for 
monitoring the effectiveness of integrated service delivery models should be 
improved and more detailed evidence provided. Such data can then be used to 
develop meaningful indicators with which impact can be measured. 
BEyOND 2015
Debates regarding the post-2015 agenda articulate a global health agenda that 
focuses on health rather than disease. As the previous discussion reveals, the HIV 
response is already recognizing and acting on the need to integrate elements of the 
HIV response within the health system. The high priority accorded to HIV, however, 
must be maintained. Those aspects of the response that have made it effective must 
be protected and embedded in future health and development goals. Some aspects 
of the HIV response do, however, require careful consideration regarding whether 
integration of services will add value. Key populations living with HIV may not 
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necessarily access public health care services. Service delivery models need to be 
tailored to the needs of these groups, for instance through the provision of bundled 
outreach services or other models, and to involve affected communities.16
As a pathfinder in the provision of person-centred and rights-based services, the 
HIV response has many lessons to share with the emerging health and development 
paradigm. 
Eliminating parallel systems and usefully integrating programmes and services 
require three different sets of action: 
 • The national-level policy and planning perspective. Joint budgeting is needed 
for HIV and other disease programmes or overall health sectors, and health 
planning should be informed by and linked to other sectoral planning (e.g. 
finance, education, labour, human rights, gender). HIV monitoring should be 
embedded in broader health information systems. 
 • The management perspective. Donor approaches should support, rather 
than undermine, integrated planning and programme management, while 
governance structures should be strengthened and adapted to support 
integration. Human resources for health will need to be rigorously analysed 
to ensure sufficient numbers of workers and the right distribution of skills to 
deliver integrated health care. 
 • The point of service delivery perspective. At the point of delivery, HIV services 
should be integrated with health and other services where appropriate. Quality 
of service delivery should be closely monitored and improved where necessary. 
As the body of evidence relating to country experiences expands, capturing both 
positive and negative outcomes will be essential to providing clearer guidance and 
indicators on how best to approach integration of the HIV response within wider 
health and development efforts and identifying which elements are key to successful 
outcomes.
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NATIONAL LEADERSHIP AND INNOVATION
Integrating services for the prevention of mother-to-child HIV 
transmission within maternal and child health services.
Throughout the world, countries are pursuing innovative approaches to the 
integration of prevention of mother-to-child HIV transmission with broader maternal 
and child health services. These approaches, in turn, are improving health outcomes 
for women and children.
As a result of an integrated approach to service delivery for women and children, 
Gambia has exceeded its target for the number of babies born to women living 
with HIV who receive cotrimoxazole within the first two months of life (target: 944; 
current: 1070 (113%)). Uptake of prophylaxis has been aided by its alignment with 
the DPT1 immunization schedule delivered through integrated infant welfare clinics. 
Guinea-Bissau has integrated HIV testing and counselling within sexual and 
reproductive health services. Prevention of mother-to-child HIV transmission is an 
integral component of antenatal care, integrated within almost all public sector 
antenatal clinics, with systematic screening and an acceptance rate for HIV testing 
of 85%. Through scale-up of services integrated in health facilities and antenatal 
clinics, the proportion of HIV-positive pregnant women receiving antiretroviral 
therapy increased from 32% in 2010 to 50% in 2012.
Ethiopia has steadily integrated a wide range of HIV-related services – including HIV 
testing and counselling, antiretroviral therapy and prevention of mother-to-child 
transmission – within the reproductive, maternal, newborn and child health platform. 
Despite these steps, coverage for services to prevent new infections among children 
remains below 50%, underscoring the need for continued efforts to generate robust 
demand for services and improve access to and quality of services. It is especially 
important that prevention of new HIV infections among children be fully integrated 
within maternal and child health programmes and reproductive health services at 
diverse points of delivery.
In 2012, Viet Nam launched a pilot model to integrate services for prevention of 
mother-to-child HIV transmission, sexually transmitted infections and sexual and 
reproductive health in two provinces with low HIV prevalence. For the provision 
of integrated health services, including HIV counselling and testing, the model 
uses midwives as the first point of contact for pregnant women. Viet Nam plans to 
expand the model to other regions following regional needs assessment of sexual 
and reproductive health and HIV service needs, human resource capacity and 
infrastructure. To further support service integration, management of prevention of 
mother-to-child transmission is being transferred from the Viet Nam Administration 
for AIDS Control to the Maternal and Child Health Department within the Ministry 
of Health.
From a regional perspective, in Eastern and Southern Africa, the regional Joint 
Linkages SRH/HIV Project aims to integrate HIV and sexual and reproductive 
health services at the policy development, service delivery and knowledge 
generation levels. Funded by the European Union, the project has undertaken rapid 
assessments and baseline surveys in various countries, mapped HIV and sexual and 
reproductive health services, and implemented a set of integrated interventions. 
The project has been aligned with other regional initiatives, including the Maputo 
Plan of Action and the Southern African Development Community strategies for 
HIV and sexual and reproductive health. 
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A2  |  Annex: Introduction
IntroductIon
The data presented in the following tables were compiled by UNAIDS through two 
sources:  
 • Global AIDS Response Progress Reporting (GARPR), an online tool in which 
countries submit their most recent data on global indicators, and 
 • Modelled HIV estimates, created in standard modelling software by national 
epidemiological teams.
In their GARPR reports, countries provided extensive information on progress 
towards core HIV indicators. With the exception of modest adaptations to two 
indicators, core indicators remained the same for the latest round of reporting, 
permitting identification of trends at global, regional and country levels. While 
the full National Commitments and Policies Instrument, an extensive survey of 
governmental and non-governmental informants regarding HIV-related policies, 
human rights issues and service provision, was not included in 2013 GARPR, 
a short questionnaire about policies was included. A full description of the 
indicators used in GARPR and the process of compiling those data can be found at 
http://goo.gl/KYeUPt. 
The modelled HIV estimates are clearly identified in the following tables. The 
estimates are calculated using the Spectrum computer package. National files 
are developed in countries and submitted to UNAIDS for review. The results are 
approved by national representatives. For countries that do not create modelled 
estimates, draft files are created based on published or otherwise available 
information and the estimates presented in the tables are limited to ranges. Regional 
totals are calculated using all files and are not limited to country-submitted files.  The 
estimates are also limited to ranges if the country has very limited data to inform the 
model. Estimates for children in concentrated epidemics are imprecise and thus only 
ranges are provided. 
For more information on the Spectrum computer package used for the estimates 
please visit www.futuresinstitute.org. For more information on the assumptions 
and process of developing the HIV-related parameters used in Spectrum please visit 
www.epidem.org. 
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The analysis of the data set in the Global Report 2013 is based on the data portrayed 
in this data annex. The data is also made available in different visual formats on 
aidsinfo.unaids.org. This allows the data to be used for effective communication in 
reaching the targets at global and country levels.
For those interested in further analysis and disaggregation of data over longer time 
periods, the full data-set is made available through www.aidsinfoonline.org. 
We wish you an interesting journey to the data on HIV and AIDS.
http://aidsinfo.unaids.org       http://www.aidsinfoonline.org
A4  |  Annex: Epidemiology
EPIDEMIoloGY
Estimated HIV prevalence - adult (ages 15-49) 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
caribbean 1.3 1.2 1.5 1.0 0.9 1.1
Bahamas ... 3.4 3.5 ... 3.2 3.5
Barbados ... 0.6 0.9 ... 0.8 1.1
Cuba <0.1 <0.1 <0.1 <0.1 <0.1 0.1
Dominican Republic 1.3 1.1 1.5 0.7 0.6 0.8
Haiti 2.9 2.6 3.2 2.1 1.9 2.3
Jamaica 2.4 2.0 2.7 1.7 1.4 2.0
Trinidad and Tobago ... 1.1 1.4 ... 1.4 1.7
East Asia <0.1 <0.1 0.1 0.1 0.1 0.1
China1 ... ... ... <0.1 <0.1 0.1
Democratic People's 
Republic of Korea
... ... ... ... ... ...
Japan ... <0.1 <0.1 ... <0.1 <0.1
Mongolia <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Republic of Korea ... <0.1 <0.1 ... <0.1 <0.1
Eastern Europe and 
central Asia 
0.5 0.4 0.6 0.7 0.6 0.9
Armenia 0.1 <0.1 0.2 0.2 0.1 0.3
Azerbaijan <0.1 <0.1 0.1 0.2 0.1 0.2
Belarus 0.1 0.1 0.2 0.4 0.4 0.5
Georgia <0.1 <0.1 <0.1 0.3 0.2 0.4
Kazakhstan ... ... ... ... ... ...
Kyrgyzstan <0.1 <0.1 <0.1 0.3 0.2 0.4
Republic of Moldova 0.5 0.4 0.6 0.7 0.6 0.9
Russian Federation ... ... ... ... ... ...
Tajikistan <0.1 <0.1 0.1 0.3 0.2 0.6
Ukraine 0.9 0.7 1.0 0.9 0.7 1.0
Uzbekistan 0.3 0.2 0.3 0.1 0.1 0.2
latin America 0.5 0.4 0.5 0.4 0.3 0.5
Argentina 0.4 0.3 0.5 0.4 0.3 0.5
Belize 1.8 1.6 1.9 1.4 1.3 1.6
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EPIDEMIoloGY
Estimated HIV prevalence - adult (ages 15-49) 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Bolivia (Plurinational 
State of)
0.4 0.3 0.6 0.3 0.1 0.4
Brazil ... 0.4 0.5 ... 0.4 0.5
Chile 0.4 0.2 0.6 0.4 0.2 0.6
Colombia 0.6 0.5 0.8 0.5 0.4 0.7
Costa Rica 0.2 0.2 0.2 0.3 0.3 0.3
Ecuador 0.6 0.3 0.9 0.6 0.4 1.1
El Salvador 0.8 0.6 1.2 0.6 0.4 1.2
Guatemala 0.8 0.5 1.3 0.7 0.4 1.5
Guyana 0.7 0.4 1.1 1.3 0.8 2.1
Honduras 1.2 1.0 1.5 0.5 0.4 0.7
Mexico 0.3 0.3 0.4 0.2 0.2 0.3
Nicaragua <0.1 <0.1 <0.1 0.3 0.2 0.4
Panama 1.2 1.0 1.5 0.7 0.5 1.0
Paraguay 0.1 <0.1 0.4 0.3 0.2 0.6
Peru 0.6 0.4 0.8 0.4 0.2 1.3
Suriname 1.2 1.0 1.4 1.1 1.0 1.2
Uruguay 0.5 0.3 0.7 0.7 0.5 1.0
Venezuela (Bolivarian 
Republic of)
0.6 0.4 0.9 0.6 0.4 0.9
Middle East and 
North Africa 
0.1 0.1 0.1 0.1 0.1 0.2
Algeria ... ... ... ... ... ...
Djibouti 2.3 1.8 2.8 1.2 1.0 1.5
Egypt <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Iran (Islamic Republic 
of)
<0.1 <0.1 <0.1 0.2 0.1 0.2
Lebanon ... ... ... ... ... ...
Morocco <0.1 <0.1 <0.1 0.1 0.1 0.2
Oman ... <0.1 0.1 ... 0.1 0.3
Somalia 0.7 0.4 1.1 0.5 0.4 0.8
Sudan ... ... ... ... ... ...
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Tunisia <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Yemen <0.1 <0.1 <0.1 0.1 <0.1 0.3
North America 0.5 0.4 0.7 0.5 0.4 0.8
Canada ... 0.2 0.3 ... 0.2 0.4
United States of 
America
... 0.5 0.7 ... 0.4 0.9
oceania 0.2 0.2 0.3 0.2 0.2 0.3
Australia ... <0.1 0.1 ... 0.1 0.2
Fiji <0.1 <0.1 0.2 0.2 0.2 0.2
New Zealand ... <0.1 <0.1 ... <0.1 0.1
Papua New Guinea 0.7 0.5 1.0 0.5 0.4 0.7
South and  
South-East Asia 
0.4 0.3 0.4 0.3 0.2 0.4
Afghanistan <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Bangladesh <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Bhutan <0.1 <0.1 0.1 0.2 0.1 0.6
Cambodia 1.5 1.1 2.6 0.8 0.5 1.5
India1 0.4 0.3 0.5 0.3 0.2 0.3
Indonesia <0.1 <0.1 0.2 0.4 0.3 0.7
Lao People's 
Democratic Republic
0.1 <0.1 0.2 0.3 0.2 0.3
Malaysia 0.4 0.3 0.6 0.4 0.3 0.6
Maldives <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Myanmar 0.8 0.7 0.9 0.6 0.5 0.6
Nepal 0.4 0.4 0.5 0.3 0.2 0.4
Pakistan <0.1 <0.1 <0.1 <0.1 <0.1 0.2
Philippines <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Singapore ... <0.1 0.1 ... <0.1 0.1
Sri Lanka <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Thailand 1.8 1.7 1.9 1.1 1.0 1.2
Viet Nam 0.3 <0.1 0.6 0.4 0.1 0.8
EPIDEMIoloGY
Estimated HIV prevalence - adult (ages 15-49) 
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Sub-Saharan Africa 5.8 5.5 6.3 4.7 4.4 5.0
Angola 1.8 1.3 2.6 2.3 1.9 2.8
Benin 1.6 1.4 1.8 1.1 1.0 1.3
Botswana 28.1 26.7 29.6 23.0 21.8 24.4
Burkina Faso 2.2 1.9 2.6 1.0 0.8 1.1
Burundi 2.9 2.4 3.4 1.3 1.0 1.5
Cameroon 5.2 4.9 5.6 4.5 4.1 4.9
Cape Verde 0.5 0.4 0.6 0.2 0.2 0.4
Central African 
Republic
... ... ... ... ... ...
Chad 3.8 3.3 4.4 2.7 2.3 3.4
Comoros <0.1 <0.1 <0.1 2.1 1.6 2.8
Congo 4.7 4.3 5.3 2.8 2.5 3.0
Côte d'Ivoire 6.4 5.9 7.2 3.2 2.8 3.8
Democratic Republic 
of the Congo
1.5 1.4 1.7 1.1 1.0 1.2
Equatorial Guinea ... 2.0 6.6 ... 3.4 9.7
Eritrea 2.0 1.5 2.7 0.7 0.5 0.9
Ethiopia 3.6 3.3 3.9 1.3 1.2 1.5
Gabon 6.1 5.4 6.9 4.0 3.5 4.8
Gambia 1.0 0.7 1.3 1.3 0.9 1.7
Ghana 2.3 2.0 2.6 1.4 1.2 1.6
Guinea 1.3 1.1 1.5 1.7 1.4 2.0
Guinea-Bissau 2.8 2.1 3.8 3.9 2.9 5.3
Kenya 8.5 8.2 8.8 6.1 5.9 6.3
Lesotho 23.4 21.9 24.9 23.1 21.7 24.7
Liberia 2.3 1.9 2.6 0.9 0.7 1.1
Madagascar 0.7 0.5 0.8 0.5 0.4 0.6
Malawi 15.5 14.8 16.4 10.8 10.2 11.4
Mali 1.6 1.3 2.0 0.9 0.7 1.2
Mauritania 0.6 0.5 0.8 0.4 0.3 0.6
EPIDEMIoloGY
Estimated HIV prevalence - adult (ages 15-49) 
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Mauritius 1.0 0.9 1.0 1.2 1.2 1.3
Mozambique 9.0 8.1 10.2 11.1 9.9 12.9
Namibia 15.0 13.0 17.1 13.3 11.4 15.2
Niger 1.0 0.9 1.2 0.5 0.4 0.6
Nigeria 3.5 3.0 4.0 3.1 2.8 3.5
Rwanda 4.4 4.0 4.9 2.9 2.6 3.2
Sao Tome and Principe 1.1 0.7 1.5 1.0 0.8 1.4
Senegal 0.5 0.4 0.6 0.5 0.4 0.6
Sierra Leone 1.0 0.7 1.4 1.5 1.0 2.1
South Africa 15.3 14.7 15.8 17.9 17.3 18.4
South Sudan 3.1 1.4 5.2 2.7 1.8 4.0
Swaziland 24.8 23.2 26.6 26.5 24.6 28.3
Togo 4.5 3.9 5.4 2.9 2.5 3.5
Uganda 6.8 5.9 7.8 7.2 6.4 8.4
United Republic of 
Tanzania
7.5 6.7 8.3 5.1 4.6 5.7
Zambia 15.1 14.2 16.0 12.7 11.9 13.7
Zimbabwe 24.3 23.0 25.6 14.7 13.8 15.6
western and  
central Europe 
0.2 0.2 0.2 0.2 0.2 0.2
Austria ... <0.1 0.2 ... 0.3 0.5
Belgium ... 0.1 0.2 ... 0.3 0.4
Bulgaria ... <0.1 <0.1 ... <0.1 0.1
Croatia ... <0.1 <0.1 ... <0.1 <0.1
Czech Republic ... <0.1 <0.1 ... <0.1 <0.1
Denmark ... 0.1 0.1 ... 0.2 0.2
Estonia ... 0.5 0.8 ... 1.0 1.6
Finland ... <0.1 <0.1 ... <0.1 0.1
France ... 0.3 0.4 ... 0.3 0.4
Germany ... <0.1 0.1 ... 0.1 0.2
Greece ... 0.1 0.2 ... 0.1 0.2
EPIDEMIoloGY
Estimated HIV prevalence - adult (ages 15-49) 
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Hungary ... <0.1 <0.1 ... <0.1 <0.1
Iceland ... 0.2 0.3 ... 0.2 0.3
Ireland ... 0.2 0.3 ... 0.2 0.4
Israel ... 0.1 0.2 ... 0.1 0.3
Italy ... 0.3 0.3 ... 0.2 0.3
Latvia ... 0.3 0.5 ... 0.5 1.1
Lithuania ... <0.1 <0.1 ... <0.1 0.1
Luxembourg ... 0.2 0.3 ... 0.2 0.4
Malta ... <0.1 0.1 ... <0.1 0.1
Netherlands ... 0.2 0.3 ... 0.2 0.3
Norway ... 0.1 0.2 ... 0.1 0.2
Poland ... <0.1 0.1 ... <0.1 0.2
Portugal ... 0.4 0.7 ... 0.5 0.9
Romania ... <0.1 0.2 ... <0.1 0.2
Serbia ... <0.1 <0.1 ... <0.1 <0.1
Slovakia ... <0.1 <0.1 ... <0.1 <0.1
Slovenia ... <0.1 <0.1 ... <0.1 <0.1
Spain ... 0.4 0.5 ... 0.4 0.5
Sweden ... 0.1 0.2 ... 0.1 0.2
Switzerland ... 0.3 0.4 ... 0.3 0.5
Turkey ... <0.1 <0.1 ... <0.1 <0.1
United Kingdom of 
Great Britain and 
Northern Ireland
... 0.1 0.2 ... 0.2 0.3
GlobAl 0.8 0.7 0.9 0.8 0.7 0.9
EPIDEMIoloGY
Estimated HIV prevalence - adult (ages 15-49) 
1 Estimates for China and India are based on 2011 national estimates.
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EPIDEMIoloGY
People living with HIV (all ages) 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
caribbean  280 000  250 000  310 000  250 000  220 000  280 000
Bahamas ... 5 800 6 100 ... 6 700 7 400
Barbados ... <1 000 1 400 ... 1 300 1 800
Cuba 2 800 2 100 4 000 4 700 3 400 8 200
Dominican Republic 64 000 55 000 74 000 45 000 39 000 52 000
Haiti 160 000 140 000 180 000 150 000 130 000 160 000
Jamaica 34 000 28 000 40 000 28 000 23 000 34 000
Trinidad and Tobago ... 9 200 12 000 ... 13 000 15 000
East Asia  370 000  270 000  530 000  880 000  650 000 1 200 000
China1 ... ... ... 780 000 620 000 940 000
Democratic People's 
Republic of Korea
... ... ... ... ... ...
Japan ... 5 400 8 000 ... 7 100 11 000
Mongolia <500 <200 <500 1 100 1 000 1 200
Republic of Korea ... 5 500 8 900 ... 12 000 20 000
Eastern Europe and 
central Asia 
 860 000  700 000 1 100 000 1 300 000 1 000 000 1 700 000
Armenia 1 700 <1 000 3 500 3 500 2 300 5 300
Azerbaijan 3 600 2 500 5 800 10 000 8 000 14 000
Belarus 7 200 5 700 9 600 23 000 21 000 26 000
Georgia 1 500 1 100 2 200 6 600 5 200 9 500
Kazakhstan ... ... ... ... ... ...
Kyrgyzstan 1 000 <1 000 1 800 8 700 6 000 13 000
Republic of Moldova 14 000 11 000 18 000 19 000 15 000 23 000
Russian Federation ... ... ... ... ... ...
Tajikistan 1 400 <500 4 000 12 000 6 900 24 000
Ukraine 230 000 200 000 260 000 230 000 190 000 270 000
Uzbekistan 37 000 23 000 51 000 30 000 23 000 40 000
latin America 1 300 000 1 100 000 1 500 000 1 500 000 1 200 000 1 900 000
Argentina 78 000 59 000 97 000 98 000 80 000 120 000
Belize 2 500 2 200 2 800 3 100 2 800 3 400
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EPIDEMIoloGY
People living with HIV (all ages)  
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Bolivia  
(Plurinational State of)
18 000 13 000 27 000 16 000 8 500 24 000
Brazil ... 430 000 520 000 ... 530 000 660 000
Chile 33 000 16 000 50 000 39 000 25 000 61 000
Colombia 140 000 100 000 180 000 150 000 110 000 190 000
Costa Rica 5 200 4 900 5 500 9 800 8 800 11 000
Ecuador 40 000 22 000 60 000 52 000 36 000 99 000
El Salvador 26 000 19 000 38 000 25 000 16 000 45 000
Guatemala 49 000 31 000 76 000 58 000 36 000 130 000
Guyana 3 300 2 000 5 200 7 200 4 300 12 000
Honduras 43 000 36 000 52 000 26 000 21 000 33 000
Mexico 190 000 160 000 230 000 170 000 150 000 210 000
Nicaragua 1 300 <1 000 2 500 9 600 6 600 15 000
Panama 21 000 17 000 26 000 17 000 12 000 22 000
Paraguay 3 600 2 300 11 000 13 000 7 400 24 000
Peru 94 000 67 000 130 000 76 000 36 000 230 000
Suriname 3 500 2 800 4 100 4 000 3 600 4 400
Uruguay 8 400 5 800 12 000 13 000 9 800 19 000
Venezuela (Bolivarian 
Republic of)
84 000 56 000 130 000 110 000 74 000 160 000
Middle East and 
North Africa 
 150 000  100 000  230 000  260 000  200 000  380 000
Algeria ... ... ... ... ... ...
Djibouti 9 700 7 600 12 000 7 700 6 200 9 400
Egypt 2 000 1 300 3 400 6 500 4 300 10 000
Iran  
(Islamic Republic of)
15 000 7 000 29 000 71 000 53 000 100 000
Lebanon ... ... ... ... ... ...
Morocco 8 700 6 200 11 000 30 000 22 000 40 000
Oman ... <500 1 300 ... 2 800 5 700
Somalia 29 000 16 000 44 000 31 000 21 000 47 000
Sudan ... ... ... ... ... ...
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EPIDEMIoloGY
People living with HIV (all ages)  
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Tunisia <500 <500 1 100 2 300 1 400 3 800
Yemen 4 100 2 000 7 500 19 000 8 900 47 000
North America  970 000  800 000 1 200 000 1 300 000  980 000 1 900 000
Canada ... 36 000 51 000 ... 59 000 85 000
United States of 
America
... 750 000 1 200 000 ... 920 000 1 800 000
oceania  37 000  30 000  45 000  51 000  43 000  59 000
Australia ... 10 000 15 000 ... 18 000 27 000
Fiji <500 <500 <1 000 <1 000 <1 000 1 200
New Zealand ... 1 300 1 900 ... 2 200 3 600
Papua New Guinea 22 000 15 000 32 000 25 000 20 000 31 000
South and  
South-East Asia 
3 700 000 2 900 000 4 600 000 3 900 000 2 900 000 5 200 000
Afghanistan 1 600 <1 000 5 300 4 300 1 600 14 000
Bangladesh 4 000 <500 6 900 8 000 3 100 82 000
Bhutan <500 <500 <500 1 100 <1 000 2 700
Cambodia 110 000 77 000 190 000 76 000 59 000 120 000
India1 2 400 000 1 900 000 2 800 000 2 100 000 1 700 000 2 600 000
Indonesia 83 000 <100 260 000 610 000 390 000 940 000
Lao People's 
Democratic Republic
3 300 2 500 6 600 12 000 10 000 13 000
Malaysia 54 000 38 000 80 000 82 000 60 000 110 000
Maldives <100 <100 <100 <100 <100 <100
Myanmar 220 000 190 000 250 000 200 000 170 000 220 000
Nepal 50 000 41 000 63 000 49 000 39 000 65 000
Pakistan 10 000 6 500 19 000 87 000 50 000 160 000
Philippines 5 400 3 200 11 000 15 000 11 000 23 000
Singapore ... 2 200 3 900 ... 3 000 4 700
Sri Lanka 1 900 1 200 3 500 3 000 2 000 5 000
Thailand 660 000 610 000 700 000 440 000 400 000 480 000
Viet Nam 160 000 41 000 320 000 260 000 70 000 490 000
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EPIDEMIoloGY
People living with HIV (all ages)  
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Sub-Saharan Africa 21 700 000 20 200 000 23 500 000 25 000 000 23 500 000 26 600 000
Angola 130 000 96 000 190 000 250 000 210 000 300 000
Benin 62 000 55 000 70 000 72 000 64 000 80 000
Botswana 300 000 280 000 320 000 340 000 320 000 360 000
Burkina Faso 180 000 160 000 210 000 110 000 99 000 130 000
Burundi 130 000 110 000 150 000 89 000 75 000 110 000
Cameroon 480 000 450 000 530 000 600 000 550 000 660 000
Cape Verde 1 300 <1 000 1 400 <1 000 <1 000 1 200
Central African 
Republic
... ... ... ... ... ...
Chad 190 000 160 000 220 000 210 000 180 000 270 000
Comoros <100 <100 <100 7 900 6 000 11 000
Congo 92 000 84 000 100 000 74 000 68 000 81 000
Côte d'Ivoire 630 000 570 000 710 000 450 000 390 000 530 000
Democratic Republic 
of the Congo
440 000 400 000 490 000 480 000 440 000 530 000
Equatorial Guinea ... 6 700 22 000 ... 17 000 49 000
Eritrea 30 000 21 000 41 000 18 000 14 000 24 000
Ethiopia 1 300 000 1 200 000 1 400 000 760 000 690 000 840 000
Gabon 42 000 37 000 48 000 41 000 36 000 48 000
Gambia 7 200 5 400 9 600 14 000 11 000 19 000
Ghana 270 000 230 000 310 000 240 000 200 000 270 000
Guinea 64 000 52 000 77 000 120 000 97 000 140 000
Guinea-Bissau 21 000 15 000 28 000 41 000 32 000 55 000
Kenya 1 600 000 1 500 000 1 700 000 1 600 000 1 600 000 1 700 000
Lesotho 280 000 260 000 300 000 360 000 340 000 380 000
Liberia 33 000 28 000 39 000 22 000 19 000 26 000
Madagascar 55 000 44 000 67 000 59 000 49 000 69 000
Malawi 1 100 000 1 000 000 1 100 000 1 100 000 1 100 000 1 200 000
Mali 110 000 87 000 140 000 100 000 79 000 120 000
Mauritania 9 100 7 000 12 000 10 000 7 700 15 000
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Mauritius 7 300 6 700 8 200 11 000 9 600 12 000
Mozambique 850 000 760 000 970 000 1 600 000 1 400 000 1 800 000
Namibia 170 000 150 000 200 000 220 000 190 000 250 000
Niger 57 000 48 000 69 000 46 000 39 000 56 000
Nigeria 2 600 000 2 200 000 3 000 000 3 400 000 3 100 000 3 800 000
Rwanda 240 000 220 000 270 000 210 000 190 000 230 000
Sao Tome and Principe <1 000 <1 000 1 300 1 400 1 000 1 900
Senegal 27 000 23 000 32 000 43 000 35 000 52 000
Sierra Leone 27 000 19 000 37 000 58 000 42 000 82 000
South Africa 4 300 000 4 100 000 4 700 000 6 100 000 5 800 000 6 400 000
South Sudan 120 000 55 000 210 000 150 000 100 000 230 000
Swaziland 150 000 140 000 160 000 210 000 200 000 230 000
Togo 130 000 110 000 160 000 130 000 110 000 150 000
Uganda 1 000 000 910 000 1 200 000 1 500 000 1 400 000 1 800 000
United Republic of 
Tanzania
1 500 000 1 400 000 1 700 000 1 500 000 1 300 000 1 600 000
Zambia 940 000 880 000 1 000 000 1 100 000 1 000 000 1 200 000
Zimbabwe 1 800 000 1 700 000 2 000 000 1 400 000 1 300 000 1 500 000
western and  
central Europe 
 590 000  550 000  620 000  860 000  800 000  930 000
Austria ... 3 800 7 000 ... 13 000 25 000
Belgium ... 6 600 11 000 ... 16 000 26 000
Bulgaria ... 1 100 2 200 ... 2 400 5 800
Croatia ... <500 <1 000 ... <1 000 1 600
Czech Republic ... 1 100 1 400 ... 1 800 2 300
Denmark ... 3 000 4 000 ... 5 500 7 500
Estonia ... 3 500 5 300 ... 7 200 11 000
Finland ... 1 500 2 000 ... 2 600 3 600
France ... 98 000 130 000 ... 120 000 180 000
Germany ... 36 000 44 000 ... 62 000 78 000
Greece ... 7 300 9 200 ... 9 300 13 000
EPIDEMIoloGY
People living with HIV (all ages)  
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EPIDEMIoloGY
People living with HIV (all ages)  
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Hungary ... 2 000 3 200 ... 2 600 4 800
Iceland ... <500 <500 ... <500 <1 000
Ireland ... 3 600 6 100 ... 6 300 10 000
Israel ... 4 200 7 300 ... 6 700 11 000
Italy ... 84 000 120 000 ... 110 000 140 000
Latvia ... 3 500 6 100 ...  6 100 12 000
Lithuania ... <1 000 <1 000 ... <1 000 1 800
Luxembourg ... <500 <1 000 ... <1 000 1 100
Malta ... <200 <500 ... <500 <500
Netherlands ... 14 000 24 000 ... 20 000 34 000
Norway ... 2 400 4 300 ... 3 600 6 300
Poland ... 16 000 29 000 ... 25 000 46 000
Portugal ... 26 000 45 000 ... 38 000 62 000
Romania ... 12 000 20 000 ... 14 000 21 000
Serbia ... <500 3 800 ... 2 200 5 500
Slovakia ... <200 <500 ... <500 <1 000
Slovenia ... <200 <500 ... <500 <1 000
Spain ... 110 000 140 000 ... 140 000 170 000
Sweden ... 5 400 10 000 ... 7 200 13 000
Switzerland ... 11 000 17 000 ... 16 000 27 000
Turkey ... 1 300 2 300 ... 3 900 8 000
United Kingdom of 
Great Britain and 
Northern Ireland
... 37 000 56 000 ... 76 000 120 000
GlobAl 30 000 000 27 200 000 33 100 000 35 300 000 32 200 000 38 800 000
1 Estimates for China and India are based on 2011 national estimates.
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EPIDEMIoloGY
People living with HIV (ages 15+)   
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
caribbean  250 000  230 000  280 000  230 000  210 000  260 000
Bahamas ... 5 700 6 000 ... 6 600 7 300
Barbados ... <1 000 1 400 ... 1 300 1 700
Cuba 2 700 2 100 4 000 4 700 3 300 8 100
Dominican Republic 61 000 53 000 70 000 42 000 37 000 49 000
Haiti 140 000 120 000 160 000 130 000 120 000 150 000
Jamaica 33 000 28 000 39 000 28 000 23 000 33 000
Trinidad and Tobago ... 9 000 11 000 ... 13 000 15 000
East Asia  370 000  270 000  520 000  880 000  650 000 1 200 000
China1 ... ... ... ... ... ...
Democratic People's 
Republic of Korea
... ... ... ... ... ...
Japan ... 5 400 8 000 ... 7 100 11 000
Mongolia <200 <200 <500 1 000 <1 000 1 100
Republic of Korea ... 5 400 8 900 ... 12 000 20 000
Eastern Europe and 
central Asia 
 850 000  690 000 1 000 000 1 300 000  990 000 1 600 000
Armenia 1 700 <1 000 3 500 3 500 2 300 5 300
Azerbaijan 3 600 2 500 5 800 10 000 7 900 14 000
Belarus 7 200  5 700 9 500 23 000 21 000 25 000
Georgia 1 500 1 100 2 200 6 600 5 200 9 400
Kazakhstan ... ... ... ... ... ...
Kyrgyzstan <1 000 <1 000 1 700 8 700 5 900 13 000
Republic of Moldova 14 000 11 000 18 000 19 000 15 000 23 000
Russian Federation ... ... ... ... ... ...
Tajikistan 1 300 <500 3 800 11 000 6 500 23 000
Ukraine 230 000 200 000 260 000 230 000 190 000 260 000
Uzbekistan 36 000 22 000 50 000 27 000 21 000 38 000
latin America 1 300 000 1 100 000 1 500 000 1 400 000 1 200 000 1 800 000
Argentina 77 000 58 000 96 000 95 000 77 000 110 000
Belize 2 400 2 100 2 600 2 800 2 600 3 100
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EPIDEMIoloGY
People living with HIV (ages 15+)   
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Bolivia  
(Plurinational State of)
18 000 13 000 26 000 15 000 7 700 23 000
Brazil ... 420 000 510 000 ... 520 000 650 000
Chile 33 000 16 000 49 000 39 000 25 000 61 000
Colombia 140 000 100 000 180 000 140 000 100 000 190 000
Costa Rica 5 000 4 700 5 300 9 400 8 500 10 000
Ecuador 39 000 21 000 58 000 51 000 36 000 98 000
El Salvador 25 000 18 000 36 000 24 000 16 000 43 000
Guatemala 46 000 29 000 72 000 53 000 33 000 120 000
Guyana 3 100 1 900 4 900 7 000 4 100 11 000
Honduras 39 000 32 000 47 000 23 000 19 000 30 000
Mexico 190 000 150 000 230 000 170 000 150 000 210 000
Nicaragua 1 300 <1 000 2 400 9 500 6 500 15 000
Panama 20 000 16 000 25 000 16 000 12 000 21 000
Paraguay 3 500 2 200 11 000 13 000 7 200 24 000
Peru 89 000 64 000 120 000 72 000 34 000 230 000
Suriname 3 300 2 700 3 900 3 800 3 400 4 300
Uruguay 8 300 5 800 12 000 13 000 9 600 19 000
Venezuela  
(Bolivarian Republic of)
80 000 53 000 120 000 100 000 72 000 160 000
Middle East and 
North Africa 
 130 000  93 000  210 000  250 000  180 000  350 000
Algeria ... ... ... ... ... ...
Djibouti 9 200 7 200 11 000 6 500 5 200 8 000
Egypt 1 900 1 200 3 300 6 300 4 100 9 900
Iran  
(Islamic Republic of)
15 000 7 000 29 000 70 000 52 000 100 000
Lebanon ... ... ... ... ... ...
Morocco 8 300 5 900 11 000 29 000 22 000 39 000
Oman ... <500 1 300 ... 2 700 5 600
Somalia 25 000 15 000 40 000 26 000 17 000 40 000
Sudan ... ... ... ... ... ...
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EPIDEMIoloGY
People living with HIV (ages 15+)   
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Tunisia <500 <500 1 100 2 300 1 300 3 700
Yemen 3 800 1 900 7 200 18 000 8 300 44 000
North America  970 000  800 000 1 200 000 1 300 000  980 000 1 900 000
Canada ... 36 000 51 000 ... 59 000 85 000
United States  
of America
... 740 000 1 200 000 ... 920 000 1 800 000
oceania  35 000  29 000  43 000  48 000  40 000  55 000
Australia ... 10 000 15 000 ... 18 000 27 000
Fiji <500 <500 <1 000 <1 000 <1 000 1 100
New Zealand ... 1 300 1 900 ... 2 200 3 600
Papua New Guinea 21 000 14 000 29 000 22 000 18 000 28 000
South and  
South-East Asia 
3 600 000 2 800 000 4 500 000 3 700 000 2 700 000 4 900 000
Afghanistan 1 500 <1 000 5 000 4 000 1 500 13 000
Bangladesh 3 900 <500 6 700 7 600 3 000 80 000
Bhutan <500 <500 <500 1 000 <500 2 600
Cambodia 100 000 74 000 180 000 71 000 51 000 130 000
India1 2 300 000 1 900 000 2 700 000 1 900 000 1 600 000 2 400 000
Indonesia 82 000 <100 260 000 590 000 380 000 910 000
Lao People's 
Democratic Republic
3 200 2 400 6 000 11 000 9 300 12 000
Malaysia 53 000 38 000 79 000 81 000 59 000 110 000
Maldives <100 <100 <100 <100 <100 <100
Myanmar 220 000 190 000 250 000 190 000 160 000 210 000
Nepal 49 000 40 000 61 000 45 000 36 000 60 000
Pakistan 9 800 6 400 19 000 85 000 48 000 160 000
Philippines 5 100 3 000 10 000 14 000 11 000 22 000
Singapore ... 2 200 3 700 ... 2 800 4 600
Sri Lanka 1 800 1 100 3 500 2 900 1 900 4 800
Thailand 650 000 610 000 690 000 430 000 390 000 470 000
Viet Nam 160 000 41 000 310 000 250 000 68 000 480 000
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EPIDEMIoloGY
People living with HIV (ages 15+)   
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Sub-Saharan Africa 19 400 000 18 000 000 21 000 000 22 100 000 20 700 000 23 400 000
Angola 110 000 85 000 170 000 220 000 180 000 270 000
Benin 56 000 49 000 63 000 62 000 56 000 70 000
Botswana 290 000 270 000 310 000 330 000 310 000 350 000
Burkina Faso 140 000 120 000 160 000 94 000 81 000 110 000
Burundi 100 000 86 000 120 000 72 000 60 000 88 000
Cameroon 450 000 410 000 490 000 540 000 500 000 590 000
Cape Verde 1 100 <1 000 1 200 <1 000 <1 000 1 100
Central African 
Republic
... ... ... ... ... ...
Chad 170 000 140 000 190 000 180 000 150 000 220 000
Comoros <100 <100 <100 7 800 5 900 11 000
Congo 77 000 70 000 86 000 61 000 56 000 67 000
Côte d'Ivoire 570 000 510 000 650 000 390 000 340 000 450 000
Democratic Republic 
of the Congo
370 000 340 000 410 000 390 000 360 000 430 000
Equatorial Guinea ... 6 000 20 000 ... 15 000 43 000
Eritrea 26 000 19 000 35 000 15 000 12 000 20 000
Ethiopia 1 100 000 1 000 000 1 200 000 590 000 540 000 660 000
Gabon 40 000 35 000 45 000 37 000 33 000 44 000
Gambia 6 600 4 900 8 800 13 000 9 400 17 000
Ghana 240 000 210 000 280 000 210 000 180 000 240 000
Guinea 58 000 48 000 71 000 100 000 86 000 130 000
Guinea-Bissau 19 000 14 000 26 000 35 000 27 000 48 000
Kenya 1 400 000 1 300 000 1 500 000 1 400 000 1 400 000 1 500 000
Lesotho 250 000 240 000 280 000 320 000 300 000 340 000
Liberia 31 000 26 000 36 000 18 000 15 000 22 000
Madagascar 48 000 39 000 59 000 50 000 41 000 60 000
Malawi 910 000 860 000 980 000 950 000 900 000 1 000 000
Mali 94 000 77 000 120 000 84 000 66 000 100 000
Mauritania 8 200 6 300 11 000 8 700 6 300 12 000
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Mauritius 7 300 6 700 8 100 10 000 9 500 12 000
Mozambique 780 000 700 000 900 000 1 400 000 1 200 000 1 600 000
Namibia 160 000 140 000 180 000 200 000 180 000 230 000
Niger 51 000 43 000 62 000 36 000 30 000 45 000
Nigeria 2 400 000 2 000 000 2 800 000 3 000 000 2 700 000 3 300 000
Rwanda 200 000 180 000 220 000 180 000 160 000 200 000
Sao Tome and Principe <1 000 <1 000 1 200 1 200 <1 000 1 500
Senegal 24 000 20 000 29 000 37 000 30 000 44 000
Sierra Leone 25 000 18 000 35 000 52 000 37 000 74 000
South Africa 4 100 000 3 900 000 4 400 000 5 700 000 5 500 000 6 000 000
South Sudan 110 000 52 000 190 000 140 000 88 000 200 000
Swaziland 130 000 120 000 140 000 190 000 180 000 200 000
Togo 120 000 100 000 140 000 110 000 95 000 130 000
Uganda 830 000 730 000 950 000 1 400 000 1 200 000 1 600 000
United Republic of 
Tanzania
1 300 000 1 200 000 1 400 000 1 200 000 1 100 000 1 400 000
Zambia 800 000 750 000 860 000 950 000 900 000 1 000 000
Zimbabwe 1 600 000 1 600 000 1 700 000 1 200 000 1 100 000 1 300 000
western and  
central Europe 
 590 000  550 000  620 000  860 000  800 000  920 000
Austria ... 3 800 7 000 ... 13 000 25 000
Belgium ... 6 600 11 000 ... 16 000 26 000
Bulgaria ... 1 100 2 200 ... 2 300 5 700
Croatia ... <500 <1 000 ... <1 000 1 500
Czech Republic ... 1 100 1 400 ... 1 800 2 300
Denmark ... 3 000 4 000 ... 5 500 7 400
Estonia ... 3 500 5 200 ... 7 200 11 000
Finland ... 1 500 2 000 ... 2 600 3 600
France ... 98 000 130 000 ... 120 000 180 000
Germany ... 36 000 44 000 ... 62 000 78 000
Greece ... 7 300 9 200 ... 9 300 13 000
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EPIDEMIoloGY
People living with HIV (ages 15+)   
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Hungary ... 2 000 3 200 ... 2 600 4 800
Iceland ... <500 <500 ... <500 <1 000
Ireland ... 3 600 6 100 ... 6 300 10 000
Israel ... 4 200 7 300 ... 6 700 11 000
Italy ... 84 000 120 000 ... 110 000 140 000
Latvia ... 3 500 6 100 ... 6 000 12 000
Lithuania ... <1 000 <1 000 ... <1 000 1 700
Luxembourg ... <500 <1 000 ... <1 000 1 100
Malta ... <200 <500 ... <500 <500
Netherlands ... 14 000 24 000 ... 20 000 34 000
Norway ... 2 400 4 300 ... 3 600 6 300
Poland ... 16 000 29 000 ... 25 000 46 000
Portugal ... 26 000 45 000 ... 38 000 62 000
Romania ... 12 000 20 000 ... 13 000 21 000
Serbia ... <500 3 600 ... 2 100 5 400
Slovakia ... <200 <500 ... <500 <1 000
Slovenia ... <200 <500 ... <500 <1 000
Spain ... 110 000 140 000 ... 140 000 170 000
Sweden ... 5 400 10 000 ... 7 200 13 000
Switzerland ... 11 000 17 000 ... 16 000 27 000
Turkey ... 1 300 2 200 ... 3 900 7 900
United Kingdom of 
Great Britain and 
Northern Ireland
... 37 000 56 000 ... 76 000 120 000
GlobAl 27 500 000 24 900 000 30 300 000 32 100 000 29 100 000 35 300 000
1 Estimates for China and India are based on 2011 national estimates.
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
caribbean 25 000 22 000 28 000 12 000 9 400 14 000
Bahamas ... <1 000 <1 000 ... <500 <500
Barbados ... <200 <200 ... <100 <100
Cuba ... ... ... ... ... ...
Dominican Republic 5 900 5 000 7 100 <500 <200 <1 000
Haiti 14 000 12 000 16 000 8 500 6 900 11 000
Jamaica 2 900 2 300 3 600 1 400 <1 000 2 000
Trinidad and Tobago ... 1 200 1 600 ... <1 000 <1 000
East Asia 68 000 50 000 96 000 81 000 34 000 160 000
China1 ... ... ... ... ... ...
Democratic People's 
Republic of Korea
... ... ... ... ... ...
Japan ... ... ... ... ... ...
Mongolia ... ... ... ... ... ...
Republic of Korea ... ... ... ... ... ...
Eastern Europe and 
central Asia 
140 000 110 000 180 000 130 000 89 000 190 000
Armenia <500 <200 1 200 <500 <200 <1 000
Azerbaijan ... ... ... ... ... ...
Belarus 2 000 1 500 2 600 1 600 <1 000 2 400
Georgia <500 <500 <1 000 <1 000 <1 000 1 400
Kazakhstan ... ... ... ... ... ...
Kyrgyzstan <500 <200 <500 1 700 <1 000 2 600
Republic of Moldova 1 700 1 200 3 900 1 800 1 400 2 500
Russian Federation ... ... ... ... ... ...
Tajikistan <1 000 <500 3 000 2 100 <1 000 5 500
Ukraine 35 000 30 000 40 000 11 000 7 500 15 000
Uzbekistan ... ... ... ... ... ...
latin America 97 000 78 000 120 000 86 000 57 000 150 000
Argentina ... ... ... ... ... ...
Belize <500 <500 <500 <200 <100 <200
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Estimated new HIV infections (all ages)  
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Bolivia 
(Plurinational State of)
2 300 1 600 3 500 1 100 <200 1 900
Brazil ... ... ... ... ... ...
Chile ... ... ... ... ... ...
Colombia 11 000 7 700 15 000 9 000 5 600 14 000
Costa Rica ... ... ... ... ... ...
Ecuador ... ... ... ... ... ...
El Salvador ... ... ... ... ... ...
Guatemala ... ... ... ... ... ...
Guyana ... ... ... ... ... ...
Honduras ... ... ... ... ... ...
Mexico 10 000 7 400 14 000 9 300 6 200 14 000
Nicaragua <500 <200 <500 1 500 <1 000 2 600
Panama ... ... ... ... ... ...
Paraguay ... ... ... ... ... ...
Peru ... ... ... ... ... ...
Suriname <500 <500 <500 <500 <200 <500
Uruguay ... ... ... ... ... ...
Venezuela (Bolivarian 
Republic of)
... ... ... ... ... ...
Middle East and 
North Africa 
21 000 16 000 30 000 32 000 22 000 47 000
Algeria ... ... ... ... ... ...
Djibouti 1 700 1 400 2 200 <500 <200 <1 000
Egypt ... ... ... ... ... ...
Iran 
(Islamic Republic of)
... ... ... ... ... ...
Lebanon ... ... ... ... ... ...
Morocco ... ... ... ... ... ...
Oman ... ... ... ... ... ...
Somalia ... ... ... ... ... ...
Sudan ... ... ... ... ... ...
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Tunisia ... ... ... ... ... ...
Yemen ... ... ... ... ... ...
North America 46 000 33 000 63 000 48 000 15 000 100 000
Canada ... ... ... ... ... ...
United States of 
America
... 30 000 61 000 ... 13 000 100 000
oceania 4 300 3 500 5 400 2 100 1 500 2 700
Australia ... ... ... ... ... ...
Fiji ... ... ... ... ... ...
New Zealand ... ... ... ... ... ...
Papua New Guinea 3 500 2 600 4 600 <1 000 <500 1 200
South and  
South-East Asia
400 000 310 000 520 000 270 000 160 000 440 000
Afghanistan ... ... ... ... ... ...
Bangladesh <1 000 <100 3 500 <1 000 <500 19 000
Bhutan ... ... ... ... ... ...
Cambodia 6 000 3 200 14 000 1 400 <1 000 2 900
India1 260 000 220 000 310 000 130 000 80 000 230 000
Indonesia 29 000 <100 68 000 76 000 47 000 150 000
Lao People's 
Democratic Republic
... ... ... ... ... ...
Malaysia 6 200 4 200 9 500 7 400 4 800 11 000
Maldives ... ... ... ... ... ...
Myanmar 25 000 20 000 30 000 7 100 5 700 8 900
Nepal 9 500 7 100 13 000 1 200 <1 000 2 700
Pakistan 2 300 1 500 4 100 19 000 8 700 39 000
Philippines <1 000 <500 1 600 1 800 1 100 4 000
Singapore ... ... ... ... ... ...
Sri Lanka <500 <200 <1 000 <500 <200 <1 000
Thailand 24 000 21 000 38 000 8 800 5 500 24 000
Viet Nam 31 000 11 000 57 000 13 000 2 300 28 000
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Estimated new HIV infections (all ages)  
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Sub-Saharan Africa 2 600 000 2 400 000 2 800 000 1 600 000 1 400 000 1 800 000
Angola 19 000 14 000 26 000 28 000 21 000 36 000
Benin 7 400 6 500 8 500 4 100 3 200 5 200
Botswana 27 000 25 000 30 000 12 000 11 000 15 000
Burkina Faso 8 400 6 700 10 000 5 800 3 800 8 300
Burundi 5 600 4 500 7 100 4 600 2 400 7 500
Cameroon 62 000 56 000 70 000 45 000 38 000 53 000
Cape Verde ... ... ... ... ... ...
Central African 
Republic
... ... ... ... ... ...
Chad 23 000 19 000 31 000 16 000 12 000 21 000
Comoros ... ... ... ... ... ...
Congo 8 900 8 000 10 000  4 700 3 800 5 800
Côte d'Ivoire 58 000 49 000 70 000 30 000 22 000 39 000
Democratic Republic 
of the Congo
51 000 47 000 57 000 34 000 30 000 40 000
Equatorial Guinea ... ... ... ... ... ...
Eritrea 1 900 1 200 3 100 <500 <500 <1 000
Ethiopia 130 000 110 000 140 000 20 000 14 000 29 000
Gabon 5 900 5 000 6 800 1 000 <500 2 100
Gambia 1 500 1 200 2 100  <1 000 <500 1 300
Ghana 28 000 24 000 32 000 8 000 4 500 12 000
Guinea ... ... ... ... ... ...
Guinea-Bissau 4 200 3 200 5 500 3 600 2 300  5 700
Kenya 140 000 130 000 150 000 98 000 91 000 110 000
Lesotho 33 000 30 000 36 000 26 000 23 000 30 000
Liberia 4 300 3 500 5 100 <500 <200 <500
Madagascar ... ... ... ... ... ...
Malawi 110 000 100 000 120 000 66 000 58 000 76 000
Mali 11 000 8 700 15 000 4 200 1 600 7 300
Mauritania ... ... ... ... ... ...
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Mauritius ... ... ... ... ... ...
Mozambique 160 000 150 000 190 000 120 000 97 000 150 000
Namibia 23 000 20 000 27 000 10 000 8 000 13 000
Niger 7 800 6 500 9 600 1 100 <1 000 1 800
Nigeria 400 000 350 000 470 000 260 000 210 000 310 000
Rwanda 17 000 15 000 20 000 7 800 5 800 11 000
Sao Tome and Principe <500 <200 <500 <100 <100 <100
Senegal 4 700 3 900 5 700 2 000 1 300 3 000
Sierra Leone 6 100 4 500 8 200 3 100 1 200 6 900
South Africa 640 000 600 000 700 000 370 000 340 000 420 000
South Sudan ... ... ... ... ... ...
Swaziland 17 000 16 000 19 000 12 000 9 800 14 000
Togo 18 000 15 000 21 000 4 800 2 800 7 500
Uganda 94 000 82 000 110 000 140 000 110 000 170 000
United Republic of 
Tanzania
130 000 120 000 150 000 83 000 69 000 100 000
Zambia 100 000 95 000 110 000 56 000 49 000 64 000
Zimbabwe 130 000 120 000 150 000 69 000 59 000 79 000
western and  
central Europe
... ... ... 29 000 25 000 35 000
Austria ... ... ... ... ... ...
Belgium ... ... ... ... ... ...
Bulgaria ... ... ... ... ... ...
Croatia ... ... ... ... ... ...
Czech Republic ... ... ... ... ... ...
Denmark ... ... ... ... ... ...
Estonia ... ... ... ... ... ...
Finland ... ... ... ... ... ...
France ... 3 600 6 600 ... 2 500 9 600
Germany ... ... ... ... ... ...
Greece ... ... ... ... ... ...
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Estimated new HIV infections (all ages)  
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Hungary ... ... ... ... ... ...
Iceland ... ... ... ... ... ...
Ireland ... ... ... ... ... ...
Israel ... ... ... ... ... ...
Italy ... ... ... ... ... ...
Latvia ... ... ... ... ... ...
Lithuania ... ... ... ... ... ...
Luxembourg ... ... ... ... ... ...
Malta ... ... ... ... ... ...
Netherlands ... ... ... ... ... ...
Norway ... ... ... ... ... ...
Poland ... ... ... ... ... ...
Portugal ... ... ... ... ... ...
Romania ... ... ... ... ... ...
Serbia ... ... ... ... ... ...
Slovakia ... ... ... ... ... ...
Slovenia ... ... ... ... ... ...
Spain ... ... ... ... ... ...
Sweden ... ... ... ... ... ...
Switzerland ... ... ... ... ... ...
Turkey ... ... ... ... ... ...
GlobAl 3 400 000 3 100 000 3 700 000 2 300 000 1 900 000 2 700 000
1 Estimates for China and India are based on 2011 national estimates. 
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
caribbean 22 000 19 000 24 000 11 000 9 100 14 000
Bahamas ... <1 000 <1 000 ... <500 <500
Barbados ... <200 <200 ... <100 <100
Cuba ... ... ... ... ... ...
Dominican Republic 5 200 4 400 6 300 <500 <200 <1 000
Haiti 11 000 9 700 13 000 8 200 6 600 10 000
Jamaica 2 700 2 100 3 300 1 400 <1 000 1 900
Trinidad and Tobago ... 1 200 1 500 ... <500 <1 000
East Asia 67 000 49 000 95 000 80 000 34 000 150 000
China1 ... ... ... ... ... ...
Democratic People's 
Republic of Korea
... ... ... ... ... ...
Japan ... ... ... ... ... ...
Mongolia ... ... ... ... ... ...
Republic of Korea ... ... ... ... ... ...
Eastern Europe and 
central Asia
140 000 110 000 170 000 130 000 89 000 190 000
Armenia <500 <200 1 200 <500 <200 <1 000
Azerbaijan ... ... ... ... ... ...
Belarus 2 000 1 500 2 600 1 600 <1 000 2 400
Georgia <500 <500  <1 000 <1 000 <1 000 1 400
Kazakhstan ... ... ... ... ... ...
Kyrgyzstan <500 <200 <500 1 700 <1 000 2 600
Republic of Moldova 1 600 1 200 3 900 1 800 1 400 2 400
Russian Federation ... ... ... ... ... ...
Tajikistan <1 000 <500 3 100 2 000 <1 000 5 200
Ukraine 34 000 29 000 39 000 11 000 7 400 15 000
Uzbekistan ... ... ... ... ... ...
latin America 90 000 72 000 110 000 84 000 56 000 150 000
Argentina ... ... ... ... ... ...
Belize <500 <500 <500 <200 <100 <200
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Estimated new HIV infections (ages 15+) 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Bolivia  
(Plurinational State of)
2 200 1 400 3 300 1 000 <100 1 800
Brazil ... ... ... ... ... ...
Chile ... ... ... ... ... ...
Colombia 9 900 7 100 14 000 8 700 5 400 13 000
Costa Rica ... ... ... ... ... ...
Ecuador ... ... ... ... ... ...
El Salvador ... ... ... ... ... ...
Guatemala ... ... ... ... ... ...
Guyana ... ... ... ... ... ...
Honduras ... ... ... ... ... ...
Mexico 9 800  6 900 13 000 9 200 6 100 14 000
Nicaragua <500 <200 <500 1 500 <1 000 2 600
Panama ... ... ... ... ... ...
Paraguay ... ... ... ... ... ...
Peru ... ... ... ... ... ...
Suriname <500 <500 <500 <500 <200 <500
Uruguay ... ... ... ... ... ...
Venezuela  
(Bolivarian Republic of)
... ... ... ... ... ...
Middle East and 
North Africa
18 000 14 000 25 000 29 000 20 000 43 000
Algeria ... ... ... ... ... ...
Djibouti 1 600 1 200 2 000 <200 <200 <500
Egypt ... ... ... ... ... ...
Iran  
(Islamic Republic of)
... ... ... ... ... ...
Lebanon ... ... ... ... ... ...
Morocco ... ... ... ... ... ...
Oman ... ... ... ... ... ...
Somalia ... ... ... ... ... ...
Sudan ... ... ... ... ... ...
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Tunisia ... ... ... ... ... ...
Yemen ... ... ... ... ... ...
North America 46 000 33 000 63 000 48 000 15 000 100 000
Canada ... ... ... ... ... ...
United States of 
America
... 30 000 61 000 ... 13 000 100 000
oceania 3 900 3 100 4 800 1 800 1 200 2 400
Australia ... ... ... ... ... ...
Fiji ... ... ... ... ... ...
New Zealand ... ... ... ... ... ...
Papua New Guinea 3 000 2 200 4 100 <500 <500 <1 000
South and 
South-East Asia
370 000 280 000 480 000 250 000 140 000 410 000
Afghanistan ... ... ... ... ... ...
Bangladesh <500 <100 3 400 <1 000 <500 18 000
Bhutan ... ... ... ... ... ...
Cambodia 4 900 2 500 12 000 1 200 <100 <100
India1 240 000 190 000 280 000 120 000 70 000 210 000
Indonesia 29 000 <100 67 000 72 000 44 000 140 000
Lao People's 
Democratic Republic
... ... ... ... ... ...
Malaysia 6 100 4 100 9 400 7 300 4 700 11 000
Maldives ... ... ... ... ... ...
Myanmar 24 000 19 000 29 000 6 400 5 000 8 000
Nepal 8 900 6 600 12 000 <1 000 <500 2 000
Pakistan 2 200 1 500 4 000 18 000 8 400 38 000
Philippines <1 000 <500 1 500 1 700 1 100 3 900
Singapore ... ... ... ... ... ...
Sri Lanka <500 <200 <1 000 <500 <200 <1 000
Thailand 23 000 20 000 36 000 8 700 5 400 23 000
Viet Nam 30 000 11 000 55 000 13 000 2 200 27 000
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Sub-Saharan Africa 2 100 000 1 900 000 2 200 000 1 400 000 1 200 000 1 500 000
Angola 16 000 12 000 21 000 23 000 17 000 30 000
Benin 5 900 5 100 6 900 3 400 2 500 4 300
Botswana 24 000 22 000 26 000 12 000 10 000 14 000
Burkina Faso 3 800 2 600 5 400 4 500 2 800 6 600
Burundi 2 000 1 100 2 900 3 300 1 600 5 900
Cameroon 53 000 47 000 60 000 39 000 33 000 46 000
Cape Verde ... ... ... ... ... ...
Central African 
Republic
... ... ... ... ... ...
Chad 18 000 14 000 24 000 12 000 8 200 16 000
Comoros ... ... ... ... ... ...
Congo 6 600 5 900 7 600 3 400 2 700 4 300
Côte d'Ivoire 46 000 37 000 56 000 25 000 19 000 33 000
Democratic Republic 
of the Congo
38 000 34 000 42 000 24 000 21 000 28 000
Equatorial Guinea ... ... ... ... ... ...
Eritrea 1 200 <1 000 2 500 <500 <200 <1 000
Ethiopia 87 000 74 000 100 000 11 000 4 800 18 000
Gabon 5 200 4 300 6 000 <1 000 <500 1 700
Gambia 1 300 1 000 1 800 <1 000 <500 1 200
Ghana 23 000 19 000 27 000 7 100 4 000 11 000
Guinea ... ... ... ... ... ...
Guinea-Bissau 3 600 2 700 4 700 2 800 1 700 4 500
Kenya 97 000 90 000 110 000 85 000 80 000 96 000
Lesotho 27 000 24 000 30 000 23 000 20 000 26 000
Liberia 3 600 2 900 4 400 <100 <100 <100
Madagascar ... ... ... ... ... ...
Malawi 83 000 78 000 91 000 55 000 49 000 63 000
Mali 8 200 6 000 11 000  3 000 <1 000 5 500
Mauritania ... ... ... ... ... ...
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Mauritius ... ... ... ... ... ...
Mozambique 140 000 130 000 160 000 100 000 85 000 130 000
Namibia 20 000 18 000 23 000 9 700 74 00 12 000
Niger 6 200 5 100 7 600 <200 <100 <500
Nigeria 350 000 290 000 400 000 200 000 160 000 250 000
Rwanda 11 000 8 800 13 000 6 900 5 100 9 300
Sao Tome and Principe <500 <200 <500 <100 <100 <100
Senegal 4 000 3 300 4 800 1 300 <1 000 2 100
Sierra Leone 5 500 4 100 7 400 2 800 1 000 6 100
South Africa 560 000 530 000 620 000 350 000 320 000 390 000
South Sudan ... ... ... ... ... ...
Swaziland 14 000 13 000 15 000 10 000 8 400 12 000
Togo 15 000 12 000 18 000 4 100 2 300 6 500
Uganda 69 000 59 000 81 000 120 000 100 000 150 000
United Republic of 
Tanzania
91 000 80 000 100 000 69 000 58 000 85 000
Zambia 75 000 70 000 81 000 46 000 41 000 54 000
Zimbabwe 97 000 87 000 110 000 59 000 51 000 69 000
western and  
central Europe
… ... ... 29 000 25 000 34 000
Austria ... ... ... ... ... ...
Belgium ... ... ... ... ... ...
Bulgaria ... ... ... ... ... ...
Croatia ... ... ... ... ... ...
Czech Republic ... ... ... ... ... ...
Denmark ... ... ... ... ... ...
Estonia ... ... ... ... ... ...
Finland ... ... ... ... ... ...
France ... 3 600 6 600 ... 2 500 9 500
Germany ... ... ... ... ... ...
Greece ... ... ... ... ... ...
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Hungary ... ... ... ... ... ...
Iceland ... ... ... ... ... ...
Ireland ... ... ... ... ... ...
Israel ... ... ... ... ... ...
Italy ... ... ... ... ... ...
Latvia ... ... ... ... ... ...
Lithuania ... ... ... ... ... ...
Luxembourg ... ... ... ... ... ...
Malta ... ... ... ... ... ...
Netherlands ... ... ... ... ... ...
Norway ... ... ... ... ... ...
Poland ... ... ... ... ... ...
Portugal ... ... ... ... ... ...
Romania ... ... ... ... ... ...
Serbia ... ... ... ... ... ...
Slovakia ... ... ... ... ... ...
Slovenia ... ... ... ... ... ...
Spain ... ... ... ... ... ...
Sweden ... ... ... ... ... ...
Switzerland ... ... ... ... ... ...
Turkey ... ... ... ... ... ...
United Kingdom of 
Great Britain and 
Northern Ireland
... ... ... ... ... ...
GlobAl 2 800 000 2 600 000 3 100 000 2 000 000 1 700 000 2 400 000
1 Estimates for China and India are based on 2011 national estimates. 
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Females Males
estimate lower estimate upper estimate estimate lower estimate upper estimate
caribbean 0.5 0.4 0.6 0.3 0.3 0.4
Bahamas ... 1.4 2.2 ... 1.0 1.6
Barbados ... 0.2 0.3 ... 0.3 0.5
Cuba <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Dominican Republic 0.2 0.1 0.3 0.1 <0.1 0.2
Haiti 0.9 0.8 1.1 0.6 0.4 0.8
Jamaica 0.5 0.4 0.6 0.9 0.5 1.5
Trinidad and Tobago ... 0.7 1.2 ... 0.5 0.7
East Asia <0.1 <0.1 <0.1 <0.1 <0.1 0.1
China2 ... ... ... ... ... ...
Democratic People's 
Republic of Korea
... ... ... ... ... ...
Japan ... <0.1 <0.1 ... <0.1 <0.1
Mongolia <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Republic of Korea ... <0.1 <0.1 ... <0.1 <0.1
Eastern Europe and 
central Asia 
0.2 0.1 0.3 0.3 0.2 0.4
Armenia <0.1 <0.1 <0.1 <0.1 <0.1 0.1
Azerbaijan <0.1 <0.1 <0.1 0.2 0.1 0.3
Belarus 0.2 0.1 0.3 0.3 0.2 0.4
Georgia 0.1 <0.1 0.2 0.3 0.2 0.5
Kazakhstan ... ... ... ... ... ...
Kyrgyzstan <0.1 <0.1 <0.1 0.2 <0.1 0.2
Republic of Moldova ... 0.1 0.3 ... 0.1 0.2
Russian Federation ... ... ... ... ... ...
Tajikistan 0.1 <0.1 0.3 0.1 <0.1 0.3
Ukraine 0.5 0.3 0.7 0.4 0.3 0.5
Uzbekistan <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
latin America 0.1 <0.1 0.2 0.2 0.1 0.4
Argentina 0.1 <0.1 0.2 0.2 0.1 0.3
Belize 0.6 0.5 0.7 0.5 0.3 0.8
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Percentage of young people aged 15 to 24 who are living with HIV1, 2012 
Females Males
estimate lower estimate upper estimate estimate lower estimate upper estimate
Bolivia  
(Plurinational State of)
<0.1 <0.1 0.2 0.1 <0.1 0.3
Brazil ... 0.1 0.1 ... 0.2 0.4
Chile <0.1 <0.1 0.1 0.2 0.1 0.6
Colombia 0.2 0.1 0.3 0.3 0.2 0.5
Costa Rica 0.2 0.1 0.2 0.1 0.1 0.2
Ecuador 0.2 0.1 0.5 0.4 0.2 1.3
El Salvador 0.2 0.1 0.5 0.3 0.1 0.8
Guatemala 0.2 0.1 0.8 0.3 0.1 1.1
Guyana 0.8 0.4 1.5 0.5 0.2 1.1
Honduras 0.2 0.1 0.2 0.2 0.2 0.4
Mexico <0.1 <0.1 <0.1 0.1 <0.1 0.2
Nicaragua 0.2 0.1 0.3 0.3 0.2 0.5
Panama 0.3 0.2 0.4 0.4 0.2 0.6
Paraguay 0.3 0.1 0.6 0.2 <0.1 0.5
Peru 0.2 <0.1 0.6 0.2 <0.1 1.1
Suriname 0.7 0.5 0.9 0.4 0.3 0.7
Uruguay 0.2 0.1 0.4 0.5 0.3 0.9
Venezuela  
(Bolivarian Republic of)
0.3 0.1 0.4 0.3 0.2 0.6
Middle East and 
North Africa
<0.1 <0.1 0.1 <0.1 <0.1 0.2
Algeria ... ... ... ... ... ...
Djibouti 0.3 0.2 0.5 0.2 0.1 0.2
Egypt <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Iran  
(Islamic Republic of)
<0.1 <0.1 0.2 0.1 <0.1 0.2
Lebanon ... ... ... ... ... ...
Morocco <0.1 <0.1 0.1 0.1 <0.1 0.2
Oman ... <0.1 0.2 ... <0.1 0.3
Somalia 0.2 0.1 0.4 0.2 <0.1 0.3
Sudan ... ... ... ... ... ...
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Females Males
estimate lower estimate upper estimate estimate lower estimate upper estimate
Tunisia <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Yemen 0.1 <0.1 0.3 0.1 <0.1 0.3
North America 0.1 <0.1 0.2 0.3 0.1 0.5
Canada ... <0.1 <0.1 ... <0.1 0.2
United States of 
America
... <0.1 0.2 ... 0.1 0.5
oceania <0.1 <0.1 <0.1 <0.1 <0.1 0.1
Australia ... <0.1 <0.1 ... <0.1 0.1
Fiji 0.1 <0.1 0.2 0.1 <0.1 0.2
New Zealand ... <0.1 <0.1 ... <0.1 <0.1
Papua New Guinea 0.1 <0.1 0.2 <0.1 <0.1 0.1
South and  
South-East Asia
0.1 <0.1 0.2 0.1 <0.1 0.2
Afghanistan <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Bangladesh <0.1 <0.1 <0.1 <0.1 <0.1 0.1
Bhutan <0.1 <0.1 0.2 0.1 <0.1 0.4
Cambodia 0.2 0.1 0.3 0.2 0.1 0.2
India2 0.1 <0.1 0.2 0.1 <0.1 0.2
Indonesia 0.5 0.3 0.8 0.4 0.2 0.8
Lao People's 
Democratic Republic
0.2 0.2 0.3 0.2 0.1 0.3
Malaysia <0.1 <0.1 <0.1 0.1 <0.1 0.2
Maldives <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Myanmar 0.1 <0.1 0.1 <0.1 <0.1 0.2
Nepal <0.1 <0.1 0.1 <0.1 <0.1 0.2
Pakistan <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Philippines <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Singapore ... <0.1 <0.1 ... <0.1 <0.1
Sri Lanka <0.1 <0.1 <0.1 <0.1 <0.1 <0.1
Thailand 0.3 0.2 0.4 0.3 0.2 0.6
Viet Nam 0.1 <0.1 0.2 0.2 <0.1 0.6
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Percentage of young people aged 15 to 24 who are living with HIV1, 2012 
Females Males
estimate lower estimate upper estimate estimate lower estimate upper estimate
Sub-Saharan Africa 2.5 2.3 3.0 1.2 0.9 1.6
Angola 1.2 0.9 1.5 0.6 0.4 0.9
Benin 0.4 0.3 0.5 0.2 0.2 0.3
Botswana 6.7 5.8 8.4 3.7 2.3 5.5
Burkina Faso 0.5 0.4 0.6 0.4 0.3 0.5
Burundi 0.6 0.4 0.8 0.4 0.3 0.6
Cameroon 1.8 1.6 2.3 1.0 0.6 1.4
Cape Verde <0.1 <0.1 0.2 <0.1 <0.1 0.1
Central African 
Republic
... ... ... ... ... ...
Chad 1.1 0.8 1.5 0.6 0.4 0.9
Comoros 1.6 0.9 2.8 2.8 1.2 6.3
Congo 1.3 1.1 1.6 0.8 0.6 1.1
Côte d'Ivoire 1.2 1.0 1.6 0.7 0.5 1.0
Democratic Republic 
of the Congo
0.8 0.7 1.0 0.4 0.3 0.6
Equatorial Guinea ... 1.6 5.5 ... 0.7 3.1
Eritrea 0.2 0.1 0.3 0.2 0.1 0.3
Ethiopia 0.5 0.3 0.6 0.3 0.2 0.3
Gabon 1.6 1.1 2.6 0.4 0.2 0.6
Gambia 0.5 0.3 0.8 0.2 0.1 0.5
Ghana 0.5 0.4 0.6 0.3 0.2 0.4
Guinea 0.8 0.6 1.1 0.4 0.2 0.6
Guinea-Bissau 1.7 1.1 2.6 0.9 0.5 1.5
Kenya 3.6 3.0 4.6 1.8 1.5 2.3
Lesotho 10.7 9.4 13.0 5.8 3.8 8.4
Liberia 0.1 <0.1 0.2 <0.1 <0.1 0.1
Madagascar 0.3 0.2 0.4 0.3 0.2 0.4
Malawi 4.5 4.0 5.4 2.7 2.0 3.7
Mali 0.3 0.2 0.5 0.2 <0.1 0.3
Mauritania 0.2 0.1 0.4 0.1 <0.1 0.2
Mauritius 0.3 0.2 0.3 0.3 0.2 0.5
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Females Males
estimate lower estimate upper estimate estimate lower estimate upper estimate
Mozambique 6.6 5.7 8.1 2.8 2.1 3.8
Namibia 4.1 3.2 5.5 2.2 1.4 3.4
Niger 0.1 <0.1 0.2 <0.1 <0.1 0.1
Nigeria 1.3 1.1 1.6 0.7 0.4 1.0
Rwanda 1.3 1.2 1.6 1.0 0.8 1.2
Sao Tome and Principe 0.4 0.3 0.7 0.3 0.1 0.6
Senegal 0.3 0.2 0.4 0.1 <0.1 0.2
Sierra Leone 1.0 0.6 1.7 0.3 0.1 0.5
South Africa 13.9 12.9 16.8 3.9 2.5 5.7
South Sudan 1.2 0.7 2.0 0.6 0.3 1.2
Swaziland 20.0 17.2 24.5 10.3 6.7 14.7
Togo 0.9 0.7 1.3 0.5 0.3 0.8
Uganda 4.0 3.4 4.9 2.3 1.6 3.2
United Republic of 
Tanzania
3.6 3.1 4.6 1.8 1.3 2.6
Zambia 4.6 4.1 5.6 3.5 2.5 4.9
Zimbabwe 6.3 5.6 7.5 3.9 2.9 5.2
western and  
central Europe
<0.1 <0.1 <0.1 <0.1 <0.1 0.1
Austria ... <0.1 0.2 ... 0.1 0.4
Belgium ... <0.1 0.2 ... <0.1 0.3
Bulgaria ... <0.1 <0.1 ... <0.1 0.2
Croatia ... <0.1 <0.1 ... <0.1 <0.1
Czech Republic ... <0.1 <0.1 ... <0.1 <0.1
Denmark ... <0.1 <0.1 ... <0.1 0.1
Estonia ... 0.4 0.9 ... 0.6 1.2
Finland ... <0.1 <0.1 ... <0.1 <0.1
France ... <0.1 0.2 ... <0.1 0.2
Germany ... <0.1 <0.1 ... <0.1 0.1
Greece ... <0.1 <0.1 ... <0.1 0.1
Hungary ... <0.1 <0.1 ... <0.1 0.2
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EPIDEMIoloGY
Percentage of young people aged 15 to 24 who are living with HIV1, 2012 
Females Males
estimate lower estimate upper estimate estimate lower estimate upper estimate
Iceland ... <0.1 0.1 ... <0.1 0.2
Ireland ... <0.1 0.1 ... <0.1 0.2
Israel ... <0.1 <0.1 ... <0.1 0.1
Italy ... <0.1 <0.1 ... <0.1 0.1
Latvia ... 0.1 0.6 ... 0.2 0.9
Lithuania ... <0.1 <0.1 ... <0.1 0.1
Luxembourg ... <0.1 0.1 ... <0.1 0.2
Malta ... <0.1 <0.1 ... <0.1 <0.1
Netherlands ... <0.1 <0.1 ... <0.1 0.2
Norway ... <0.1 <0.1 ... <0.1 <0.1
Poland ... <0.1 <0.1 ... <0.1 0.1
Portugal ... <0.1 0.2 ... <0.1 0.3
Romania ... <0.1 <0.1 ... <0.1 <0.1
Serbia ... <0.1 <0.1 ... <0.1 <0.1
Slovakia ... <0.1 <0.1 ... <0.1 <0.1
Slovenia ... <0.1 <0.1 ... <0.1 0.1
Spain ... <0.1 <0.1 ... <0.1 0.2
Sweden ... <0.1 <0.1 ... <0.1 <0.1
Switzerland ... <0.1 0.2 ... <0.1 0.2
Turkey ... <0.1 <0.1 ... <0.1 <0.1
United Kingdom of 
Great Britain and 
Northern Ireland
... <0.1 0.1 ... <0.1 0.2
GlobAl 0.5 0.4 0.6 0.3 0.2 0.4
1 For the indicator definition, go to http://www.indicatorregistry.org/node/844  
2 Estimates for China and India are based on 2011 national estimates. 
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
caribbean 24 000 21 000 27 000 11 000 9 400 14 000
Bahamas ... <500 <500 ... <500 <500
Barbados ... <100 <100 ... <100 <100
Cuba <500 <200 <500 <100 <100 <100
Dominican Republic 4 600 3 900 5 500 1 900 1 400 2 600
Haiti 15 000 14 000 17 000 7 500 6 200 8 900
Jamaica 2 700 2 300 3 400 1 300 <1 000 1 800
Trinidad and Tobago ... <500 <1 000 ... <500 <1 000
East Asia 18 000 12 000 35 000 41 000 25 000 64 000
China1 ... ... ... ... ... ...
Democratic People's 
Republic of Korea
... ... ... ... ... ...
Japan ... <200 <500 ... <100 <200
Mongolia <100 <100 <100 <100 <100 <100
Republic of Korea ... <100 <200 ... <200 1 100
Eastern Europe and 
central Asia
36 000 26 000 47 000 91 000 66 000 120 000
Armenia <100 <100 <200 <500 <200 <500
Azerbaijan <200 <100 <200 <1 000 <500 <1 000
Belarus <500 <200 <500 1 200 1 000 1 500
Georgia <100 <100 <100 <200 <200 <500
Kazakhstan ... ... ... ... ... ...
Kyrgyzstan <100 <100 <200 <500 <200 <1 000
Republic of Moldova <1 000 <1 000  <1 000 1 300 <1 000 1 800
Russian Federation ... ... ... ... ... ...
Tajikistan <100 <100 <200 <1 000 <500 <1 000
Ukraine 8 600 6 900 10 000 18 000 15 000 22 000
Uzbekistan 1 800 <1 000 2 900 2 400 1 700 3 500
latin America 82 000 63 000 100 000 52 000 35 000 75 000
Argentina 2 900 1 700 4 300 3 700 2 200 5 300
Belize <200 <100 <200 <200 <100 <200
EPIDEMIoloGY
Estimated AIDS deaths 
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EPIDEMIoloGY
Estimated AIDS deaths 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Bolivia 
(Plurinational State of)
<1 000 <1 000 1 700 1 300 <1 000 2 000
Brazil ... 18 000 27 000 ... 11 000 19 000
Chile ... ... ... ... ... ...
Colombia 8 700 6 400 12 000 6 500 3 800 10 000
Costa Rica <200 <200 <200 <500 <500 <500
Ecuador 2 800 1 100 4 700 2 700 1 600 4 400
El Salvador 1 600 1 100 2 400 <1 000 <500 2 100
Guatemala 2 000 1 100 3 200 3 400 1 800 7 100
Guyana <200 <100 <500 <100 <100 <500
Honduras 3 600 3 000 4 400 1 700 1 300 2 200
Mexico ... ... ... ... ... ...
Nicaragua <100 <100 <200 <200 <100 <500
Panama 1 700 1 300 2 100 <1 000 <500 <1 000
Paraguay <500 <200 <1 000 <500 <100 <1 000
Peru 9 300 4 900 15 000 4 100 1 700 10 000
Suriname <500 <200 <500 <200 <200 <200
Uruguay ... ... ... ... ... ...
Venezuela 
(Bolivarian Republic of)
6 800 4 100 11 000 3 800 1 400 7 900
Middle East and 
North Africa
8 300 4 600 14 000 17 000 12 000 26 000
Algeria ... ... ... ... ... ...
Djibouti <1 000 <500 <1 000 <1 000 <1 000 1 000
Egypt <200 <100 <500 <500 <200 <1 000
Iran 
(Islamic Republic of)
<500 <200 1 200 4 600 3 200 6 400
Lebanon ... ... ... ... ... ...
Morocco <500 <500 <500 1 200 <1 000 1 800
Oman ... <100 <100 ... <200 <500
Somalia 2 000 <1 000 3 300 2 500 1 700 3 900
Sudan ... ... ... ... ... ...
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Tunisia <100 <100 <100 <100 <100 <200
Yemen <500 <100 <500 <1 000 <500 2 400
North America 19 000 15 000 24 000 20 000 16 000 27 000
Canada ... <200 <500 ... <500 <500
United States of 
America
... 15 000 24 000 ... 16 000 27 000
oceania 1 500 <1 000 2 200 1 200 <1 000 1 800
Australia ... <200 <200 ... <200 <500
Fiji <100 <100 <100 <100 <100 <100
New Zealand ... <100 <100 ... <100 <100
Papua New Guinea 1 300 <1 000 2 000 <1 000 <1 000 1 600
South and  
South-East Asia
220 000 160 000 320 000 220 000 150 000 310 000
Afghanistan <200 <100 <500 <500 <100 <1 000
Bangladesh <200 <100 <1 000 <500 <200 2 300
Bhutan <100 <100 <100 <100 <100 <200
Cambodia 6 000 4 500 9 500 2 700 1 900 4 700
India1 130 000 99 000 210 000 140 000 100 000 170 000
Indonesia 1 300 <100 41 000 27 000 16 000 42 000
Lao People's 
Democratic Republic
<100 <100 <500 <500 <500 <1 000
Malaysia 4 200 3 000 6 000 5 200 3 100 8 000
Maldives <100 <100 <100 <100 <100 <100
Myanmar 9 800 8 500 11 000 12 000 9 700 14 000
Nepal 1 600 1 200 2 200 4 100 3 100 5 600
Pakistan <500 <500 <1 000 3 500 2 100 6 600
Philippines <500 <200 <1 000 <500 <200 <1 000
Singapore ... <100 <500 ... <100 <500
Sri Lanka <100 <100 <200 <200 <200 <500
Thailand 61 000 54 000 67 000 21 000 18 000 24 000
Viet Nam 5 500 <1 000 12 000 12 000 2 500 24 000
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EPIDEMIoloGY
Estimated AIDS deaths 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Sub-Saharan Africa 1 500 000 1 400 000 1 700 000 1 200 000 1 100 000 1 300 000
Angola 8 400 6 200 13 000 13 000 9 200 17 000
Benin 4 100 3 400 4 900 3 100 2 500 3 900
Botswana 21 000 19 000 23 000 5 700 5 000 6 800
Burkina Faso 19 000 17 000 23 000 5 500 4 100 7 100
Burundi 13 000 11 000 16 000 4 800 3 600 6 300
Cameroon 29 000 26 000 33 000 35 000 30 000 40 000
Cape Verde <200 <100 <200 <100 <100 <100
Central African 
Republic
... ... ... ... ... ...
Chad 14 000 11 000 16 000 14 000 12 000 19 000
Comoros <100 <100 <100 <100 <100 <100
Congo 9 000 8 000 10 000 5 200 4 500 5 900
Côte d'Ivoire 46 000 40 000 55 000 31 000 26 000 38 000
Democratic Republic 
of the Congo
31 000 28 000 36 000 32 000 29 000 36 000
Equatorial Guinea ... <500 1 300 ... <500 2 900
Eritrea 2 700 1 400 3 800 1 200 <1 000 1 900
Ethiopia 100 000 89 000 110 000 47 000 40 000 56 000
Gabon 2 400 2 000 2 800 2 300 1 900 2 900
Gambia <500 <500 <500 <1 000 <500 <1 000
Ghana 19 000 16 000 24 000 12 000 8 900 15 000
Guinea 3 300 2 500 4 500 5 100 3 700 6 800
Guinea-Bissau <1 000 <1 000 1 300 2 300 1 600 3 100
Kenya 130 000 120 000 140 000 57 000 51 000 65 000
Lesotho 16 000 15 000 18 000 15 000 14 000 17 000
Liberia 2 000 1 600 2 500 1 700 1 300 2 100
Madagascar 4 600 3 800 5 700 6 200 5 300 7 200
Malawi 86 000 81 000 95 000 46 000 40 000 52 000
Mali 7 800 5 500 10 000 4 900 3 300 6 800
Mauritania <500 <500 <1 000 <1 000 <1 000 1 100
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Mauritius <500 <500 <1 000 <1 000 <1 000 <1 000
Mozambique 39 000 35 000 46 000 77 000 65 000 93 000
Namibia 9 300 7 900 11 000  5 000 3 400 7 100
Niger 3 200 2 600 3 900 3 400 2 600 4 300
Nigeria 150 000 120 000 200 000 240 000 210 000 280 000
Rwanda 23 000 21 000 26 000 5 600 4 200 7 500
Sao Tome and Principe <100 <100 <100 <100 <100 <200
Senegal 1 300 1 100 1 600 1 900 1 400 2 500
Sierra Leone 1 100 <1 000 1 700 3 300 2 200 5 100
South Africa 200 000 190 000 230 000 240 000 220 000 270 000
South Sudan 6 900 1 900 17 000 13 000 8 400 20 000
Swaziland 7 700 6 900 8 700 5 500 4 800 6 300
Togo 7 900 6 500 9 800 7 200 5 500 9 500
Uganda 110 000 94 000 120 000 63 000 52 000 81 000
United Republic of 
Tanzania
120 000 100 000 130 000 80 000 69 000 94 000
Zambia 77 000 72 000 84 000 30 000 26 000 36 000
Zimbabwe 160 000 150 000 170 000 39 000 34 000 45 000
western and  
central Europe
8 100 7 300 8 700 7 600 6 900 8 300
Austria ... <100 <100 ... <100 <200
Belgium ... <100 <100 ... <100 <200
Bulgaria ... <100 <200 ... <200 <500
Croatia ... <100 <100 ... <100 <100
Czech Republic ... <100 <100 ... <100 <100
Denmark ... <100 <100 ... <100 <100
Estonia ... <100 <200 ... <500 <1 000
Finland ... <100 <100 ... <100 <100
France ... 1 500 1 900 ... <1 000 1 400
Germany ... <1 000 <1 000 ... <500 <500
Greece ... <200 <500 ... <200 <500
EPIDEMIoloGY
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Estimated AIDS deaths 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Hungary ... <200 <500 ... <100 <200
Iceland ... <100 <100 ... <100 <100
Ireland ... <100 <100 ... <100 <100
Israel ... <100 <100 ... <100 <100
Italy ... 1 000 1 400 ... 1 200 1 700
Latvia ... <100 <500 ... <500 <1 000
Lithuania ... <100 <100 ... <100 <200
Luxembourg ... <100 <100 ... <100 <100
Malta ... <100 <100 ... <100 <100
Netherlands ... <200 <500 ... <200 <200
Norway ... <100 <100 ... <100 <100
Poland ... <100 <200 ... <200 <500
Portugal ... <200 <500 ... <500 <500
Romania ... <100 <500 ... <500 <1 000
Serbia ... <100 <500 ... <100 <200
Slovakia ... <100 <100 ... <100 <100
Slovenia ... <100 <100 ... <100 <100
Spain ... 1 800 2 400 ... <1 000 <1 000
Sweden ... <100 <100 ... <100 <100
Switzerland ... <200 <500 ... <100 <200
Turkey ... <100 <100 ... <100 <100
United Kingdom of 
Great Britain and 
Northern Ireland
... <500 <500 ... <500 <1 000
GlobAl 1 900 000 1 700 000 2 200 000 1 600 000 1 400 000 1 900 000
1 Estimates for China and India are based on 2011 national estimates. 
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REDUcE SExUAl tRANSMISSIoN oF HIV bY 50% bY 2015
HIV testing, multiple sexual partnerships and condom use
Population receiving an 
HIV test and receiving 
test results in the last 
12 months1
Percentage of adults 
15-49 who report 
having more than
one sexual partner in
the past 12 months2
Percentage of adults 
15-49 who had more 
than one sexual 
partner in the past 12 
months who reported 
use of a condom
during last 
intercourse3 
Year, Source Females Males Females Males Females Males
caribbean
Dominican Republic 2007, DHS 20.5 18.6 3.0 24.3 34.9 45.0
Haiti 2012, DHS 20.6 13.4 1.3 23.0 43.2 43.3
Eastern Europe and central Asia
Armenia 2010, DHS 1.9 0.5 0 15.2 ... 72.3
Azerbaijan 2006, DHS 0 6.1 ... 26.0
Republic of Moldova 2005, DHS 11.9 10.1 1.3 11.3 27.4 71.5
Ukraine 2007, DHS 12.3 7.2 2.3 12.9 48.0 46.4
latin America 
Bolivia (Plurinational State of) 2008, DHS ... 1.9 ... 12.0 ... 35.2
Colombia 2010, DHS 8.9 ... 3.9 ... 33.7 ...
Guyana 2009, DHS 27.0 21.6 1.3 9.9 47.9 65.4
Honduras 2005–06, DHS ... ... 0.7 ... 26.5 ...
South and South-East Asia 
Cambodia 2010, DHS 8.0 6.1 0 1.5 ... 39.5
India 2005–06, NFHS 1.2 1.4 0.1 1.3 11.8 22.7
Nepal 2011, DHS 2.9 7.5 0.1 3.8 ... 26.5
Timor-Leste 2009, DHS ... ... 0 1.4 ... 19.1
Viet Nam 2005, PAIS 2.0 2.6 ... ... ... ...
Sub-Saharan Africa 
Benin 2012, DHS 14.6 5.2 1.3 21.2 29.9 22.1
Burkina Faso 2010, DHS 11.2 8.4 0.6 16.6 62.3 26.5
Burundi 2010, DHS 18.7 11.7 0.3 3.1 14.3 14.3
Cameroon 2011, MICS 22.3 20.4 ... ... 37.3 43.0
Cape Verde 2012, AIS 47.3 27.9 5.0 34.4 51.1 73.2
Congo 2009, AIS 8.5 7.1 6.8 28.4 29.0 27.9
Côte d’Ivoire 2005, AIS 3.7 3.2 3.6 23.7 40.7 37.5
Democratic Republic of the Congo 2007, DHS 4.1 3.8 3.0 16.8 8.5 15.9
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HIV testing, multiple sexual partnerships and condom use
Population receiving an 
HIV test and receiving 
test results in the last 
12 months1
Percentage of adults 
15-49 who report 
having more than
one sexual partner in
the past 12 months2
Percentage of adults 
15-49 who had more 
than one sexual 
partner in the past 12 
months who reported 
use of a condom
during last 
intercourse3 
Year, Source Females Males Females Males Females Males
Eritrea 2012, DHS 41.5 41.7 56.4 41.3 2.3 18.2
Ethiopia 2011, DHS 20.0 20.7 0.4 3.5 47.1 15.5
Kenya 2008–09, DHS 29.3 22.8 1.2 9.3 31.8 37.0
Gabon 2012, DHS 10.1 29.0 ... ... 44.0 51.1
Ghana 2008, DHS 6.8 4.1 1.0 11.3 18.1 26.2
Guinea 2005, DHS 1.1 2.9 2.0 24.7 19.7 24.4
Lesotho 2009, DHS 42.0 24.0 6.4 21.9 38.5 52.3
Liberia 2007, DHS 1.6 2.3 5.8 18.0 13.5 22.3
Madagascar 2008–09, DHS 4.2 3.6 2.1 15.5 7.6 7.4
Malawi 2010, DHS ... 31.3 0.7 9.2 27.3 24.5
Mali 2006, DHS 3.1 2.7 1.2 15.2 8.1 12.2
Mozambique 2011, DHS 25.9 14.2 2.8 29.5 30.6 25.5
Namibia 2006, DHS 28.6 17.6 1.7 11.2 65.7 74.4
Niger 2006, DHS 0.9 1.6 0.7 12.3 7.6 6.6
Nigeria 2008, DHS 6.6 6.5 1.0 9.9 22.9 33.1
Rwanda 2010–11, DHS 38.6 37.7 0.6 3.9 28.9 27.5
Sao Tome and Principe 2008–09, DHS 31.4 22.8 1.0 16.5 ... 32.9
Senegal 2010–11, DHS 13.6 9.0 0.5 8.4 22.3 20.7
Sierra Leone 2008, DHS 4.1 3.4 3.5 15.7 6.8 15.2
Swaziland 2006–07, DHS 21.9 8.9 1.6 13.6 55.0 55.8
United Republic of Tanzania 2010, DHS 29.5 25.0 3.5 20.7 27.2 23.6
Uganda 2006, DHS 12.0 10.4 1.8 20.5 23.9 20.4
Zambia 2007, DHS 18.5 11.7 1.2 14.4 33.1 28.0
Zimbabwe 2010–11, DHS 33.6 20.5 1.1 10.6 48.0 33.1
western and central Europe 
Albania 2008–09, DHS 0.2 0.6 0.1 5.4 ... 36.9
Bosnia and Herzegovina 2012, MICS ... ... ... ... 17.1 43.5
1 For the indicator definition, go to http://www.indicatorregistry.org/node/843. 
2 For the indicator definition, go to http://www.indicatorregistry.org/node/661.  
3 For the indicator definition, go to http://www.indicatorregistry.org/node/842. 
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Sex workers – population size estimation
Population size 
estimate
Year when 
estimation was 
performed
caribbean
Jamaica 14 957 2011
Eastern Europe and central Asia
Armenia 6 200 2010
Azerbaijan 25 054 2011
Belarus 50 000 2012
Kazakhstan 20 270 2012
Kyrgyzstan  [5 900–8 100] 2010
Republic of Moldova 14 768 2011
Tajikistan 12 500 2009
latin America 
Argentina 72 000 2012
Belize  [346–595] 2012
El Salvador 13 292 2011
Guatemala 21 845 2011
Nicaragua 11 543 2012
Panama  [5 000–10 000] 2012
Paraguay 1 252 2011
Peru 35 560 2010
Middle East and North Africa
Djibouti 2 865 2012
Egypt 24 000 2011
Morocco 66 000 2010
Tunisia 25 000 2012
oceania 
Australia 25 000 2011
Fiji 857 2012
South and South-East Asia 
Bangladesh  [63 600–74 300] 2009
Malaysia 60 000 2010
Myanmar 43 432 2012
Population size 
estimate
Year when 
estimation was 
performed
Nepal 26 878 2011
Pakistan 136 000 2009
Sri Lanka 41 000 2010
Thailand 123 530 2012
Viet Nam 65 166 2011
Sub-Saharan Africa 
Benin 12 789 2012
Cape Verde 1 096 2011
Chad 1 171 2009
Comoros 200 2012
Equatorial Guinea 5 791 2012
Gambia 3 100 2009
Ghana 51 937 2011
Guinea 4 796 2012
Guinea-Bissau 3 138 2012
Kenya 133 675 
[76 654–208 711]
2012
Liberia 1 822 2011
Mauritius 9 000 2012
Niger 27 471 2012
Nigeria 459 887 2012
Rwanda 12 278 2012
Senegal 4 200 2012
Togo 8 000 2009
western and central Europe 
Serbia 3 901 2011
Note: UNAIDS did not request sources or methods for key population 
size estimates. We present these data as reflective of the reporting 
countries’ commitments to estimate population size. UNAIDS cannot 
vouch for the accuracy of these estimates. Any secondary use of these 
data should be conducted with very careful consideration.  
     
 UNAIDS 2013 Global report  |  A49
Population size 
estimate
Year when 
estimation was 
performed
Nepal 26 878 2011
Pakistan 136 000 2009
Sri Lanka 41 000 2010
Thailand 123 530 2012
Viet Nam 65 166 2011
Sub-Saharan Africa 
Benin 12 789 2012
Cape Verde 1 096 2011
Chad 1 171 2009
Comoros 200 2012
Equatorial Guinea 5 791 2012
Gambia 3 100 2009
Ghana 51 937 2011
Guinea 4 796 2012
Guinea-Bissau 3 138 2012
Kenya 133 675 
[76 654–208 711]
2012
Liberia 1 822 2011
Mauritius 9 000 2012
Niger 27 471 2012
Nigeria 459 887 2012
Rwanda 12 278 2012
Senegal 4 200 2012
Togo 8 000 2009
western and central Europe 
Serbia 3 901 2011
REDUcE SExUAl tRANSMISSIoN oF HIV bY 50% bY 2015
Percentage of sex workers reporting the use of a condom with their most recent client1 
2009 2012
caribbean
Cuba 56 70
Dominican Republic 81 85
Haiti 90 90
Jamaica 97 91
East Asia
Mongolia 90 80
Eastern Europe and central Asia
Belarus 70 85
Kazakhstan 96 97
Kyrgyzstan 94 88
Tajikistan 84 71
latin America 
Argentina 99 96
Colombia ... 98
El Salvador ... 97
Guatemala 96 99
Guyana 61 94
Honduras 80 79
Nicaragua 74 96
Panama 76 99
Middle East and North Africa 
Morocco 54 50
Tunisia 52 55
oceania
Papua New Guinea 50 80
South and South-East Asia 
Afghanistan 58 51
2009 2012
Indonesia 68 58
Lao People's 
Democratic Republic
94 92
Malaysia 61 84
Pakistan 38 35
Viet Nam 78 83
Sub-Saharan Africa 
Benin 25 85
Burkina Faso 99 98
Burundi 82 91
Cameroon 73 73
Côte d'Ivoire 97 93
Democratic Republic 
of the Congo
62 32
Eritrea 45 71
Gabon 76 58
Guinea 65 77
Guinea-Bissau 93 93
Niger 85 95
Senegal 97 94
Togo 88 91
western and central Europe 
Bosnia and 
Herzegovina
76 88
Estonia 94 98
Montenegro 72 78
Romania 98 89
Serbia 91 91
The former Yugoslav 
Republic of Macedonia
78 89
Note: Data presented in this annex are only those data included in the trend analyses in the text, i.e., from countries reporting a minimum of 3 unique data  
points since 2007. All reported country data are available at AIDSinfo Online Database (www.aidsinfoonline.org).
1 For the indicator definition, go to http://www.indicatorregistry.org/node/663.
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Percentage of sex workers who are living with HIV1
2009 2012
caribbean
Cuba 0.3 1.0
Dominican Republic 4.8 3.7
Haiti 5.3 8.4
Jamaica 4.9 4.6
Eastern Europe and central Asia 
Azerbaijan 1.7 0.2
Belarus 6.4 0.7
Kazakhstan 1.3 1.2
Kyrgyzstan 1.6 3.5
Tajikistan 2.8 3.7
latin America
Argentina 5.4 5.4
Bolivia (Plurinational 
State of)
0.4 0.6
Brazil 5.2 4.9
Chile 0.7 0.3
Guyana 16.6 16.6
Honduras 2.3 2.8
Paraguay 1.8 2.0
Middle East and North Africa 
Tunisia 0.4 0.6
oceania
Papua New Guinea 5.9 17.8
South and South-East Asia 
Afghanistan 0 0.3
2009 2012
Indonesia 10.2 9.0
Lao People's 
Democratic Republic
0.5 1.0
Malaysia 10.5 4.2
Myanmar 18.1 7.1
Pakistan 2.3 2.4
Viet Nam 3.2 2.7
Sub-Saharan Africa
Benin 24.7 21.0
Burkina Faso 8.9 16.4
Burundi 39.8 26.5
Cameroon 35.5 36.8
Chad 20.0 20.0
Côte d'Ivoire 35.5 28.7
Eritrea 7.8 6.0
Guinea 32.7 16.7
Guinea-Bissau 39.6 39.0
Niger 35.6 17.3
Senegal 19.8 18.5
Togo 29.3 13.1
western and central Europe 
Bosnia and 
Herzegovina
0 0.5
Estonia 7.7 6.2
Lithuania 0 0.3
Montenegro 0.8 0
Serbia 2.2 2.0
Note: Data presented in this annex are only those data included in the trend analyses in the text, i.e., from countries reporting a minimum of 3 unique data  
points since 2007. All reported country data are available at AIDSinfo Online Database (www.aidsinfoonline.org). 
1 For the indicator definition, go to http://www.indicatorregistry.org/node/847.  
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2009 2012
Indonesia 10.2 9.0
Lao People's 
Democratic Republic
0.5 1.0
Malaysia 10.5 4.2
Myanmar 18.1 7.1
Pakistan 2.3 2.4
Viet Nam 3.2 2.7
Sub-Saharan Africa
Benin 24.7 21.0
Burkina Faso 8.9 16.4
Burundi 39.8 26.5
Cameroon 35.5 36.8
Chad 20.0 20.0
Côte d'Ivoire 35.5 28.7
Eritrea 7.8 6.0
Guinea 32.7 16.7
Guinea-Bissau 39.6 39.0
Niger 35.6 17.3
Senegal 19.8 18.5
Togo 29.3 13.1
western and central Europe 
Bosnia and 
Herzegovina
0 0.5
Estonia 7.7 6.2
Lithuania 0 0.3
Montenegro 0.8 0
Serbia 2.2 2.0
REDUcE SExUAl tRANSMISSIoN oF HIV bY 50% bY 2015
Men who have sex with men – population size estimation  
Population size 
estimate
Year when 
estimation was 
performed
caribbean
Jamaica 38 138 2011
Eastern Europe and central Asia 
Armenia 6 600 2010
Azerbaijan 6 572 2011
Belarus 55 000 2012
Kazakhstan 31 940 2012
Republic of Moldova 22 285 2011
latin America 
Argentina 300 000 2012
El Salvador 19 688 2011
Guatemala 109 152 2011
Nicaragua 40 956 2012
Panama  [30 335–43 336] 2012
Paraguay 24 159 2011
Peru 435 426 2010
Middle East and North Africa 
Egypt 48 000 2011
Morocco 44 000 2010
Tunisia 28 000 2012
North America 
Canada 369 532 
[312 681–426 384]
2011
South and South-East Asia 
Bangladesh [21 833–110 581] 2010
Population size 
estimate
Year when 
estimation was 
performed
Nepal 256 600 2011
Sri Lanka 31 000 2010
Thailand 550 571 2012
Viet Nam 285 388 2011
Sub-Saharan Africa 
Benin 1 382 2012
Comoros 66 2012
Gambia 150 2009
Ghana 30 583 2011
Guinea 613 2012
Guinea-Bissau 7 048 2012
Kenya 13 000 2012
Liberia 711 2011
Mauritius 9 000 2012
Niger 10 205 2012
Nigeria 25 476 2012
Senegal 1 840 2012
Seychelles 266 2011
Togo 751 2011
western and central Europe 
Serbia 55 447 2011
United Kingdom of 
Great Britain and 
Northern Ireland
424 200 2011
Note: UNAIDS did not request sources or methods for key population size estimates. We present these data as reflective of the reporting countries’ 
commitments to estimate population size. UNAIDS cannot vouch for the accuracy of these estimates. Any secondary use of these data should be conducted 
with very careful consideration.        
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REDUcE SExUAl tRANSMISSIoN oF HIV bY 50% bY 2015
Percentage of men reporting the use of a condom the last time they had anal sex with a male 
partner1 
2009 2012
caribbean
Cuba 52 59
Dominican Republic 66 40
Haiti 73 73
Jamaica 73 77
East Asia
Mongolia 78 70
Eastern Europe and central Asia 
Belarus 61 63
Georgia 62 73
Kazakhstan 76 86
latin America 
Brazil 48 60
Costa Rica 65 56
El Salvador 55 57
Guatemala 78 61
Honduras 47 71
Nicaragua 36 51
Panama 86 48
Paraguay 63 74
Middle East and North Africa 
Egypt 13 20
Tunisia 40 29
oceania
Papua New Guinea 51 63
2009 2012
South and South-East Asia 
Bangladesh 31 26
Indonesia 57 60
Malaysia 21 77
Nepal 75 75
Viet Nam 66 67
Sub-Saharan Africa 
Burkina Faso 52 58
Cameroon 43 57
Côte d'Ivoire 42 70
Senegal 76 76
Togo 72 47
western and central Europe 
Bosnia and 
Herzegovina
56 20
Bulgaria 70 66
Estonia 47 42
Latvia 50 40
Lithuania 47 48
Romania 43 42
Serbia 67 58
The former Yugoslav 
Republic of  
Macedonia
56 49
Note: Data presented in this annex are only those data included in the trend analyses in the text, i.e., from countries reporting a minimum of 3 unique data  
points since 2007. All reported country data are available at AIDSinfo Online Database (www.aidsinfoonline.org).  
1 For the indicator definition, go to http://www.indicatorregistry.org/node/664. 
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REDUcE SExUAl tRANSMISSIoN oF HIV bY 50% bY 2015
Percentage of men who have sex with men who are living with HIV1
2009 2012
caribbean
Cuba 0.7 7.4
Dominican Republic 10.7 7.1
Jamaica 31.8 37.6
East Asia
Mongolia 1.8 10.7
Eastern Europe and central Asia 
Belarus 2.7 1.3
Georgia 3.6 13.0
Kazakhstan 0.3 0.6
latin America 
Argentina 11.8 15.7
Brazil 12.6 10.5
Costa Rica 12.7 10.9
El Salvador 9.8 10.2
Guatemala 7.6 13.3
Guyana 19.4 19.4
Honduras 6.6 6.8
Nicaragua 4.2 6.6
Peru 10.1 12.4
Middle East and North Africa 
Egypt 5.6 4.1
2009 2012
Lebanon 1.0 1.2
Tunisia 4.8 10.1
South and South-East Asia 
Indonesia 5.2 8.5
Lao People's 
Democratic Republic
5.6 18.2
Malaysia 3.9 12.6
Thailand 13.5 7.1
Viet Nam 16.7 16.7
Sub-Saharan Africa 
Côte d'Ivoire 24.5 18.8
South Africa 13.2 9.9
western and central Europe 
Bosnia and 
Herzegovina
0.7 1.2
Bulgaria 3.3 0.6
Latvia 4.0 7.8
Lithuania 0 2.6
Romania 4.4 5.0
Serbia 6.1 4.4
The former Yugoslav 
Republic of  
Macedonia
2.8 0.5
Note: Data presented in this annex are only those data included in the trend analyses in the text, i.e., from countries reporting a minimum of 3 unique data  
points since 2007. All reported country data are available at AIDSinfo Online Database (www.aidsinfoonline.org). 
1 For the indicator definition, go to http://www.indicatorregistry.org/node/850.  
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HAlVE tHE tRANSMISSIoN oF HIV AMoNG PEoPlE wHo INJEct DRUGS bY 2015
People who inject drugs – population size estimation
Population size 
estimate
Year when 
estimation was 
performed
Eastern Europe and central Asia
Armenia 12 700 2010
Azerbaijan 71 283 2011
Belarus 75 000 2012
Kazakhstan 116 840 2012
Republic of Moldova 31 562 2011
Tajikistan 25 000 2009
latin America 
Mexico 164 157 2011
Middle East and North Africa 
Egypt 100 000 2011
Morocco 5 000 2012
Tunisia 9 000 2012
North America 
Canada 112 930 
[89 432–135 591]
2011
South and South-East Asia 
Bangladesh  [21 800–23 800] 2009
Nepal 31 308 2011
Pakistan 914 000 2009
Population size 
estimate
Year when 
estimation was 
performed
Sri Lanka 1 200 2012
Thailand 40 300 2011
Viet Nam 217 432 2011
Sub-Saharan Africa 
Benin 35 2012
Cape Verde 15 2011
Kenya 18 327 2012
Liberia 457 2011
Madagascar 14 445 2011
Mauritius 10 000 2011
Niger 670 2012
Nigeria 11 692 2012
Senegal 1 324 2011
Seychelles 345 2011
Togo 390 2011
western and central Europe 
Romania 19 265 2011
Serbia 30 383 2011
United Kingdom of 
Great Britain and 
Northern Ireland
547 500 2011
Note: UNAIDS did not request sources or methods for key population size estimates.  We present these data as reflective of the reporting countries’ 
commitments to estimate population size. UNAIDS cannot vouch for the accuracy of these estimates. Any secondary use of these data should be conducted 
with very careful consideration.       
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Population size 
estimate
Year when 
estimation was 
performed
Sri Lanka 1 200 2012
Thailand 40 300 2011
Viet Nam 217 432 2011
Sub-Saharan Africa 
Benin 35 2012
Cape Verde 15 2011
Kenya 18 327 2012
Liberia 457 2011
Madagascar 14 445 2011
Mauritius 10 000 2011
Niger 670 2012
Nigeria 11 692 2012
Senegal 1 324 2011
Seychelles 345 2011
Togo 390 2011
western and central Europe 
Romania 19 265 2011
Serbia 30 383 2011
United Kingdom of 
Great Britain and 
Northern Ireland
547 500 2011
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HAlVE tHE tRANSMISSIoN oF HIV AMoNG PEoPlE wHo INJEct DRUGS bY 2015
Number of syringes distributed per person who injects drugs per year by needle and syringe 
programmes1   
2010 2011 2012
East Asia
China ... 180 193
Eastern Europe and central Asia 
Armenia 16 28 28
Azerbaijan ... 49 37
Belarus 47 48 21
Georgia 27 22 23
Kazakhstan 176 154 190
Kyrgyzstan ... 151 253
Republic of Moldova 66 58 60
Tajikistan 104 88 199
Ukraine 62 75 ...
Uzbekistan ... 173 124
latin America 
Mexico 3 7 12
Middle East and North Africa 
Iran (Islamic Republic of) ... 30 74
Morocco ... 13 45
Tunisia ... 15 9
oceania
Australia ... 203 203
New Zealand ... 277 ...
South and South-East Asia 
Afghanistan 35 80 119
Bangladesh 214 264 237
Cambodia 44 120 35
India 228 387 163
Indonesia 10 7 22
Lao People's Democratic Republic ... ... 182
Malaysia 17 116 94
Myanmar 92 118 116
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HAlVE tHE tRANSMISSIoN oF HIV AMoNG PEoPlE wHo INJEct DRUGS bY 2015
Number of syringes distributed per person who injects drugs per year by needle and syringe 
programmes1    
2010 2011 2012
Nepal 57 71 36
Pakistan ... 42 98
Thailand ... 10 12
Viet Nam 141 140 180
Sub-Saharan Africa 
Madagascar ... 543 632
Mauritius 52 31 28
Senegal ... 10 6
western and central Europe 
Albania ... 90 ...
Bosnia and Herzegovina 51 26 51
Bulgaria ... 34 34
Cyprus ... <1 ...
Czech Republic ... 202 ...
Estonia ... 153 ...
Finland ... 202 ...
Greece ... 7 56
Hungary 66 114 74
Latvia 17 19 ...
Lithuania ... 32 ...
Luxembourg ... 124 ...
Malta ... 302 ...
Norway ... 254 ...
Poland ... 78 47
Romania 55 49 52
Serbia 26 69 38
Sweden ... 214 ...
Switzerland ... 88 ...
The former Yugoslav Republic  
of Macedonia
49 23 28
1 For the indicator definition, go to http://www.indicatorregistry.org/node/851. 
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HAlVE tHE tRANSMISSIoN oF HIV AMoNG PEoPlE wHo INJEct DRUGS bY 2015
Percentage of people who inject drugs who report the use of a condom at last sexual 
intercourse1
2009 2012
Eastern Europe and central Asia 
Belarus 59 53
Georgia 78 34
Kazakhstan 46 51
Kyrgyzstan 53 49
Republic of Moldova 36 23
Tajikistan 28 52
Uzbekistan 26 43
latin America 
Brazil 70 41
Mexico 28 58
Paraguay 22 45
Middle East and North Africa 
Iran (Islamic Republic of) 33 15
Morocco 13 31
Tunisia 35 19
North America 
Canada 39 36
oceania
Australia 27 19
2009 2012
South and South-East Asia 
Afghanistan 35 23
Bangladesh 43 45
Indonesia 36 52
Malaysia 28 27
Nepal 51 47
Pakistan 31 23
Thailand 42 49
Viet Nam 52 49
Sub-Saharan Africa 
Benin 30 53
Mauritius 31 25
western and central Europe 
Bosnia and Herzegovina 30 31
Bulgaria 38 59
Estonia 66 36
Romania 17 56
Serbia 29 31
Sweden 7 8
Switzerland 50 48
The former Yugoslav  
Republic of Macedonia
51 54
Note: Data presented in this annex are only those data included in the trend analyses in the text, i.e., from countries reporting a minimum of 3 unique data  
points since 2007. All reported country data are available at AIDSinfo Online Database (www.aidsinfoonline.org).    
1 For the indicator definition, go to http://www.indicatorregistry.org/node/852.
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HAlVE tHE tRANSMISSIoN oF HIV AMoNG PEoPlE wHo INJEct DRUGS bY 2015
Percentage of people who inject drugs who reported using sterile injecting equipment the last 
time they injected1    
2009 2012
Eastern Europe and central Asia 
Belarus 87 89
Georgia 48 83
Kazakhstan 63 58
Republic of Moldova 99 100
Tajikistan 63 94
Uzbekistan 82 80
latin America 
Brazil 54 54
Mexico 40 41
Paraguay 71 92
Middle East and North Africa 
Iran (Islamic Republic of) 74 92
Morocco 7 67
Tunisia 78 88
oceania
Australia 80 79
South and South-East Asia 
Afghanistan 94 78
Bangladesh 32 36
2009 2012
Indonesia 88 87
Malaysia 83 98
Nepal 99 95
Pakistan 77 66
Thailand 63 80
Viet Nam 95 96
Sub-Saharan Africa 
Benin 31 71
Mauritius 72 89
western and central Europe 
Albania 82 75
Bosnia and Herzegovina 87 92
Lithuania 98 77
Montenegro 24 95
Romania 85 16
Serbia 80 85
Sweden 58 65
The former Yugoslav  
Republic of Macedonia
73 92
Note: Data presented in this annex are only those data included in the trend analyses in the text, i.e., from countries reporting a minimum of 3 unique data  
points since 2007. All reported country data are available at AIDSinfo Online Database (www.aidsinfoonline.org). 
1 For the indicator definition, go to http://www.indicatorregistry.org/node/853. 
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HAlVE tHE tRANSMISSIoN oF HIV AMoNG PEoPlE wHo INJEct DRUGS bY 2015
Percentage of people who inject drugs who are living with HIV1
2009 2012
Eastern Europe and central Asia 
Belarus 13.7 17.1
Georgia 2.2 3.0
Kazakhstan 2.9 4.0
Kyrgyzstan 14.3 14.6
Republic of Moldova 16.4 7.9
Tajikistan 17.6 13.5
latin America 
Brazil 5.9 5.9
Mexico 5.0 5.8
Middle East and North Africa 
Iran (Islamic Republic of) 14.3 13.6
Morocco 2.1 11.4
Tunisia 3.1 3.0
North America 
Canada 12.7 10.9
oceania
Australia 1.5 1.2
New Zealand 0.3 0.4
South and South-East Asia 
Afghanistan 7.1 4.4
Bangladesh 1.6 1.1
Indonesia 52.4 36.4
2009 2012
Malaysia 22.1 18.9
Myanmar 36.3 18.0
Nepal 20.7 6.3
Pakistan 20.8 27.2
Thailand 38.7 25.2
Viet Nam 18.4 11.6
Sub-Saharan Africa 
Mauritius 47.1 51.6
western and central Europe 
Albania 0 0.5
Bosnia and Herzegovina 0.4 0.3
Bulgaria 6.8 7.0
Estonia 62.5 52.4
Latvia 22.6 11.2
Lithuania 8.0 4.6
Luxembourg 1.8 2.4
Montenegro 0 0.3
Romania 1.1 6.9
Serbia 4.8 1.7
Switzerland 10.9 7.3
The former Yugoslav  
Republic of Macedonia
0.8 0
United Kingdom of Great 
Britain and Northern Ireland
1.6 1.0
Note: Data presented in this annex are only those data included in the trend analyses in the text, i.e., from countries reporting a minimum of 3 unique data  
points since 2007. All reported country data are available at AIDSinfo Online Database (www.aidsinfoonline.org).   
1 For the indicator definition, go to http://www.indicatorregistry.org/node/855.
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2009 2012
Malaysia 22.1 18.9
Myanmar 36.3 18.0
Nepal 20.7 6.3
Pakistan 20.8 27.2
Thailand 38.7 25.2
Viet Nam 18.4 11.6
Sub-Saharan Africa 
Mauritius 47.1 51.6
western and central Europe 
Albania 0 0.5
Bosnia and Herzegovina 0.4 0.3
Bulgaria 6.8 7.0
Estonia 62.5 52.4
Latvia 22.6 11.2
Lithuania 8.0 4.6
Luxembourg 1.8 2.4
Montenegro 0 0.3
Romania 1.1 6.9
Serbia 4.8 1.7
Switzerland 10.9 7.3
The former Yugoslav  
Republic of Macedonia
0.8 0
United Kingdom of Great 
Britain and Northern Ireland
1.6 1.0
A62  |  Annex: Eliminate HIV infections among children and reduce maternal deaths
ElIMINAtE HIV INFEctIoNS AMoNG cHIlDREN AND REDUcE MAtERNAl DEAtHS
Percentage of infants born to HIV-positive women receiving a virological test for HIV within 2 
months of birth1
2012
Eastern Europe and central Asia 
Antigua and Barbuda 14
Bahamas 90
Dominican Republic 44
Haiti 70
Saint Lucia 50
Saint Vincent and the Grenadines 74
Trinidad and Tobago 27
East Asia 
China 34
Mongolia 100
Eastern Europe and central Asia 
Armenia 54
Azerbaijan 97
Belarus 78
Georgia 100
Kazakhstan 98
Kyrgyzstan 15
Republic of Moldova 95
Uzbekistan 45
latin America 
Argentina 70
Brazil 21
Chile 97
Colombia 68
Costa Rica 100
Ecuador 90
2012
El Salvador 11
Guatemala 14
Guyana 39
Honduras 39
Nicaragua 55
Panama 35
Paraguay 43
Peru 17
Uruguay 100
Venezuela (Bolivarian Republic of) 26
Middle East and North Africa 
Algeria 100
Djibouti 28
Egypt 100
Iran (Islamic Republic of) 46
Lebanon 9
Morocco 47
Oman 52
Tunisia 7
United Arab Emirates 100
Yemen 20
oceania 
Australia 100
Fiji 71
Micronesia (Federated States of) 0
New Zealand 100
Papua New Guinea 31
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2012
El Salvador 11
Guatemala 14
Guyana 39
Honduras 39
Nicaragua 55
Panama 35
Paraguay 43
Peru 17
Uruguay 100
Venezuela (Bolivarian Republic of) 26
Middle East and North Africa 
Algeria 100
Djibouti 28
Egypt 100
Iran (Islamic Republic of) 46
Lebanon 9
Morocco 47
Oman 52
Tunisia 7
United Arab Emirates 100
Yemen 20
oceania 
Australia 100
Fiji 71
Micronesia (Federated States of) 0
New Zealand 100
Papua New Guinea 31
ElIMINAtE HIV INFEctIoNS AMoNG cHIlDREN AND REDUcE MAtERNAl DEAtHS
Percentage of infants born to HIV-positive women receiving a virological test for HIV within 2 
months of birth1
2012
Samoa 1
South and South-East Asia 
Cambodia 33
Lao People's Democratic Republic 7
Malaysia 100
Myanmar 7
Pakistan 0
Philippines 3
Sri Lanka 40
Thailand 77
Viet Nam 24
Sub-Saharan Africa 
Angola 9
Benin 26
Botswana 39
Burkina Faso 40
Burundi 8
Cameroon 46
Cape Verde 63
Chad 3
Comoros 0
Congo 8
Côte d'Ivoire 15
Democratic Republic of the Congo 3
Ethiopia 19
Gabon 47
Ghana 16
2012
Guinea 0
Kenya 39
Liberia 93
Madagascar 0
Malawi 4
Mali 19
Mauritius 18
Mozambique 35
Namibia 62
Rwanda 75
Senegal 10
Sierra Leone 3
Togo 13
United Republic of Tanzania 32
Zambia 74
Zimbabwe 36
western and central Europe 
Albania 0
Bosnia and Herzegovina 100
Bulgaria 100
Poland 100
Romania 96
Serbia 100
Slovakia 100
Spain 100
1 For the indicator definition, go to http://www.indicatorregistry.org/node/857.
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ElIMINAtE HIV INFEctIoNS AMoNG cHIlDREN AND REDUcE MAtERNAl DEAtHS
New HIV infections among children 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
caribbean 3 500 3 000 4 000 <500 <500 <1 000
Bahamas ... ... ... ... ... ...
Barbados ... ... ... ... ... ...
Cuba ... ... ... ... ... ...
Dominican Republic ... ... ... ... ... ...
Haiti 2 500 2 100 2 900 <500 <500 <1 000
Jamaica ... ... ... ... ... ...
Trinidad and Tobago ... ... ... ... ... ...
East Asia 1 000 <1 000 1 500 1 500 <1 000 3 300
China1 ... ... ... ... ... ...
Democratic People's 
Republic of Korea
... ... ... ... ... ...
Japan ... ... ... ... ... ...
Mongolia ... ... ... ... ... ...
Republic of Korea ... ... ... ... ... ...
Eastern Europe and 
central Asia
3 700 2 900 4 700 <1 000 <500 1 200
Armenia ... ... ... ... ... ...
Azerbaijan ... ... ... ... ... ...
Belarus ... ... ... ... ... ...
Georgia ... ... ... ... ... ...
Kazakhstan ... ... ... ... ... ...
Kyrgyzstan ... ... ... ... ... ...
Republic of Moldova ... ... ... ... ... ...
Russian Federation ... ... ... ... ... ...
Tajikistan ... ... ... ... ... ...
Ukraine ... ... ... ... ... ...
Uzbekistan ... ... ... ... ... ...
latin America  7 400 6 000 9 000 2 000 <1 000 4 600
Argentina ... ... ... ... ... ...
Belize ... ... ... ... ... ...
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ElIMINAtE HIV INFEctIoNS AMoNG cHIlDREN AND REDUcE MAtERNAl DEAtHS
New HIV infections among children 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Bolivia (Plurinational 
State of)
... ... ... ... ... ...
Brazil ... ... ... ... ... ...
Chile ... ... ... ... ... ...
Colombia ... ... ... ... ... ...
Costa Rica ... ... ... ... ... ...
Ecuador ... ... ... ... ... ...
El Salvador ... ... ... ... ... ...
Guatemala ... ... ... ... ... ...
Guyana ... ... ... ... ... ...
Honduras ... ... ... ... ... ...
Mexico ... ... ... ... ... ...
Nicaragua ... ... ... ... ... ...
Panama ... ... ... ... ... ...
Paraguay ... ... ... ... ... ...
Peru ... ... ... ... ... ...
Suriname ... ... ... ... ... ...
Uruguay ... ... ... ... ... ...
Venezuela (Bolivarian 
Republic of)
... ... ... ... ... ...
Middle East and 
North Africa
2 600 1 700 4 200 3 000 2 000 4 600
Algeria ... ... ... ... ... ...
Djibouti <200 <200 <500 <200 <100 <200
Egypt ... ... ... ... ... ...
Iran  
(Islamic Republic of)
... ... ... ... ... ...
Lebanon ... ... ... ... ... ...
Morocco ... ... ... ... ... ...
Oman ... ... ... ... ... ...
Somalia ... ... ... ... ... ...
Sudan ... ... ... ... ... ...
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Tunisia ... ... ... ... ... ...
Yemen ... ... ... ... ... ...
North America <200 <200 <500 <200 <200 <500
Canada ... ... ... ... ... ...
United States  
of America
... ... ... ... ... ...
oceania <500 <500 < 1 000 <500 <200 <500
Australia ... ... ... ... ... ...
Fiji ... ... ... ... ... ...
New Zealand ... ... ... ... ... ...
Papua New Guinea <500 <500 <1 000 <500 <200 <500
South and  
South-East Asia
30 000 26 000 42 000 21 000 16 000 32 000
Afghanistan ... ... ... ... ... ...
Bangladesh ... ... ... ... ... ...
Bhutan ... ... ... ... ... ...
Cambodia ... ... ... ... ... ...
India1 ... ... ... ... ... ...
Indonesia ... ... ... ... ... ...
Lao People's 
Democratic Republic
... ... ... ... ... ...
Malaysia ... ... ... ... ... ...
Maldives ... ... ... ... ... ...
Myanmar ... ... ... ... ... ...
Nepal ... ... ... ... ... ...
Pakistan ... ... ... ... ... ...
Philippines ... ... ... ... ... ...
Singapore ... ... ... ... ... ...
Sri Lanka ... ... ... ... ... ...
Thailand ... ... ... ... ... ...
Viet Nam ... ... ... ... ... ...
ElIMINAtE HIV INFEctIoNS AMoNG cHIlDREN AND REDUcE MAtERNAl DEAtHS
New HIV infections among children 
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ElIMINAtE HIV INFEctIoNS AMoNG cHIlDREN AND REDUcE MAtERNAl DEAtHS
New HIV infections among children 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Sub-Saharan Africa 500 000 460 000 560 000 230 000 200 000 280 000
Angola 3 600 2 600 5 300 5 100 4 000 6 600
Benin 1 500 1 300 1 800 <1 000 <1 000 <1 000
Botswana 3 200 2 900 3 500 <500 <500 <1 000
Burkina Faso 4 600 3 800 5 500 1 300 <1 000 1 800
Burundi 3 600 3 000 4 500 1 300 <1 000 1 800
Cameroon 9 700 8 500 11 000 5 800 4 600 7 100
Cape Verde ... ... ... ... ... ...
Central African 
Republic
... ... ... ... ... ...
Chad 5 200 4 300 6 200 4 100 3 200 5 500
Comoros ... ... ... ... ... ...
Congo 2 300 2 000 2 600 1 300 1 100 1 500
Côte d'Ivoire 13 000 11 000 15 000 4 700 3 400 6 400
Democratic Republic 
of the Congo
14 000 12 000 16 000 11 000 9 300 12 000
Equatorial Guinea ... ... ... ... ... ...
Eritrea <1 000 <500 <1 000 <200 <100 <500
Ethiopia 39 000 33 000 45 000 9 500 7 300 12 000
Gabon <1 000 <1 000 <1 000 <500 <200 <500
Gambia ... ... ... ... ... ...
Ghana 5 200 4 400 6 200 <1 000 <1 000 1 500
Guinea ... ... ... ... ... ...
Guinea-Bissau <1 000 <500 <1 000 <1 000 <1 000 1 200
Kenya 40 000 35 000 45 000 13 000 10 000 17 000
Lesotho 6 100 5 500 6 600 3 700 3 100 4 300
Liberia <1 000 <1 000 <1 000 <500 <200 <500
Madagascar ... ... ... ... ... ...
Malawi 28 000 25 000 31 000 11 000 8 200 14 000
Mali ... ... ... ... ... ...
Mauritania ... ... ... ... ... ...
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Mauritius ... ... ... ... ... ...
Mozambique 21 000 19 000 25 000 14 000 11 000 20 000
Namibia 3 100 2 600 3 700 <1 000 <1 000 1 200
Niger ... ... ... ... ... ...
Nigeria 58 000 48 000 70 000 59 000 49 000 70 000
Rwanda 6 400 5 600 7 300 <1 000 <500 1 500
Sao Tome and Principe ... ... ... ... ... ...
Senegal ... ... ... ... ... ...
Sierra Leone <1 000 <500 <1 000 <500 <500 <1 000
South Africa 75 000 67 000 82 000 21 000 19 000 32 000
South Sudan ... ... ... ... ... ...
Swaziland 3 600 3 200 3 900 1 600 1 300 2 000
Togo 3 000 2 400 3 600 <1 000 <500 1 200
Uganda 25 000 21 000 30 000 15 000 10 000 22 000
United Republic  
of Tanzania
42 000 37 000 48 000 14 000 8 600 21 000
Zambia 27 000 24 000 30 000 9 400 8 300 11 000
Zimbabwe 37 000 34 000 41 000 9 300 7 000 12 000
western and  
central Europe
... ... ... <200 <100 <200
Austria ... ... ... ... ... ...
Belgium ... ... ... ... ... ...
Bulgaria ... ... ... ... ... ...
Croatia ... ... ... ... ... ...
Czech Republic ... ... ... ... ... ...
Denmark ... ... ... ... ... ...
Estonia ... ... ... ... ... ...
Finland ... ... ... ... ... ...
France ... ... ... ... ... ...
Germany ... ... ... ... ... ...
Greece ... ... ... ... ... ...
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New HIV infections among children 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Hungary ... ... ... ... ... ...
Iceland ... ... ... ... ... ...
Ireland ... ... ... ... ... ...
Israel ... ... ... ... ... ...
Italy ... ... ... ... ... ...
Latvia ... ... ... ... ... ...
Lithuania ... ... ... ... ... ...
Luxembourg ... ... ... ... ... ...
Malta ... ... ... ... ... ...
Netherlands ... ... ... ... ... ...
Norway ... ... ... ... ... ...
Poland ... ... ... ... ... ...
Portugal ... ... ... ... ... ...
Romania ... ... ... ... ... ...
Serbia ... ... ... ... ... ...
Slovakia ... ... ... ... ... ...
Slovenia ... ... ... ... ... ...
Spain ... ... ... ... ... ...
Sweden ... ... ... ... ... ...
Switzerland ... ... ... ... ... ...
Turkey ... ... ... ... ... ...
United Kingdom of 
Great Britain and 
Northern Ireland
... ... ... ... ... ...
GlobAl 550 000 500 000 620 000 260 000 230 000 320 000
1 Estimates for China and India are based on 2011 national estimates.
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ElIMINAtE HIV INFEctIoNS AMoNG cHIlDREN AND REDUcE MAtERNAl DEAtHS
Preventing mother-to-child transmission of HIV1, 2012
Number of 
pregnant women 
living with HIV 
who received 
antiretrovirals 
for preventing 
mother-to-child 
transmission2
Estimated number of pregnant women
living with HIV needing antiretrovirals for
preventing mother-to-child-transmission
Estimated percentage of pregnant 
women living with HIV who received 
antiretrovirals for preventing mother-to-
child-transmission
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
caribbean 6 913 6 700 5 700 7 700 >95 89 >95
Bahamas   87 ... ... ... ... ... ...
Barbados   24 ... ... ... ... ... ...
Cuba   106 ... ... ... ... ... ...
Dominican Republic  1 300 ... ... ... … ... ...
Haiti  4 889 5 000 4 200 5 700 >95 85 >95
Jamaica   295 ... ... ... … ... ...
Trinidad and Tobago   212 ... ... ... … … …
East Asia 2 361 9 000 5 900 14 000 26 17 42
China3 … ... ... ... … … …
Democratic People's 
Republic of Korea
… ... ... ... … … …
Japan … ... ... ... … … …
Mongolia   5 ... ... ... … ... ...
Republic of Korea   … ... ... ... … … …
Eastern Europe and 
central Asia 
 19 619 12 000 8 800 17 000 … >95 >95
Armenia   13 ... ... ... … ... ...
Azerbaijan   35 ... ... ... … ... ...
Belarus   203 ... ... ... … ... ...
Georgia   24 ... ... ... … ... ...
Kazakhstan 302 ... ... ... … … …
Kyrgyzstan   111 ... ... ... … ... ...
Republic of Moldova   141 ... ... ... … ... ...
Russian Federation … ... ... ... … … …
Tajikistan   62 ... ... ... … ... ...
Ukraine  5 220 ... ... ... … ... ...
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Preventing mother-to-child transmission of HIV1, 2012
Number of 
pregnant women 
living with HIV 
who received 
antiretrovirals 
for preventing 
mother-to-child 
transmission2
Estimated number of pregnant women
living with HIV needing antiretrovirals for
preventing mother-to-child-transmission
Estimated percentage of pregnant 
women living with HIV who received 
antiretrovirals for preventing mother-to-
child-transmission
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Uzbekistan   508 ... … … … … …
latin America  14 810 18 000 13 000 26 000 83 61 >95
Argentina  1 612 ... ... ... … … …
Belize   40 ... ... ... … … …
Bolivia  
(Plurinational State of)
  163 ... ... ... … … …
Brazil  7 641 ... ... ... … … …
Chile   157 ... ... ... … … …
Colombia   854 ... ... ... … … …
Costa Rica   37 ... ... ... … … …
Ecuador   550 ... ... ... … … …
El Salvador   166 ... ... ... … … …
Guatemala   252 ... ... ... … … …
Guyana   152 ... ... ... … … …
Honduras   238 ... ... ... … … …
Mexico 773 ... ... ... … … …
Nicaragua   141 ... ... ... … … …
Panama   187 ... ... ... … … …
Paraguay   215 ... ... ... … … …
Peru   696 ... ... ... … … …
Suriname   107 ... ... ... … … …
Uruguay   139 ... ... ... … … …
Venezuela  
(Bolivarian Republic of)
  690 ... ... ... … … …
Middle East and North 
Africa
  710 8 400 5 900 13 000 8 6 13
Algeria … ... ... ... … … …
Djibouti   63 <500 <500 <500 20 15 26
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Number of 
pregnant women 
living with HIV 
who received 
antiretrovirals 
for preventing 
mother-to-child 
transmission2
Estimated number of pregnant women
living with HIV needing antiretrovirals for
preventing mother-to-child-transmission
Estimated percentage of pregnant 
women living with HIV who received 
antiretrovirals for preventing mother-to-
child-transmission
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Egypt   9 ... ... ... … ... ...
Iran  
(Islamic Republic of)
  115 ... ... ... … ... ...
Lebanon 5 ... ... ... … … …
Morocco   195 ... ... ... … ... ...
Oman   31 ... ... ... … … …
Somalia   57 ... ... ... … ... ...
Sudan 191 ... ... ... … ... ...
Tunisia   9 ... ... ... … ... ...
Yemen   20 ... ... ... … ... ...
North America ... 6 400 3 600 11 000 >95 55 >95
Canada ... ... ... ... … … …
United States of 
America
... ... ... ... … … …
oceania   496 1 000 <1 000 1 300 49 38 63
Australia   ... ... ... ... … … …
Fiji   14 ... ... ... … ... ...
New Zealand ... ... ... ... … … …
Papua New Guinea   328 <1 000 <1 000 1 100 39 29 51
South and  
South-East Asia
 11 820 66 000 52 000 92 000 18 14 25
Afghanistan   7 ... ... ... … ... ...
Bangladesh   16 ... ... ... … ... ...
Bhutan   9 ... ... ... … ... ...
Cambodia  1 058 ... ... ... … ... ...
India3 ... ... ... ... … ... ...
Indonesia  1 048 ... ... ... … ... ...
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Number of 
pregnant women 
living with HIV 
who received 
antiretrovirals 
for preventing 
mother-to-child 
transmission2
Estimated number of pregnant women
living with HIV needing antiretrovirals for
preventing mother-to-child-transmission
Estimated percentage of pregnant 
women living with HIV who received 
antiretrovirals for preventing mother-to-
child-transmission
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Lao People's 
Democratic Republic
  49 ... ... ... … ... ...
Malaysia   342 ... ... ... … ... ...
Maldives   ... ... ... … ... ...
Myanmar  2 890 ... ... ... … ... ...
Nepal   110 ... ... ... … ... ...
Pakistan   55 ... ... ... … ... ...
Philippines   19 ... ... ... … ... ...
Singapore   ... ... ... … … …
Sri Lanka   5 ... ... ... … ... ...
Thailand  4 918 ... ... ... … ... ...
Viet Nam  1 294 ... ... ... … ... ...
Sub-Saharan Africa  861 036 1 400 000 1 200 000 1 500 000 64 58 70
Angola  2 656 15 000 12 000 19 000 17 14 22
Benin  1 349 3 400 2 900 4 000 40 34 47
Botswana  12 207 13 000 11 000 14 000 >95 86 >95
Burkina Faso  3 582 5 400 4 400 6 700 66 53 81
Burundi  2 742 5 100 3 900 6 500 54 41 69
Cameroon  17 362 27 000 23 000 31 000 64 56 73
Cape Verde   244 ... ... ... … ... ...
Central African Republic … ... ... ... … … …
Chad  1 680 12 000 10 000 16 000 14 11 18
Comoros   3 ... ... ... … ... ...
Congo   579 3 100 2 700 3 500 19 17 22
Côte d'Ivoire  13 294 20 000 16 000 24 000 68 55 84
Democratic Republic of 
the Congo
 4 176 32 000 28 000 37 000 13 11 15
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Number of 
pregnant women 
living with HIV 
who received 
antiretrovirals 
for preventing 
mother-to-child 
transmission2
Estimated number of pregnant women
living with HIV needing antiretrovirals for
preventing mother-to-child-transmission
Estimated percentage of pregnant 
women living with HIV who received 
antiretrovirals for preventing mother-to-
child-transmission
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Equatorial Guinea   ... ... ... ... ... … …
Eritrea   291 <1 000 <500 <1 000 46 34 69
Ethiopia  15 828 38 000 32 000 46 000 41 35 49
Gabon  1 064 1 500 1 300 1 900 70 57 87
Gambia  1 068 ... ... ... … ... ...
Ghana  8 957 9 500 7 800 11 000 95 77 >95
Guinea  2 755 6 300 5 000 8 000 44 34 55
Guinea-Bissau   738 2 200 1 600 3 100 33 25 46
Kenya  45 397 86 000 76 000 97 000 53 47 60
Lesotho  9 153 16 000 14 000 17 000 58 52 64
Liberia   850 <1 000 <1 000 1 300 87 69 >95
Madagascar   77 ... ... ... … ... ...
Malawi  40 770 68 000 61 000 75 000 60 54 67
Mali  3 339 ... ... ... … ... ...
Mauritania   554 ... ... ... … ... ...
Mauritius   95 ... ... ... … ... ...
Mozambique  80 779 94 000 81 000 110 000 86 74 >95
Namibia  7 619 8 100 6 700 9 700 94 78 >95
Niger   707 ... ... ... … ... ...
Nigeria  33 323 200 000 170 000 230 000 17 15 19
Rwanda  9 057 10 000 9 000 12 000 87 75 >95
Sao Tome and Principe   36 ... ... ... … ... ...
Senegal  1 000 ... ... ... … ... ...
Sierra Leone  3 018 3 200 2 300 4 800 93 67 >95
South Africa  234 952 280 000 260 000 310 000 83 75 90
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Number of 
pregnant women 
living with HIV 
who received 
antiretrovirals 
for preventing 
mother-to-child 
transmission2
Estimated number of pregnant women
living with HIV needing antiretrovirals for
preventing mother-to-child-transmission
Estimated percentage of pregnant 
women living with HIV who received 
antiretrovirals for preventing mother-to-
child-transmission
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
South Sudan  1 002 7 500 4 600 12 000 13 8 21
Swaziland  10 167 12 000 11 000 13 000 83 75 92
Togo  4 411 5 100 4 200 6 300 86 70 >95
Uganda  73 870 100 000 88 000 120 000 72 62 86
United Republic  
of Tanzania
 73 955 97 000 83 000 110 000 77 66 89
Zambia  76 963 79 000 71 000 88 000 >95 87 >95
Zimbabwe  55 849 68 000 60 000 76 000 82 72 91
western and  
central Europe
... 4 800 4 000 5 800 >95 81 >95
Austria ... ... ... ... … … …
Belgium ... ... ... ... … … …
Bulgaria ... ... ... ... … … …
Croatia ... ... ... ... … … …
Czech Republic ... ... ... ... … … …
Denmark ... ... ... ... … … …
Estonia ... ... ... ... … … …
Finland ... ... ... ... … … …
France ... ... ... ... … … …
Germany ... ... ... ... … … …
Greece ... ... ... ... … … …
Hungary ... ... ... ... … … …
Iceland ... ... ... ... … … …
Ireland ... ... ... ... … … …
Israel ... ... ... ... … … …
Italy ... ... ... ... … … …
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Number of 
pregnant women 
living with HIV 
who received 
antiretrovirals 
for preventing 
mother-to-child 
transmission2
Estimated number of pregnant women
living with HIV needing antiretrovirals for
preventing mother-to-child-transmission
Estimated percentage of pregnant 
women living with HIV who received 
antiretrovirals for preventing mother-to-
child-transmission
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Latvia ... ... ... ... … … …
Lithuania ... ... ... ... … … …
Luxembourg ... ... ... ... … … …
Malta ... ... ... ... … … …
Netherlands ... ... ... ... … … …
Norway ... ... ... ... … … …
Poland ... ... ... ... … … …
Portugal ... ... ... ... … … …
Romania ... ... ... ... … … …
Serbia ... ... ... ... … … …
Slovakia ... ... ... ... … … …
Slovenia ... ... ... ... … … …
Spain ... ... ... ... … … …
Sweden ... ... ... ... … … …
Switzerland ... ... ... ... … … …
Turkey ... ... ... ... … … …
United Kingdom of 
Great Britain and 
Northern Ireland
... ... ... ... … … …
low- and middle- 
income countries 
 928 883 1 500 000 1 300 000 1 600 000 62 57 70
1 For the indicator definition, go to http://www.indicatorregistry.org/node/856. Indicator excludes women who received single-dose nevirapine.  
2 Number of women receiving antiretroviral medicines is based on national Spectrum files. For countries with no national Spectrum file, the values reported in 
the Global AIDS Response Progress Report are listed.  
3 Estimates for China and India are based on 2011 national estimates.  
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REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
twelve-month retention on antiretroviral therapy1, 2012
Percentage of adults and children 
with HIV known to be on treatment 
12 months after initiation of 
antiretroviral therapy
total number of adults and children 
in the cohort or study who were 
initiated on antiretroviral therapy
caribbean
Antigua and Barbuda 92 269
Bahamas 53 93
Barbados 83 119
Cuba 95 1 497
Haiti 75 6 532
Jamaica 74 665
Saint Kitts and Nevis 33 6
Saint Lucia 81 21
Saint Vincent and the Grenadines 75 32
Trinidad and Tobago 92 477
East Asia
China 86 46 170
Mongolia 88 17
Eastern Europe and central Asia 
Armenia 84 106
Azerbaijan 70 345
Belarus 79 1 136
Georgia 86 435
Kazakhstan 81 852
Kyrgyzstan 73 229
Republic of Moldova 82 530
Tajikistan 74 395
Ukraine 84 6 555
Uzbekistan 90 1 624
latin America 
Bolivia (Plurinational State of) 67 264
Brazil 80 41 663
Chile 97 343
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REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
twelve-month retention on antiretroviral therapy1, 2012
Percentage of adults and children 
with HIV known to be on treatment 
12 months after initiation of 
antiretroviral therapy
total number of adults and children 
in the cohort or study who were 
initiated on antiretroviral therapy
Colombia 53 22 912
Ecuador 85 10 630
El Salvador 87 1 163
Guatemala 82 1 966
Guyana 81 545
Honduras 89 1 077
Mexico 92 16 971
Nicaragua 74 562
Paraguay 87 721
Suriname 67 277
Uruguay 72 523
Venezuela (Bolivarian Republic of) 94 43 032
Middle East and North Africa 
Algeria 89 706
Bahrain 100 22
Djibouti 93 93
Egypt 93 251
Iran (Islamic Republic Of) 83 1 106
Lebanon 85 89
Morocco 91 575
Oman 78 120
Somalia 74 239
Sudan 64 673
Tunisia 92 47
Yemen 80 94
oceania 
Fiji 89 18
New Zealand 100 210
Palau 100 3
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Percentage of adults and children 
with HIV known to be on treatment 
12 months after initiation of 
antiretroviral therapy
total number of adults and children 
in the cohort or study who were 
initiated on antiretroviral therapy
Papua New Guinea 83 1 006
Solomon Islands 100 1
South and South-East Asia 
Afghanistan 100 30
Bangladesh 91 534
Brunei Darussalam 83 6
Cambodia 87 3 677
Indonesia 66 6 085
Lao People's Democratic Republic 86 524
Malaysia 96 3 236
Maldives 86 7
Philippines 87 107
Sri Lanka 76 80
Thailand 82 20 733
Viet Nam 83 7 015
Sub-Saharan Africa 
Botswana 86 14 927
Burundi 91 4 614
Cameroon 61 3 360
Cape Verde 96 904
Chad 68 10 546
Comoros 80 5
Côte d'Ivoire 60 16 077
Democratic Republic of the Congo 79 836
Equatorial Guinea 61 500
Ethiopia 83 6 943
Gambia 86 1 278
Ghana 95 73 339
Guinea 72 1 184
REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
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Percentage of adults and children 
with HIV known to be on treatment 
12 months after initiation of 
antiretroviral therapy
total number of adults and children 
in the cohort or study who were 
initiated on antiretroviral therapy
Guinea-Bissau 72 1 922
Kenya 92 47 564
Lesotho 72 18 875
Madagascar 73 116
Malawi 79 114 122
Mali 64 14 678
Mauritania 89 208
Mauritius 72 462
Mozambique 74 2 210
Namibia 83 17 485
Niger 75 2 268
Nigeria 78 111 418
Sao Tome and Principe 77 56
Seychelles 81 104
Sierra Leone 70 ...
South Sudan 71 ...
Swaziland 89 14 496
Togo 82 6 509
Zambia 80 144 854
Zimbabwe 85 8 044
western and central Europe 
Bosnia and Herzegovina 100 22
Bulgaria 71 93
Lithuania 95 291
Montenegro 80 5
Romania 91 553
Slovakia 92 153
The former Yugoslav Republic of Macedonia 93 45
REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
twelve-month retention on antiretroviral therapy1, 2012
1 For the indicator definition, go to http://www.indicatorregistry.org/node/860.
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REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Estimated number of adults receiving and needing antiretroviral therapy, and coverage1, 2012
Reported number 
of adults on ARt3
Estimated number of adults needing 
antiretroviral therapy based on wHo 
2010 guidelines2
Estimated ARt coverage based  
on wHo 2010 guidelines2
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
caribbean 80 190 120 000 110 000 130 000 72 67 78
Bahamas 921 ... ... ... … … …
Barbados 1 004 ... ... ... … … …
Cuba 8 074 3 900 2 900 5 800 >95 >95 >95
Dominican Republic 21 138 27 000 25 000 30 000 78 72 86
Haiti 40 964 65 000 61 000 71 000 63 58 68
Jamaica 10 014 15 000 13 000 17 000 68 60 77
Trinidad and Tobago 5 407 ... ... ... … … …
East Asia 151 572 350 000 290 000 440 000 47 39 60
China4 151 519 ... ... ... … … …
Democratic People's 
Republic of Korea
… ... ... ... … … …
Japan ... ... ... ... … … …
Mongolia 53 <500 <500 <500 6 5 6
Republic of Korea ... ... ... ... … … …
Eastern Europe and 
central Asia
176 760 510 000 430 000 580 000 35 30 41
Armenia 436 1 300 <1 000 1 800 34 25 48
Azerbaijan 885 3 800 3 000 4 800 24 19 31
Belarus 4 120 9 400 8 700 10 000 44 40 48
Georgia 1 598 2 300 1 900 3 100 71 60 >95
Kazakhstan 2 338 ... ... ... … … …
Kyrgyzstan 457 2 200 1 600 3 300 20 14 30
Republic of Moldova 2 012 7 200 6 100 8 700 28 24 34
Russian Federation … ... ... ... … … …
Tajikistan 895 3 400 2 200 5 500 27 18 44
Ukraine 38 082 100 000 89 000 110 000 39 35 45
Uzbekistan 3 491 11 000 9 200 15 000 31 25 39
latin America 619 104 790 000 700 000 920 000 75 67 87
Argentina 47 725 59 000 52 000 66 000 81 71 90
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REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Estimated number of adults receiving and needing antiretroviral therapy, and coverage1, 2012
Reported number 
of adults on ARt3
Estimated number of adults needing 
antiretroviral therapy based on wHo 
2010 guidelines2
Estimated ARt coverage based  
on wHo 2010 guidelines2
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Belize 1 166 1 600 1 500 1 700 73 68 77
Bolivia 
(Plurinational State of)
2 278 6 300 4 300 9 100 36 25 52
Brazil 307 025 ... 320 000 370 000 … 81 93
Chile 18 898 22 000 17 000 29 000 86 67 >95
Colombia 33 148 60 000 52 000 82 000 51 41 65
Costa Rica 3 631 5 100 4 800 5 500 76 71 82
Ecuador 9 080 21 000 16 000 32 000 42 32 63
El Salvador 6 308 13 000 10 000 19 000 50 38 72
Guatemala 14 112 27 000 19 000 44 000 53 39 89
Guyana 3 516 3 800 2 400 5 400 93 58 >95
Honduras 8 187 14 000 12 000 16 000 60 53 70
Mexico 82 000 100 000 91 000 110 000 82 74 91
Nicaragua 2 086 2 900 2 100 4 200 72 52 >95
Panama 5 668 9 200 7 500 11 000 76 62 93
Paraguay 3 606 5 000 3 400 7 600 72 49 >95
Peru 27 007 36 000 23 000 74 000 60 39 >95
Suriname 1 288 2 000 1 900 2 100 65 62 70
Uruguay 3 928 6 100 5 000 7 700 64 52 81
Venezuela (Bolivarian 
Republic of)
42 060 59 000 46 000 79 000 72 56 >95
Middle East and 
North Africa
19 424 92 000 70 000 130 000 22 17 30
Algeria 3 134 ... ... ... … … …
Djibouti 1 442 4 100 3 400 4 800 35 29 42
Egypt 954 2 500 2 300 7 700 38 34 >95
Iran 
(Islamic Republic of)
3 417 27 000 21 000 36 000 13 10 17
Lebanon 536 ... ... ... … … …
Morocco 5 059 10 000 8 400 13 000 48 39 61
Oman 731 ... ... ... … … …
A84  |  Annex: Reach 15 million people living with HIV with lifesaving antiretroviral treatment by 2015
Reported number 
of adults on ARt3
Estimated number of adults needing 
antiretroviral therapy based on wHo 
2010 guidelines2
Estimated ARt coverage based  
on wHo 2010 guidelines2
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Somalia 1 407 9 500 6 800 14 000 15 10 22
Sudan 2 405 ... ... ... ... ... ...
Tunisia 443 <1 000 <1 000 1 200 56 37 83
Yemen 703 4 600 2 500 12 000 15 8 42
North America ... 880 000 730 000 1 100 000 91 76 >95
Canada ... ... ... ... … … …
United States of 
America
... ... ... ... … … …
oceania 11 169 28 000 24 000 31 000 >95 84 >95
Australia ... ... ... ... … … …
Fiji 127 <500 <500 <500 42 35 52
New Zealand ... ... ... ... … … …
Papua New Guinea 11 042 13 000 11 000 15 000 84 73 >95
South and 
South-East Asia
1 028 036 1 800 000 1 500 000 2 300 000 52 42 65
Afghanistan 150 1 200 <1 000 3 500 9 4 26
Bangladesh 783 2 900 1 300 17 000 27 12 >95
Bhutan 33 <500 <200 <1 000 11 6 23
Cambodia 44 318 54 000 39 000 95 000 82 60 >95
India4 570 620 1 000 000 880 000 1 100 000 51 44 57
Indonesia 29 960 170 000 120 000 240 000 18 12 25
Lao People's 
Democratic Republic
2 212 4 100 3 700 4 700 54 48 61
Malaysia 14 594 35 000 28 000 45 000 41 32 52
Maldives 5 <100 <100 <100 27 22 35
Myanmar 49 676 110 000 95 000 120 000 46 41 51
Nepal 7 168 22 000 19 000 27 000 33 28 40
Pakistan 2 996 21 000 13 000 36 000 14 9 25
Philippines 3 459 4 500 3 500 6 400 76 59 >95
Singapore ... ... ... ... … … …
Sri Lanka 363 1 100 <1 000 1 700 35 27 54
REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
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REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Estimated number of adults receiving and needing antiretroviral therapy, and coverage1, 2012
Reported number 
of adults on ARt3
Estimated number of adults needing 
antiretroviral therapy based on wHo 
2010 guidelines2
Estimated ARt coverage based  
on wHo 2010 guidelines2
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Thailand 232 816 280 000 270 000 300 000 76 71 80
Viet Nam 68 883 120 000 40 000 220 000 58 19 >95
Sub-Saharan Africa 6 991 492 10 300 000 9 900 000 10 900 000 68 65 72
Angola 39 704 85 000 72 000 100 000 48 41 57
Benin 23 400 34 000 31 000 36 000 70 65 75
Botswana 201 822 200 000 190 000 210 000 >95 >95 >95
Burkina Faso 39 047 54 000 49 000 59 000 72 66 79
Burundi 27 098 40 000 36 000 46 000 67 60 76
Cameroon 117 791 240 000 230 000 260 000 49 46 52
Cape Verde 798 <1 000 <1 000 <1 000 >95 >95 >95
Central African 
Republic
… ... ... ... … … …
Chad 35 014 82 000 73 000 98 000 43 38 51
Comoros 23 <500 <500 <500 7 5 9
Congo 16 086 36 000 34 000 39 000 44 41 48
Côte d'Ivoire 104 750 190 000 180 000 210 000 55 50 61
Democratic Republic 
of the Congo
59 468 170 000 160 000 180 000 38 36 41
Equatorial Guinea 6 512 ... ... ... … … …
Eritrea 7 608 9 400 8 000 12 000 81 68 >95
Ethiopia 270 460 400 000 370 000 430 000 68 63 72
Gabon 14 512 22 000 20 000 24 000 67 62 73
Gambia 3 300 5 600 4 500 6 900 64 51 79
Ghana 66 366 110 000 96 000 120 000 62 56 69
Guinea 25 552 45 000 39 000 52 000 57 50 65
Guinea-Bissau 5 766 14 000 12 000 18 000 43 35 54
Kenya 548 588 680 000 630 000 680 000 81 75 80
Lesotho 87 352 150 000 140 000 160 000 59 56 61
Liberia 5 048 11 000 9 700 12 000 47 42 52
Madagascar 357 25 000 21 000 28 000 1 1 2
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Reported number 
of adults on ARt3
Estimated number of adults needing 
antiretroviral therapy based on wHo 
2010 guidelines2
Estimated ARt coverage based  
on wHo 2010 guidelines2
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Malawi 368 690 480 000 470 000 500 000 76 73 79
Mali 26 839 46 000 40 000 52 000 58 51 66
Mauritania 1 830 4 500 3 600 5 700 41 33 52
Mauritius 1 517 4 200 3 900 4 800 36 33 40
Mozambique 282 687 590 000 540 000 650 000 48 44 53
Namibia 105 347 120 000 110 000 130 000 91 83 >95
Niger 11 137 20 000 18 000 24 000 55 47 64
Nigeria 459 465 1 300 000 1 200 000 1 400 000 36 33 39
Rwanda 107 021 110 000 110 000 120 000 94 89 >95
Sao Tome and Principe 285 <1 000 <500 <1 000 51 40 66
Senegal 13 485 20 000 18 000 23 000 67 59 75
Sierra Leone 7 802 22 000 18 000 30 000 35 28 47
South Africa 2 010 340 2 500 000 2 400 000 2 600 000 81 79 86
South Sudan 4 376 49 000 34 000 73 000 9 6 13
Swaziland 80 103 93 000 89 000 96 000 87 83 90
Togo 28 213 57 000 51 000 65 000 50 45 57
Uganda 403 089 580 000 530 000 640 000 70 64 78
United Republic of 
Tanzania
399 886 580 000 540 000 630 000 68 64 74
Zambia 446 841 520 000 500 000 540 000 86 83 91
Zimbabwe 518 801 610 000 590 000 640 000 85 81 88
western and  
central Europe
... 560 000 520 000 590 000 >95 94 >95
Austria ... ... ... ... … … …
Belgium ... ... ... ... … … …
Bulgaria ... ... ... ... … … …
Croatia ... ... ... ... … … …
Czech Republic ... ... ... ... … … …
Denmark ... ... ... ... … … …
Estonia ... ... ... ... … … …
REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Estimated number of adults receiving and needing antiretroviral therapy, and coverage1, 2012
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REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Estimated number of adults receiving and needing antiretroviral therapy, and coverage1, 2012
1 For the indicator definition, go to http://www.indicatorregistry.org/node/859. 
2 Based on national Spectrum files. 
3 Based on Global AIDS Response Progress Reporting (GARPR) data.  
4 Estimates for China and India are based on 2011 national estimates.
Reported number 
of adults on ARt3
Estimated number of adults needing 
antiretroviral therapy based on wHo 
2010 guidelines2
Estimated ARt coverage based  
on wHo 2010 guidelines2
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Finland ... ... ... ... … … …
France ... ... ... ... … … …
Germany ... ... ... ... … … …
Greece ... ... ... ... … … …
Hungary ... ... ... ... … … …
Iceland ... ... ... ... … … …
Ireland ... ... ... ... … … …
Israel ... ... ... ... … … …
Italy ... ... ... ... … … …
Latvia ... ... ... ... … … …
Lithuania ... ... ... ... … … …
Luxembourg ... ... ... ... … … …
Malta ... ... ... ... … … …
Netherlands ... ... ... ... … … …
Norway ... ... ... ... … … …
Poland ... ... ... ... … … …
Portugal ... ... ... ... … … …
Romania ... ... ... ... … … …
Serbia ... ... ... ... … … …
Slovakia ... ... ... ... … … …
Slovenia ... ... ... ... … … …
Spain ... ... ... ... … … …
Sweden ... ... ... ... … … …
Switzerland ... ... ... ... … … …
Turkey ... ... ... ... … … …
United Kingdom of 
Great Britain and 
Northern Ireland
... ... ... ... … … …
low- and middle-
income countries
9 090 394 14 000 000 13 100 000 15 200 000 64 60 69
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REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Estimated children receiving and needing antiretroviral therapy, and coverage1, 2012
Reported number 
of children 0-14 
years receiving 
ARt2
Estimated number of children needing 
antiretroviral therapy3
Estimated antiretroviral therapy coverage 
among children3
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
caribbean 3 826 9 200 8 000 11 000 44 38 50
Bahamas ... ... ... ... … … …
Barbados ... ... ... ... … … …
Cuba 24 ... ... ... ... ... ...
Dominican Republic 1 083 ... ... ... ... ... ...
Haiti 2 265 6 700 5 700 7 800 34 29 40
Jamaica 454 ... ... ... ... ... ...
Trinidad and Tobago ... ... ... ... … … …
East Asia 2 085 6 400 4 700 8 800 33 24 46
China4 … ... ... ... … … …
Democratic People's 
Republic of Korea
… ... ... ... … … …
Japan ... ... ... ... … … …
Mongolia … ... ... ... … … …
Republic of Korea ... ... ... ... … … …
Eastern Europe and 
central Asia 
8 784 12 000 12 000 12 000 75 73 78
Armenia 13 ... ... ... … … …
Azerbaijan 22 ... ... ... … … …
Belarus 154 ... ... ... … … …
Georgia 42 ... ... ... … … …
Kazakhstan … ... ... ... … … …
Kyrgyzstan 70 ... ... ... … … …
Republic of Moldova 63 ... ... ... … … …
Russian Federation … ... ... ... … … …
Tajikistan 149 ... ... ... … … …
Ukraine 2 268 ... ... ... … … …
Uzbekistan 2 530 ... ... ... … … …
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Estimated children receiving and needing antiretroviral therapy, and coverage1, 2012
Reported number 
of children 0-14 
years receiving 
ARt2
Estimated number of children needing 
antiretroviral therapy3
Estimated antiretroviral therapy coverage 
among children3
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
latin America 22 661 30 000 25 000 39 000 75 62 >95
Argentina 3 000 ... ... ... ... ... ...
Belize 95 ... ... ... ... ... ...
Bolivia 
(Plurinational State of)
86 ... ... ... ... ... ...
Brazil … ... ... ... ... ... ...
Chile 173 ... ... ... ... ... ...
Colombia 6 249 ... ... ... ... ... ...
Costa Rica 61 ... ... ... ... ... ...
Ecuador 550 ... ... ... ... ... ...
El Salvador 335 ... ... ... ... ... ...
Guatemala 1 024 ... ... ... ... ... ...
Guyana 201 ... ... ... ... ... ...
Honduras 783 ... ... ... ... ... ...
Mexico 1 800 ... ... ... ... ... ...
Nicaragua 104 ... ... ... ... ... ...
Panama 256 ... ... ... ... ... ...
Paraguay 181 ... ... ... ... ... ...
Peru 495 ... ... ... ... ... ...
Suriname 84 ... ... ... ... ... ...
Uruguay 118 ... ... ... ... ... ...
Venezuela 
(Bolivarian Republic of)
972 ... ... ... ... ... ...
Middle East and 
North Africa 
1 011 13 000 8 600 21 000 8 6 13
Algeria 262 ... ... ... … … …
Djibouti 40 <1 000 <1 000 <1 000 6 5 8
Egypt 42 ... ... ... ... ... ...
Iran 
(Islamic Republic of)
141 ... ... ... ... ... ...
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Reported number 
of children 0-14 
years receiving 
ARt2
Estimated number of children needing 
antiretroviral therapy3
Estimated antiretroviral therapy coverage 
among children3
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Lebanon … ... ... ... … … …
Morocco 244 ... ... ... … … …
Oman ... ... ... ... … … …
Somalia 43 ... ... ... … … …
Sudan 170 ... ... ... ... ... ...
Tunisia 12 ... ... ... … … …
Yemen 53 ... ... ... … … …
North America ... 1 900 1 300 2 700 92 65 >95
Canada ... ... ... ... … … …
United States of 
America
... ... ... ... … … …
oceania 729 1 800 1 400 2 400 40 31 51
Australia ... ... ... ... … … …
Fiji 7 ... ... ... … … …
New Zealand ... ... ... ... … … …
Papua New Guinea 722 1 800 1 400 2 300 39 30 51
South and  
South-East Asia 
56 401 130 000 110 000 170 000 43 37 56
Afghanistan 8 ... ... ... … … …
Bangladesh 48 ... ... ... … … …
Bhutan 5 ... ... ... … … …
Cambodia 4 595 ... ... ... … … …
India4 34 367 ... ... ... … … …
Indonesia 1 695 ... ... ... … … …
Lao People's 
Democratic Republic
163 ... ... ... … … …
Malaysia 490 ... ... ... … … …
Maldives 0 ... ... ... … … …
Myanmar 4 033 ... ... ... … … …
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Estimated children receiving and needing antiretroviral therapy, and coverage1, 2012
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Estimated children receiving and needing antiretroviral therapy, and coverage1, 2012
Reported number 
of children 0-14 
years receiving 
ARt2
Estimated number of children needing 
antiretroviral therapy3
Estimated antiretroviral therapy coverage 
among children3
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Nepal 699 ... ... ... ... ... ...
Pakistan 139 ... ... ... ... ... ...
Philippines 33 ... ... ... ... ... ...
Singapore ... ... ... ... … … …
Sri Lanka 24 ... ... ... ... ... ...
Thailand 6 274 ... ... ... ... ... ...
Viet Nam 3 828 ... ... ... ... ... ...
Sub-Saharan Africa 551 065 1 700 000 1 600 000 1 900 000 32 30 36
Angola 2 903 19 000 15 000 24 000 15 12 19
Benin 2 635 5 300 4 500 6 200 49 42 58
Botswana 10 261 10 000 9 900 10 000 >95 >95 >95
Burkina Faso 6 863 12 000 9 700 14 000 59 49 72
Burundi 2 023 9 700 7 800 12 000 21 17 26
Cameroon 4 992 33 000 29 000 38 000 15 13 17
Cape Verde 66 ... ... ... ... ... ...
Central African 
Republic
… ... ... ... … … …
Chad 5 812 20 000 17 000 25 000 29 24 37
Comoros 1 ... ... ... ... ... ...
Congo 1 148 7 500 6 600 8 500 15 14 17
Côte d'Ivoire 5 620 35 000 29 000 41 000 16 14 19
Democratic Republic 
of the Congo
4 751 53 000 47 000 61 000 9 8 10
Equatorial Guinea ... ... ... ... … … …
Eritrea 632 1 900 1 400 2 600 34 26 46
Ethiopia 17 677 78 000 71 000 96 000 23 20 28
Gabon 494 2 000 1 700 2 400 24 20 29
Gambia 271 ... ... ... ... ... ...
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Reported number 
of children 0-14 
years receiving 
ARt2
Estimated number of children needing 
antiretroviral therapy3
Estimated antiretroviral therapy coverage 
among children3
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Ghana 3 504 14 000 12 000 17 000 25 20 30
Guinea 1 114 8 300 6 800 10 000 13 11 17
Guinea-Bissau 335 3 300 2 500 4 400 11 8 14
Kenya 55 439 150 000 130 000 180 000 38 34 45
Lesotho 5 395 22 000 19 000 24 000 25 22 27
Liberia 430 2 100 1 800 2 500 20 17 24
Madagascar 14 ... ... ... ... ... ...
Malawi 36 441 100 000 90 000 110 000 36 33 41
Mali 1 912 ... ... ... ... ... ...
Mauritania 51 ... ... ... ... ... ...
Mauritius 10 ... ... ... ... ... ...
Mozambique 27 164 100 000 88 000 120 000 27 23 32
Namibia 11 340 13 000 12 000 15 000 88 79 >95
Niger 673 ... ... ... ... ... ...
Nigeria 31 556 260 000 220 000 290 000 12 11 14
Rwanda 7 597 18 000 15 000 21 000 43 36 52
Sao Tome and Principe 11 ... ... ... ... ... ...
Senegal 1 207 ... ... ... ... ... ...
Sierra Leone 457 3 000 2 200 4 700 15 11 24
South Africa 140 541 220 000 210 000 250 000 63 57 69
South Sudan 553 11 000 7 200 17 000 5 3 8
Swaziland 7 431 14 000 12 000 15 000 54 49 59
Togo 2 098 8 800 7 200 11 000 24 19 30
Uganda 35 453 110 000 88 000 130 000 33 28 41
United Republic of 
Tanzania
32 407 130 000 110 000 150 000 26 22 30
Zambia 34 084 89 000 80 000 99 000 38 35 43
Zimbabwe 46 874 100 000 94 000 120 000 45 40 50
REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Estimated children receiving and needing antiretroviral therapy, and coverage1, 2012
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Estimated children receiving and needing antiretroviral therapy, and coverage1, 2012
Reported number 
of children 0-14 
years receiving 
ARt2
Estimated number of children needing 
antiretroviral therapy3
Estimated antiretroviral therapy coverage 
among children3
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
western and  
central Europe 
... <1 000 <1 000 <1 000 68 62 76
Austria ... ... ... ... … … …
Belgium ... ... ... ... … … …
Bulgaria ... ... ... ... … … …
Croatia ... ... ... ... … … …
Czech Republic ... ... ... ... … … …
Denmark ... ... ... ... … … …
Estonia ... ... ... ... … … …
Finland ... ... ... ... … … …
France ... ... ... ... … … …
Germany ... ... ... ... … … …
Greece ... ... ... ... … … …
Hungary ... ... ... ... … … …
Iceland ... ... ... ... … … …
Ireland ... ... ... ... … … …
Israel ... ... ... ... … … …
Italy ... ... ... ... … … …
Latvia ... ... ... ... … … …
Lithuania ... ... ... ... … … …
Luxembourg ... ... ... ... … … …
Malta ... ... ... ... … … …
Netherlands ... ... ... ... … … …
Norway ... ... ... ... … … …
Poland ... ... ... ... … … …
Portugal ... ... ... ... … … …
Romania ... ... ... ... … … …
Serbia ... ... ... ... … … …
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Reported number 
of children 0-14 
years receiving 
ARt2
Estimated number of children needing 
antiretroviral therapy3
Estimated antiretroviral therapy coverage 
among children3
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Slovakia ... ... ... ... … … …
Slovenia ... ... ... ... … … …
Spain ... ... ... ... … … …
Sweden ... ... ... ... … … …
Switzerland ... ... ... ... … … …
Turkey ... ... ... ... … … …
United Kingdom of 
Great Britain and 
Northern Ireland
... ... ... ... … … …
low- and middle-
income countries 
646 812 1 900 000 1 700 000 2 200 000 34 31 39
REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Estimated children receiving and needing antiretroviral therapy, and coverage1, 2012
1 For the indicator definition, go to http://www.indicatorregistry.org/node/859.  
2 Based on Global AIDS Response Progress Reporting (GARPR) data. 
3 Based on national Spectrum files.  
4 Estimates for China and India are based on 2011 national estimates. 
 UNAIDS 2013 Global report  |  A95
A96  |  Annex: Reach 15 million people living with HIV with lifesaving antiretroviral treatment by 2015
REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Projected number of people in need of antiretroviral therapy according to 2013 wHo 
antiretroviral criteria guidelines1
2013
estimate lower estimate upper estimate
caribbean
Cuba  5 800  4 200  8 700
Dominican Republic  50 000  45 000  55 000
Haiti  130 000  120 000  140 000
Jamaica  24 000  21 000  28 000
East Asia
China2 ... ... ...
Democratic People's Republic of Korea ... ... ...
Mongolia  1 000 <1 000  1 100
Eastern Europe and central Asia
Armenia  2 500  1 800  3 500
Azerbaijan  8 800  7 000  11 000
Belarus  18 000  17 000  19 000
Georgia  5 900  5 000  7 900
Kazakhstan ... ... ...
Kyrgyzstan  7 200  5 200  10 000
Republic of Moldova  7 600  6 500  9 200
Russian Federation  730 000  580 000  880 000
Tajikistan  14 000  9 400  25 000
Ukraine  230 000  200 000  260 000
Uzbekistan  24 000  20 000  30 000
latin America
Argentina  93 000  83 000  100 000
Belize  2 500  2 300  2 600
Bolivia (Plurinational State of)  13 000  8 600  19 000
Brazil ... ... ...
Chile  30 000  23 000  40 000
Colombia  120 000  97 000  150 000
Costa Rica  8 800  8 200  9 500
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Projected number of people in need of antiretroviral therapy according to 2013 wHo 
antiretroviral criteria guidelines1
2013
estimate lower estimate upper estimate
Ecuador  42 000  32 000  66 000
El Salvador  21 000  16 000  32 000
Guatemala  48 000  35 000  88 000
Guyana  7 200  4 600  10 000
Honduras  23 000  20 000  27 000
Mexico  150 000  140 000  170 000
Nicaragua  9 200  6 800  13 000
Panama  13 000  10 000  17 000
Paraguay  13 000  8 700  21 000
Peru  57 000  35 000  130 000
Suriname  3 300  3 100  3 600
Uruguay  11 000  9 100  14 000
Venezuela (Bolivarian Republic of)  92 000  73 000  120 000
Middle East and North Africa
Algeria ... ... ...
Djibouti  5 800  4 800  6 900
Egypt  6 400  4 000  13 000
Iran (Islamic Republic of)  69 000  52 000  93 000
Lebanon ... ... ...
Morocco  27 000  22 000  34 000
Somalia  25 000  18 000  38 000
Sudan ... ... ...
Tunisia  1 700  1 200  2 500
Yemen  18 000  9 500  46 000
oceania
Fiji <1 000 <1 000 <1 000
Papua New Guinea  21 000  18 000  25 000
South and South-East Asia
Afghanistan  3 900  1 600  12 000
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2013
estimate lower estimate upper estimate
Bangladesh  7 100  3 100  53 000
Bhutan <1 000 <1 000  2 000
Cambodia  70 000  52 000  120 000
India2 1 900 000 1 700 000 2 200 000
Indonesia  540 000  380 000  780 000
Lao People's Democratic Republic  10 000  9 000  11 000
Malaysia  60 000  47 000  75 000
Maldives <100 <100 <100
Myanmar  170 000  150 000  190 000
Nepal  50 000  42 000  63 000
Pakistan  85 000  53 000  150 000
Philippines  14 000  11 000  21 000
Sri Lanka  2 700  2 100  4 200
Thailand  380 000  360 000  400 000
Viet Nam  250 000  80 000  460 000
Sub-Saharan Africa
Angola  220 000  190 000  260 000
Benin  66 000  61 000  72 000
Botswana  300 000  280 000  310 000
Burkina Faso  95 000  85 000  110 000
Burundi  80 000  71 000  92 000
Cameroon  520 000  480 000  560 000
Cape Verde  1 000 <1 000  1 200
Central African Republic  110 000  97 000  120 000
Chad  160 000  140 000  200 000
Comoros ... ... ...
Congo  67 000  62 000  72 000
Côte d'Ivoire  350 000  320 000  400 000
Democratic Republic of the Congo  490 000  450 000  530 000
REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Projected number of people in need of antiretroviral therapy according to 2013 wHo 
antiretroviral criteria guidelines1
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Projected number of people in need of antiretroviral therapy according to 2013 wHo 
antiretroviral criteria guidelines1
2013
estimate lower estimate upper estimate
Eritrea  15 000  12 000  19 000
Ethiopia  780 000  730 000  850 000
Gabon  35 000  32 000  39 000
Gambia  12 000  9 800  15 000
Ghana  200 000  180 000  230 000
Guinea  110 000  94 000  130 000
Guinea-Bissau  40 000  32 000  51 000
Kenya 1 300 000 1 300 000 1 400 000
Lesotho  280 000  260 000  290 000
Liberia  19 000  17 000  21 000
Madagascar  52 000  43 000  60 000
Malawi  950 000  910 000 1 000 000
Mali  95 000  80 000  110 000
Mauritania  8 700  6 900  11 000
Mauritius  7 500  7 000  8 400
Mozambique  730 000  660 000  810 000
Namibia  200 000  180 000  220 000
Niger  60 000  52 000  71 000
Nigeria 3 000 000 2 700 000 3 300 000
Rwanda  170 000  160 000  190 000
Sao Tome and Principe  1 200 <1 000  1 500
Senegal  37 000  33 000  43 000
Sierra Leone  49 000  39 000  67 000
South Africa 5 300 000 5 100 000 5 600 000
South Sudan  140 000  98 000  220 000
Swaziland  190 000  180 000  200 000
Togo  110 000  94 000  120 000
Uganda 1 400 000 1 200 000 1 500 000
United Republic of Tanzania 1 300 000 1 200 000 1 400 000
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2013
estimate lower estimate upper estimate
Zambia  980 000  930 000 1 000 000
Zimbabwe 1 100 000 1 100 000 1 200 000
western and central Europe
Bulgaria  3 000  2 100  4 500
Latvia  6 400  5 000  8 400
Lithuania <1 000 <1 000  1 300
Romania  16 000  15 000  18 000
Serbia  2 700  1 900  3 800
Turkey  5 000  3 700  6 600
low- and middle-income countries 28 300 000 26 300 000 30 600 000
REAcH 15 MIllIoN PEoPlE lIVING wItH HIV wItH lIFESAVING ANtIREtRoVIRAl 
tREAtMENt bY 2015
Projected number of people in need of antiretroviral therapy according to 2013 wHo 
antiretroviral criteria guidelines1
Source: UNAIDS 2012 Estimates.  
1 The calculations assume the following individuals are eligible for antiretroviral therapy:  all adults 15+ years with CD4 < 500ml, all pregnant women living 
with HIV, all adults co-infected with HIV and tuberculosis, all HIV discordant couples, and all children living with HIV under five years. 
2 Estimates for China and India are based on 2011 national estimates.
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HAlVE tUbERcUloSIS DEAtHS AMoNG PEoPlE lIVING wItH HIV bY 2015
Percentage of estimated HIV-positive incident tb cases that received treatment for both tb and 
HIV2
2012
caribbean 
Antigua and Barbuda 100
Bahamas 59
Barbados 67
Cuba 94
Dominican Republic 50
Grenada1 0
Haiti 29
Jamaica1 35
Saint Lucia 100
Saint Vincent and the Grenadines 63
Trinidad and Tobago 29
East Asia 
China 47
Mongolia 27
Eastern Europe and central Asia 
Armenia 100
Azerbaijan 45
Belarus 55
Georgia 52
Kazakhstan 20
Kyrgyzstan1 41
Republic of Moldova 30
Tajikistan 22
Ukraine 92
Uzbekistan 23
latin America 
Belize 73
Bolivia (Plurinational State of) 38
Brazil 57
Chile1 2
Colombia 30
2012
Costa Rica1 38
Ecuador1 69
El Salvador 89
Guatemala1 16
Guyana 84
Honduras 51
Mexico 19
Nicaragua1 58
Panama1 97
Paraguay 50
Suriname 53
Uruguay 23
Venezuela (Bolivarian Republic of) 43
Middle East and North Africa
Algeria1 31
Bahrain 8
Djibouti 15
Iran (Islamic Republic Of) 40
Lebanon 7
Morocco 61
Oman 100
Qatar 100
Somalia 6
Sudan 1
Tunisia 8
Yemen1 10
oceania 
Fiji 100
New Zealand1 100
Papua New Guinea 30
South and South-East Asia 
Afghanistan 2
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2012
Costa Rica1 38
Ecuador1 69
El Salvador 89
Guatemala1 16
Guyana 84
Honduras 51
Mexico 19
Nicaragua1 58
Panama1 97
Paraguay 50
Suriname 53
Uruguay 23
Venezuela (Bolivarian Republic of) 43
Middle East and North Africa
Algeria1 31
Bahrain 8
Djibouti 15
Iran (Islamic Republic Of) 40
Lebanon 7
Morocco 61
Oman 100
Qatar 100
Somalia 6
Sudan 1
Tunisia 8
Yemen1 10
oceania 
Fiji 100
New Zealand1 100
Papua New Guinea 30
South and South-East Asia 
Afghanistan 2
HAlVE tUbERcUloSIS DEAtHS AMoNG PEoPlE lIVING wItH HIV bY 2015
Percentage of estimated HIV-positive incident tb cases that received treatment for both tb and 
HIV2
2012
Bangladesh 26
Brunei Darussalam 100
Cambodia 47
India 20
Indonesia1 56
Lao People's Democratic Republic1 56
Malaysia 19
Maldives 0
Myanmar 22
Nepal 20
Pakistan 1
Sri Lanka 65
Thailand 30
Viet Nam 24
Sub-Saharan Africa 
Angola 21
Benin1 11
Botswana 49
Burkina Faso 31
Burundi 24
Cameroon 22
Cape Verde 62
Central African Republic 5
Chad 15
Comoros 40
Congo 4
Côte d'Ivoire 30
Democratic Republic of the Congo 14
Equatorial Guinea1 62
Ethiopia 35
Gabon 29
2012
Ghana 37
Guinea 24
Kenya 59
Lesotho 42
Liberia 15
Madagascar 3
Malawi 57
Mali 35
Mauritania1 2
Mauritius 64
Mozambique 19
Namibia 46
Niger1 27
Nigeria 24
Rwanda1 48
Sao Tome and Principe 100
Senegal 33
Seychelles 100
Sierra Leone 24
South Africa 31
South Sudan 28
Swaziland 29
Togo 40
Uganda 28
United Republic of Tanzania 34
Zambia 41
western and central Europe 
Romania 35
Serbia 90
Slovakia 0
Turkey 106
Source: WHO Global TB database as of 23 July 2013, unless otherwise specified.      
1 Based on figures reported by countries through Global AIDS Response Progress Reporting (GARPR) 2013.  
2 For the indicator definition, go to http://www.indicatorregistry.org/node/651. 
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HAlVE tUbERcUloSIS DEAtHS AMoNG PEoPlE lIVING wItH HIV bY 2015
HIV-positive tuberculosis patients on antiretroviral therapy
 
2012
caribbean 
Antigua and Barbuda 2
Bahamas 5
Barbados 1
Cuba 51
Dominica 0
Dominican Republic 268
Grenada1 0
Haiti 1 252
Jamaica1 14
Saint Kitts and Nevis 0
Saint Lucia 1
Saint Vincent and the Grenadines 6
Trinidad and Tobago 24
East Asia 
China 3 454
Mongolia 3
Eastern Europe and central Asia 
Armenia 55
Azerbaijan 63
Belarus 153
Georgia 26
Kazakhstan 51
Kyrgyzstan1 118
Republic of Moldova 103
Tajikistan 78
Ukraine 4 433
Uzbekistan 103
latin America 
Belize 19
2012
Bolivia (Plurinational State of) 164
Brazil 9 049
Chile1 2
Colombia 474
Costa Rica1 24
Ecuador1 583
El Salvador 178
Guatemala1 243
Guyana 168
Honduras 192
Mexico 298
Nicaragua1 58
Panama1 224
Paraguay 121
Peru 847
Suriname 25
Uruguay 32
Venezuela (Bolivarian Republic of) 517
Middle East and North Africa 
Algeria1 110
Bahrain 1
Djibouti 83
Egypt 17
Iran (Islamic Republic of) 117
Iraq 1
Jordan 0
Kuwait 3
Lebanon 3
Morocco 357
Oman 14
Qatar 1
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Somalia 51
Sudan 40
Syrian Arab Republic 5
Tunisia 14
United Arab Emirates1 12
Yemen1 16
oceania 
Fiji 3
Kiribati 0
Marshall Islands 0
Micronesia (Federated States of) 0
New Zealand1 3
Palau 0
Papua New Guinea 325
Samoa 0
Solomon Islands 0
Tonga 0
Tuvalu 0
Vanuatu 0
South and South-East Asia 
Afghanistan 5
Bangladesh 63
Brunei Darussalam 2
Cambodia 1 268
India 25 790
Indonesia2 4 209
Lao People's Democratic Republic1 263
Malaysia 434
Maldives 0
Myanmar 4 270
Nepal 217
2012
Pakistan 22
Sri Lanka 11
Thailand 3 591
Timor-Leste 4
Viet Nam 2 232
Sub-Saharan Africa 
Angola 1 149
Benin1 113
Botswana 2 475
Burkina Faso 503
Burundi 588
Cameroon 4 261
Cape Verde 44
Central African Republic 290
Chad 626
Comoros 4
Congo 152
Côte d'Ivoire 2 396
Democratic Republic of the Congo 2 296
Equatorial Guinea1 123
Ethiopia 8 022
Gabon 559
Gambia 146
Ghana 1 033
Guinea 903
Guinea-Bissau 0
Kenya 26 487
Lesotho 4 171
Liberia 115
Madagascar 18
Malawi 9 144
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Mali 425
Mauritania1 14
Mauritius 9
Mozambique 15 391
Namibia 3 362
Niger2 516
Nigeria 10 866
Rwanda1 1 395
Sao Tome and Principe 18
Senegal 561
Seychelles 3
Sierra Leone 931
South Africa 101 937
South Sudan 147
Swaziland 3 762
Togo 476
Uganda 9 962
2012
United Republic of Tanzania 10 993
Zambia 14 471
western and central Europe 
Albania 7
Andorra 0
Bulgaria 3
Estonia 28
Greece1 28
Iceland 0
Latvia 65
Montenegro 0
Romania 205
Serbia 6
Slovakia 0
Slovenia 0
The former Yugoslav  
Republic of Macedonia
0
Turkey 35
Source: WHO Global TB database as of 23 July 2013, unless otherwise specified.      
1 Reported by countries through Global AIDS Response Progress Reporting (GARPR) 2013.     
2 TB and AIDS programme numbers had discrepancies. TB programme data was partial, hence, AIDS programme data was used.  
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Source: UNAIDS/WHO estimates 2013.
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Estimated number of tb-related deaths among people living with HIV in Africa, in tb/HIV high 
burden countries, 2004 and 2012   
2004 2012
estimate lower 
estimate
upper 
estimate
estimate lower 
estimate
upper 
estimate
Angola 780 660 900 1 300 1 100 1 400
Botswana 3 000 2 600 3 700 930 740 1 100
Burkina Faso 1 300 1 100 1 500 470 400 540
Burundi 2 600 2 200 3 000 850 700 1 000
Cambodia 3 100 2 700 3 500 560 410 700
Cameroon 12 000 11 000 14 000 7 700 6 500 9 300
Central African Republic 8 700 7 600 10 000 2 400 2 000 2 900
Chad 1 900 1 700 2 300 1 400 1 200 1 700
Congo 1 300 1 000 1 500 1 000 820 1 200
Côte d'Ivoire 9 800 8 400 11 600 2 500 2 200 3 100
Democratic Republic of the Congo 6 700 5 600 8 500 6 300 5 500 8 100
Djibouti 230 190 260 150 120 170
Ethiopia 27 000 21 000 35 000 5 600 4 600 7 300
Ghana 2 600 2 400 3 200 540 490 630
Kenya 15 000 12 000 18 000 7 700 6 600 8 900
Lesotho 1 400 910 1 900 1 500 1 300 1 900
Malawi 14 000 12 000 16 000 3 500 3 100 4 300
Mali 610 520 730 360 310 420
Mozambique 34 000 28 000 41 000 45 000 35 000 53 000
Namibia 9 800 8 600 12 000 1 600 1 300 2 000
Nigeria 39 000 22 000 65 000 19 000 11 000 25 000
Rwanda 4 100 3 600 4 900 740 600 920
Sierra Leone 1 000 880 1 200 2 000 1 600 2 200
South Africa 99 000 88 000 120 000 88 000 75 000 100 000
Sudan 2 100 1 900 2 500 2 100 1 900 2 500
Swaziland 3 100 2 500 3 700 4 300 4 000 5 100
Togo 490 410 570 380 310 440
Uganda 25 000 21 000 29 000 9 200 8 000 12 000
United Republic of Tanzania 11 000 9 200 13 000 7 000 5 800 8 000
Zambia 11 000 9 700 13 000 7 600 6 200 8 900
Zimbabwe 36 000 30 000 40 000 18 000 15 000 20 000
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cloSE tHE GlobAl AIDS RESoURcE GAP
Domestic HIV spending from domestic public sources (US$)  
2010 2011 2012
caribbean 
Antigua and Barbuda 300 777 326 796 297 612
Cuba 58 593 535 60 633 504 ...
Dominica 223 664 223 664 ...
Grenada 5 521 182 713 ...
Haiti 1 608 233 1 608 233 ...
Jamaica 3 848 958 ... ...
Saint Vincent and the Grenadines 2 508 745 1 267 636 615 427
East Asia 
China 497 309 403 529 376 000 554 007 385
Democratic People's Republic of Korea 1 009 600 1 070 420 ...
Mongolia 950 996 1 169 128 ...
Eastern Europe and central Asia 
Armenia 1 961 038 2 079 270 1 090 732
Azerbaijan 6 857 540 8 563 409 ...
Belarus 13 246 041 9 668 805 ...
Georgia 4 362 929 4 562 010 4 545 234
Kazakhstan ... 30 346 857 30 352 251
Kyrgyzstan 1 407 901 1 441 565 3 886 526
Republic of Moldova 4 617 721 5 125 529 2 381 845
Tajikistan 1 718 968 2 269 834 ...
Ukraine 38 054 198 ... ...
Uzbekistan 16 985 205 12 636 531 13 334 449
latin America 
Belize 1 134 649 ... ...
Bolivia (Plurinational State of) ... 2 276 663 ...
Brazil 745 830 717 ... ...
Chile 119 224 642 123 044 300 132 689 469
Colombia 86 962 224 102 516 422 ...
 UNAIDS 2013 Global report  |  A109
cloSE tHE GlobAl AIDS RESoURcE GAP
Domestic HIV spending from domestic public sources (US$)  
2010 2011 2012
Costa Rica 24 765 744 ... ...
Ecuador 24 270 868 ... ...
El Salvador 37 297 450 ... 41 243 741
Guatemala 28 765 245 ... 25 324 612
Honduras 16 025 455 ... ...
Nicaragua 9 682 304 ... ...
Panama 15 702 066 ... ...
Paraguay 2 677 348 2 507 935 ...
Peru 15 445 506 ... ...
Suriname 1 939 620 2 249 605 ...
Venezuela (Bolivarian Republic of) 109 037 329 80 352 294 ...
Middle East and North Africa 
Algeria 5 345 581 8 258 614 9 187 280
Djibouti 627 309 596 705 867 075
Jordan 1 000 000 1 000 000 ...
Lebanon 1 570 000 1 570 000 ...
Morocco 6 357 832 6 728 697 7 493 931
Syrian Arab Republic ... 620 000 ...
Tunisia 110 040 117 400 ...
Yemen 442 233 467 395 ...
oceania 
Fiji 419 594 467 602 ...
Marshall Islands 200 027 120 246 235 704
Palau 394 323 394 323 ...
Papua New Guinea 12 077 392 ... ...
Samoa 161 694 172 845 ...
Solomon Islands 150 032 151 749 ...
Tuvalu 12 000 20 180 ...
Vanuatu 36 510 36 482 ...
A110  |  Annex: Close the global AIDS resource gap
2010 2011 2012
South and South-East Asia 
Afghanistan 200 000 ... 24 250
Bangladesh 1 202 508 746 225 977 247
Cambodia ... 5 644 947 5 671 862
Indonesia 27 577 082 ... ...
Lao People's Democratic Republic 827 689 827 689 ...
Malaysia 31 383 249 36 668 151 54 416 987
Myanmar 2 596 875 3 944 294 ...
Pakistan 4 768 321 ... ...
Philippines 3 372 467 4 126 663 ...
Sri Lanka 2 277 815 ... ...
Thailand 200 251 009 267 932 277 ...
Viet Nam 21 431 087 ... ...
Sub-Saharan Africa 
Angola 15 877 187 21 462 786 ...
Benin 6 937 649 7 796 210 11 467 748
Botswana 262 400 227 299 022 611 ...
Burkina Faso 11 118 571 ... ...
Burundi 1 774 303 2 034 615 1 358 187
Cameroon 14 395 254 ... ...
Cape Verde 499 368 522 275 17 194
Central African Republic 1 873 217 1 887 321 ...
Chad 3 862 235 2 766 010 6 212 969
Comoros 169 643 936 323 174 303
Congo 8 104 228 ... ...
Democratic Republic of the Congo 2 759 539 ... ...
Gabon 6 166 691 6 423 890 12 297 465
Ghana 8 087 144 14 854 634 ...
Guinea 317 576 638 185 2 302 175
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2010 2011 2012
Guinea-Bissau 611 774 ... ...
Kenya 134 682 271 162 569 668 ...
Liberia 83 100 190 000 ...
Madagascar 4 473 518 6 479 528 4 144 594
Mali 6 502 189 ... ...
Mauritania 698 854 3 720 945 616 666
Mauritius 4 894 627 ... ...
Namibia 168 791 097 ... ...
Niger 69 420 82 936 3 894 068
Nigeria 125 139 587 ... ...
Sao Tome and Principe 7 803 112 650 ...
Senegal ... 2 709 561 ...
Seychelles 2 297 113 2 003 196 4 278 262
Togo 8 878 290 4 074 688 5 614 798
Zimbabwe 20 833 554 28 061 185 37 084 924
western and central Europe 
Bulgaria 4 252 150 6 668 195 ...
Latvia 5 996 109 7 192 416 ...
Lithuania ... 3 601 011 2 496 551
Romania 91 512 275 102 458 472 88 082 973
Serbia ... ... 9 071 059
The former Yugoslav  
Republic of Macedonia
2 366 290 ... ...
Turkey ... ... 12 291 905
cloSE tHE GlobAl AIDS RESoURcE GAP
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cloSE tHE GlobAl AIDS RESoURcE GAP
Domestic HIV Spending from international sources (US$)     
Multilaterals Multilaterals
bilaterals UN Agencies Global Fund Development banks other multilaterals other international
2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012
caribbean
Antigua and 
Barbuda
820 914 246 310 ... 6 866 6 866 3 509 233 300 37 290 21 542 ... ... ... ... ... ... ... ... 664 499
Cuba ... ... ... ... ... ... 8 261 407 9 321 423 ... ... ... ... ... ... ... ... ... ...
Grenada 49 936 6 361 ... 1 178 34 666 ... 14 839 11 355 ... ... ... ... ... 48 982 ... 22 028 2 727 ...
Haiti 129 685 595 148 224 334 ... 13 250 596 50 569 
566
... 21 587 726 8 607 148 ... ... ... ... ... ... ... ... ... ...
Jamaica 360 894 ... ... 258 577 ... ... 9 680 362 ... ... ... ... ... ... ... ... 472 073 ... ...
Saint Vincent and 
the Grenadines
1 332 973 733 063 ... 33 512 ... 8 765 116 050 82 558 92 267 ... 718 655 ... ... ... 720 147 ... 34 434 ...
East Asia
China 14 787 060 13 690 093 3 319 375 5 675 752 2 935 759 602 155 40 436 517 27 664 861 64 216 671 ... ... ... 25 418 125 15 706 811 ... ... ... 8 483 235
Democratic 
People's Republic 
of Korea
... ... ... 5 000 75 000 ... ... ... ... ... ... ... ... ... ... ... ... ...
Eastern Europe and central Asia
Armenia ... ... ... 126 671 188 352 126 960 2 885 885 3 227 460 3 561 135 ... ... ... ... ... 19 891 72 194 85 353 530 992
Azerbaijan ... ... ... 171 014 152 855 ... 616 197 5 416 440 ... ... ... ... ... ... ... 591 500 423 000 ...
Belarus 234 102 4 749 ... 238 119 266 925 ... 5 946 198 9 778 974 ... ... ... ... ... ... ... 58 522 145 031 ...
Georgia 1 070 223 2 125 481 1 112 293 212 468 401 494 307 243 5 300 330 5 146 960 8 783 691 ... ... ... ... ... ... 249 945 847 976 861 115
Kazakhstan ... ... ... ... 338 007 120 714 ... 5 151 157 6 961 187 ... ... ... ... 9 133 188 ... 1 041 864 375 555
Kyrgyzstan 319 578 319 578 ... 1 753 560 905 000 1 371 130 5 836 715 2 152 922 6 759 253 1 517 507 551 780 ... 400 000 350 000 ... ... ... 1 382 380
Republic of 
Moldova
182 941 236 752 139 249 403 777 979 690 303 987 5 302 443 7 161 464 6 213 396 ... ... ... ... ... ... 214 054 141 112 53 783
Tajikistan 2 564 546 2 751 455 ... 537 086 743 891 ... 9 825 871 8 815 922 ... ... ... ... 586 650 720 935 ... ... ... ...
Ukraine 3 384 197 ... ... 1 758 678 ... ... 26 858 256 ... ... ... ... ... 183 024 ... ... 1 693 574 ... ...
Uzbekistan 165 236 ... ... 468 000 468 000 848 538 6 045 177 6 045 177 9 923 281 ... ... ... ... ... ... ... ... ...
latin America
Belize 529 130 ... ... 280 346 ... ... ... ... ... ... ... ... ... ... ... 603 420 ... ...
Bolivia (Plurinational 
State of)
... 156 582 ... ... 499 221 ... ... 4 799 828 ... ... ... ... ... ... ... ... 1 519 416 ...
Brazil ... ... ... 7 468 124 ... ... ... ... ... ... ... ... ... ... ... 1 699 227 ... ...
Chile 57 283 ... ... 411 244 ... ... ... ... ... ... ... ... ... ... ... ... 383 172 439 387
Colombia ... ... ... 275 591 332 690 63 999 ... 1 839 543 9 587 253 ... ... ... ... ... ... ... ... ...
Costa Rica 311 345 ... ... 338 411 ... ... ... ... ... ... ... ... 504 393 ... ... 1 024 748 ... ...
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Multilaterals Multilaterals
bilaterals UN Agencies Global Fund Development banks other multilaterals other international
2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012
caribbean
Antigua and 
Barbuda
820 914 246 310 ... 6 866 6 866 3 509 233 300 37 290 21 542 ... ... ... ... ... ... ... ... 664 499
Cuba ... ... ... ... ... ... 8 261 407 9 321 423 ... ... ... ... ... ... ... ... ... ...
Grenada 49 936 6 361 ... 1 178 34 666 ... 14 839 11 355 ... ... ... ... ... 48 982 ... 22 028 2 727 ...
Haiti 129 685 595 148 224 334 ... 13 250 596 50 569 
566
... 21 587 726 8 607 148 ... ... ... ... ... ... ... ... ... ...
Jamaica 360 894 ... ... 258 577 ... ... 9 680 362 ... ... ... ... ... ... ... ... 472 073 ... ...
Saint Vincent and 
the Grenadines
1 332 973 733 063 ... 33 512 ... 8 765 116 050 82 558 92 267 ... 718 655 ... ... ... 720 147 ... 34 434 ...
East Asia
China 14 787 060 13 690 093 3 319 375 5 675 752 2 935 759 602 155 40 436 517 27 664 861 64 216 671 ... ... ... 25 418 125 15 706 811 ... ... ... 8 483 235
Democratic 
People's Republic 
of Korea
... ... ... 5 000 75 000 ... ... ... ... ... ... ... ... ... ... ... ... ...
Eastern Europe and central Asia
Armenia ... ... ... 126 671 188 352 126 960 2 885 885 3 227 460 3 561 135 ... ... ... ... ... 19 891 72 194 85 353 530 992
Azerbaijan ... ... ... 171 014 152 855 ... 616 197 5 416 440 ... ... ... ... ... ... ... 591 500 423 000 ...
Belarus 234 102 4 749 ... 238 119 266 925 ... 5 946 198 9 778 974 ... ... ... ... ... ... ... 58 522 145 031 ...
Georgia 1 070 223 2 125 481 1 112 293 212 468 401 494 307 243 5 300 330 5 146 960 8 783 691 ... ... ... ... ... ... 249 945 847 976 861 115
Kazakhstan ... ... ... ... 338 007 120 714 ... 5 151 157 6 961 187 ... ... ... ... 9 133 188 ... 1 041 864 375 555
Kyrgyzstan 319 578 319 578 ... 1 753 560 905 000 1 371 130 5 836 715 2 152 922 6 759 253 1 517 507 551 780 ... 400 000 350 000 ... ... ... 1 382 380
Republic of 
Moldova
182 941 236 752 139 249 403 777 979 690 303 987 5 302 443 7 161 464 6 213 396 ... ... ... ... ... ... 214 054 141 112 53 783
Tajikistan 2 564 546 2 751 455 ... 537 086 743 891 ... 9 825 871 8 815 922 ... ... ... ... 586 650 720 935 ... ... ... ...
Ukraine 3 384 197 ... ... 1 758 678 ... ... 26 858 256 ... ... ... ... ... 183 024 ... ... 1 693 574 ... ...
Uzbekistan 165 236 ... ... 468 000 468 000 848 538 6 045 177 6 045 177 9 923 281 ... ... ... ... ... ... ... ... ...
latin America
Belize 529 130 ... ... 280 346 ... ... ... ... ... ... ... ... ... ... ... 603 420 ... ...
Bolivia (Plurinational 
State of)
... 156 582 ... ... 499 221 ... ... 4 799 828 ... ... ... ... ... ... ... ... 1 519 416 ...
Brazil ... ... ... 7 468 124 ... ... ... ... ... ... ... ... ... ... ... 1 699 227 ... ...
Chile 57 283 ... ... 411 244 ... ... ... ... ... ... ... ... ... ... ... ... 383 172 439 387
Colombia ... ... ... 275 591 332 690 63 999 ... 1 839 543 9 587 253 ... ... ... ... ... ... ... ... ...
Costa Rica 311 345 ... ... 338 411 ... ... ... ... ... ... ... ... 504 393 ... ... 1 024 748 ... ...
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Multilaterals Multilaterals
bilaterals UN Agencies Global Fund Development banks other multilaterals other international
2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012
Ecuador 29 658 ... ... 1 336 249 ... ... 26 364 ... ... ... ... ... 727 674 ... ... 855 594 ... ...
El Salvador 2 101 422 ... 2 758 436 273 174 ... 575 666 7 451 451 ... 9 301 591 ... ... 46 916 645 969 ... 198 784 983 416 ... 1 095 296
Guatemala 3 413 212 ... 3 401 047 1 569 879 ... 1 159 823 5 661 421 ... 12 312 352 63 778 ... ... 162 901 ... ... 2 014 505 ... 1 081 601
Honduras 5 065 130 ... ... 1 344 386 ... ... 8 010 681 ... ... ... ... ... 42 406 ... ... 1 253 743 ... ...
Nicaragua 2 554 713 ... ... 2 113 283 ... ... 9 155 592 ... ... 11 892 ... ... 91 960 ... ... 134 531 ... ...
Paraguay 2 857 575 ... ... 318 962 739 922 ... 3 588 531 4 115 637 ... 2 268 ... ... ... ... ... ... 239 221 ...
Peru 2 575 018 ... ... 403 751 ... ... 7 278 840 ... ... ... ... ... ... ... ... 2 216 561 ... ...
Suriname 2 547 077 1 253 125 ... 73 872 67 700 ... 1 485 037 1 009 894 ... ... ... ... ... ... ... ... 12 385 ...
Venezuela 
(Bolivarian  
Republic of)
... ... ... 626 411 133 327 ... ... ... ... ... ... ... ... ... ... ... ... ...
Middle East and North Africa
Algeria 289 363 548 057 180 195 180 699 319 371 609 511 ... ... ... ... ... ... ... ... ... 403 4 524 99 135
Djibouti 1 059 733 123 916 143 655 1 971 916 1 597 164 1 137 495 1 358 827 1 975 708 1 574 418 28 249 ... ... ... ... 105 812 ... ... ...
Jordan ... ... ... ... ... ... 723 768 433 831 968 902 ... ... ... ... ... ... ... ... ...
Morocco 46 215 50 836 56 618 881 906 742 118 826 517 4 811 881 4 190 951 4 667 574 ... ... ... ... ... ... 1 359 102 1 405 370 1 565 199
Syrian Arab 
Republic
... ... ... ... 189 850 ... ... ... ... ... ... ... ... ... ... ... ... ...
Tunisia ... ... ... ... ... ... 2 928 100 2 615 149 ... ... ... ... ... ... ... ... 10 000 ...
Yemen ... ... ... 923 775 461 636 ... ... 351 385 ... ... ... ... ... ... ... 844 990 333 504 ...
oceania
Fiji 149 660 164 857 ... 339 790 653 830 335 118 72 512 206 829 ... 43 333 ... ... 853 432 587 591 ... 218 669 174 503 ...
Kiribati ... ... ... ... ... ... 424 106 83 959 134 298 ... ... 19 692 5 694 174 929 185 287 ... ... ...
Marshall Islands 72 449 25 021 95 250 ... ... ... 118 457 83 557 34 991 ... ... ... ... ... ... ... ... ...
Micronesia 
(Federated States of)
265 491 290 594 296 349 68 898 ... ... 115 772 86 810 96 236 ... ... ... 71 645 96 066 54 103 ... ... ...
Papua New Guinea 28 199 728 ... ... 2 495 709 ... ... 4 572 622 ... ... 2 607 197 ... ... 74 194 ... ... 872 219 ... ...
Samoa ... ... ... 95 536 29 583 ... 82 661 102 625 ... ... ... ... ... ... ... 5 137 2 430 ...
Solomon Islands 393 993 439 782 ... 44 612 17 436 ... ... ... ... ... ... ... 167 661 ... 215 690 131 802 ...
Tuvalu ... ... ... ... ... ... 43 641 121 916 ... 4 000 ... ... ... ... ... ... 35 000 ...
Vanuatu 898 503 1 397 372 ... 38 888 28 769 ... 177 211 328 393 175 692 ... ... ... 510 411 49 077 20 692 ... 43 397 131 705
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Multilaterals Multilaterals
bilaterals UN Agencies Global Fund Development banks other multilaterals other international
2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012
Ecuador 29 658 ... ... 1 336 249 ... ... 26 364 ... ... ... ... ... 727 674 ... ... 855 594 ... ...
El Salvador 2 101 422 ... 2 758 436 273 174 ... 575 666 7 451 451 ... 9 301 591 ... ... 46 916 645 969 ... 198 784 983 416 ... 1 095 296
Guatemala 3 413 212 ... 3 401 047 1 569 879 ... 1 159 823 5 661 421 ... 12 312 352 63 778 ... ... 162 901 ... ... 2 014 505 ... 1 081 601
Honduras 5 065 130 ... ... 1 344 386 ... ... 8 010 681 ... ... ... ... ... 42 406 ... ... 1 253 743 ... ...
Nicaragua 2 554 713 ... ... 2 113 283 ... ... 9 155 592 ... ... 11 892 ... ... 91 960 ... ... 134 531 ... ...
Paraguay 2 857 575 ... ... 318 962 739 922 ... 3 588 531 4 115 637 ... 2 268 ... ... ... ... ... ... 239 221 ...
Peru 2 575 018 ... ... 403 751 ... ... 7 278 840 ... ... ... ... ... ... ... ... 2 216 561 ... ...
Suriname 2 547 077 1 253 125 ... 73 872 67 700 ... 1 485 037 1 009 894 ... ... ... ... ... ... ... ... 12 385 ...
Venezuela 
(Bolivarian  
Republic of)
... ... ... 626 411 133 327 ... ... ... ... ... ... ... ... ... ... ... ... ...
Middle East and North Africa
Algeria 289 363 548 057 180 195 180 699 319 371 609 511 ... ... ... ... ... ... ... ... ... 403 4 524 99 135
Djibouti 1 059 733 123 916 143 655 1 971 916 1 597 164 1 137 495 1 358 827 1 975 708 1 574 418 28 249 ... ... ... ... 105 812 ... ... ...
Jordan ... ... ... ... ... ... 723 768 433 831 968 902 ... ... ... ... ... ... ... ... ...
Morocco 46 215 50 836 56 618 881 906 742 118 826 517 4 811 881 4 190 951 4 667 574 ... ... ... ... ... ... 1 359 102 1 405 370 1 565 199
Syrian Arab 
Republic
... ... ... ... 189 850 ... ... ... ... ... ... ... ... ... ... ... ... ...
Tunisia ... ... ... ... ... ... 2 928 100 2 615 149 ... ... ... ... ... ... ... ... 10 000 ...
Yemen ... ... ... 923 775 461 636 ... ... 351 385 ... ... ... ... ... ... ... 844 990 333 504 ...
oceania
Fiji 149 660 164 857 ... 339 790 653 830 335 118 72 512 206 829 ... 43 333 ... ... 853 432 587 591 ... 218 669 174 503 ...
Kiribati ... ... ... ... ... ... 424 106 83 959 134 298 ... ... 19 692 5 694 174 929 185 287 ... ... ...
Marshall Islands 72 449 25 021 95 250 ... ... ... 118 457 83 557 34 991 ... ... ... ... ... ... ... ... ...
Micronesia 
(Federated States of)
265 491 290 594 296 349 68 898 ... ... 115 772 86 810 96 236 ... ... ... 71 645 96 066 54 103 ... ... ...
Papua New Guinea 28 199 728 ... ... 2 495 709 ... ... 4 572 622 ... ... 2 607 197 ... ... 74 194 ... ... 872 219 ... ...
Samoa ... ... ... 95 536 29 583 ... 82 661 102 625 ... ... ... ... ... ... ... 5 137 2 430 ...
Solomon Islands 393 993 439 782 ... 44 612 17 436 ... ... ... ... ... ... ... 167 661 ... 215 690 131 802 ...
Tuvalu ... ... ... ... ... ... 43 641 121 916 ... 4 000 ... ... ... ... ... ... 35 000 ...
Vanuatu 898 503 1 397 372 ... 38 888 28 769 ... 177 211 328 393 175 692 ... ... ... 510 411 49 077 20 692 ... 43 397 131 705
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Multilaterals Multilaterals
bilaterals UN Agencies Global Fund Development banks other multilaterals other international
2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012
South and South-East Asia
Afghanistan 90 499 1 456 111 ... 849 942 1 172 183 27 092 1 774 255 1 645 560 1 829 829 1 523 129 3 728 220 2 080 692 ... ... ... ... ... 676 536
Bangladesh 2 869 608 3 190 243 3 785 791 232 797 202 846 546 436 10 461 394 12 389 199 6 875 780 ... 1 690 130 ... ... ... 2 577 348 682 428 488 206 672
Cambodia 15 713 795 15 872 474 7 128 857 4 320 352 18 030 595 20 027 132 ... ... ... ... 1 745 621 1 165 243 ... 3 990 878 2 913 501
Indonesia 13 030 257 ... ... ... ... ... ... ... ... ... ... ... 28 193 858 ... ... ... ... ...
Lao People's 
Democratic 
Republic
1 206 336 1 841 772 ... 972 646 934 476 ... 4 357 227 7 562 540 ... 163 594 231 690 ... 250 914 ... ... 801 333 345 968 ...
Malaysia ... ... ... 561 880 307 629 ... ... 2 232 176 1 725 292 ... ... ... ... ... ... ... ... ...
Myanmar ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 37 904 167 42 349 184 ...
Pakistan 2 312 562 ... ... 3 996 848 ... ... 388 442 ... ... 284 301 ... ... 380 983 ... ... 800 838 ... ...
Philippines 597 420 624 340 ... 1 007 266 1 171 076 ... 3 278 792 1 955 077 ... ... ... ... ... 24 881 ... 119 242 96 768 ...
Sri Lanka ... ... ... 1 046 040 ... ... 267 529 ... ... ... ... ... 568 614 ... ... 152 214 ... ...
Thailand 7 071 757 8 103 688 ... 1 473 326 1 488 538 ... 26 021 888 35 359 954 ... 54 915 120 790 ... ... ... ... 1 304 782 1 357 422 ...
Viet Nam 84 013 483 ... ... 1 343 508 ... ... 6 650 517 ... ... 8 001 304 ... ... 1 517 166 ... ... 695 801 ... ...
Sub-Saharan Africa
Angola 4 057 292 9 014 036 ... 3 879 748 894 705 ... 8 199 031 263 478 ... ... 126 898 ... 2 051 653 1 327 135 ... ... 388 500 ...
Benin 119 433 3 967 181 2 970 320 3 228 966 3 071 804 1 727 806 2 368 720 11 669 947 12 766 641 1 613 734 320 288 ... ... 159 011 698 521 3 929 033 92 462 190 493
Botswana 88 439 410 76 787 833 ... 2 028 440 2 723 550 ... ... ... ... ... ... ... 297 015 331 272 ... 9 904 538 11 551 282 ...
Burkina Faso 17 330 444 ... ... 7 264 617 ... ... 13 963 876 ... ... 24 081 ... ... ... ... ... 414 874 ... ...
Burundi ... 8 500 000 8 500 000 ... 544 314 1 032 781 ... 14 145 538 11 365 873 ... ... ... ... ... ... 39 908 205 218 971 ...
Cameroon 8 679 422 ... ... 3 562 002 ... ... 17 134 894 ... ... ... ... ... ... ... ... 11 539 968 ... ...
Cape Verde ... ... ... 149 724 94 703 759 1 711 088 2 853 473 16 002 ... ... ... ... ... ... 185 032 124 985 ...
Central African 
Republic
747 766 420 561 ... 8 055 827 7 063 516 ... 3 979 986 6 189 238 ... ... ... ... ... ... ... 240 603 112 671 ...
Chad 2 897 656 144 184 311 178 2 142 046 3 036 244 3 209 744 1 705 808 8 225 860 5 247 126 661 033 ... 82 871 522 711 4 631 043 ... ... 30 944 829 603
Comoros ... ... ... ... ... 72 309 ... ... 1 233 403 ... ... ... ... ... 47 590 ... ... ...
Congo 381 566 ... ... 337 139 ... ... 6 354 280 ... ... 807  570 ... ... ... ... ... 487 802 ... ...
Democratic 
Republic of the 
Congo
24 298 279 ... ... 16 480 566 ... ... 30 107 409 ... ... 26 737 388 ... ... 163 387 ... ... 4 650 788 ... ...
Gabon 489 931 920 533 ... 578 116 1 124 598 2 005 277 1 288 011 915 788 ... ... 643 284 ... ... ... ... ... ... ...
Ghana 7 835 285 20 922 460 ... 3 384 797 5 488 229 ... 27 525 703 23 226 584 ... ... ... ... 216 699 ... ... 9 052 997 11 170 672 ...
cloSE tHE GlobAl AIDS RESoURcE GAP
Domestic HIV Spending from international sources (US$)     
 UNAIDS 2013 Global report  |  A117
Multilaterals Multilaterals
bilaterals UN Agencies Global Fund Development banks other multilaterals other international
2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012
South and South-East Asia
Afghanistan 90 499 1 456 111 ... 849 942 1 172 183 27 092 1 774 255 1 645 560 1 829 829 1 523 129 3 728 220 2 080 692 ... ... ... ... ... 676 536
Bangladesh 2 869 608 3 190 243 3 785 791 232 797 202 846 546 436 10 461 394 12 389 199 6 875 780 ... 1 690 130 ... ... ... 2 577 348 682 428 488 206 672
Cambodia 15 713 795 15 872 474 7 128 857 4 320 352 18 030 595 20 027 132 ... ... ... ... 1 745 621 1 165 243 ... 3 990 878 2 913 501
Indonesia 13 030 257 ... ... ... ... ... ... ... ... ... ... ... 28 193 858 ... ... ... ... ...
Lao People's 
Democratic 
Republic
1 206 336 1 841 772 ... 972 646 934 476 ... 4 357 227 7 562 540 ... 163 594 231 690 ... 250 914 ... ... 801 333 345 968 ...
Malaysia ... ... ... 561 880 307 629 ... ... 2 232 176 1 725 292 ... ... ... ... ... ... ... ... ...
Myanmar ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 37 904 167 42 349 184 ...
Pakistan 2 312 562 ... ... 3 996 848 ... ... 388 442 ... ... 284 301 ... ... 380 983 ... ... 800 838 ... ...
Philippines 597 420 624 340 ... 1 007 266 1 171 076 ... 3 278 792 1 955 077 ... ... ... ... ... 24 881 ... 119 242 96 768 ...
Sri Lanka ... ... ... 1 046 040 ... ... 267 529 ... ... ... ... ... 568 614 ... ... 152 214 ... ...
Thailand 7 071 757 8 103 688 ... 1 473 326 1 488 538 ... 26 021 888 35 359 954 ... 54 915 120 790 ... ... ... ... 1 304 782 1 357 422 ...
Viet Nam 84 013 483 ... ... 1 343 508 ... ... 6 650 517 ... ... 8 001 304 ... ... 1 517 166 ... ... 695 801 ... ...
Sub-Saharan Africa
Angola 4 057 292 9 014 036 ... 3 879 748 894 705 ... 8 199 031 263 478 ... ... 126 898 ... 2 051 653 1 327 135 ... ... 388 500 ...
Benin 119 433 3 967 181 2 970 320 3 228 966 3 071 804 1 727 806 2 368 720 11 669 947 12 766 641 1 613 734 320 288 ... ... 159 011 698 521 3 929 033 92 462 190 493
Botswana 88 439 410 76 787 833 ... 2 028 440 2 723 550 ... ... ... ... ... ... ... 297 015 331 272 ... 9 904 538 11 551 282 ...
Burkina Faso 17 330 444 ... ... 7 264 617 ... ... 13 963 876 ... ... 24 081 ... ... ... ... ... 414 874 ... ...
Burundi ... 8 500 000 8 500 000 ... 544 314 1 032 781 ... 14 145 538 11 365 873 ... ... ... ... ... ... 39 908 205 218 971 ...
Cameroon 8 679 422 ... ... 3 562 002 ... ... 17 134 894 ... ... ... ... ... ... ... ... 11 539 968 ... ...
Cape Verde ... ... ... 149 724 94 703 759 1 711 088 2 853 473 16 002 ... ... ... ... ... ... 185 032 124 985 ...
Central African 
Republic
747 766 420 561 ... 8 055 827 7 063 516 ... 3 979 986 6 189 238 ... ... ... ... ... ... ... 240 603 112 671 ...
Chad 2 897 656 144 184 311 178 2 142 046 3 036 244 3 209 744 1 705 808 8 225 860 5 247 126 661 033 ... 82 871 522 711 4 631 043 ... ... 30 944 829 603
Comoros ... ... ... ... ... 72 309 ... ... 1 233 403 ... ... ... ... ... 47 590 ... ... ...
Congo 381 566 ... ... 337 139 ... ... 6 354 280 ... ... 807  570 ... ... ... ... ... 487 802 ... ...
Democratic 
Republic of the 
Congo
24 298 279 ... ... 16 480 566 ... ... 30 107 409 ... ... 26 737 388 ... ... 163 387 ... ... 4 650 788 ... ...
Gabon 489 931 920 533 ... 578 116 1 124 598 2 005 277 1 288 011 915 788 ... ... 643 284 ... ... ... ... ... ... ...
Ghana 7 835 285 20 922 460 ... 3 384 797 5 488 229 ... 27 525 703 23 226 584 ... ... ... ... 216 699 ... ... 9 052 997 11 170 672 ...
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Multilaterals Multilaterals
bilaterals UN Agencies Global Fund Development banks other multilaterals other international
2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012
Guinea 2 937 281 3 008 420 1 135 908 1 780 330 1 355 255 4 897 526 1 463 210 4 611 586 773 945 ... ... 88 996 ... ... 878 754 4 925 974 5 163 845 1 711 334
Guinea-Bissau 3 959 113 ... ... 687 951 ... ... ... ... ... ... ... ... ... ... ... ... ... ...
Kenya 554 075 845 554 497 335 ... ... 7 620 359 ... 15 266 186 20 864 464 ... ... ... ... ... ... ... 22 034 292 ... ...
Liberia ... 539 765 ... 2 763 451 7 588 885 ... 25 511 143 22 804 922 ... ... ... ... ... ... ... ... ... ...
Madagascar 1 968 850 2 406 633 1 433 205 1 417 801 1 540 707 1 349 969 1 485 034 4 475 148 2 463 869 ... 21 246 ... ... 15 391 ... 66 330 10 935 179 741
Mali 3 919 460 ... ... 450 946 ... ... 14 931 689 ... ... 8 018 577 ... ... 109 648 ... ... 2 585 546 ... ...
Mauritania ... ... ... 247 500 291 600 281 450 ... 69 957 3 036 125 ... ... ... ... ... ... ... ... ...
Mauritius 105 559 ... ... 291 226 ... ... 1 675 382 ... ... ... ... ... 202 511 ... ... 89 241 ... ...
Namibia 93 028 647 ... ... 7 860 111 ... ... 9 324 333 ... ... ... ... ... ... ... ... ... ... ...
Niger 2 475 111 2 660 802 3 581 728 581 263 5 987 007 3 869 274 9 493 223 5 824 701 2 926 358 ... 2 689 284 548 231 782 14 301 32 525 1 329 766 1 083 592 ...
Nigeria 284 908 865 ... ... 18 410 698 ... ... 65 899 650 ... ... 1 505 746 ... ... 45 762 ... ... 156 616 ... ...
Sao Tome  
and Principe
... ... 225 477 259 461 273 686 14 924 260 248 294 122 82 727 43 656 118 046 ... ... ... ... 34 585 82 365 ...
Senegal ... 4 446 971 ... ... 375 212 ... ... 14 800 499 ... ... ... ... ... 186 494 ... ... ... ...
Seychelles ... ... ... 17 581 53 040 170 405 ... ... ... 24 104 ... ... 3 827 13 174 ... 11 983 ... 200 240
Togo 1 605 831 1 713 886 4 794 200 1 506 109 1 499 068 1 535 628 6 937 675 10 670 960 3 476 107 ... ... ... ... 1 015 344 1 091 481 3 463 112 637 841 90 042
Zimbabwe 49 772 291 77 692 280 91 023 382 17 972 300 27 240 
021
5 446 365 66 042 408 26 233 338 107 083 627 30 000 ... ... 16 724 223 32 791 644 84 770 13 577 964 12 073 887 23 967 887
western and central Europe
Bulgaria 19 713 ... ... 81 000 95 000 ... 5 494 807 6 382 691 ... ... ... ... ... ... ... 44 937 ... ...
Latvia ... ... ... 146 569 25 228 ... ... ... ... ... ... ... ... ... ... 25 990 70 621 ...
Lithuania ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 68 390 ...
Romania ... ... ... 660 616 716 706 20 000 1 417 679 ... ... 1 771 480 4 577 421 ... 56 078 203 467 ... 89 902 179 530 671 044
Serbia ... ... 115 171 ... ... 198 435 ... ... 3 859 000 ... ... ... ... ... 36 920 ... ... 78 501
The former 
Yugoslav Republic 
of Macedonia
... ... ... 462 347 ... ... 1 723 215 ... ... ... ... ... ... ... ... 171 120 ... ...
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Multilaterals Multilaterals
bilaterals UN Agencies Global Fund Development banks other multilaterals other international
2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012 2010 2011 2012
Guinea 2 937 281 3 008 420 1 135 908 1 780 330 1 355 255 4 897 526 1 463 210 4 611 586 773 945 ... ... 88 996 ... ... 878 754 4 925 974 5 163 845 1 711 334
Guinea-Bissau 3 959 113 ... ... 687 951 ... ... ... ... ... ... ... ... ... ... ... ... ... ...
Kenya 554 075 845 554 497 335 ... ... 7 620 359 ... 15 266 186 20 864 464 ... ... ... ... ... ... ... 22 034 292 ... ...
Liberia ... 539 765 ... 2 763 451 7 588 885 ... 25 511 143 22 804 922 ... ... ... ... ... ... ... ... ... ...
Madagascar 1 968 850 2 406 633 1 433 205 1 417 801 1 540 707 1 349 969 1 485 034 4 475 148 2 463 869 ... 21 246 ... ... 15 391 ... 66 330 10 935 179 741
Mali 3 919 460 ... ... 450 946 ... ... 14 931 689 ... ... 8 018 577 ... ... 109 648 ... ... 2 585 546 ... ...
Mauritania ... ... ... 247 500 291 600 281 450 ... 69 957 3 036 125 ... ... ... ... ... ... ... ... ...
Mauritius 105 559 ... ... 291 226 ... ... 1 675 382 ... ... ... ... ... 202 511 ... ... 89 241 ... ...
Namibia 93 028 647 ... ... 7 860 111 ... ... 9 324 333 ... ... ... ... ... ... ... ... ... ... ...
Niger 2 475 111 2 660 802 3 581 728 581 263 5 987 007 3 869 274 9 493 223 5 824 701 2 926 358 ... 2 689 284 548 231 782 14 301 32 525 1 329 766 1 083 592 ...
Nigeria 284 908 865 ... ... 18 410 698 ... ... 65 899 650 ... ... 1 505 746 ... ... 45 762 ... ... 156 616 ... ...
Sao Tome  
and Principe
... ... 225 477 259 461 273 686 14 924 260 248 294 122 82 727 43 656 118 046 ... ... ... ... 34 585 82 365 ...
Senegal ... 4 446 971 ... ... 375 212 ... ... 14 800 499 ... ... ... ... ... 186 494 ... ... ... ...
Seychelles ... ... ... 17 581 53 040 170 405 ... ... ... 24 104 ... ... 3 827 13 174 ... 11 983 ... 200 240
Togo 1 605 831 1 713 886 4 794 200 1 506 109 1 499 068 1 535 628 6 937 675 10 670 960 3 476 107 ... ... ... ... 1 015 344 1 091 481 3 463 112 637 841 90 042
Zimbabwe 49 772 291 77 692 280 91 023 382 17 972 300 27 240 
021
5 446 365 66 042 408 26 233 338 107 083 627 30 000 ... ... 16 724 223 32 791 644 84 770 13 577 964 12 073 887 23 967 887
western and central Europe
Bulgaria 19 713 ... ... 81 000 95 000 ... 5 494 807 6 382 691 ... ... ... ... ... ... ... 44 937 ... ...
Latvia ... ... ... 146 569 25 228 ... ... ... ... ... ... ... ... ... ... 25 990 70 621 ...
Lithuania ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 68 390 ...
Romania ... ... ... 660 616 716 706 20 000 1 417 679 ... ... 1 771 480 4 577 421 ... 56 078 203 467 ... 89 902 179 530 671 044
Serbia ... ... 115 171 ... ... 198 435 ... ... 3 859 000 ... ... ... ... ... 36 920 ... ... 78 501
The former 
Yugoslav Republic 
of Macedonia
... ... ... 462 347 ... ... 1 723 215 ... ... ... ... ... ... ... ... 171 120 ... ...
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cloSE tHE GlobAl AIDS RESoURcE GAP
total domestic HIV spending from domestic public and international sources (US$)1
2010 2011 2012
caribbean 
Antigua and Barbuda 1 361 858 617 262 987 161
Cuba 66 854 940 69 954 928 ...
Dominica 223 664 223 664 ...
Grenada 93 501 286 803 ...
Haiti 166 132 144 209 009 280 ...
Jamaica 14 620 864 ... ...
Saint Vincent and the Grenadines 3 991 280 2 836 345 1 436 605
East Asia
China 583 626 880 589 373 504 630 628 800
Democratic People's Republic of Korea 1 014 600 1 145 420 ...
Mongolia 3 501 188 3 731 466 ...
Eastern Europe and central Asia 
Armenia 5 045 789 5 580 436 5 329 710
Azerbaijan 8 236 251 14 555 704 ...
Belarus 19 722 982 19 864 484 ...
Georgia 11 195 893 13 083 921 15 609 576
Kazakhstan ... 36 887 020 37 809 896
Kyrgyzstan 11 235 261 5 720 845 13 399 289
Republic of Moldova 10 720 936 13 644 548 9 092 261
Tajikistan 15 233 122 15 302 037 ...
Ukraine 71 931 928 ... ...
Uzbekistan 23 663 618 19 149 708 24 106 268
latin America 
Belize 2 547 545 ... ...
Bolivia (Plurinational State of) ... 9 251 710 ...
Brazil 754 998 080 ... ...
Chile 119 693 168 123 427 472 133 128 856
Colombia1 87 237 816 104 688 656 10 671 901
Costa Rica 26 944 640 ... ...
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cloSE tHE GlobAl AIDS RESoURcE GAP
total domestic HIV spending from domestic public and international sources (US$)1
2010 2011 2012
Ecuador 27 246 408 ... ...
El Salvador 48 752 880 ... 59 224 233
Guatemala 41 650 940 ... 43 279 436
Honduras 31 741 800 ... ...
Nicaragua 23 744 276 ... ...
Panama 17 229 700 ... ...
Paraguay 9 444 684 7 602 715 ...
Peru 27 919 674 ... ...
Suriname 6 045 606 4 592 708 ...
Venezuela (Bolivarian Republic of) 109 663 744 80 485 624 ...
Middle East and North Africa 
Algeria 5 816 047 9 130 566 10 076 121
Djibouti 5 046 034 4 293 493 3 828 456
Jordan 1 723 768 1 433 832 968 902
Lebanon 2 420 000 2 420 000 ...
Morocco 13 456 936 13 117 972 14 609 839
Syrian Arab Republic ... 809 850 ...
Tunisia 3 038 140 2 742 549 ...
Yemen 2 210 998 1 613 920 ...
oceania 
Fiji 2 096 989 2 255 212 335 118
Kiribati 429 800 258 888 339 277
Marshall Islands 390 933 228 824 365 945
Micronesia (Federated States of) 521 806 473 470 446 688
Palau 982 489 1 044 959 ...
Papua New Guinea 50 899 064 ... ...
Samoa 345 028 307 482 ...
Solomon Islands 804 327 908 429 ...
Tuvalu 59 641 177 096 ...
Vanuatu 1 661 523 1 883 490 328 089
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2010 2011 2012
South and South-East Asia 
Afghanistan 4 437 825 8 002 074 4 638 399
Bangladesh 15 114 988 18 647 130 12 394 502
Cambodia ... 52 254 696 49 970 564
Indonesia 68 801 200 ... ...
Lao People's Democratic Republic 8 579 739 11 744 135 ...
Malaysia 31 945 130 39 207 956 56 142 280
Myanmar 40 501 040 46 293 476 ...
Pakistan 12 932 295 ... ...
Philippines 8 375 187 7 998 805 ...
Sri Lanka 4 312 212 ... ...
Thailand 236 177 680 314 362 656 ...
Viet Nam 123 652 864 ... ...
Sub-Saharan Africa 
Angola 34 064 912 33 477 540 ...
Benin 18 197 534 27 076 904 29 821 530
Botswana 363 069 632 390 416 544 ...
Burkina Faso 50 116 464 ... ...
Burundi 41 682 508 25 443 438 22 256 840
Cameroon 55 311 540 ... ...
Cape Verde 2 545 213 3 595 435 33 955
Central African Republic 14 897 398 15 673 308 ...
Chad 11 791 489 18 834 284 15 893 491
Comoros 169 643 936 324 1 527 605
Congo 16 472 586 ... ...
Democratic Republic of the Congo 105 197 360 ... ...
Gabon 8 522 748 10 028 093 14 302 741
Ghana 56 102 624 75 662 576 ...
Guinea 11 424 371 14 777 291 11 788 635
Guinea-Bissau 5 258 837 ... ...
Kenya 726 058 624 745 551 808 ...
cloSE tHE GlobAl AIDS RESoURcE GAP
total domestic HIV spending from domestic public and international sources (US$)1
 UNAIDS 2013 Global report  |  A123
2010 2011 2012
Liberia 28 357 694 31 123 572 ...
Madagascar 9 411 533 14 949 588 9 571 378
Malawi 65 560 000 77 390 000 ...
Mali 36 518 056 ... ...
Mauritania 946 354 4 082 502 3 934 241
Mauritius 7 258 547 ... ...
Namibia 279 004 192 ... ...
Niger 14 180 564 15 656 028 14 588 501
Nigeria 496 066 912 ... ...
Sao Tome and Principe 605 751 880 869 323 128
Senegal ... 22 518 738 ...
Seychelles 2 354 608 2 069 411 4 648 906
Togo 22 391 016 19 611 786 16 602 255
Zimbabwe 184 952 736 204 092 352 264 690 960
western and central Europe 
Bulgaria 9 892 606 13 145 886 ...
Latvia 6 168 667 7 288 265 ...
Lithuania ... 3 669 401 2 496 551
Romania 95 508 032 108 135 600 88 774 016
Serbia ... ... 13 359 087
The former Yugoslav Republic  
of Macedonia
4 722 972 ... ...
Turkey ... ... 12 291 905
cloSE tHE GlobAl AIDS RESoURcE GAP
total domestic HIV spending from domestic public and international sources (US$)1
1 For the indicator definition, go to http://www.indicatorregistry.org/node/861.
A124  |  Annex: Eliminate gender inequalities and gender-based abuse and violence 
ElIMINAtE GENDER INEqUAlItIES AND GENDER-bASED AbUSE AND VIolENcE AND 
INcREASE tHE cAPAcItY oF woMEN AND GIRlS to PRotEct tHEMSElVES FRoM HIV
Young people’s knowledge about HIV prevention
comprehensive correct knowledge about AIDS among 
young people aged 15-24 (2 ways to prevent AIDS and 
reject 3 misconceptions)1 (%)
Year, Source Females Males
caribbean
Dominican Republic 2007, DHS 40.8 33.7
Haiti 2005–06, DHS 33.9 40.1
Eastern Europe and central Asia 
Armenia 2005, DHS 22.6 15.1
Azerbaijan 2006, DHS 4.8 5.3
Ukraine 2007, DHS 44.8 42.8
latin America 
Bolivia (Plurinational State of) 2008, DHS 22.4 27.7
Belize 2011, MICS 42.9 0
Colombia 2010, DHS 24.1 0
Guyana 2009, DHS 54.1 46.6
Honduras 2005–06, DHS 29.7 0
Nicaragua 2001, DHS 22.2 0
Middle East and North Africa 
Egypt 2005, DHS 4.4 0
Jordan 2007, DHS 12.5 5.0
Morocco 2003–04, DHS 11.7 0
South and South-East Asia 
Cambodia 2010, DHS 44.4 43.7
India 2005–06, NFHS 19.9 36.1
Nepal 2011, DHS 25.8 33.9
Timor-Leste 2009, DHS 12.2 19.7
Viet Nam 2005, PAIS 42.3 50.3
Sub-Saharan Africa 
Benin 2006, DHS 8.4 14.2
Burkina Faso 2010, DHS 31.1 35.7
Burundi 2010, DHS 44.5 46.5
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ElIMINAtE GENDER INEqUAlItIES AND GENDER-bASED AbUSE AND VIolENcE AND 
INcREASE tHE cAPAcItY oF woMEN AND GIRlS to PRotEct tHEMSElVES FRoM HIV
Young people’s knowledge about HIV prevention
comprehensive correct knowledge about AIDS among 
young people aged 15-24 (2 ways to prevent AIDS and 
reject 3 misconceptions)1 (%)
Year, Source Females Males
Cameroon 2011, MICS 28.7 33.5
Cape Verde 2012, AIDS 90.1 88.9
Congo 2009, AIS 8.3 21.9
Democratic Republic of the Congo 2007, DHS 15.1 20.7
Eritrea 2012, DHS 24.7 33.8
Ethiopia 2011, DHS 23.9 34.2
Kenya 2008–09, DHS 46.6 55.3
Gabon 2012, DHS 28.8 36.1
Lesotho 2009, DHS 38.6 28.7
Madagascar 2008–09, DHS 22.5 26.0
Malawi 2010, DHS 41.8 44.7
Mozambique 2011, DHS 30.2 51.8
Namibia 2006, DHS 59.4 52.9
Niger 2006, DHS 13.4 15.9
Nigeria 2008, DHS 22.2 32.6
Rwanda 2010–11, DHS 52.0 46.1
Sao Tome and Principe 2008–09, DHS 42.6 43.4
Senegal 2010–11, DHS 29.4 30.7
Sierra Leone 2008, DHS 17.2 27.6
Swaziland 2006–07, DHS 52.1 52.3
United Republic of Tanzania 2010, DHS 48.2 42.7
Uganda 2006, DHS 31.9 38.2
Zambia 2007, DHS 34.0 36.9
Zimbabwe 2010–11, DHS 51.9 47.0
western and central Europe 
Albania 2008–09, DHS 35.9 22.0
Bosnia and Herzegovina 2012, MICS 47.5 47.3
Montenegro 2012, AIDS 22.0 22.3
1 For the indicator definition, go to http://www.indicatorregistry.org/node/658.
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ElIMINAtE GENDER INEqUAlItIES AND GENDER-bASED AbUSE AND VIolENcE AND 
INcREASE tHE cAPAcItY oF woMEN AND GIRlS to PRotEct tHEMSElVES FRoM HIV
Proportion of ever-married or partnered women aged 15-49 who experienced physical or 
sexual violence from a male intimate partner in the past 12 months1
20122
caribbean
Dominican Republic 12
Haiti 16
Jamaica 10
East Asia 
Mongolia 10
Eastern Europe and central Asia
Azerbaijan 10
Republic of Moldova 25
latin America 
Bolivia (Plurinational State of) 24
El Salvador 8
Guatemala 28
Honduras 15
Mexico 17
Nicaragua 22
Panama 15
Peru 14
Middle East and North Africa 
Morocco 15
Tunisia 16
oceania 
Marshall Islands 25
Vanuatu 60
South and South-East Asia 
Bangladesh 22
Cambodia 10
Nepal 14
20122
Timor-Leste 29
Sub-Saharan Africa 
Angola 29
Burkina Faso 9
Cameroon 51
Central African Republic 40
Chad 30
Côte d'Ivoire 31
Democratic Republic of the Congo 59
Gabon 45
Ghana 19
Guinea 23
Guinea-Bissau 40
Kenya 32
Liberia 35
Madagascar 9
Malawi 22
Mauritius 23
Nigeria 15
Rwanda 44
Sao Tome and Principe 26
Sierra Leone 10
Swaziland 8
Togo 22
United Republic of Tanzania 35
Zimbabwe 27
western and central Europe 
Czech Republic 11
1 For the indicator definition, go to http://www.indicatorregistry.org/node/863.  
2 Latest reported.
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20122
Timor-Leste 29
Sub-Saharan Africa 
Angola 29
Burkina Faso 9
Cameroon 51
Central African Republic 40
Chad 30
Côte d'Ivoire 31
Democratic Republic of the Congo 59
Gabon 45
Ghana 19
Guinea 23
Guinea-Bissau 40
Kenya 32
Liberia 35
Madagascar 9
Malawi 22
Mauritius 23
Nigeria 15
Rwanda 44
Sao Tome and Principe 26
Sierra Leone 10
Swaziland 8
Togo 22
United Republic of Tanzania 35
Zimbabwe 27
western and central Europe 
Czech Republic 11
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ElIMINAtE GENDER INEqUAlItIES AND GENDER-bASED AbUSE AND VIolENcE AND 
INcREASE tHE cAPAcItY oF woMEN AND GIRlS to PRotEct tHEMSElVES FRoM HIV
Number of HIV infected female adults 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
caribbean 130 000 120 000 150 000 120 000 110 000 140 000
Bahamas ... 2 600 2 800 ... 3 300 3 700
Barbados ... <500 <500 ... <500 <500
Cuba <500 <500 <500 <1 000 <1 000 1 500
Dominican Republic 31 000 27 000 35 000 22 000 19 000 26 000
Haiti 80 000 71 000 90 000 78 000 70 000 88 000
Jamaica 13 000 11 000 15 000 9 300 7 800 11 000
Trinidad and Tobago ... 4 600 5 800 ... 6 800 8 000
East Asia 100 000 74 000 140 000 250 000 180 000 350 000
China1 ... ... ... ... ... ...
Democratic People's 
Republic of Korea
... ... ... ... ... ...
Japan ... <1 000 1 200 ... 1 100 1 700
Mongolia <200 <100 <200 <1 000 <500 <1 000
Republic of Korea ... 1 600 2 600 ... 3 600 5 800
Eastern Europe and 
central Asia 
360 000 280 000 450 000 430 000 340 000 550 000
Armenia <200 <100 <500 <1 000 <500 <1 000
Azerbaijan <1 000 <500 <1 000 1 100 <1 000 1 500
Belarus 2 500 1 900 3 300 7 100 6 400 8 000
Georgia <500 <500 <1 000 1 400 1 100 2 000
Kazakhstan ... ... ... ... ... ...
Kyrgyzstan <500 <500 <1 000 1 600 1 100 2 300
Republic of Moldova 3 700 2 900 4 800 6 500 5 300 8 200
Russian Federation ... ... ... ... ... ...
Tajikistan <500 <200 1 600 4 100 2 300 8 400
Ukraine 76 000 65 000 87 000 95 000 80 000 110 000
Uzbekistan 8 000 5 000 11 000 7 200 5 400 10 000
latin America 370 000 330 000 440 000 430 000 350 000 550 000
Argentina 23 000 17 000 29 000 32 000 26 000 37 000
Belize 1 000 <1 000 1 100 1 300 1 200 1 500
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ElIMINAtE GENDER INEqUAlItIES AND GENDER-bASED AbUSE AND VIolENcE AND 
INcREASE tHE cAPAcItY oF woMEN AND GIRlS to PRotEct tHEMSElVES FRoM HIV
Number of HIV infected female adults 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Bolivia 
(Plurinational State of)
5 100 3 700 7 400 4 600 2 500 7 100
Brazil ... 130 000 170 000 ... 160 000 190 000
Chile 4 100 1 800 6 900 5 400 3 600 8 100
Colombia 39 000 29 000 52 000 42 000 32 000 56 000
Costa Rica 2 400 2 300 2 600 4 000 3 600 4 500
Ecuador 7 800 4 200 12 000 12 000 8 300 21 000
El Salvador 8 800 6 400 13 000 9 000 5 900 16 000
Guatemala 19 000 12 000 30 000 20 000 12 000 44 000
Guyana 1 500 <1 000 2 400 3 600 2 100 5 700
Honduras 17 000 14 000 21 000 9 400 8 000 11 000
Mexico 39 000 32 000 47 000 38 000 32 000 46 000
Nicaragua <500 <200 <1 000 2 900 2 000 4 400
Panama 5 800 4 800 7 100 5 000 3 700 6 600
Paraguay 1 200 <1 000 4 000 5 500 3 100 10 000
Peru 27 000 19 000 36 000 23 000 11 000 68 000
Suriname 1 600 1 300 1 900 2 000 1 800 2 200
Uruguay 1 700 1 200 2 600 2 700 2 100 4 000
Venezuela (Bolivarian 
Republic of)
26 000 17 000 40 000 38 000 27 000 56 000
Middle East and 
North Africa
62 000 41 000 110 000 100 000 74 000 150 000
Algeria ... ... ... ... ... ...
Djibouti 5 000 3 900 6 000 3 700 3 000 4 700
Egypt <1 000 <500 1 100 1 400 <1 000 2 100
Iran 
(Islamic Republic of)
1 200 <1 000 2 300 19 000 13 000 30 000
Lebanon ... ... ... ... ... ...
Morocco 4 400 3 100 5 700 11 000 8 500 14 000
Oman ... <100 <500 ... <1 000 1 400
Somalia 12 000 7 000 19 000 13 000 8 600 20 000
Sudan ... ... ... ... ... ...
A130  |  Annex: Eliminate gender inequalities and gender-based abuse and violence 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Tunisia <500 <200 <1 000 <1 000 <500 1 100
Yemen 1 300 <1 000 2 400 7 700 3 600 19 000
North America 180 000 150 000 230 000 260 000 190 000 380 000
Canada ... 7 100 10 000 ... 11 000 17 000
United States of 
America
... 140 000 230 000 ... 180 000 370 000
oceania 14 000 11 000 19 000 18 000 15 000 21 000
Australia ... 2 100 3 100 ... 3 800 6 100
Fiji <100 <100 <200 <500 <500 <500
New Zealand ... <500 <500 ... <500 <1 000
Papua New Guinea 11 000 7 700 16 000 12 000 10 000 16 000
South and  
South-East Asia
1 200 000 960 000 1 500 000 1 400 000 1 100 000 1 800 000
Afghanistan <1 000 <500 1 700 1 400 <1 000 4 600
Bangladesh <1 000 <100 1 300 2 700 1 000 28 000
Bhutan <100 <100 <100 <500 <200 <1 000
Cambodia 51 000 34 000 99 000 39 000 26 000 76 000
India1 800 000 660 000 930 000 750 000 610 000 940 000
Indonesia 25 000 <100 80 000 230 000 150 000 370 000
Lao People's 
Democratic Republic
1 400 1 100 2 700 4 900 4 200 5 600
Malaysia 4 800 3 400 7 300 12 000 8 500 16 000
Maldives <100 <100 <100 <100 <100 <100
Myanmar 48 000 42 000 54 000 63 000 55 000 71 000
Nepal 14 000 12 000 18 000 14 000 12 000 19 000
Pakistan 2 400 1 600 4 800 24 000 14 000 44 000
Philippines 2 300 1 300 4 600 2 200 1 700 3 200
Singapore ... <1 000 1 100 ... <1 000 1 300
Sri Lanka <500 <500 <1 000 <1 000 <1 000 1 500
Thailand 210 000 190 000 230 000 200 000 180 000 210 000
Viet Nam 51 000 14 000 100 000 71 000 20 000 140 000
ElIMINAtE GENDER INEqUAlItIES AND GENDER-bASED AbUSE AND VIolENcE AND 
INcREASE tHE cAPAcItY oF woMEN AND GIRlS to PRotEct tHEMSElVES FRoM HIV
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ElIMINAtE GENDER INEqUAlItIES AND GENDER-bASED AbUSE AND VIolENcE AND 
INcREASE tHE cAPAcItY oF woMEN AND GIRlS to PRotEct tHEMSElVES FRoM HIV
Number of HIV infected female adults 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Sub-Saharan Africa 11 100 000 10 300 000 12 000 000 12 900 000 12 000 000 13 700 000
Angola 67 000 50 000 98 000 130 000 110 000 160 000
Benin 33 000 29 000 37 000 37 000 33 000 41 000
Botswana 160 000 150 000 170 000 180 000 170 000 190 000
Burkina Faso 84 000 72 000 98 000 55 000 47 000 64 000
Burundi 62 000 52 000 75 000 43 000 36 000 53 000
Cameroon 260 000 240 000 280 000 310 000 290 000 340 000
Cape Verde <1 000 <500 <1 000 <500 <500 <1 000
Central African 
Republic
... ... ... ... ... ...
Chad 97 000 82 000 110 000 100 000 88 000 130 000
Comoros <100 <100 <100 2 300 1 700 3 100
Congo 44 000 40 000 50 000 36 000 32 000 39 000
Côte d'Ivoire 320 000 280 000 360 000 220 000 190 000 260 000
Democratic Republic 
of the Congo
210 000 190 000 240 000 230 000 210 000 260 000
Equatorial Guinea ... 3 300 11 000 ... 8 500 24 000
Eritrea 16 000 11 000 21 000 8 800 7 000 12 000
Ethiopia 700 000 630 000 770 000 380 000 340 000 420 000
Gabon 28 000 24 000 32 000 25 000 22 000 30 000
Gambia 3 900 2 900 5 200 7 600 5 700 10 000
Ghana 140 000 120 000 160 000 120 000 100 000 140 000
Guinea 35 000 29 000 43 000 63 000 52 000 76 000
Guinea-Bissau 11 000 7 800 15 000 21 000 16 000 28 000
Kenya 790 000 750 000 840 000 820 000 790 000 860 000
Lesotho 150 000 140 000 160 000 190 000 180 000 200 000
Liberia 18 000 15 000 21 000 11 000 9 100 13 000
Madagascar 23 000 19 000 28 000 23 000 19 000 27 000
Malawi 530 000 490 000 560 000 560 000 520 000 590 000
Mali 56 000 45 000 70 000 50 000 40 000 62 000
Mauritania 4 800 3 600 6 400 5 000 3 700 7 200
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2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Mauritius 2 000 1 800 2 300 2 800 2 500 3 200
Mozambique 450 000 400 000 520 000 810 000 730 000 930 000
Namibia 93 000 80 000 110 000 120 000 100 000 130 000
Niger 26 000 22 000 32 000 20 000 16 000 25 000
Nigeria 1 400 000 1 200 000 1 600 000 1 700 000 1 500 000 1 900 000
Rwanda 110 000 100 000 130 000 100 000 95 000 120 000
Sao Tome and Principe <500 <500 <1 000 <1 000 <500 <1 000
Senegal 16 000 13 000 19 000 24 000 20 000 29 000
Sierra Leone 15 000 10 000 20 000 31 000 22 000 44 000
South Africa 2 400 000 2 200 000 2 600 000 3 400 000 3 200 000 3 600 000
South Sudan 65 000 29 000 110 000 78 000 51 000 120 000
Swaziland 77 000 71 000 83 000 110 000 100 000 120 000
Togo 69 000 59 000 83 000 65 000 56 000 76 000
Uganda 460 000 410 000 540 000 780 000 690 000 900 000
United Republic of 
Tanzania
740 000 670 000 830 000 730 000 660 000 810 000
Zambia 400 000 370 000 430 000 490 000 460 000 530 000
Zimbabwe 930 000 880 000 1 000 000 700 000 660 000 740 000
western and  
central Europe
140 000 120 000 150 000 210 000 190 000 230 000
Austria ... <1 000 1 500 ... 2 900 5 600
Belgium ... 1 900 3 200 ... 5 100 8 300
Bulgaria ... <500 <500 ... <1 000 1 100
Croatia ... <100 <200 ... <200 <500
Czech Republic ... <200 <500 ... <500 <500
Denmark ... <1 000 1 100 ... 1 400 2 000
Estonia ... 1 000 1 600 ... 2 200 3 400
Finland ... <500 <1 000 ... <1 000 1 100
France ... 29 000 38 000 ... 38 000 59 000
Germany ... 5 800 7 400 ... 10 000 13 000
Greece ... 1 500 1 900 ... 2 200 2 900
ElIMINAtE GENDER INEqUAlItIES AND GENDER-bASED AbUSE AND VIolENcE AND 
INcREASE tHE cAPAcItY oF woMEN AND GIRlS to PRotEct tHEMSElVES FRoM HIV
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ElIMINAtE GENDER INEqUAlItIES AND GENDER-bASED AbUSE AND VIolENcE AND 
INcREASE tHE cAPAcItY oF woMEN AND GIRlS to PRotEct tHEMSElVES FRoM HIV
Number of HIV infected female adults 
2001 2012
estimate lower estimate upper estimate estimate lower estimate upper estimate
Hungary ... <500 <500 ... <500 <500
Iceland ... <100 <200 ... <200 <500
Ireland ... 1 100 1 800 ... 1 900 3 000
Israel ... 1 300 2 200 ... 2 100 3 400
Italy ... 8 600 12 000 ... 11 000 15 000
Latvia ... 1 000 1 800 ... 1 800 3 800
Lithuania ... <100 <100 ... <200 <200
Luxembourg ... <200 <500 ... <500 <500
Malta ... <100 <100 ... <100 <200
Netherlands ... 2 100 3 700 ... 3 000 5 300
Norway ... <1 000 1 300 ... 1 000 1 900
Poland ... 3 300 5 900 ... 5 200 9 500
Portugal ... 7 700 13 000 ... 11 000 19 000
Romania ... 3 500 5 700 ... 4 100 6 200
Serbia ... <100 <1 000 ... <500 1 200
Slovakia ... <100 <100 ... <100 <100
Slovenia ... <100 <100 ... <100 <100
Spain ... 25 000 32 000 ... 31 000 39 000
Sweden ... 1 600 3 000 ... 2 200 4 100
Switzerland ... 3 100 5 100 ... 4 700 8 200
Turkey ... <500 <1 000 ... 1 200 2 400
United Kingdom of 
Great Britain and 
Northern Ireland
... 11 000 17 000 ... 23 000 37 000
GlobAl 13 700 000 12 500 000 15 000 000 16 100 000 14 800 000 17 400 000
1 Estimates for China and India are based on 2011 national estimates. 
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ElIMINAtE HIV-RElAtED REStRIctIoNS oN ENtRY, StAY AND RESIDENcE
HIV-specific restrictions on entry, stay, or residence 
2009 2013
caribbean 
Antigua and Barbuda No No
Barbados No No
Cuba Yes Yes
Dominica No No
Dominican Republic Yes Yes
Grenada No No
Haiti No No
Jamaica No No
Saint Kitts and Nevis No No
Saint Lucia No No
Trinidad and Tobago No No
East Asia
China No No
Democratic People's  
Republic of Korea
Yes Yes
Japan No No
Mongolia Yes No
Republic of Korea Yes No
Eastern Europe and central Asia 
Armenia Yes No
Azerbaijan No No
Belarus Yes Yes
Georgia No No
Kazakhstan No No
Kyrgyzstan No No
Republic of Moldova Yes No
Russian Federation Yes Yes
Tajikistan Yes Yes
Turkmenistan Yes Yes
Ukraine Yes No
Uzbekistan Yes Yes
2009 2013
latin America 
Argentina No No
Belize Yes Yes
Brazil No No
Chile No No
Colombia No No
Costa Rica No No
Ecuador Yes No
El Salvador No No
Guatemala No No
Guyana No No
Mexico No No
Nicaragua Yes Yes
Panama No No
Paraguay Yes Yes
Peru No No
Uruguay No No
Venezuela  
(Bolivarian Republic of)
No No
Middle East and North Africa 
Bahrain Yes Yes
Djibouti No No
Egypt Yes Yes
Iran (Islamic Republic of) No No
Iraq Yes Yes
Jordan Yes Yes
Kuwait Yes Yes
Lebanon Yes Yes
Libya No No
Morocco No No
Oman Yes Yes
Qatar Yes Yes
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2009 2013
latin America 
Argentina No No
Belize Yes Yes
Brazil No No
Chile No No
Colombia No No
Costa Rica No No
Ecuador Yes No
El Salvador No No
Guatemala No No
Guyana No No
Mexico No No
Nicaragua Yes Yes
Panama No No
Paraguay Yes Yes
Peru No No
Uruguay No No
Venezuela  
(Bolivarian Republic of)
No No
Middle East and North Africa 
Bahrain Yes Yes
Djibouti No No
Egypt Yes Yes
Iran (Islamic Republic of) No No
Iraq Yes Yes
Jordan Yes Yes
Kuwait Yes Yes
Lebanon Yes Yes
Libya No No
Morocco No No
Oman Yes Yes
Qatar Yes Yes
ElIMINAtE HIV-RElAtED REStRIctIoNS oN ENtRY, StAY AND RESIDENcE
HIV-specific restrictions on entry, stay, or residence 
2009 2013
Saudi Arabia Yes Yes
Somalia No No
Sudan Yes Yes
Syrian Arab Republic Yes Yes
Tunisia No No
United Arab Emirates Yes Yes
Yemen Yes Yes
North America 
Canada No No
United States of America No No
oceania
Australia Yes Yes
Fiji Yes No
Marshall Islands Yes Yes
Micronesia  
(Federated States of)
No No
New Zealand Yes Yes
Papua New Guinea Yes Yes
Samoa Yes Yes
Solomon Islands Yes Yes
Tonga Yes Yes
Vanuatu No No
South and South-East Asia 
Bangladesh No No
Brunei Darussalam Yes Yes
Cambodia No No
India Yes No
Indonesia No No
Lao People's  
Democratic Republic
No No
Malaysia Yes Yes
Maldives No No
2009 2013
Myanmar No No
Nepal No No
Pakistan No No
Philippines No No
Singapore Yes Yes
Sri Lanka No No
Thailand No No
Viet Nam No No
Sub-Saharan Africa 
Benin No No
Botswana No No
Burkina Faso No No
Burundi No No
Cameroon No No
Central African Republic No No
Chad No No
Comoros Yes Yes
Congo No No
Côte d'Ivoire No No
Democratic Republic  
of the Congo
No No
Ethiopia No No
Gabon No No
Gambia No No
Ghana No No
Guinea No No
Guinea-Bissau No No
Kenya No No
Lesotho No No
Liberia No No
Madagascar No No
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2009 2013
Malawi No No
Mali No No
Mauritania No No
Mauritius Yes Yes
Mozambique No No
Namibia No No
Nigeria No No
Rwanda No No
Senegal No No
Sierra Leone No No
South Africa No No
Swaziland No No
Togo No No
Uganda No No
United Republic of Tanzania No No
Zambia No No
Zimbabwe No No
western and central Europe 
Albania No No
Andorra Yes Yes
Austria No No
Belgium No No
Bosnia and Herzegovina No No
Bulgaria No No
Croatia No No
Cyprus Yes Yes
Czech Republic No No
Denmark No No
Estonia No No
Finland No No
France No No
2009 2013
Greece No No
Hungary No No
Iceland No No
Ireland No No
Israel Yes Yes
Italy No No
Latvia No No
Liechtenstein No No
Lithuania Yes Yes
Luxembourg No No
Malta No No
Monaco No No
Montenegro No No
Netherlands No No
Norway No No
Poland No No
Portugal No No
Romania No No
San Marino No No
Serbia No No
Slovakia Yes Yes
Slovenia No No
Spain No No
Sweden No No
Switzerland No No
The former Yugoslav  
Republic of Macedonia
No No
Turkey No No
United Kingdom of Great 
Britain and Northern Ireland
No No
ElIMINAtE HIV-RElAtED REStRIctIoNS oN ENtRY, StAY AND RESIDENcE
HIV-specific restrictions on entry, stay, or residence 
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2009 2013
Greece No No
Hungary No No
Iceland No No
Ireland No No
Israel Yes Yes
Italy No No
Latvia No No
Liechtenstein No No
Lithuania Yes Yes
Luxembourg No No
Malta No No
Monaco No No
Montenegro No No
Netherlands No No
Norway No No
Poland No No
Portugal No No
Romania No No
San Marino No No
Serbia No No
Slovakia Yes Yes
Slovenia No No
Spain No No
Sweden No No
Switzerland No No
The former Yugoslav  
Republic of Macedonia
No No
Turkey No No
United Kingdom of Great 
Britain and Northern Ireland
No No
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StRENGtHEN HIV INtEGRAtIoN
Health facilities provide HIV services integrated with other health services
ARt and chronic  
non-communicable 
diseases
ARt and general 
outpatient care
ARt and tuberculosis HIV counselling & 
testing and chronic non-
communicable diseases
HIV counselling & 
testing and general 
outpatient care
HIV counselling & 
testing and tuberculosis
HIV counselling & 
testing with sexual & 
reproductive health
PMtct with antenatal 
care/maternal & child 
health
caribbean 
Antigua and Barbuda Few Few Many Few Many Few Few Many
Barbados Few Few Few Many Many Few Many Few
Dominica Few Few Few Many Many Few Many Many
Dominican Republic Few Few Many Many Many Many Few Many
Grenada Few Few Few Few Few Many Many Many
Haiti Few Few Many Few Many Many Many Many
Jamaica Few Few Few Many Many Few Few Few
Saint Lucia Many Many Many Few Few Few Many Many
Trinidad and Tobago None None Few None Few Few None Many
East Asia
Japan Many Many Many Many Many Many Many Many
Mongolia None None Few None None Few Few Few
Eastern Europe and central Asia
Armenia Many Many Many Many Many Many Many Many
Azerbaijan None Few Few None Few Few Few None
Belarus Many Many Many Many Many Many Many Many
Kazakhstan None Many Many Many Many Many Many
Kyrgyzstan None Few Many Many Many Many Many Many
Republic of Moldova Few Few Few Few Many Few Few Many
Tajikistan None Many Many None Few Many Many Many
Uzbekistan Few Few Few Many Many Many Many Few
latin America
Argentina Many Few Many Many Many Few Many Many
Belize None Many Many None Many Many Many Many
Bolivia (Plurinational State of) Few Few Few Few Few Few Many Few
Brazil None None Many Many Many Many Many Many
Chile None None None None Many Many Many Many
Costa Rica None None None None Few Few None None
El Salvador Many Many Many Many Many Many Many Many
Guatemala None Few Few None Many Many Many Many
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ARt and chronic  
non-communicable 
diseases
ARt and general 
outpatient care
ARt and tuberculosis HIV counselling & 
testing and chronic non-
communicable diseases
HIV counselling & 
testing and general 
outpatient care
HIV counselling & 
testing and tuberculosis
HIV counselling & 
testing with sexual & 
reproductive health
PMtct with antenatal 
care/maternal & child 
health
caribbean 
Antigua and Barbuda Few Few Many Few Many Few Few Many
Barbados Few Few Few Many Many Few Many Few
Dominica Few Few Few Many Many Few Many Many
Dominican Republic Few Few Many Many Many Many Few Many
Grenada Few Few Few Few Few Many Many Many
Haiti Few Few Many Few Many Many Many Many
Jamaica Few Few Few Many Many Few Few Few
Saint Lucia Many Many Many Few Few Few Many Many
Trinidad and Tobago None None Few None Few Few None Many
East Asia
Japan Many Many Many Many Many Many Many Many
Mongolia None None Few None None Few Few Few
Eastern Europe and central Asia
Armenia Many Many Many Many Many Many Many Many
Azerbaijan None Few Few None Few Few Few None
Belarus Many Many Many Many Many Many Many Many
Kazakhstan None Many Many Many Many Many Many
Kyrgyzstan None Few Many Many Many Many Many Many
Republic of Moldova Few Few Few Few Many Few Few Many
Tajikistan None Many Many None Few Many Many Many
Uzbekistan Few Few Few Many Many Many Many Few
latin America
Argentina Many Few Many Many Many Few Many Many
Belize None Many Many None Many Many Many Many
Bolivia (Plurinational State of) Few Few Few Few Few Few Many Few
Brazil None None Many Many Many Many Many Many
Chile None None None None Many Many Many Many
Costa Rica None None None None Few Few None None
El Salvador Many Many Many Many Many Many Many Many
Guatemala None Few Few None Many Many Many Many
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ARt and chronic  
non-communicable 
diseases
ARt and general 
outpatient care
ARt and tuberculosis HIV counselling & 
testing and chronic non-
communicable diseases
HIV counselling & 
testing and general 
outpatient care
HIV counselling & 
testing and tuberculosis
HIV counselling & 
testing with sexual & 
reproductive health
PMtct with antenatal 
care/maternal & child 
health
Guyana Few Few Many Few Many Many Many Many
Honduras None None Many None None Many Few Many
Mexico Few Few Many Few Few Many Many Many
Nicaragua Few Few Few Few Few Many Few Many
Panama Few Few Many Few Few Many Few Many
Paraguay None None Few None Few Many Many Many
Peru Few Few Few Few Few Few Few Few
Uruguay None Few Few Few Few Many Many Many
Venezuela (Bolivarian Republic of) Few Few Few None Few Few None Few
Middle East and North Africa
Algeria Many Many Many Many Many Many Many Many
Bahrain None Few Few None Few Few Many Few
Djibouti Many Many Many Many Many Many Many Many
Egypt Few Many Few Few Many Many Many Few
Iraq None None Many Few Few None Many Many
Jordan None None None None None None None None
Libya Few Many None None Few Few Few
Morocco Few Many Many Many
Oman Few Few Many Few Few Many Many Many
Qatar None Many Many Many Many Many Many Many
Saudi Arabia Few Few Many Few Few Many Few Few
Somalia None Few None None Few Many Few Few
Sudan Few None Many None None Many Many Many
Tunisia Many Few Many None Few Many Few Few
United Arab Emirates Many None Many Few Few Few None Many
oceania
Australia Few Many Few Many Many Few Many Many
Fiji Few Few Few None Few Many Many Few
Marshall Islands None Few Few None Few Few Few Few
Micronesia (Federated States of) None None None None None Many Many None
New Zealand Many Many Many Many
Palau Many Many Many Many Many Many Many Many
StRENGtHEN HIV INtEGRAtIoN
Health facilities provide HIV services integrated with other health services
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ARt and chronic  
non-communicable 
diseases
ARt and general 
outpatient care
ARt and tuberculosis HIV counselling & 
testing and chronic non-
communicable diseases
HIV counselling & 
testing and general 
outpatient care
HIV counselling & 
testing and tuberculosis
HIV counselling & 
testing with sexual & 
reproductive health
PMtct with antenatal 
care/maternal & child 
health
Guyana Few Few Many Few Many Many Many Many
Honduras None None Many None None Many Few Many
Mexico Few Few Many Few Few Many Many Many
Nicaragua Few Few Few Few Few Many Few Many
Panama Few Few Many Few Few Many Few Many
Paraguay None None Few None Few Many Many Many
Peru Few Few Few Few Few Few Few Few
Uruguay None Few Few Few Few Many Many Many
Venezuela (Bolivarian Republic of) Few Few Few None Few Few None Few
Middle East and North Africa
Algeria Many Many Many Many Many Many Many Many
Bahrain None Few Few None Few Few Many Few
Djibouti Many Many Many Many Many Many Many Many
Egypt Few Many Few Few Many Many Many Few
Iraq None None Many Few Few None Many Many
Jordan None None None None None None None None
Libya Few Many None None Few Few Few
Morocco Few Many Many Many
Oman Few Few Many Few Few Many Many Many
Qatar None Many Many Many Many Many Many Many
Saudi Arabia Few Few Many Few Few Many Few Few
Somalia None Few None None Few Many Few Few
Sudan Few None Many None None Many Many Many
Tunisia Many Few Many None Few Many Few Few
United Arab Emirates Many None Many Few Few Few None Many
oceania
Australia Few Many Few Many Many Few Many Many
Fiji Few Few Few None Few Many Many Few
Marshall Islands None Few Few None Few Few Few Few
Micronesia (Federated States of) None None None None None Many Many None
New Zealand Many Many Many Many
Palau Many Many Many Many Many Many Many Many
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ARt and chronic  
non-communicable 
diseases
ARt and general 
outpatient care
ARt and tuberculosis HIV counselling & 
testing and chronic non-
communicable diseases
HIV counselling & 
testing and general 
outpatient care
HIV counselling & 
testing and tuberculosis
HIV counselling & 
testing with sexual & 
reproductive health
PMtct with antenatal 
care/maternal & child 
health
Papua New Guinea None None None None None Few Few Few
South and South-East Asia
Bangladesh None None Few None Few Few Few Few
Bhutan Few Many Few None Many Few Many Many
Brunei Darussalam None None Few None Few Few Few Few
Malaysia Many Many Many Many Many Many Many Many
Myanmar Few Few Few Few Few Few Many Many
Nepal Few Few Few Few Few Few Few Few
Pakistan None None Few None Few Few Few Few
Philippines None None Many None Few Many Few Few
Sri Lanka None None Many None None Few Many Few
Thailand None Few Many None Few Many Many Many
Viet Nam None Few Many Few Many Many Few Many
Sub-Saharan Africa
Benin Many Many Many Many Many Many Many Many
Botswana None None Few Few Many Many Many Many
Burundi Few Few Few Few Many Many Many Few
Cameroon Many Many Many None Many Many Many Many
Cape Verde Many Many Many Many Many Many Many Many
Chad Few Few Many Few Few Few Many Many
Comoros Few Few Many Few Many Few Many Many
Democratic Republic of the Congo None Few Few Few Few Few Few Few
Equatorial Guinea Few Many Few Few Few Few Few Many
Eritrea None Few Few None Many Many Few Many
Ethiopia Few Few Few Many Many Many Many Many
Gabon Few Few Few Few Few Few Few Many
Gambia Few Few Many Many Few Many Many Many
Ghana None None Many None Few Many Few Many
Guinea Few Few Many Few Few Many Many Many
Guinea-Bissau None None Many None Few Few Many Many
Kenya Few Many Many Few Many Many Many Many
Lesotho Many Many Many Few Many Many Many Many
StRENGtHEN HIV INtEGRAtIoN
Health facilities provide HIV services integrated with other health services
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ARt and chronic  
non-communicable 
diseases
ARt and general 
outpatient care
ARt and tuberculosis HIV counselling & 
testing and chronic non-
communicable diseases
HIV counselling & 
testing and general 
outpatient care
HIV counselling & 
testing and tuberculosis
HIV counselling & 
testing with sexual & 
reproductive health
PMtct with antenatal 
care/maternal & child 
health
Papua New Guinea None None None None None Few Few Few
South and South-East Asia
Bangladesh None None Few None Few Few Few Few
Bhutan Few Many Few None Many Few Many Many
Brunei Darussalam None None Few None Few Few Few Few
Malaysia Many Many Many Many Many Many Many Many
Myanmar Few Few Few Few Few Few Many Many
Nepal Few Few Few Few Few Few Few Few
Pakistan None None Few None Few Few Few Few
Philippines None None Many None Few Many Few Few
Sri Lanka None None Many None None Few Many Few
Thailand None Few Many None Few Many Many Many
Viet Nam None Few Many Few Many Many Few Many
Sub-Saharan Africa
Benin Many Many Many Many Many Many Many Many
Botswana None None Few Few Many Many Many Many
Burundi Few Few Few Few Many Many Many Few
Cameroon Many Many Many None Many Many Many Many
Cape Verde Many Many Many Many Many Many Many Many
Chad Few Few Many Few Few Few Many Many
Comoros Few Few Many Few Many Few Many Many
Democratic Republic of the Congo None Few Few Few Few Few Few Few
Equatorial Guinea Few Many Few Few Few Few Few Many
Eritrea None Few Few None Many Many Few Many
Ethiopia Few Few Few Many Many Many Many Many
Gabon Few Few Few Few Few Few Few Many
Gambia Few Few Many Many Few Many Many Many
Ghana None None Many None Few Many Few Many
Guinea Few Few Many Few Few Many Many Many
Guinea-Bissau None None Many None Few Few Many Many
Kenya Few Many Many Few Many Many Many Many
Lesotho Many Many Many Few Many Many Many Many
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ARt and chronic  
non-communicable 
diseases
ARt and general 
outpatient care
ARt and tuberculosis HIV counselling & 
testing and chronic non-
communicable diseases
HIV counselling & 
testing and general 
outpatient care
HIV counselling & 
testing and tuberculosis
HIV counselling & 
testing with sexual & 
reproductive health
PMtct with antenatal 
care/maternal & child 
health
Liberia Many Few Many Many Many Many Many Many
Madagascar None Few Few None Many Few Many Many
Malawi None Few Many None Many Many Many Many
Mauritania None Few Few None Few Few Many Few
Mauritius None None Many Few None Many Many Many
Mozambique Few Many Many Few Many Many Many Many
Namibia None None Many Many Many Many Many Many
Niger Few Many Many Few Many Many Many Many
Nigeria Few Few Few Few Few Many Few Few
Rwanda Many Many Many Many Many Many Many Many
Senegal Few Many Many Few Many Many Many Many
Seychelles Few Few Many Few Few Many Many Many
Sierra Leone Many Many Many Few Many Few Many Many
South Africa Few Few Few Few Few Few Few Few
Swaziland Many Many Many Many Many Few Many Many
Togo Few Few Many Few Many Many Many Many
Uganda Many Many Many Many Many Few Many Many
United Republic of Tanzania Few Many Many Few Many Many Many Many
Zambia Many Many Many Many Many Many Many Many
Zimbabwe Few Many Many Few Many Many Many Many
western and central Europe
Ireland Many Many Many Few Many Many Many Many
Lithuania Few Few Few Many Many Few Many Few
Malta None None Many None Many Many Many Many
Montenegro None None None None Few Few Few
Poland Many Many None None Many None Few Many
Romania Many Many Many Many Many Many Many Many
Serbia Many Many Many Few Few Few Few Few
Slovakia None None Few None None Few Few Many
Spain Many Many Many Many Many Many Many Many
United Kingdom of Great Britain  
and Northern Ireland
Few None Few Few None Few Many Many
StRENGtHEN HIV INtEGRAtIoN
Health facilities provide HIV services integrated with other health services
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ARt and chronic  
non-communicable 
diseases
ARt and general 
outpatient care
ARt and tuberculosis HIV counselling & 
testing and chronic non-
communicable diseases
HIV counselling & 
testing and general 
outpatient care
HIV counselling & 
testing and tuberculosis
HIV counselling & 
testing with sexual & 
reproductive health
PMtct with antenatal 
care/maternal & child 
health
Liberia Many Few Many Many Many Many Many Many
Madagascar None Few Few None Many Few Many Many
Malawi None Few Many None Many Many Many Many
Mauritania None Few Few None Few Few Many Few
Mauritius None None Many Few None Many Many Many
Mozambique Few Many Many Few Many Many Many Many
Namibia None None Many Many Many Many Many Many
Niger Few Many Many Few Many Many Many Many
Nigeria Few Few Few Few Few Many Few Few
Rwanda Many Many Many Many Many Many Many Many
Senegal Few Many Many Few Many Many Many Many
Seychelles Few Few Many Few Few Many Many Many
Sierra Leone Many Many Many Few Many Few Many Many
South Africa Few Few Few Few Few Few Few Few
Swaziland Many Many Many Many Many Few Many Many
Togo Few Few Many Few Many Many Many Many
Uganda Many Many Many Many Many Few Many Many
United Republic of Tanzania Few Many Many Few Many Many Many Many
Zambia Many Many Many Many Many Many Many Many
Zimbabwe Few Many Many Few Many Many Many Many
western and central Europe
Ireland Many Many Many Few Many Many Many Many
Lithuania Few Few Few Many Many Few Many Few
Malta None None Many None Many Many Many Many
Montenegro None None None None Few Few Few
Poland Many Many None None Many None Few Many
Romania Many Many Many Many Many Many Many Many
Serbia Many Many Many Few Few Few Few Few
Slovakia None None Few None None Few Few Many
Spain Many Many Many Many Many Many Many Many
United Kingdom of Great Britain  
and Northern Ireland
Few None Few Few None Few Many Many
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orphans Non-orphans
2009 2012 2009 2012
caribbean
Bahamas 100  ... 100  ... 
Cuba 100 100 100 100
Dominican Republic 69 95 97 98
Haiti 77 92 89 96
Saint Kitts and Nevis 100 100 100 100
Saint Lucia 100  ... 72  ... 
East Asia
Mongolia  ... 100  ... 98
latin America
Belize 62 62 ... 95
Costa Rica  ... 95  ... 93
Honduras 59 25 55 84
Peru  ... 89  ... 94
Suriname  ... 86  ... 97
Uruguay  ... 100  ...  ... 
Middle East and North Africa
Iran (Islamic Republic of) 75 75 92 92
Oman  ... 100  ...  ...
Somalia  ... 25  ... 29
Sudan 54 78 67 82
oceania
Papua New Guinea 75  ... 87  ...
Vanuatu  ... 74  ... 83
South and South-East Asia
Cambodia 76 70 92 81
Indonesia 87 87 93 93
Thailand 96  ... 96  ...
Timor-Leste  ... 66  ... 87
StRENGtHEN HIV INtEGRAtIoN
current school attendance among young people aged 10-141   
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StRENGtHEN HIV INtEGRAtIoN
current school attendance among young people aged 10-141   
orphans Non-orphans
2009 2012 2009 2012
Sub-Saharan Africa
Angola 75 71 87 90
Benin 6 63  ... 76
Botswana  ... 98  ...  ...
Burkina Faso 56 61 49 55
Burundi ... 75  ... 91
Cameroon 79  ... 86  ...
Central African Republic 65 70 67 79
Chad 54 67 46 57
Congo 82  ... 93 96
Côte d'Ivoire 36 46 36 71
Democratic Republic  
of the Congo
63 63 81 85
Ethiopia 53 69 59 76
Gabon 81 96 96 98
Gambia  ... 91  ... 94
Ghana 67 67 88 88
Guinea-Bissau ... 78  ... 72
Kenya 64 94 61 98
Lesotho  ... 93  ... 95
Madagascar  ... 60  ... 81
Malawi 89 91 91 93
Mali 42 54 48 62
Mauritania 51  ... 71  ...
Mozambique 79 66 87 79
Namibia 95 94 94 95
Niger 25 25 38 37
Nigeria ... 84 ... 84
Rwanda 75 88 91 96
Sao Tome and Principe  ... 100  ... 90
A148  |  Annex: Strengthen HIV integration
orphans Non-orphans
2009 2012 2009 2012
Senegal  ... 90  ... 94
Seychelles  ... 100  ... 100
Sierra Leone 47 47 76 76
South Africa 98 98 99 99
Swaziland 90 97 93 99
Togo 92 77 96 89
Uganda  ...  ... 82  
United Republic of Tanzania 60 32  ... 62
Zambia 81  ... 88 ... 
Zimbabwe  ... 88  ... 95
western and central Europe
Spain 99  ...  ...  ... 
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1 For the indicator definition, go to http://www.indicatorregistry.org/node/864.
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